hgnc_symbol,hgnc_id,go_name,go_id,go_domain,ncon_gene,ncon_go,mean_padj,cilow_padj,ciupp_padj,mean_pval,cilow_pval,ciupp_pval,mean_sim,sem_sim
AARD,33842,,,,nan,nan,,,,,,,,
ABHD5,21396,phosphatidic acid biosynthetic process,GO:0006654,biological process,15.0,4.0,5.451e-02,2.146e-02,1.385e-01,3.551e-02,1.208e-02,1.044e-01,8.102e-01,2.685e-02
ABHD5,21396,lipid homeostasis,GO:0055088,biological process,15.0,12.0,5.820e-02,1.898e-02,1.785e-01,4.110e-02,1.118e-02,1.511e-01,7.930e-01,3.428e-02
ABHD5,21396,positive regulation of triglyceride catabolic process,GO:0010898,biological process,15.0,5.0,7.914e-02,8.427e-03,7.431e-01,5.137e-02,2.669e-03,9.886e-01,7.430e-01,9.722e-02
ABHD5,21396,negative regulation of sequestering of triglyceride,GO:0010891,biological process,15.0,3.0,1.108e-01,2.080e-02,5.898e-01,9.804e-02,1.737e-02,5.534e-01,6.777e-01,6.170e-02
ABHD5,21396,lipid droplet,GO:0005811,cellular component,15.0,10.0,6.169e-02,3.505e-02,1.086e-01,3.638e-02,1.140e-02,1.161e-01,8.072e-01,2.902e-02
ABHD5,21396,1-acylglycerol-3-phosphate O-acyltransferase activity,GO:0003841,molecular function,15.0,4.0,4.820e-02,1.547e-02,1.502e-01,1.210e-02,4.180e-03,3.502e-02,9.061e-01,1.642e-02
ABHD5,21396,lysophosphatidic acid acyltransferase activity,GO:0042171,molecular function,15.0,5.0,4.820e-02,1.547e-02,1.502e-01,1.337e-02,2.675e-03,6.680e-02,8.926e-01,2.508e-02
ABHD5,21396,carboxylic ester hydrolase activity,GO:0052689,molecular function,15.0,116.0,9.333e-02,2.682e-02,3.248e-01,5.957e-02,8.800e-03,4.033e-01,7.419e-01,6.056e-02
ACACA,84,cytosol,GO:0005829,cellular component,18.0,76.0,5.413e-02,4.496e-02,6.518e-02,3.157e-02,2.063e-02,4.832e-02,8.234e-01,1.052e-02
ACACA,84,actin cytoskeleton,GO:0015629,cellular component,18.0,9.0,5.413e-02,4.496e-02,6.518e-02,4.171e-02,2.372e-02,7.335e-02,7.937e-01,1.471e-02
ACACA,84,fibrillar center,GO:0001650,cellular component,18.0,6.0,6.061e-02,4.511e-02,8.145e-02,5.349e-02,2.917e-02,9.808e-02,7.659e-01,1.668e-02
ACACA,84,acetyl-CoA carboxylase activity,GO:0003989,molecular function,18.0,2.0,5.413e-02,4.496e-02,6.518e-02,2.031e-02,3.419e-03,1.206e-01,8.601e-01,4.116e-02
ACACA,84,identical protein binding,GO:0042802,molecular function,18.0,35.0,5.413e-02,4.496e-02,6.518e-02,2.336e-02,1.709e-02,3.195e-02,8.540e-01,7.658e-03
ACACA,84,protein binding,GO:0005515,molecular function,18.0,347.0,5.413e-02,4.496e-02,6.518e-02,3.739e-02,2.269e-02,6.163e-02,8.056e-01,1.272e-02
ACADM,89,medium-chain fatty acid catabolic process,GO:0051793,biological process,32.0,3.0,2.070e-02,1.174e-02,3.651e-02,5.409e-03,1.659e-03,1.763e-02,9.473e-01,1.183e-02
ACADM,89,fatty acid beta-oxidation using acyl-CoA dehydrogenase,GO:0033539,biological process,32.0,2.0,2.070e-02,1.174e-02,3.651e-02,6.119e-03,1.879e-03,1.992e-02,9.425e-01,1.129e-02
ACADM,89,fatty acid beta-oxidation,GO:0006635,biological process,32.0,9.0,2.130e-02,1.144e-02,3.965e-02,7.212e-03,2.109e-03,2.467e-02,9.345e-01,1.442e-02
ACADM,89,"carnitine metabolic process, CoA-linked",GO:0019254,biological process,32.0,2.0,2.416e-02,1.803e-02,3.239e-02,1.132e-02,5.349e-03,2.396e-02,9.134e-01,1.040e-02
ACADM,89,medium-chain fatty acid metabolic process,GO:0051791,biological process,32.0,5.0,2.576e-02,1.541e-02,4.305e-02,1.456e-02,6.324e-03,3.354e-02,8.943e-01,1.556e-02
ACADM,89,oxidation-reduction process,GO:0055114,biological process,32.0,42.0,2.619e-02,9.898e-03,6.929e-02,1.616e-02,2.055e-03,1.271e-01,8.721e-01,3.505e-02
ACADM,89,carnitine biosynthetic process,GO:0045329,biological process,32.0,3.0,2.689e-02,2.279e-02,3.171e-02,1.691e-02,6.295e-03,4.543e-02,8.811e-01,2.027e-02
ACADM,89,mitochondrion,GO:0005739,cellular component,32.0,35.0,2.357e-02,1.628e-02,3.413e-02,8.698e-03,7.018e-03,1.078e-02,9.302e-01,2.659e-03
ACADM,89,mitochondrial matrix,GO:0005759,cellular component,32.0,6.0,2.357e-02,1.628e-02,3.413e-02,1.102e-02,9.746e-03,1.246e-02,9.173e-01,1.737e-03
ACADM,89,nucleus,GO:0005634,cellular component,32.0,81.0,2.962e-02,2.186e-02,4.015e-02,2.249e-02,1.709e-02,2.960e-02,8.579e-01,6.729e-03
ACADM,89,mitochondrial membrane,GO:0031966,cellular component,32.0,4.0,3.049e-02,2.097e-02,4.432e-02,2.427e-02,1.429e-02,4.122e-02,8.501e-01,1.281e-02
ACADM,89,axon,GO:0030424,cellular component,32.0,9.0,3.118e-02,2.528e-02,3.847e-02,2.685e-02,2.062e-02,3.496e-02,8.400e-01,6.449e-03
ACADM,89,medium-chain-acyl-CoA dehydrogenase activity,GO:0070991,molecular function,32.0,2.0,2.070e-02,1.174e-02,3.651e-02,5.156e-03,1.907e-03,1.394e-02,9.500e-01,7.498e-03
ACADM,89,acyl-CoA dehydrogenase activity,GO:0003995,molecular function,32.0,8.0,2.965e-02,1.605e-02,5.477e-02,2.527e-02,9.048e-03,7.060e-02,8.443e-01,2.373e-02
ACADM,89,identical protein binding,GO:0042802,molecular function,32.0,35.0,3.101e-02,2.119e-02,4.538e-02,2.723e-02,1.648e-02,4.500e-02,8.386e-01,1.235e-02
ACAT2,94,fatty acid beta-oxidation,GO:0006635,biological process,27.0,9.0,3.253e-02,2.486e-02,4.257e-02,1.086e-02,7.661e-03,1.540e-02,9.176e-01,5.035e-03
ACAT2,94,mitochondrion,GO:0005739,cellular component,27.0,35.0,3.253e-02,2.486e-02,4.257e-02,1.368e-02,8.967e-03,2.086e-02,9.020e-01,7.205e-03
ACAT2,94,nucleolus,GO:0005730,cellular component,27.0,18.0,3.665e-02,3.141e-02,4.276e-02,2.555e-02,1.931e-02,3.379e-02,8.451e-01,6.867e-03
ACAT2,94,cytosol,GO:0005829,cellular component,27.0,76.0,3.665e-02,3.141e-02,4.276e-02,2.644e-02,2.406e-02,2.906e-02,8.414e-01,2.261e-03
ACAT2,94,nucleoplasm,GO:0005654,cellular component,27.0,51.0,3.665e-02,3.141e-02,4.276e-02,3.107e-02,2.491e-02,3.876e-02,8.251e-01,5.468e-03
ACAT2,94,extracellular exosome,GO:0070062,cellular component,27.0,77.0,3.665e-02,3.141e-02,4.276e-02,3.239e-02,2.506e-02,4.185e-02,8.208e-01,6.260e-03
ACAT2,94,cytoplasm,GO:0005737,cellular component,27.0,78.0,3.665e-02,3.141e-02,4.276e-02,3.367e-02,2.581e-02,4.392e-02,8.169e-01,6.604e-03
ACAT2,94,acetyl-CoA C-acetyltransferase activity,GO:0003985,molecular function,27.0,3.0,2.787e-02,1.676e-02,4.634e-02,5.106e-03,1.067e-03,2.444e-02,9.470e-01,1.251e-02
ACAT2,94,acetyl-CoA C-acyltransferase activity,GO:0003988,molecular function,27.0,3.0,2.928e-02,2.018e-02,4.251e-02,8.580e-03,3.064e-03,2.403e-02,9.275e-01,1.255e-02
ACAT2,94,protein binding,GO:0005515,molecular function,27.0,347.0,3.746e-02,3.358e-02,4.179e-02,3.746e-02,3.358e-02,4.179e-02,8.059e-01,2.788e-03
ACKR2,1565,,,,nan,nan,,,,,,,,
ACLY,115,oxaloacetate metabolic process,GO:0006107,biological process,38.0,6.0,2.913e-02,2.663e-02,3.186e-02,9.878e-03,2.623e-03,3.719e-02,9.162e-01,1.922e-02
ACLY,115,acetyl-CoA biosynthetic process,GO:0006085,biological process,38.0,8.0,2.966e-02,2.572e-02,3.420e-02,1.212e-02,8.198e-03,1.792e-02,9.106e-01,5.802e-03
ACLY,115,citrate metabolic process,GO:0006101,biological process,38.0,4.0,2.966e-02,2.572e-02,3.420e-02,1.593e-02,1.358e-02,1.870e-02,8.909e-01,3.319e-03
ACLY,115,lipid biosynthetic process,GO:0008610,biological process,38.0,20.0,3.045e-02,2.597e-02,3.569e-02,1.652e-02,7.170e-03,3.806e-02,8.845e-01,1.803e-02
ACLY,115,fatty acid biosynthetic process,GO:0006633,biological process,38.0,16.0,3.128e-02,2.518e-02,3.885e-02,2.418e-02,1.465e-02,3.990e-02,8.506e-01,1.216e-02
ACLY,115,membrane,GO:0016020,cellular component,38.0,58.0,2.966e-02,2.572e-02,3.420e-02,1.996e-02,1.862e-02,2.140e-02,8.702e-01,1.588e-03
ACLY,115,cytosol,GO:0005829,cellular component,38.0,76.0,2.966e-02,2.572e-02,3.420e-02,2.045e-02,1.677e-02,2.493e-02,8.677e-01,4.703e-03
ACLY,115,extracellular exosome,GO:0070062,cellular component,38.0,77.0,2.966e-02,2.572e-02,3.420e-02,2.109e-02,1.479e-02,3.007e-02,8.643e-01,8.609e-03
ACLY,115,nucleoplasm,GO:0005654,cellular component,38.0,51.0,3.299e-02,2.671e-02,4.074e-02,2.578e-02,1.448e-02,4.590e-02,8.441e-01,1.400e-02
ACLY,115,plasma membrane,GO:0005886,cellular component,38.0,61.0,3.478e-02,2.981e-02,4.059e-02,3.180e-02,2.362e-02,4.281e-02,8.227e-01,7.329e-03
ACLY,115,ATP citrate synthase activity,GO:0003878,molecular function,38.0,2.0,2.913e-02,2.663e-02,3.186e-02,5.381e-03,3.135e-03,9.239e-03,9.500e-01,4.554e-03
ACLY,115,protein binding,GO:0005515,molecular function,38.0,347.0,3.503e-02,2.847e-02,4.310e-02,3.236e-02,2.058e-02,5.087e-02,8.208e-01,1.106e-02
ACOXL,25621,,,,nan,nan,,,,,,,,
ACSS2,15814,lipid biosynthetic process,GO:0008610,biological process,37.0,20.0,3.216e-02,1.503e-02,6.884e-02,1.886e-02,5.314e-03,6.694e-02,8.710e-01,2.899e-02
ACSS2,15814,intracellular membrane-bounded organelle,GO:0043231,cellular component,37.0,48.0,2.657e-02,2.122e-02,3.328e-02,1.851e-02,1.205e-02,2.843e-02,8.767e-01,9.626e-03
ACSS2,15814,cytosol,GO:0005829,cellular component,37.0,76.0,2.657e-02,2.122e-02,3.328e-02,1.946e-02,1.420e-02,2.666e-02,8.725e-01,7.391e-03
ACSS2,15814,nucleoplasm,GO:0005654,cellular component,37.0,51.0,2.688e-02,2.091e-02,3.454e-02,2.263e-02,1.275e-02,4.017e-02,8.571e-01,1.371e-02
ACSS2,15814,acetate-CoA ligase activity,GO:0003987,molecular function,37.0,3.0,3.668e-02,1.109e-02,1.214e-01,1.565e-02,1.108e-03,2.208e-01,8.687e-01,5.724e-02
ACSS3,24723,mitochondrial matrix,GO:0005759,cellular component,24.0,6.0,8.306e-03,6.512e-03,1.059e-02,4.153e-03,3.256e-03,5.297e-03,9.590e-01,1.846e-03
ACSS3,24723,propionate-CoA ligase activity,GO:0050218,molecular function,24.0,3.0,2.252e-02,1.662e-03,3.051e-01,2.252e-02,1.662e-03,3.051e-01,8.407e-01,6.481e-02
ACTR3B,17256,extracellular exosome,GO:0070062,cellular component,3.0,77.0,2.603e-02,8.179e-03,8.286e-02,2.250e-02,8.382e-03,6.040e-02,8.562e-01,2.320e-02
ACTR3B,17256,actin filament binding,GO:0051015,molecular function,3.0,6.0,2.346e-02,6.359e-03,8.657e-02,1.862e-02,2.942e-03,1.179e-01,8.659e-01,3.941e-02
ACYP2,180,identical protein binding,GO:0042802,molecular function,8.0,35.0,5.059e-02,4.492e-02,5.698e-02,2.303e-02,1.240e-02,4.277e-02,8.549e-01,1.477e-02
ACYP2,180,protein binding,GO:0005515,molecular function,8.0,347.0,5.059e-02,4.492e-02,5.698e-02,3.808e-02,2.334e-02,6.214e-02,8.036e-01,1.255e-02
ACYP2,180,acylphosphatase activity,GO:0003998,molecular function,8.0,2.0,6.003e-02,3.317e-02,1.086e-01,6.003e-02,3.317e-02,1.086e-01,7.523e-01,1.725e-02
ADAL,31853,,,,nan,nan,,,,,,,,
ADAM12,190,positive regulation of angiogenesis,GO:0045766,biological process,7.0,12.0,8.360e-02,7.092e-02,9.854e-02,3.838e-02,1.313e-02,1.122e-01,8.010e-01,2.840e-02
ADAM12,190,plasma membrane,GO:0005886,cellular component,7.0,61.0,8.360e-02,7.092e-02,9.854e-02,7.421e-02,5.087e-02,1.083e-01,7.272e-01,1.154e-02
ADAM12,190,nucleoplasm,GO:0005654,cellular component,7.0,51.0,8.360e-02,7.092e-02,9.854e-02,7.727e-02,6.242e-02,9.565e-02,7.224e-01,6.490e-03
ADAM12,190,SH3 domain binding,GO:0017124,molecular function,7.0,2.0,8.360e-02,7.092e-02,9.854e-02,7.426e-02,4.703e-02,1.172e-01,7.268e-01,1.365e-02
ADAM9,216,,,,nan,nan,,,,,,,,
ADAMTS1,217,positive regulation of vascular smooth muscle cell proliferation,GO:1904707,biological process,5.0,3.0,9.699e-02,5.307e-02,1.773e-01,3.790e-02,3.232e-02,4.444e-02,8.046e-01,4.003e-03
ADAMTS1,217,positive regulation of G1/S transition of mitotic cell cycle,GO:1900087,biological process,5.0,7.0,1.262e-01,6.718e-02,2.370e-01,9.744e-02,3.254e-02,2.918e-01,6.867e-01,3.634e-02
ADAMTS1,217,positive regulation of vascular associated smooth muscle cell migration,GO:1904754,biological process,5.0,4.0,1.589e-01,4.481e-02,5.634e-01,1.261e-01,1.623e-02,9.797e-01,6.361e-01,6.901e-02
ADAMTS1,217,collagen-containing extracellular matrix,GO:0062023,cellular component,5.0,36.0,1.104e-01,7.215e-02,1.689e-01,7.328e-02,5.830e-02,9.211e-02,7.291e-01,6.996e-03
ADAMTS3,219,protein processing,GO:0016485,biological process,9.0,19.0,7.362e-02,5.000e-02,1.084e-01,2.381e-02,5.473e-03,1.036e-01,8.480e-01,3.486e-02
ADAMTS3,219,positive regulation of vascular endothelial growth factor signaling pathway,GO:1900748,biological process,9.0,4.0,1.004e-01,2.998e-02,3.359e-01,4.585e-02,3.847e-03,5.466e-01,7.681e-01,7.250e-02
ADAMTS3,219,collagen biosynthetic process,GO:0032964,biological process,9.0,3.0,1.133e-01,5.809e-02,2.211e-01,8.864e-02,3.690e-02,2.129e-01,7.013e-01,2.931e-02
ADAMTS3,219,vascular endothelial growth factor production,GO:0010573,biological process,9.0,2.0,1.505e-01,3.089e-02,7.330e-01,1.262e-01,1.927e-02,8.258e-01,6.337e-01,7.878e-02
ADAMTS3,219,extracellular space,GO:0005615,cellular component,9.0,43.0,6.788e-02,5.089e-02,9.054e-02,2.246e-02,1.326e-02,3.805e-02,8.580e-01,1.267e-02
ADAMTS3,219,extracellular exosome,GO:0070062,cellular component,9.0,77.0,9.163e-02,7.594e-02,1.106e-01,5.205e-02,3.490e-02,7.764e-02,7.696e-01,1.076e-02
ADAMTS3,219,endopeptidase activity,GO:0004175,molecular function,9.0,11.0,6.788e-02,5.089e-02,9.054e-02,1.936e-02,9.660e-03,3.879e-02,8.709e-01,1.501e-02
ADAMTS3,219,protein binding,GO:0005515,molecular function,9.0,347.0,1.675e-01,1.497e-01,1.874e-01,1.522e-01,1.120e-01,2.068e-01,6.243e-01,1.176e-02
ADAMTS9,13202,,,,nan,nan,,,,,,,,
ADAMTSL2,14631,negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030512,biological process,3.0,7.0,8.572e-02,2.174e-02,3.380e-01,5.400e-02,6.379e-03,4.571e-01,7.516e-01,6.618e-02
ADAMTSL2,14631,protein binding,GO:0005515,molecular function,3.0,347.0,1.821e-01,1.682e-01,1.971e-01,1.737e-01,1.509e-01,2.000e-01,6.029e-01,5.705e-03
ADCYAP1R1,242,intracellular membrane-bounded organelle,GO:0043231,cellular component,17.0,48.0,1.444e-01,8.087e-02,2.578e-01,5.290e-02,3.351e-02,8.350e-02,7.677e-01,1.271e-02
ADCYAP1R1,242,receptor complex,GO:0043235,cellular component,17.0,29.0,1.444e-01,8.087e-02,2.578e-01,6.246e-02,1.032e-02,3.779e-01,7.403e-01,4.992e-02
ADCYAP1R1,242,neuron projection,GO:0043005,cellular component,17.0,22.0,1.747e-01,6.973e-02,4.376e-01,1.531e-01,5.977e-02,3.920e-01,6.194e-01,3.678e-02
ADCYAP1R1,242,protein binding,GO:0005515,molecular function,17.0,347.0,1.507e-01,8.679e-02,2.617e-01,7.567e-02,3.568e-02,1.604e-01,7.228e-01,2.327e-02
ADCYAP1R1,242,peptide hormone binding,GO:0017046,molecular function,17.0,12.0,1.548e-01,8.901e-02,2.693e-01,1.012e-01,4.328e-02,2.364e-01,6.832e-01,2.767e-02
ADCYAP1R1,242,G protein-coupled peptide receptor activity,GO:0008528,molecular function,17.0,28.0,2.777e-01,4.472e-02,1.724e+00,2.760e-01,4.398e-02,1.732e+00,4.619e-01,1.257e-01
ADGRD1,19893,,,,nan,nan,,,,,,,,
ADORA1,262,plasma membrane,GO:0005886,cellular component,14.0,61.0,2.838e-02,1.979e-02,4.068e-02,2.052e-02,1.640e-02,2.566e-02,8.672e-01,5.485e-03
ADORA1,262,protein binding,GO:0005515,molecular function,14.0,347.0,2.838e-02,1.979e-02,4.068e-02,2.838e-02,1.979e-02,4.068e-02,8.343e-01,8.794e-03
ADRA1B,278,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,GO:0001994,biological process,29.0,2.0,1.186e-01,3.448e-02,4.081e-01,2.092e-02,5.103e-03,8.575e-02,8.600e-01,3.145e-02
ADRA1B,278,phospholipase C-activating G protein-coupled receptor signaling pathway,GO:0007200,biological process,29.0,10.0,1.209e-01,3.393e-02,4.306e-01,2.870e-02,3.438e-03,2.396e-01,8.224e-01,4.786e-02
ADRA1B,278,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,GO:0007188,biological process,29.0,5.0,1.209e-01,3.393e-02,4.306e-01,3.401e-02,4.120e-03,2.807e-01,8.060e-01,4.905e-02
ADRA1B,278,adenylate cyclase-activating adrenergic receptor signaling pathway,GO:0071880,biological process,29.0,4.0,1.209e-01,3.393e-02,4.306e-01,4.251e-02,4.553e-03,3.969e-01,7.815e-01,5.480e-02
ADRA1B,278,positive regulation of vasoconstriction,GO:0045907,biological process,29.0,4.0,1.650e-01,3.503e-02,7.769e-01,5.428e-02,2.416e-03,1.219e+00,7.314e-01,1.060e-01
ADRA1B,278,positive regulation of MAPK cascade,GO:0043410,biological process,29.0,13.0,1.701e-01,1.471e-01,1.967e-01,4.595e-02,1.922e-02,1.098e-01,7.823e-01,2.248e-02
ADRA1B,278,positive regulation of smooth muscle contraction,GO:0045987,biological process,29.0,8.0,1.934e-01,5.425e-02,6.898e-01,6.564e-02,3.165e-03,1.361e+00,7.051e-01,1.100e-01
ADRA1B,278,positive regulation of cytosolic calcium ion concentration,GO:0007204,biological process,29.0,11.0,2.197e-01,1.248e-01,3.868e-01,1.362e-01,3.978e-02,4.664e-01,6.354e-01,4.430e-02
ADRA1B,278,glucose homeostasis,GO:0042593,biological process,29.0,5.0,2.445e-01,1.738e-01,3.439e-01,1.607e-01,1.132e-01,2.283e-01,6.152e-01,1.380e-02
ADRA1B,278,behavior,GO:0007610,biological process,29.0,28.0,2.955e-01,5.032e-02,1.735e+00,1.811e-01,1.286e-02,2.551e+00,5.185e-01,1.570e-01
ADRA1B,278,cell-cell signaling,GO:0007267,biological process,29.0,35.0,3.353e-01,1.026e-01,1.096e+00,2.642e-01,3.929e-02,1.777e+00,4.943e-01,8.761e-02
ADRA1B,278,integral component of plasma membrane,GO:0005887,cellular component,29.0,28.0,2.024e-01,1.374e-01,2.980e-01,6.472e-02,8.689e-03,4.821e-01,7.337e-01,5.600e-02
ADRA1B,278,plasma membrane,GO:0005886,cellular component,29.0,61.0,2.167e-01,1.240e-01,3.787e-01,1.218e-01,3.712e-02,3.997e-01,6.533e-01,4.137e-02
ADRA1B,278,nucleus,GO:0005634,cellular component,29.0,81.0,2.409e-01,1.268e-01,4.577e-01,1.789e-01,5.409e-02,5.919e-01,5.897e-01,4.761e-02
ADRA1B,278,nuclear membrane,GO:0031965,cellular component,29.0,6.0,2.434e-01,1.595e-01,3.715e-01,1.605e-01,6.289e-02,4.095e-01,6.116e-01,3.675e-02
ADRA1B,278,cytoplasm,GO:0005737,cellular component,29.0,78.0,2.477e-01,1.318e-01,4.656e-01,2.031e-01,8.304e-02,4.968e-01,5.702e-01,3.733e-02
ADRA1B,278,protein heterodimerization activity,GO:0046982,molecular function,29.0,8.0,2.024e-01,1.374e-01,2.980e-01,1.106e-01,9.226e-02,1.326e-01,6.734e-01,6.476e-03
ADRA1B,278,protein binding,GO:0005515,molecular function,29.0,347.0,2.189e-01,1.257e-01,3.812e-01,1.506e-01,7.000e-02,3.241e-01,6.238e-01,2.898e-02
ADRA1B,278,alpha1-adrenergic receptor activity,GO:0004937,molecular function,29.0,2.0,2.246e-01,1.221e-01,4.132e-01,1.389e-01,3.716e-02,5.188e-01,6.316e-01,4.681e-02
ADRA1B,278,adrenergic receptor activity,GO:0004935,molecular function,29.0,4.0,2.756e-01,1.701e-01,4.465e-01,2.275e-01,9.527e-02,5.433e-01,5.487e-01,3.822e-02
AGFG2,5177,,,,nan,nan,,,,,,,,
AGL,321,glycogen catabolic process,GO:0005980,biological process,18.0,6.0,5.137e-02,2.273e-02,1.161e-01,2.198e-02,2.362e-03,2.045e-01,8.485e-01,5.439e-02
AGL,321,cytoplasm,GO:0005737,cellular component,18.0,78.0,4.633e-02,3.098e-02,6.929e-02,4.167e-02,2.815e-02,6.171e-02,7.942e-01,1.009e-02
AGL,321,"amylo-alpha-1,6-glucosidase activity",GO:0004135,molecular function,18.0,3.0,4.451e-02,3.082e-02,6.429e-02,2.233e-02,8.002e-03,6.229e-02,8.575e-01,2.473e-02
AGL,321,4-alpha-glucanotransferase activity,GO:0004134,molecular function,18.0,3.0,4.633e-02,3.098e-02,6.929e-02,3.149e-02,2.026e-02,4.894e-02,8.237e-01,1.082e-02
AGL,321,protein binding,GO:0005515,molecular function,18.0,347.0,4.633e-02,3.098e-02,6.929e-02,3.185e-02,1.418e-02,7.155e-02,8.218e-01,2.044e-02
AGT,333,positive regulation of peptidyl-tyrosine phosphorylation,GO:0050731,biological process,61.0,8.0,7.954e-02,6.580e-02,9.615e-02,1.420e-02,6.542e-03,3.084e-02,8.966e-01,1.444e-02
AGT,333,positive regulation of phosphatidylinositol 3-kinase signaling,GO:0014068,biological process,61.0,5.0,7.954e-02,6.580e-02,9.615e-02,1.767e-02,8.014e-03,3.895e-02,8.784e-01,1.625e-02
AGT,333,positive regulation of activation of Janus kinase activity,GO:0010536,biological process,61.0,5.0,7.954e-02,6.580e-02,9.615e-02,2.579e-02,1.436e-02,4.630e-02,8.439e-01,1.427e-02
AGT,333,positive regulation of endothelial cell migration,GO:0010595,biological process,61.0,6.0,7.954e-02,6.580e-02,9.615e-02,2.759e-02,2.177e-02,3.496e-02,8.372e-01,5.756e-03
AGT,333,positive regulation of protein tyrosine kinase activity,GO:0061098,biological process,61.0,7.0,7.972e-02,6.555e-02,9.695e-02,2.563e-02,1.051e-02,6.253e-02,8.439e-01,2.116e-02
AGT,333,negative regulation of neurotrophin TRK receptor signaling pathway,GO:0051387,biological process,61.0,4.0,8.195e-02,7.105e-02,9.452e-02,3.492e-02,9.676e-03,1.260e-01,8.111e-01,3.173e-02
AGT,333,G protein-coupled receptor signaling pathway,GO:0007186,biological process,61.0,43.0,8.291e-02,6.451e-02,1.066e-01,2.937e-02,1.289e-02,6.693e-02,8.306e-01,2.034e-02
AGT,333,positive regulation of branching involved in ureteric bud morphogenesis,GO:0090190,biological process,61.0,5.0,8.291e-02,6.451e-02,1.066e-01,3.191e-02,1.355e-02,7.511e-02,8.218e-01,2.153e-02
AGT,333,regulation of cardiac conduction,GO:1903779,biological process,61.0,11.0,8.528e-02,6.346e-02,1.146e-01,5.219e-02,2.055e-02,1.325e-01,7.675e-01,2.499e-02
AGT,333,regulation of extracellular matrix assembly,GO:1901201,biological process,61.0,6.0,8.624e-02,6.306e-02,1.179e-01,5.211e-02,2.210e-02,1.229e-01,7.679e-01,2.314e-02
AGT,333,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,61.0,35.0,8.785e-02,5.957e-02,1.296e-01,5.016e-02,1.660e-02,1.515e-01,7.712e-01,3.084e-02
AGT,333,positive regulation of epidermal growth factor receptor signaling pathway,GO:0045742,biological process,61.0,7.0,9.137e-02,6.255e-02,1.335e-01,6.373e-02,2.991e-02,1.358e-01,7.444e-01,2.265e-02
AGT,333,positive regulation of gap junction assembly,GO:1903598,biological process,61.0,3.0,9.206e-02,8.587e-02,9.869e-02,6.133e-02,3.823e-02,9.841e-02,7.503e-01,1.338e-02
AGT,333,negative regulation of endopeptidase activity,GO:0010951,biological process,61.0,9.0,9.434e-02,6.260e-02,1.422e-01,3.968e-02,6.226e-03,2.529e-01,7.922e-01,5.112e-02
AGT,333,positive regulation of cellular protein metabolic process,GO:0032270,biological process,61.0,9.0,1.019e-01,8.972e-02,1.157e-01,8.339e-02,6.563e-02,1.060e-01,7.126e-01,7.394e-03
AGT,333,regulation of blood pressure,GO:0008217,biological process,61.0,8.0,1.030e-01,5.047e-02,2.102e-01,7.796e-02,2.688e-02,2.261e-01,7.170e-01,3.381e-02
AGT,333,positive regulation of extrinsic apoptotic signaling pathway,GO:2001238,biological process,61.0,5.0,1.043e-01,6.496e-02,1.676e-01,5.258e-02,4.745e-03,5.826e-01,7.550e-01,6.313e-02
AGT,333,renal system process,GO:0003014,biological process,61.0,14.0,1.087e-01,4.247e-02,2.780e-01,7.444e-02,1.529e-02,3.624e-01,7.176e-01,5.232e-02
AGT,333,kidney development,GO:0001822,biological process,61.0,5.0,1.158e-01,5.510e-02,2.435e-01,9.495e-02,2.776e-02,3.247e-01,6.893e-01,3.877e-02
AGT,333,positive regulation of cholesterol esterification,GO:0010873,biological process,61.0,4.0,1.382e-01,1.063e-01,1.797e-01,1.318e-01,9.272e-02,1.873e-01,6.468e-01,1.284e-02
AGT,333,extracellular space,GO:0005615,cellular component,61.0,43.0,7.954e-02,6.580e-02,9.615e-02,2.917e-02,2.463e-02,3.454e-02,8.316e-01,4.165e-03
AGT,333,collagen-containing extracellular matrix,GO:0062023,cellular component,61.0,36.0,8.431e-02,6.726e-02,1.057e-01,4.022e-02,3.173e-02,5.098e-02,7.984e-01,5.974e-03
AGT,333,extracellular exosome,GO:0070062,cellular component,61.0,77.0,9.535e-02,8.703e-02,1.045e-01,6.517e-02,4.587e-02,9.259e-02,7.432e-01,1.017e-02
AGT,333,blood microparticle,GO:0072562,cellular component,61.0,8.0,9.535e-02,8.703e-02,1.045e-01,6.721e-02,4.855e-02,9.306e-02,7.396e-01,9.578e-03
AGT,333,extracellular region,GO:0005576,cellular component,61.0,17.0,1.025e-01,8.409e-02,1.249e-01,8.291e-02,5.629e-02,1.221e-01,7.130e-01,1.202e-02
AGT,333,type 1 angiotensin receptor binding,GO:0031702,molecular function,61.0,2.0,7.954e-02,6.580e-02,9.615e-02,2.134e-02,1.185e-02,3.841e-02,8.631e-01,1.421e-02
AGT,333,type 2 angiotensin receptor binding,GO:0031703,molecular function,61.0,2.0,7.954e-02,6.580e-02,9.615e-02,2.203e-02,1.083e-02,4.480e-02,8.597e-01,1.723e-02
AGT,333,serine-type endopeptidase inhibitor activity,GO:0004867,molecular function,61.0,2.0,8.083e-02,7.023e-02,9.303e-02,2.673e-02,9.721e-03,7.352e-02,8.397e-01,2.523e-02
AGT,333,protein binding,GO:0005515,molecular function,61.0,347.0,1.214e-01,7.441e-02,1.981e-01,1.063e-01,4.655e-02,2.429e-01,6.764e-01,2.760e-02
AHCYL2,22204,S-adenosylmethionine cycle,GO:0033353,biological process,14.0,3.0,3.499e-02,1.561e-02,7.843e-02,3.172e-02,1.269e-02,7.927e-02,8.219e-01,2.325e-02
AHCYL2,22204,cytosol,GO:0005829,cellular component,14.0,76.0,2.783e-02,1.901e-02,4.076e-02,1.729e-02,1.492e-02,2.003e-02,8.839e-01,3.217e-03
AHCYL2,22204,protein binding,GO:0005515,molecular function,14.0,347.0,2.783e-02,1.901e-02,4.076e-02,2.129e-02,7.505e-03,6.039e-02,8.601e-01,2.303e-02
AK3,17376,ITP metabolic process,GO:0046041,biological process,16.0,5.0,5.347e-02,3.024e-02,9.456e-02,2.348e-02,1.874e-02,2.942e-02,8.538e-01,5.601e-03
AK3,17376,GTP metabolic process,GO:0046039,biological process,16.0,5.0,5.347e-02,3.024e-02,9.456e-02,2.651e-02,2.056e-02,3.419e-02,8.413e-01,6.172e-03
AK3,17376,UTP metabolic process,GO:0046051,biological process,16.0,5.0,5.347e-02,3.024e-02,9.456e-02,2.890e-02,2.302e-02,3.628e-02,8.325e-01,5.598e-03
AK3,17376,AMP metabolic process,GO:0046033,biological process,16.0,8.0,6.454e-02,3.223e-02,1.293e-01,4.627e-02,1.624e-02,1.318e-01,7.808e-01,2.731e-02
AK3,17376,mitochondrion,GO:0005739,cellular component,16.0,35.0,5.668e-02,3.548e-02,9.055e-02,4.134e-02,1.462e-02,1.169e-01,7.937e-01,2.674e-02
AK3,17376,nucleoside triphosphate adenylate kinase activity,GO:0046899,molecular function,16.0,3.0,7.521e-02,2.501e-02,2.262e-01,4.858e-02,6.739e-03,3.502e-01,7.683e-01,5.567e-02
AK3,17376,protein binding,GO:0005515,molecular function,16.0,347.0,7.689e-02,3.735e-02,1.583e-01,7.304e-02,3.598e-02,1.483e-01,7.278e-01,2.161e-02
AKIRIN1,25744,,,,nan,nan,,,,,,,,
ALAS1,396,mitochondrion,GO:0005739,cellular component,24.0,35.0,1.320e-02,8.348e-03,2.086e-02,3.666e-03,7.604e-04,1.768e-02,9.573e-01,1.233e-02
ALAS1,396,nucleoplasm,GO:0005654,cellular component,24.0,51.0,1.567e-02,1.239e-02,1.981e-02,8.913e-03,4.542e-03,1.749e-02,9.275e-01,8.813e-03
ALAS1,396,cytosol,GO:0005829,cellular component,24.0,76.0,1.567e-02,1.239e-02,1.981e-02,1.012e-02,6.315e-03,1.620e-02,9.213e-01,6.459e-03
ALAS1,396,identical protein binding,GO:0042802,molecular function,24.0,35.0,1.769e-02,1.062e-02,2.948e-02,1.341e-02,7.436e-03,2.418e-02,9.023e-01,1.110e-02
ALAS1,396,protein binding,GO:0005515,molecular function,24.0,347.0,1.997e-02,1.252e-02,3.185e-02,1.997e-02,1.252e-02,3.185e-02,8.695e-01,1.112e-02
ALDH1A1,402,oxidation-reduction process,GO:0055114,biological process,21.0,42.0,3.160e-02,2.154e-02,4.636e-02,2.686e-02,1.390e-02,5.192e-02,8.400e-01,1.627e-02
ALDH1A1,402,extracellular exosome,GO:0070062,cellular component,21.0,77.0,3.004e-02,2.431e-02,3.711e-02,2.574e-02,2.171e-02,3.053e-02,8.443e-01,4.205e-03
ALDH1A1,402,cytosol,GO:0005829,cellular component,21.0,76.0,3.004e-02,2.431e-02,3.711e-02,2.667e-02,2.198e-02,3.236e-02,8.406e-01,4.784e-03
ALDH1A1,402,benzaldehyde dehydrogenase (NAD+) activity,GO:0018479,molecular function,21.0,3.0,2.821e-02,1.967e-02,4.046e-02,8.510e-03,2.282e-03,3.173e-02,9.249e-01,1.818e-02
ALDH1A1,402,aldehyde dehydrogenase (NAD+) activity,GO:0004029,molecular function,21.0,22.0,2.821e-02,1.967e-02,4.046e-02,1.321e-02,7.427e-03,2.349e-02,9.039e-01,9.081e-03
ALDH1L1,3978,extracellular exosome,GO:0070062,cellular component,14.0,77.0,3.104e-02,2.000e-02,4.819e-02,1.856e-02,1.148e-02,3.002e-02,8.764e-01,1.118e-02
ALDH1L1,3978,cytosol,GO:0005829,cellular component,14.0,76.0,3.104e-02,2.000e-02,4.819e-02,2.485e-02,1.428e-02,4.323e-02,8.477e-01,1.348e-02
ALDH1L1,3978,aldehyde dehydrogenase (NAD+) activity,GO:0004029,molecular function,14.0,22.0,3.104e-02,2.000e-02,4.819e-02,1.981e-02,6.390e-03,6.139e-02,8.676e-01,2.631e-02
ALDH1L1,3978,formyltetrahydrofolate dehydrogenase activity,GO:0016155,molecular function,14.0,2.0,3.892e-02,2.607e-02,5.811e-02,3.593e-02,1.961e-02,6.584e-02,8.097e-01,1.522e-02
ALDH3B2,411,3-chloroallyl aldehyde dehydrogenase activity,GO:0004028,molecular function,28.0,2.0,3.737e-02,1.507e-02,9.266e-02,3.626e-02,1.493e-02,8.806e-02,8.080e-01,2.278e-02
ALDH3B2,411,aldehyde dehydrogenase [NAD(P)+] activity,GO:0004030,molecular function,28.0,6.0,3.737e-02,1.507e-02,9.266e-02,3.735e-02,1.504e-02,9.276e-02,8.049e-01,2.343e-02
ALDOA,414,fructose metabolic process,GO:0006000,biological process,38.0,4.0,6.741e-02,3.628e-02,1.252e-01,1.133e-02,2.005e-03,6.407e-02,9.036e-01,2.418e-02
ALDOA,414,striated muscle contraction,GO:0006941,biological process,38.0,5.0,8.348e-02,2.213e-02,3.149e-01,3.017e-02,9.185e-03,9.907e-02,8.267e-01,3.044e-02
ALDOA,414,glycolytic process,GO:0006096,biological process,38.0,13.0,8.358e-02,2.206e-02,3.166e-01,2.869e-02,2.373e-03,3.469e-01,8.193e-01,6.527e-02
ALDOA,414,"fructose 1,6-bisphosphate metabolic process",GO:0030388,biological process,38.0,5.0,1.043e-01,4.037e-02,2.694e-01,6.267e-02,3.295e-02,1.192e-01,7.472e-01,1.882e-02
ALDOA,414,ATP biosynthetic process,GO:0006754,biological process,38.0,7.0,1.065e-01,3.840e-02,2.956e-01,8.494e-02,3.239e-02,2.228e-01,7.064e-01,3.188e-02
ALDOA,414,binding of sperm to zona pellucida,GO:0007339,biological process,38.0,2.0,1.350e-01,4.422e-02,4.119e-01,1.194e-01,4.113e-02,3.469e-01,6.571e-01,3.994e-02
ALDOA,414,muscle cell cellular homeostasis,GO:0046716,biological process,38.0,3.0,1.643e-01,6.661e-02,4.052e-01,1.565e-01,6.344e-02,3.859e-01,6.154e-01,3.764e-02
ALDOA,414,regulation of cell shape,GO:0008360,biological process,38.0,9.0,2.657e-01,7.476e-02,9.445e-01,2.657e-01,7.476e-02,9.445e-01,5.085e-01,6.219e-02
ALDOA,414,extracellular exosome,GO:0070062,cellular component,38.0,77.0,8.348e-02,2.213e-02,3.149e-01,2.503e-02,3.704e-03,1.692e-01,8.401e-01,4.715e-02
ALDOA,414,extracellular space,GO:0005615,cellular component,38.0,43.0,8.358e-02,2.206e-02,3.166e-01,2.748e-02,2.129e-03,3.546e-01,8.229e-01,6.693e-02
ALDOA,414,cytosol,GO:0005829,cellular component,38.0,76.0,9.273e-02,2.677e-02,3.212e-01,5.533e-02,1.729e-02,1.770e-01,7.590e-01,3.324e-02
ALDOA,414,membrane,GO:0016020,cellular component,38.0,58.0,9.313e-02,2.653e-02,3.269e-01,6.064e-02,1.434e-02,2.565e-01,7.457e-01,4.290e-02
ALDOA,414,actin cytoskeleton,GO:0015629,cellular component,38.0,9.0,9.579e-02,2.499e-02,3.672e-01,6.732e-02,1.315e-02,3.447e-01,7.307e-01,5.043e-02
ALDOA,414,sperm head,GO:0061827,cellular component,38.0,2.0,9.648e-02,1.571e-02,5.925e-01,4.629e-02,2.468e-03,8.683e-01,7.575e-01,9.258e-02
ALDOA,414,nucleus,GO:0005634,cellular component,38.0,81.0,1.129e-01,5.054e-02,2.522e-01,8.382e-02,6.713e-02,1.047e-01,7.117e-01,6.996e-03
ALDOA,414,cytoskeletal protein binding,GO:0008092,molecular function,38.0,23.0,6.741e-02,3.628e-02,1.252e-01,6.190e-03,3.328e-03,1.151e-02,9.444e-01,5.553e-03
ALDOA,414,fructose-bisphosphate aldolase activity,GO:0004332,molecular function,38.0,2.0,6.741e-02,3.628e-02,1.252e-01,2.295e-02,1.716e-02,3.069e-02,8.560e-01,7.059e-03
ALDOA,414,cadherin binding,GO:0045296,molecular function,38.0,13.0,6.946e-02,3.783e-02,1.275e-01,1.924e-02,7.434e-03,4.978e-02,8.708e-01,2.157e-02
ALDOA,414,RNA binding,GO:0003723,molecular function,38.0,60.0,7.687e-02,4.377e-02,1.350e-01,3.685e-02,9.159e-03,1.482e-01,8.046e-01,3.622e-02
ALDOA,414,fructose binding,GO:0070061,molecular function,38.0,2.0,7.932e-02,2.496e-02,2.521e-01,2.781e-02,1.222e-02,6.331e-02,8.361e-01,2.034e-02
ALDOA,414,protein binding,GO:0005515,molecular function,38.0,347.0,1.014e-01,3.682e-02,2.791e-01,6.378e-02,3.757e-02,1.083e-01,7.454e-01,1.519e-02
ALG3,23056,,,,nan,nan,,,,,,,,
ALKAL2,27683,,,,nan,nan,,,,,,,,
AMPD3,470,IMP biosynthetic process,GO:0006188,biological process,21.0,7.0,3.469e-02,2.172e-02,5.541e-02,2.669e-02,1.246e-02,5.715e-02,8.403e-01,1.876e-02
AMPD3,470,AMP metabolic process,GO:0046033,biological process,21.0,8.0,4.448e-02,7.782e-03,2.542e-01,2.699e-02,1.842e-03,3.954e-01,8.221e-01,6.874e-02
AMPD3,470,cytosol,GO:0005829,cellular component,21.0,76.0,2.979e-02,2.032e-02,4.366e-02,1.720e-02,1.369e-02,2.160e-02,8.841e-01,4.859e-03
AMPD3,470,protein binding,GO:0005515,molecular function,21.0,347.0,2.979e-02,2.032e-02,4.366e-02,1.635e-02,9.979e-03,2.679e-02,8.873e-01,1.038e-02
AMPD3,470,AMP deaminase activity,GO:0003876,molecular function,21.0,2.0,4.739e-02,2.555e-02,8.789e-02,4.399e-02,1.964e-02,9.854e-02,7.873e-01,2.148e-02
ANG,483,activation of phospholipase C activity,GO:0007202,biological process,32.0,2.0,1.003e-01,5.659e-02,1.777e-01,2.279e-02,1.713e-02,3.031e-02,8.567e-01,7.031e-03
ANG,483,activation of phospholipase A2 activity,GO:0032431,biological process,32.0,3.0,1.003e-01,5.659e-02,1.777e-01,2.563e-02,9.900e-03,6.636e-02,8.442e-01,2.349e-02
ANG,483,cell migration,GO:0016477,biological process,32.0,37.0,1.003e-01,5.659e-02,1.777e-01,2.786e-02,9.266e-03,8.376e-02,8.352e-01,2.777e-02
ANG,483,positive regulation of phosphorylation,GO:0042327,biological process,32.0,8.0,1.003e-01,5.659e-02,1.777e-01,3.673e-02,1.491e-02,9.047e-02,8.069e-01,2.257e-02
ANG,483,response to hypoxia,GO:0001666,biological process,32.0,7.0,1.003e-01,5.659e-02,1.777e-01,4.578e-02,2.234e-02,9.383e-02,7.831e-01,1.917e-02
ANG,483,positive regulation of endothelial cell proliferation,GO:0001938,biological process,32.0,6.0,1.007e-01,5.647e-02,1.796e-01,5.384e-02,2.936e-02,9.874e-02,7.652e-01,1.650e-02
ANG,483,activation of protein kinase B activity,GO:0032148,biological process,32.0,2.0,1.015e-01,5.609e-02,1.836e-01,6.275e-02,4.176e-02,9.428e-02,7.477e-01,1.159e-02
ANG,483,negative regulation of smooth muscle cell proliferation,GO:0048662,biological process,32.0,5.0,1.217e-01,6.233e-02,2.377e-01,9.299e-02,5.311e-02,1.628e-01,6.967e-01,1.799e-02
ANG,483,diacylglycerol biosynthetic process,GO:0006651,biological process,32.0,3.0,1.299e-01,3.941e-02,4.280e-01,7.399e-02,7.271e-03,7.529e-01,7.099e-01,7.339e-02
ANG,483,angiogenesis,GO:0001525,biological process,32.0,9.0,1.353e-01,3.837e-02,4.768e-01,9.174e-02,1.400e-02,6.011e-01,6.853e-01,6.486e-02
ANG,483,rRNA transcription,GO:0009303,biological process,32.0,6.0,1.449e-01,4.253e-02,4.936e-01,1.155e-01,2.676e-02,4.983e-01,6.583e-01,4.960e-02
ANG,483,response to hormone,GO:0009725,biological process,32.0,34.0,1.699e-01,1.370e-01,2.107e-01,1.348e-01,7.899e-02,2.300e-01,6.428e-01,1.973e-02
ANG,483,positive regulation of protein secretion,GO:0050714,biological process,32.0,17.0,2.692e-01,4.480e-02,1.618e+00,1.861e-01,1.265e-02,2.739e+00,5.288e-01,1.358e-01
ANG,483,basement membrane,GO:0005604,cellular component,32.0,4.0,1.003e-01,5.659e-02,1.777e-01,2.135e-02,5.017e-03,9.085e-02,8.562e-01,2.997e-02
ANG,483,angiogenin-PRI complex,GO:0032311,cellular component,32.0,2.0,1.003e-01,5.659e-02,1.777e-01,2.510e-02,9.394e-03,6.707e-02,8.454e-01,2.293e-02
ANG,483,actin cytoskeleton,GO:0015629,cellular component,32.0,9.0,1.003e-01,5.659e-02,1.777e-01,2.839e-02,1.708e-02,4.717e-02,8.343e-01,1.243e-02
ANG,483,extracellular space,GO:0005615,cellular component,32.0,43.0,1.003e-01,5.659e-02,1.777e-01,3.101e-02,1.440e-02,6.677e-02,8.250e-01,1.903e-02
ANG,483,nucleolus,GO:0005730,cellular component,32.0,18.0,1.070e-01,7.518e-02,1.523e-01,6.280e-02,4.009e-02,9.836e-02,7.475e-01,1.288e-02
ANG,483,nucleus,GO:0005634,cellular component,32.0,81.0,1.476e-01,9.431e-02,2.311e-01,1.234e-01,8.058e-02,1.890e-01,6.565e-01,1.573e-02
ANG,483,actin binding,GO:0003779,molecular function,32.0,5.0,1.003e-01,5.659e-02,1.777e-01,2.265e-02,1.391e-02,3.689e-02,8.569e-01,1.174e-02
ANG,483,protein binding,GO:0005515,molecular function,32.0,347.0,1.054e-01,6.888e-02,1.612e-01,6.144e-02,5.121e-02,7.373e-02,7.507e-01,5.093e-03
ANG,483,protein homodimerization activity,GO:0042803,molecular function,32.0,21.0,1.069e-01,7.477e-02,1.528e-01,6.115e-02,4.437e-02,8.427e-02,7.509e-01,9.327e-03
ANG,483,peptide binding,GO:0042277,molecular function,32.0,14.0,1.077e-01,5.162e-02,2.246e-01,6.689e-02,2.880e-02,1.554e-01,7.379e-01,2.583e-02
ANG,483,heparin binding,GO:0008201,molecular function,32.0,6.0,1.161e-01,5.016e-02,2.688e-01,7.679e-02,2.413e-02,2.443e-01,7.187e-01,3.480e-02
ANG,483,copper ion binding,GO:0005507,molecular function,32.0,7.0,1.387e-01,4.517e-02,4.262e-01,9.131e-02,1.152e-02,7.236e-01,6.856e-01,6.304e-02
ANG,483,signaling receptor binding,GO:0005102,molecular function,32.0,61.0,1.657e-01,3.680e-02,7.465e-01,1.434e-01,2.314e-02,8.885e-01,6.175e-01,6.841e-02
ANG,483,ribonuclease activity,GO:0004540,molecular function,32.0,13.0,1.738e-01,3.801e-02,7.944e-01,1.504e-01,2.148e-02,1.053e+00,6.079e-01,7.074e-02
ANKEF1,15803,,,,nan,nan,,,,,,,,
ANKRD40,28233,protein binding,GO:0005515,molecular function,2.0,347.0,1.348e-01,7.570e-02,2.401e-01,1.348e-01,7.570e-02,2.401e-01,6.425e-01,2.157e-02
ANXA1,533,cellular response to vascular endothelial growth factor stimulus,GO:0035924,biological process,80.0,3.0,3.403e-01,2.431e-01,4.765e-01,1.704e-02,2.031e-03,1.430e-01,8.689e-01,4.148e-02
ANXA1,533,negative regulation of interleukin-8 secretion,GO:2000483,biological process,80.0,4.0,3.403e-01,2.431e-01,4.765e-01,4.190e-02,2.923e-02,6.006e-02,7.937e-01,9.187e-03
ANXA1,533,regulation of interleukin-1 production,GO:0032652,biological process,80.0,8.0,3.403e-01,2.431e-01,4.765e-01,4.962e-02,1.809e-02,1.361e-01,7.727e-01,2.822e-02
ANXA1,533,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",GO:0007187,biological process,80.0,4.0,3.403e-01,2.431e-01,4.765e-01,5.392e-02,2.003e-02,1.452e-01,7.632e-01,2.867e-02
ANXA1,533,response to estradiol,GO:0032355,biological process,80.0,6.0,3.403e-01,2.431e-01,4.765e-01,5.912e-02,2.156e-02,1.621e-01,7.519e-01,2.955e-02
ANXA1,533,response to interleukin-1,GO:0070555,biological process,80.0,4.0,3.465e-01,2.334e-01,5.145e-01,5.073e-02,1.119e-02,2.301e-01,7.666e-01,4.331e-02
ANXA1,533,cellular response to hydrogen peroxide,GO:0070301,biological process,80.0,6.0,3.465e-01,2.334e-01,5.145e-01,8.149e-02,1.972e-02,3.368e-01,7.083e-01,4.465e-02
ANXA1,533,positive regulation of cell migration involved in sprouting angiogenesis,GO:0090050,biological process,80.0,4.0,3.536e-01,2.530e-01,4.941e-01,7.226e-02,2.788e-02,1.872e-01,7.282e-01,2.759e-02
ANXA1,533,regulation of inflammatory response,GO:0050727,biological process,80.0,14.0,3.600e-01,2.454e-01,5.282e-01,1.065e-01,7.791e-02,1.455e-01,6.788e-01,1.104e-02
ANXA1,533,response to peptide hormone,GO:0043434,biological process,80.0,18.0,3.612e-01,2.459e-01,5.305e-01,8.869e-02,7.225e-03,1.089e+00,6.834e-01,7.660e-02
ANXA1,533,regulation of leukocyte migration,GO:0002685,biological process,80.0,12.0,3.612e-01,2.459e-01,5.305e-01,1.030e-01,1.240e-02,8.558e-01,6.672e-01,6.672e-02
ANXA1,533,cellular response to glucocorticoid stimulus,GO:0071385,biological process,80.0,7.0,3.612e-01,2.459e-01,5.305e-01,1.079e-01,1.160e-02,1.003e+00,6.582e-01,7.134e-02
ANXA1,533,inflammatory response,GO:0006954,biological process,80.0,7.0,3.612e-01,2.459e-01,5.305e-01,1.274e-01,5.501e-02,2.951e-01,6.495e-01,2.992e-02
ANXA1,533,gliogenesis,GO:0042063,biological process,80.0,2.0,3.644e-01,2.703e-01,4.914e-01,1.070e-01,2.606e-02,4.392e-01,6.698e-01,4.901e-02
ANXA1,533,cell surface receptor signaling pathway,GO:0007166,biological process,80.0,32.0,3.652e-01,2.888e-01,4.617e-01,5.761e-02,5.194e-03,6.389e-01,7.437e-01,6.684e-02
ANXA1,533,regulation of cell population proliferation,GO:0042127,biological process,80.0,34.0,3.723e-01,2.777e-01,4.992e-01,1.322e-01,8.493e-02,2.059e-01,6.461e-01,1.617e-02
ANXA1,533,positive regulation of neutrophil apoptotic process,GO:0033031,biological process,80.0,5.0,3.740e-01,2.844e-01,4.916e-01,1.600e-01,5.305e-02,4.827e-01,6.098e-01,4.433e-02
ANXA1,533,positive regulation of T cell proliferation,GO:0042102,biological process,80.0,10.0,3.799e-01,2.994e-01,4.821e-01,1.255e-01,6.739e-02,2.337e-01,6.533e-01,2.331e-02
ANXA1,533,monocyte chemotaxis,GO:0002548,biological process,80.0,4.0,3.799e-01,2.994e-01,4.821e-01,1.355e-01,5.681e-02,3.230e-01,6.395e-01,3.307e-02
ANXA1,533,granulocyte chemotaxis,GO:0071621,biological process,80.0,6.0,3.799e-01,2.994e-01,4.821e-01,1.832e-01,1.106e-01,3.032e-01,5.923e-01,2.053e-02
ANXA1,533,prolactin secretion,GO:0070459,biological process,80.0,3.0,3.800e-01,2.416e-01,5.979e-01,1.947e-01,3.727e-02,1.017e+00,5.661e-01,6.726e-02
ANXA1,533,myoblast migration involved in skeletal muscle regeneration,GO:0014839,biological process,80.0,2.0,3.807e-01,3.017e-01,4.805e-01,1.759e-01,9.154e-02,3.379e-01,5.982e-01,2.683e-02
ANXA1,533,positive regulation of interleukin-2 production,GO:0032743,biological process,80.0,5.0,3.808e-01,3.016e-01,4.807e-01,2.506e-01,1.746e-01,3.596e-01,5.343e-01,1.729e-02
ANXA1,533,negative regulation of T-helper 2 cell differentiation,GO:0045629,biological process,80.0,4.0,3.818e-01,2.446e-01,5.959e-01,2.233e-01,6.046e-02,8.249e-01,5.456e-01,5.705e-02
ANXA1,533,arachidonic acid secretion,GO:0050482,biological process,80.0,3.0,3.869e-01,2.615e-01,5.724e-01,1.991e-01,7.446e-02,5.325e-01,5.721e-01,4.465e-02
ANXA1,533,negative regulation of phospholipase A2 activity,GO:1900138,biological process,80.0,3.0,3.869e-01,2.549e-01,5.872e-01,2.300e-01,7.593e-02,6.968e-01,5.425e-01,5.070e-02
ANXA1,533,alpha-beta T cell differentiation,GO:0046632,biological process,80.0,8.0,3.920e-01,3.105e-01,4.947e-01,2.339e-01,1.722e-01,3.176e-01,5.484e-01,1.406e-02
ANXA1,533,response to X-ray,GO:0010165,biological process,80.0,3.0,3.985e-01,3.100e-01,5.123e-01,2.700e-01,2.076e-01,3.512e-01,5.196e-01,1.333e-02
ANXA1,533,positive regulation of T-helper 1 cell differentiation,GO:0045627,biological process,80.0,4.0,4.009e-01,3.056e-01,5.259e-01,2.750e-01,1.752e-01,4.315e-01,5.145e-01,2.305e-02
ANXA1,533,positive regulation of wound healing,GO:0090303,biological process,80.0,11.0,4.016e-01,2.707e-01,5.958e-01,2.665e-01,9.542e-02,7.443e-01,5.138e-01,4.886e-02
ANXA1,533,insulin secretion,GO:0030073,biological process,80.0,4.0,4.029e-01,2.189e-01,7.415e-01,2.189e-01,3.651e-02,1.312e+00,5.379e-01,7.984e-02
ANXA1,533,response to drug,GO:0042493,biological process,80.0,76.0,4.061e-01,3.450e-01,4.780e-01,2.753e-01,1.727e-01,4.388e-01,5.142e-01,2.384e-02
ANXA1,533,positive regulation of G1/S transition of mitotic cell cycle,GO:1900087,biological process,80.0,7.0,4.101e-01,3.442e-01,4.887e-01,2.708e-01,1.369e-01,5.358e-01,5.153e-01,3.381e-02
ANXA1,533,neutrophil homeostasis,GO:0001780,biological process,80.0,3.0,4.164e-01,3.382e-01,5.126e-01,3.094e-01,1.806e-01,5.301e-01,4.878e-01,2.804e-02
ANXA1,533,phagocytosis,GO:0006909,biological process,80.0,4.0,4.241e-01,2.138e-01,8.410e-01,2.239e-01,1.873e-02,2.677e+00,5.122e-01,1.072e-01
ANXA1,533,keratinocyte differentiation,GO:0030216,biological process,80.0,4.0,4.295e-01,3.236e-01,5.699e-01,2.841e-01,1.207e-01,6.686e-01,5.012e-01,4.705e-02
ANXA1,533,neutrophil clearance,GO:0097350,biological process,80.0,2.0,4.318e-01,2.781e-01,6.705e-01,2.237e-01,2.947e-02,1.699e+00,5.274e-01,8.905e-02
ANXA1,533,DNA duplex unwinding,GO:0032508,biological process,80.0,5.0,4.486e-01,3.228e-01,6.234e-01,3.684e-01,2.224e-01,6.104e-01,4.456e-01,3.179e-02
ANXA1,533,positive regulation of prostaglandin biosynthetic process,GO:0031394,biological process,80.0,4.0,4.508e-01,3.063e-01,6.637e-01,2.604e-01,4.450e-02,1.524e+00,5.009e-01,8.321e-02
ANXA1,533,regulation of hormone secretion,GO:0046883,biological process,80.0,21.0,4.607e-01,2.197e-01,9.658e-01,1.493e-01,4.496e-03,4.961e+00,5.542e-01,1.456e-01
ANXA1,533,positive regulation of vesicle fusion,GO:0031340,biological process,80.0,9.0,4.786e-01,2.517e-01,9.103e-01,2.006e-01,2.228e-02,1.807e+00,5.321e-01,1.165e-01
ANXA1,533,endocrine pancreas development,GO:0031018,biological process,80.0,2.0,4.809e-01,2.879e-01,8.031e-01,4.229e-01,2.165e-01,8.258e-01,4.040e-01,4.819e-02
ANXA1,533,negative regulation of exocytosis,GO:0045920,biological process,80.0,7.0,5.130e-01,2.282e-01,1.153e+00,3.263e-01,5.629e-02,1.892e+00,4.276e-01,1.181e-01
ANXA1,533,hepatocyte differentiation,GO:0070365,biological process,80.0,2.0,5.263e-01,4.508e-01,6.143e-01,4.830e-01,4.134e-01,5.643e-01,3.737e-01,1.153e-02
ANXA1,533,actin cytoskeleton reorganization,GO:0031532,biological process,80.0,3.0,5.502e-01,2.441e-01,1.240e+00,4.487e-01,1.074e-01,1.875e+00,3.587e-01,9.265e-02
ANXA1,533,prostate gland development,GO:0030850,biological process,80.0,3.0,5.732e-01,2.346e-01,1.400e+00,4.877e-01,1.187e-01,2.004e+00,3.264e-01,1.004e-01
ANXA1,533,peptide cross-linking,GO:0018149,biological process,80.0,37.0,5.949e-01,2.791e-01,1.268e+00,5.427e-01,2.041e-01,1.443e+00,3.064e-01,8.270e-02
ANXA1,533,regulation of cell shape,GO:0008360,biological process,80.0,9.0,6.092e-01,4.510e-01,8.230e-01,5.831e-01,4.202e-01,8.091e-01,3.067e-01,3.082e-02
ANXA1,533,cornified envelope,GO:0001533,cellular component,80.0,2.0,3.403e-01,2.431e-01,4.765e-01,2.595e-02,2.282e-02,2.951e-02,8.433e-01,3.111e-03
ANXA1,533,focal adhesion,GO:0005925,cellular component,80.0,6.0,3.465e-01,2.334e-01,5.145e-01,6.952e-02,1.603e-02,3.014e-01,7.279e-01,4.719e-02
ANXA1,533,vesicle,GO:0031982,cellular component,80.0,6.0,3.548e-01,2.533e-01,4.968e-01,8.850e-02,3.598e-02,2.177e-01,7.015e-01,2.815e-02
ANXA1,533,adherens junction,GO:0005912,cellular component,80.0,6.0,3.612e-01,2.459e-01,5.305e-01,7.630e-02,2.220e-02,2.623e-01,7.189e-01,3.626e-02
ANXA1,533,endosome,GO:0005768,cellular component,80.0,15.0,3.612e-01,2.459e-01,5.305e-01,1.120e-01,5.190e-02,2.419e-01,6.691e-01,2.665e-02
ANXA1,533,plasma membrane,GO:0005886,cellular component,80.0,61.0,3.666e-01,2.613e-01,5.145e-01,1.762e-01,9.520e-02,3.261e-01,5.982e-01,2.499e-02
ANXA1,533,collagen-containing extracellular matrix,GO:0062023,cellular component,80.0,36.0,3.666e-01,2.613e-01,5.145e-01,1.822e-01,9.680e-02,3.428e-01,5.924e-01,2.552e-02
ANXA1,533,extracellular exosome,GO:0070062,cellular component,80.0,77.0,3.668e-01,2.616e-01,5.141e-01,1.781e-01,1.068e-01,2.969e-01,5.972e-01,2.037e-02
ANXA1,533,extracellular space,GO:0005615,cellular component,80.0,43.0,3.807e-01,3.017e-01,4.805e-01,1.928e-01,1.193e-01,3.115e-01,5.834e-01,2.022e-02
ANXA1,533,actin filament,GO:0005884,cellular component,80.0,5.0,3.887e-01,2.782e-01,5.432e-01,1.904e-01,7.760e-02,4.673e-01,5.812e-01,4.072e-02
ANXA1,533,cell surface,GO:0009986,cellular component,80.0,11.0,3.922e-01,3.078e-01,4.998e-01,2.430e-01,1.915e-01,3.083e-01,5.411e-01,1.148e-02
ANXA1,533,cytosol,GO:0005829,cellular component,80.0,76.0,3.931e-01,3.107e-01,4.975e-01,2.739e-01,2.215e-01,3.387e-01,5.167e-01,1.056e-02
ANXA1,533,nucleus,GO:0005634,cellular component,80.0,81.0,4.009e-01,3.056e-01,5.259e-01,2.826e-01,1.752e-01,4.558e-01,5.084e-01,2.434e-02
ANXA1,533,cytoplasm,GO:0005737,cellular component,80.0,78.0,4.071e-01,3.054e-01,5.427e-01,3.165e-01,2.140e-01,4.680e-01,4.841e-01,2.106e-02
ANXA1,533,nucleoplasm,GO:0005654,cellular component,80.0,51.0,4.089e-01,3.114e-01,5.370e-01,3.215e-01,2.325e-01,4.445e-01,4.810e-01,1.770e-02
ANXA1,533,extrinsic component of external side of plasma membrane,GO:0031232,cellular component,80.0,3.0,4.874e-01,3.942e-01,6.027e-01,4.269e-01,3.508e-01,5.195e-01,4.097e-01,1.298e-02
ANXA1,533,extrinsic component of membrane,GO:0019898,cellular component,80.0,8.0,5.248e-01,3.977e-01,6.925e-01,4.821e-01,3.502e-01,6.636e-01,3.726e-01,2.312e-02
ANXA1,533,calcium-dependent protein binding,GO:0048306,molecular function,80.0,4.0,3.612e-01,2.459e-01,5.305e-01,9.839e-02,1.747e-02,5.541e-01,6.788e-01,5.511e-02
ANXA1,533,cadherin binding involved in cell-cell adhesion,GO:0098641,molecular function,80.0,4.0,3.612e-01,2.459e-01,5.305e-01,1.210e-01,5.215e-02,2.810e-01,6.571e-01,2.961e-02
ANXA1,533,phospholipase A2 inhibitor activity,GO:0019834,molecular function,80.0,2.0,3.799e-01,2.994e-01,4.821e-01,1.870e-01,1.139e-01,3.069e-01,5.887e-01,2.019e-02
ANXA1,533,protein binding,GO:0005515,molecular function,80.0,347.0,4.007e-01,3.032e-01,5.295e-01,2.638e-01,1.414e-01,4.919e-01,5.219e-01,2.980e-02
ANXA1,533,calcium-dependent phospholipid binding,GO:0005544,molecular function,80.0,2.0,4.111e-01,2.188e-01,7.723e-01,2.068e-01,2.199e-02,1.945e+00,5.382e-01,9.447e-02
AP3M1,569,lysosomal membrane,GO:0005765,cellular component,6.0,10.0,7.669e-02,3.985e-03,1.476e+00,4.058e-02,9.672e-04,1.703e+00,7.583e-01,8.196e-02
AP3M1,569,protein binding,GO:0005515,molecular function,6.0,347.0,9.759e-02,1.534e-02,6.208e-01,5.806e-02,2.045e-02,1.648e-01,7.544e-01,2.922e-02
AP3M1,569,Rab GTPase binding,GO:0017137,molecular function,6.0,3.0,1.376e-01,1.139e-02,1.662e+00,1.203e-01,6.388e-03,2.267e+00,6.245e-01,1.008e-01
APBA1,578,chemical synaptic transmission,GO:0007268,biological process,9.0,15.0,7.883e-01,6.949e-01,8.943e-01,7.711e-01,7.052e-01,8.432e-01,1.858e-01,1.198e-02
APBA1,578,plasma membrane,GO:0005886,cellular component,9.0,61.0,4.129e-01,3.436e-01,4.963e-01,2.066e-01,1.830e-01,2.332e-01,5.724e-01,5.323e-03
APBA1,578,Golgi apparatus,GO:0005794,cellular component,9.0,16.0,4.129e-01,3.436e-01,4.963e-01,2.564e-01,2.152e-01,3.055e-01,5.305e-01,8.638e-03
APBA1,578,cytoplasm,GO:0005737,cellular component,9.0,78.0,4.256e-01,3.521e-01,5.145e-01,3.192e-01,2.641e-01,3.859e-01,4.834e-01,1.059e-02
APBA1,578,synapse,GO:0045202,cellular component,9.0,21.0,4.484e-01,3.696e-01,5.440e-01,3.033e-01,1.662e-01,5.533e-01,4.907e-01,3.379e-02
APBA1,578,dendritic spine,GO:0043197,cellular component,9.0,4.0,5.016e-01,2.093e-01,1.202e+00,3.022e-01,3.302e-02,2.766e+00,4.303e-01,1.330e-01
APBA1,578,amyloid-beta binding,GO:0001540,molecular function,9.0,3.0,4.040e-01,3.167e-01,5.152e-01,9.073e-02,2.891e-02,2.848e-01,6.964e-01,3.619e-02
APBA1,578,protein binding,GO:0005515,molecular function,9.0,347.0,4.129e-01,3.436e-01,4.963e-01,2.624e-01,2.154e-01,3.197e-01,5.257e-01,9.678e-03
APOBR,24087,,,,nan,nan,,,,,,,,
APOO,28727,cristae formation,GO:0042407,biological process,10.0,2.0,4.830e-01,3.782e-01,6.168e-01,4.550e-01,3.718e-01,5.567e-01,3.916e-01,1.395e-02
APOO,28727,mitochondrion,GO:0005739,cellular component,10.0,35.0,4.271e-01,3.055e-01,5.972e-01,1.650e-01,5.515e-02,4.936e-01,6.053e-01,4.197e-02
APOO,28727,endoplasmic reticulum membrane,GO:0005789,cellular component,10.0,12.0,4.271e-01,3.055e-01,5.972e-01,2.030e-01,6.727e-02,6.128e-01,5.674e-01,4.722e-02
APOO,28727,integral component of mitochondrial inner membrane,GO:0031305,cellular component,10.0,5.0,4.271e-01,3.055e-01,5.972e-01,2.253e-01,1.834e-01,2.768e-01,5.561e-01,9.551e-03
APOO,28727,cytosol,GO:0005829,cellular component,10.0,76.0,4.271e-01,3.055e-01,5.972e-01,2.384e-01,1.463e-01,3.884e-01,5.435e-01,2.246e-02
APOO,28727,extracellular region,GO:0005576,cellular component,10.0,17.0,4.437e-01,3.045e-01,6.465e-01,3.425e-01,2.381e-01,4.928e-01,4.655e-01,2.028e-02
APOO,28727,MICOS complex,GO:0061617,cellular component,10.0,2.0,4.512e-01,3.784e-01,5.380e-01,3.448e-01,2.021e-01,5.884e-01,4.620e-01,2.978e-02
APOO,28727,Golgi membrane,GO:0000139,cellular component,10.0,4.0,4.573e-01,2.977e-01,7.023e-01,4.175e-01,1.998e-01,8.726e-01,4.076e-01,4.590e-02
APOO,28727,protein binding,GO:0005515,molecular function,10.0,347.0,4.271e-01,3.055e-01,5.972e-01,2.462e-01,1.250e-01,4.850e-01,5.353e-01,3.110e-02
AQP11,19940,,,,nan,nan,,,,,,,,
ARHGAP24,25361,protein binding,GO:0005515,molecular function,2.0,347.0,6.230e-02,4.563e-02,8.506e-02,6.230e-02,4.563e-02,8.506e-02,7.486e-01,9.040e-03
ARHGEF37,34430,,,,nan,nan,,,,,,,,
ARNTL,701,response to redox state,GO:0051775,biological process,19.0,6.0,9.306e-02,2.999e-02,2.887e-01,5.326e-02,4.172e-03,6.800e-01,7.506e-01,6.952e-02
ARNTL,701,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,19.0,35.0,1.002e-01,5.128e-02,1.959e-01,3.398e-02,5.167e-03,2.234e-01,8.092e-01,4.922e-02
ARNTL,701,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,19.0,62.0,1.030e-01,5.960e-02,1.779e-01,4.568e-02,1.605e-02,1.300e-01,7.820e-01,2.863e-02
ARNTL,701,positive regulation of protein acetylation,GO:1901985,biological process,19.0,6.0,1.115e-01,8.048e-02,1.546e-01,6.825e-02,4.999e-02,9.316e-02,7.376e-01,9.110e-03
ARNTL,701,regulation of hair cycle,GO:0042634,biological process,19.0,8.0,1.193e-01,8.446e-02,1.685e-01,9.838e-02,5.532e-02,1.749e-01,6.887e-01,1.886e-02
ARNTL,701,circadian regulation of gene expression,GO:0032922,biological process,19.0,5.0,1.217e-01,9.439e-02,1.568e-01,1.002e-01,6.629e-02,1.514e-01,6.871e-01,1.431e-02
ARNTL,701,transcription factor complex,GO:0005667,cellular component,19.0,8.0,8.801e-02,4.267e-02,1.815e-01,2.895e-02,8.507e-03,9.853e-02,8.309e-01,3.104e-02
ARNTL,701,intracellular membrane-bounded organelle,GO:0043231,cellular component,19.0,48.0,1.046e-01,6.013e-02,1.819e-01,6.081e-02,1.717e-02,2.153e-01,7.478e-01,3.473e-02
ARNTL,701,nucleus,GO:0005634,cellular component,19.0,81.0,1.115e-01,8.048e-02,1.546e-01,7.549e-02,6.007e-02,9.486e-02,7.252e-01,6.991e-03
ARNTL,701,nucleoplasm,GO:0005654,cellular component,19.0,51.0,1.169e-01,8.802e-02,1.552e-01,8.795e-02,5.249e-02,1.473e-01,7.046e-01,1.636e-02
ARNTL,701,repressing transcription factor binding,GO:0070491,molecular function,19.0,3.0,7.790e-02,2.940e-02,2.064e-01,1.148e-02,5.608e-03,2.352e-02,9.125e-01,1.133e-02
ARNTL,701,E-box binding,GO:0070888,molecular function,19.0,3.0,7.790e-02,2.940e-02,2.064e-01,1.387e-02,8.431e-03,2.282e-02,9.004e-01,9.478e-03
ARNTL,701,Hsp90 protein binding,GO:0051879,molecular function,19.0,2.0,7.790e-02,2.940e-02,2.064e-01,2.369e-02,6.134e-03,9.151e-02,8.492e-01,3.178e-02
ARNTL,701,DNA binding,GO:0003677,molecular function,19.0,27.0,1.038e-01,6.160e-02,1.750e-01,5.400e-02,2.534e-02,1.151e-01,7.644e-01,2.030e-02
ARNTL,701,aryl hydrocarbon receptor binding,GO:0017162,molecular function,19.0,3.0,1.116e-01,6.973e-02,1.787e-01,6.977e-02,2.245e-02,2.168e-01,7.306e-01,3.530e-02
ARNTL,701,protein binding,GO:0005515,molecular function,19.0,347.0,1.330e-01,1.119e-01,1.582e-01,1.279e-01,1.118e-01,1.464e-01,6.516e-01,4.989e-03
ARRDC2,25225,,,,nan,nan,,,,,,,,
ASB12,19763,protein ubiquitination,GO:0016567,biological process,9.0,10.0,2.964e-02,1.502e-02,5.846e-02,1.720e-02,8.934e-03,3.310e-02,8.822e-01,1.460e-02
ASB12,19763,ubiquitin ligase complex,GO:0000151,cellular component,9.0,14.0,2.693e-02,1.279e-02,5.669e-02,9.220e-03,1.615e-03,5.265e-02,9.147e-01,2.790e-02
ASB12,19763,ubiquitin protein ligase activity,GO:0061630,molecular function,9.0,4.0,3.398e-02,1.185e-02,9.747e-02,2.766e-02,7.116e-03,1.075e-01,8.345e-01,3.368e-02
ASB12,19763,protein binding,GO:0005515,molecular function,9.0,347.0,4.620e-02,1.042e-02,2.049e-01,4.198e-02,8.602e-03,2.049e-01,7.878e-01,4.439e-02
ASF1B,20996,,,,nan,nan,,,,,,,,
ASPH,757,activation of cysteine-type endopeptidase activity,GO:0097202,biological process,19.0,3.0,2.897e-02,1.100e-02,7.627e-02,1.326e-02,2.113e-03,8.318e-02,8.905e-01,2.837e-02
ASPH,757,positive regulation of proteolysis,GO:0045862,biological process,19.0,9.0,3.159e-02,1.607e-02,6.210e-02,2.080e-02,8.258e-03,5.237e-02,8.629e-01,2.013e-02
ASPH,757,plasma membrane,GO:0005886,cellular component,19.0,61.0,2.420e-02,9.694e-03,6.041e-02,9.812e-03,1.739e-03,5.536e-02,9.109e-01,2.935e-02
ASPH,757,endoplasmic reticulum,GO:0005783,cellular component,19.0,34.0,2.640e-02,1.269e-02,5.491e-02,1.496e-02,3.948e-03,5.672e-02,8.872e-01,2.346e-02
ASPH,757,cortical endoplasmic reticulum,GO:0032541,cellular component,19.0,3.0,7.340e-02,4.073e-02,1.323e-01,7.340e-02,4.073e-02,1.323e-01,7.279e-01,1.730e-02
ASPH,757,protein binding,GO:0005515,molecular function,19.0,347.0,3.305e-02,1.513e-02,7.217e-02,2.288e-02,8.642e-03,6.058e-02,8.548e-01,2.301e-02
ATP10A,13542,,,,nan,nan,,,,,,,,
AXL,905,cell migration,GO:0016477,biological process,38.0,37.0,2.488e-01,1.450e-01,4.270e-01,2.614e-02,1.853e-02,3.686e-02,8.428e-01,8.459e-03
AXL,905,transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007169,biological process,38.0,24.0,2.488e-01,1.450e-01,4.270e-01,5.420e-02,1.224e-02,2.400e-01,7.590e-01,4.283e-02
AXL,905,cellular response to interferon-alpha,GO:0035457,biological process,38.0,3.0,2.488e-01,1.450e-01,4.270e-01,6.579e-02,1.370e-02,3.160e-01,7.337e-01,5.020e-02
AXL,905,positive regulation of kinase activity,GO:0033674,biological process,38.0,15.0,2.542e-01,1.532e-01,4.219e-01,1.193e-01,6.505e-02,2.189e-01,6.609e-01,2.194e-02
AXL,905,positive regulation of pinocytosis,GO:0048549,biological process,38.0,4.0,2.644e-01,1.395e-01,5.012e-01,1.081e-01,2.655e-02,4.405e-01,6.680e-01,5.052e-02
AXL,905,positive regulation of protein kinase B signaling,GO:0051897,biological process,38.0,8.0,2.652e-01,1.719e-01,4.090e-01,9.454e-02,4.003e-02,2.233e-01,6.928e-01,2.832e-02
AXL,905,phagocytosis,GO:0006909,biological process,38.0,4.0,2.829e-01,1.675e-01,4.777e-01,1.802e-01,9.889e-02,3.283e-01,5.942e-01,2.591e-02
AXL,905,natural killer cell differentiation,GO:0001779,biological process,38.0,4.0,2.834e-01,1.182e-01,6.796e-01,9.593e-02,5.832e-03,1.578e+00,6.552e-01,1.088e-01
AXL,905,positive regulation of natural killer cell differentiation,GO:0032825,biological process,38.0,5.0,2.908e-01,1.288e-01,6.565e-01,1.768e-01,4.099e-02,7.628e-01,5.838e-01,6.843e-02
AXL,905,positive regulation of cytokine-mediated signaling pathway,GO:0001961,biological process,38.0,20.0,2.924e-01,1.271e-01,6.725e-01,1.503e-01,1.871e-02,1.207e+00,5.991e-01,9.003e-02
AXL,905,cellular response to lipopolysaccharide,GO:0071222,biological process,38.0,7.0,3.102e-01,1.593e-01,6.040e-01,1.705e-01,3.118e-02,9.328e-01,5.898e-01,6.705e-02
AXL,905,viral entry into host cell,GO:0046718,biological process,38.0,6.0,3.111e-01,1.565e-01,6.185e-01,2.334e-01,8.458e-02,6.442e-01,5.397e-01,5.205e-02
AXL,905,dendritic cell differentiation,GO:0097028,biological process,38.0,5.0,3.318e-01,2.508e-01,4.390e-01,2.539e-01,2.085e-01,3.092e-01,5.324e-01,9.423e-03
AXL,905,platelet activation,GO:0030168,biological process,38.0,2.0,3.414e-01,3.187e-01,3.658e-01,1.913e-01,4.665e-02,7.843e-01,5.744e-01,5.676e-02
AXL,905,multicellular organism development,GO:0007275,biological process,38.0,16.0,3.429e-01,2.790e-01,4.215e-01,2.444e-01,1.357e-01,4.404e-01,5.375e-01,2.866e-02
AXL,905,nervous system development,GO:0007399,biological process,38.0,2.0,3.545e-01,3.300e-01,3.808e-01,2.568e-01,1.055e-01,6.253e-01,5.241e-01,4.118e-02
AXL,905,negative regulation of apoptotic process,GO:0043066,biological process,38.0,29.0,3.673e-01,2.536e-01,5.321e-01,3.095e-01,1.963e-01,4.880e-01,4.885e-01,2.410e-02
AXL,905,negative regulation of dendritic cell apoptotic process,GO:2000669,biological process,38.0,3.0,3.915e-01,2.678e-01,5.723e-01,3.390e-01,2.024e-01,5.680e-01,4.664e-01,2.926e-02
AXL,905,negative regulation of interferon-gamma production,GO:0032689,biological process,38.0,5.0,4.174e-01,3.368e-01,5.174e-01,3.701e-01,2.773e-01,4.941e-01,4.472e-01,1.778e-02
AXL,905,cell maturation,GO:0048469,biological process,38.0,14.0,5.012e-01,3.330e-01,7.545e-01,4.961e-01,3.183e-01,7.732e-01,3.614e-01,3.217e-02
AXL,905,integral component of plasma membrane,GO:0005887,cellular component,38.0,28.0,2.488e-01,1.450e-01,4.270e-01,3.867e-02,1.772e-02,8.436e-02,8.013e-01,2.023e-02
AXL,905,actin cytoskeleton,GO:0015629,cellular component,38.0,9.0,2.542e-01,1.532e-01,4.219e-01,6.933e-02,4.078e-02,1.179e-01,7.352e-01,1.544e-02
AXL,905,plasma membrane,GO:0005886,cellular component,38.0,61.0,2.542e-01,1.532e-01,4.219e-01,1.074e-01,6.315e-02,1.828e-01,6.767e-01,1.884e-02
AXL,905,receptor complex,GO:0043235,cellular component,38.0,29.0,2.549e-01,1.369e-01,4.746e-01,9.009e-02,1.746e-02,4.650e-01,6.920e-01,5.351e-02
AXL,905,cell surface,GO:0009986,cellular component,38.0,11.0,2.623e-01,1.633e-01,4.213e-01,1.008e-01,4.992e-02,2.033e-01,6.847e-01,2.461e-02
AXL,905,extracellular exosome,GO:0070062,cellular component,38.0,77.0,2.623e-01,1.633e-01,4.213e-01,1.065e-01,8.228e-02,1.377e-01,6.789e-01,9.102e-03
AXL,905,extracellular space,GO:0005615,cellular component,38.0,43.0,2.623e-01,1.633e-01,4.213e-01,1.074e-01,5.039e-02,2.290e-01,6.753e-01,2.617e-02
AXL,905,intracellular membrane-bounded organelle,GO:0043231,cellular component,38.0,48.0,2.846e-01,1.651e-01,4.908e-01,1.766e-01,7.823e-02,3.987e-01,5.956e-01,3.553e-02
AXL,905,host cell surface,GO:0044228,cellular component,38.0,2.0,3.766e-01,2.856e-01,4.966e-01,2.893e-01,1.643e-01,5.095e-01,5.019e-01,3.098e-02
AXL,905,protein tyrosine kinase activity,GO:0004713,molecular function,38.0,6.0,2.488e-01,1.450e-01,4.270e-01,3.155e-02,1.084e-02,9.184e-02,8.228e-01,2.609e-02
AXL,905,transmembrane receptor protein tyrosine kinase activity,GO:0004714,molecular function,38.0,21.0,2.488e-01,1.450e-01,4.270e-01,5.569e-02,2.142e-02,1.448e-01,7.597e-01,2.781e-02
AXL,905,phosphatidylserine binding,GO:0001786,molecular function,38.0,3.0,2.881e-01,1.614e-01,5.143e-01,1.767e-01,7.000e-02,4.460e-01,5.952e-01,3.686e-02
AXL,905,protein binding,GO:0005515,molecular function,38.0,347.0,2.896e-01,2.169e-01,3.867e-01,1.740e-01,1.433e-01,2.113e-01,6.025e-01,7.857e-03
BCHE,983,blood microparticle,GO:0072562,cellular component,9.0,8.0,2.034e-02,1.189e-02,3.481e-02,1.478e-02,4.217e-03,5.178e-02,8.894e-01,2.361e-02
BCHE,983,cholinesterase activity,GO:0004104,molecular function,9.0,3.0,1.517e-02,9.320e-03,2.468e-02,1.052e-02,1.883e-03,5.872e-02,9.092e-01,2.152e-02
BCHE,983,identical protein binding,GO:0042802,molecular function,9.0,35.0,2.034e-02,1.189e-02,3.481e-02,1.705e-02,1.111e-02,2.616e-02,8.842e-01,9.548e-03
BCL2L13,17164,,,,nan,nan,,,,,,,,
BOC,17173,nucleoplasm,GO:0005654,cellular component,3.0,51.0,9.782e-02,6.547e-02,1.462e-01,7.702e-02,4.835e-02,1.227e-01,7.221e-01,1.421e-02
BOC,17173,protein binding,GO:0005515,molecular function,3.0,347.0,9.782e-02,6.547e-02,1.462e-01,9.782e-02,6.547e-02,1.462e-01,6.904e-01,1.326e-02
BSCL2,15832,lipid droplet organization,GO:0034389,biological process,5.0,5.0,4.206e-02,3.081e-02,5.741e-02,2.150e-02,1.457e-02,3.173e-02,8.624e-01,9.440e-03
BSCL2,15832,lipid storage,GO:0019915,biological process,5.0,4.0,6.694e-02,3.642e-02,1.230e-01,5.998e-02,2.683e-02,1.341e-01,7.517e-01,2.331e-02
BSCL2,15832,integral component of endoplasmic reticulum membrane,GO:0030176,cellular component,5.0,10.0,4.206e-02,3.081e-02,5.741e-02,2.910e-02,9.866e-03,8.582e-02,8.308e-01,2.676e-02
BSCL2,15832,protein binding,GO:0005515,molecular function,5.0,347.0,4.997e-02,3.080e-02,8.107e-02,4.373e-02,1.926e-02,9.930e-02,7.880e-01,2.126e-02
BYSL,1157,rRNA processing,GO:0006364,biological process,16.0,14.0,1.194e-01,2.357e-02,6.045e-01,8.280e-02,9.015e-03,7.605e-01,6.920e-01,8.087e-02
BYSL,1157,"preribosome, small subunit precursor",GO:0030688,cellular component,16.0,3.0,5.478e-02,4.243e-02,7.072e-02,1.556e-02,7.391e-03,3.278e-02,8.897e-01,1.429e-02
BYSL,1157,nucleolus,GO:0005730,cellular component,16.0,18.0,7.079e-02,2.272e-02,2.206e-01,2.463e-02,2.279e-03,2.660e-01,8.363e-01,5.987e-02
BYSL,1157,intracellular membrane-bounded organelle,GO:0043231,cellular component,16.0,48.0,9.134e-02,7.074e-02,1.179e-01,5.327e-02,1.824e-02,1.556e-01,7.646e-01,2.887e-02
BYSL,1157,nucleus,GO:0005634,cellular component,16.0,81.0,9.153e-02,4.301e-02,1.948e-01,5.268e-02,1.839e-02,1.509e-01,7.659e-01,2.891e-02
BYSL,1157,nucleoplasm,GO:0005654,cellular component,16.0,51.0,9.153e-02,4.301e-02,1.948e-01,5.889e-02,3.124e-02,1.110e-01,7.546e-01,1.839e-02
BYSL,1157,cytoplasm,GO:0005737,cellular component,16.0,78.0,9.718e-02,4.546e-02,2.077e-01,7.790e-02,3.085e-02,1.967e-01,7.185e-01,2.825e-02
BYSL,1157,membrane,GO:0016020,cellular component,16.0,58.0,1.028e-01,5.729e-02,1.845e-01,9.348e-02,5.209e-02,1.678e-01,6.959e-01,1.924e-02
BYSL,1157,snoRNA binding,GO:0030515,molecular function,16.0,5.0,5.282e-02,4.358e-02,6.402e-02,9.526e-03,5.941e-03,1.527e-02,9.247e-01,6.324e-03
BYSL,1157,RNA binding,GO:0003723,molecular function,16.0,60.0,6.809e-02,2.491e-02,1.861e-01,2.137e-02,5.938e-03,7.690e-02,8.600e-01,3.005e-02
BYSL,1157,protein binding,GO:0005515,molecular function,16.0,347.0,1.044e-01,5.792e-02,1.882e-01,9.080e-02,4.812e-02,1.713e-01,6.995e-01,2.008e-02
CALU,1458,endoplasmic reticulum,GO:0005783,cellular component,11.0,34.0,2.344e-02,1.970e-02,2.789e-02,1.941e-02,1.661e-02,2.269e-02,8.728e-01,3.715e-03
CALU,1458,membrane,GO:0016020,cellular component,11.0,58.0,2.421e-02,1.837e-02,3.190e-02,2.266e-02,1.445e-02,3.553e-02,8.572e-01,1.092e-02
CALU,1458,calcium ion binding,GO:0005509,molecular function,11.0,6.0,2.196e-02,1.649e-02,2.926e-02,9.795e-03,2.242e-03,4.279e-02,9.150e-01,2.226e-02
CALU,1458,protein binding,GO:0005515,molecular function,11.0,347.0,2.344e-02,1.970e-02,2.789e-02,1.762e-02,1.061e-02,2.927e-02,8.809e-01,1.136e-02
CAPN6,1483,spindle microtubule,GO:0005876,cellular component,6.0,6.0,6.080e-02,3.226e-02,1.146e-01,3.692e-02,5.932e-03,2.298e-01,8.009e-01,4.413e-02
CAPN6,1483,cytoplasm,GO:0005737,cellular component,6.0,78.0,6.730e-02,4.995e-02,9.068e-02,3.947e-02,2.067e-02,7.539e-02,7.995e-01,1.643e-02
CAPN6,1483,perinuclear region of cytoplasm,GO:0048471,cellular component,6.0,11.0,7.307e-02,6.285e-02,8.494e-02,5.938e-02,2.668e-02,1.322e-01,7.530e-01,2.218e-02
CAPN6,1483,calcium-dependent cysteine-type endopeptidase activity,GO:0004198,molecular function,6.0,3.0,5.287e-02,3.217e-02,8.689e-02,2.644e-02,4.768e-03,1.466e-01,8.363e-01,4.227e-02
CAPN9,1486,cytoplasm,GO:0005737,cellular component,3.0,78.0,4.497e-02,2.493e-02,8.111e-02,4.497e-02,2.493e-02,8.111e-02,7.855e-01,1.526e-02
CAPN9,1486,calcium-dependent cysteine-type endopeptidase activity,GO:0004198,molecular function,3.0,3.0,2.891e-02,2.132e-02,3.922e-02,1.446e-02,1.066e-02,1.961e-02,8.984e-01,5.490e-03
CARD14,16446,,,,nan,nan,,,,,,,,
CCBE1,29426,positive regulation of vascular endothelial growth factor production,GO:0010575,biological process,10.0,4.0,1.323e-01,3.046e-02,5.747e-01,6.726e-02,1.159e-02,3.903e-01,7.307e-01,5.059e-02
CCBE1,29426,positive regulation of vascular endothelial growth factor signaling pathway,GO:1900748,biological process,10.0,4.0,1.463e-01,4.452e-02,4.807e-01,5.991e-02,4.265e-03,8.415e-01,7.297e-01,8.745e-02
CCBE1,29426,lymphangiogenesis,GO:0001946,biological process,10.0,3.0,1.881e-01,3.607e-02,9.809e-01,1.643e-01,1.998e-02,1.351e+00,5.889e-01,7.866e-02
CCBE1,29426,positive regulation of protein processing,GO:0010954,biological process,10.0,9.0,2.096e-01,1.083e-01,4.058e-01,1.539e-01,9.720e-02,2.437e-01,6.218e-01,1.793e-02
CCBE1,29426,extracellular matrix,GO:0031012,cellular component,10.0,17.0,8.493e-02,3.218e-02,2.242e-01,1.480e-02,5.595e-03,3.913e-02,8.920e-01,2.025e-02
CCBE1,29426,extracellular space,GO:0005615,cellular component,10.0,43.0,9.184e-02,4.258e-02,1.981e-01,3.629e-02,2.074e-02,6.351e-02,8.087e-01,1.406e-02
CCBE1,29426,collagen binding,GO:0005518,molecular function,10.0,7.0,9.533e-02,3.308e-02,2.747e-01,4.237e-02,1.470e-02,1.221e-01,7.903e-01,2.830e-02
CCBE1,29426,protease binding,GO:0002020,molecular function,10.0,6.0,1.490e-01,2.528e-02,8.779e-01,7.923e-02,3.109e-03,2.019e+00,6.865e-01,9.304e-02
CCBE1,29426,protein binding,GO:0005515,molecular function,10.0,347.0,2.096e-01,1.083e-01,4.058e-01,1.863e-01,9.626e-02,3.607e-01,5.880e-01,2.774e-02
CCNG1,1592,,,,nan,nan,,,,,,,,
CD163,1631,plasma membrane,GO:0005886,cellular component,5.0,61.0,8.138e-02,4.571e-02,1.449e-01,5.183e-02,2.860e-02,9.395e-02,7.696e-01,1.656e-02
CD163,1631,external side of plasma membrane,GO:0009897,cellular component,5.0,8.0,8.138e-02,4.571e-02,1.449e-01,6.279e-02,1.972e-02,1.999e-01,7.443e-01,3.218e-02
CD163,1631,protein binding,GO:0005515,molecular function,5.0,347.0,8.622e-02,5.659e-02,1.314e-01,8.466e-02,5.447e-02,1.316e-01,7.097e-01,1.436e-02
CD164L2,32043,cytoplasmic vesicle,GO:0031410,cellular component,2.0,28.0,1.462e-02,6.453e-03,3.313e-02,1.462e-02,6.453e-03,3.313e-02,8.942e-01,1.499e-02
CDC34,1734,protein K48-linked ubiquitination,GO:0070936,biological process,25.0,3.0,2.409e-02,1.484e-02,3.911e-02,3.246e-03,2.077e-03,5.073e-03,9.652e-01,2.702e-03
CDC34,1734,protein ubiquitination,GO:0016567,biological process,25.0,10.0,2.409e-02,1.484e-02,3.911e-02,4.381e-03,2.699e-03,7.111e-03,9.569e-01,3.640e-03
CDC34,1734,protein polyubiquitination,GO:0000209,biological process,25.0,12.0,3.171e-02,2.315e-02,4.343e-02,1.783e-02,9.388e-03,3.386e-02,8.786e-01,1.327e-02
CDC34,1734,proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043161,biological process,25.0,13.0,3.762e-02,2.725e-02,5.193e-02,2.980e-02,2.154e-02,4.123e-02,8.293e-01,7.945e-03
CDC34,1734,cellular response to interferon-beta,GO:0035458,biological process,25.0,4.0,4.034e-02,2.535e-02,6.418e-02,3.540e-02,1.986e-02,6.313e-02,8.113e-01,1.433e-02
CDC34,1734,negative regulation of cAMP-mediated signaling,GO:0043951,biological process,25.0,4.0,5.470e-02,1.425e-02,2.100e-01,5.344e-02,1.319e-02,2.166e-01,7.612e-01,4.109e-02
CDC34,1734,nuclear speck,GO:0016607,cellular component,25.0,5.0,3.210e-02,2.347e-02,4.392e-02,2.256e-02,1.048e-02,4.859e-02,8.565e-01,1.796e-02
CDC34,1734,cytosol,GO:0005829,cellular component,25.0,76.0,3.277e-02,2.910e-02,3.690e-02,1.647e-02,1.028e-02,2.637e-02,8.868e-01,9.546e-03
CDC34,1734,ubiquitin conjugating enzyme activity,GO:0061631,molecular function,25.0,4.0,3.124e-02,2.385e-02,4.092e-02,1.355e-02,9.426e-03,1.947e-02,9.030e-01,6.311e-03
CDC34,1734,ubiquitin-protein transferase activity,GO:0004842,molecular function,25.0,7.0,3.254e-02,2.189e-02,4.838e-02,1.973e-02,8.140e-03,4.782e-02,8.695e-01,2.093e-02
CDC34,1734,protein binding,GO:0005515,molecular function,25.0,347.0,3.582e-02,2.659e-02,4.826e-02,1.606e-02,4.368e-03,5.905e-02,8.830e-01,2.809e-02
CDC42EP4,17147,,,,nan,nan,,,,,,,,
CDCA7L,30777,positive regulation of cell population proliferation,GO:0008284,biological process,10.0,40.0,9.454e-02,7.226e-02,1.237e-01,8.750e-02,5.216e-02,1.468e-01,7.053e-01,1.635e-02
CDCA7L,30777,nucleolus,GO:0005730,cellular component,10.0,18.0,7.059e-02,5.134e-02,9.707e-02,3.123e-02,1.488e-02,6.552e-02,8.241e-01,1.861e-02
CDCA7L,30777,nucleus,GO:0005634,cellular component,10.0,81.0,7.059e-02,5.134e-02,9.707e-02,3.920e-02,2.507e-02,6.129e-02,8.007e-01,1.133e-02
CDCA7L,30777,cytosol,GO:0005829,cellular component,10.0,76.0,7.059e-02,5.134e-02,9.707e-02,5.027e-02,2.679e-02,9.434e-02,7.730e-01,1.724e-02
CDCA7L,30777,nucleoplasm,GO:0005654,cellular component,10.0,51.0,7.059e-02,5.134e-02,9.707e-02,5.302e-02,3.326e-02,8.451e-02,7.673e-01,1.290e-02
CDCA7L,30777,fibrillar center,GO:0001650,cellular component,10.0,6.0,8.439e-02,5.474e-02,1.301e-01,6.571e-02,2.454e-02,1.760e-01,7.396e-01,2.915e-02
CDCA7L,30777,protein binding,GO:0005515,molecular function,10.0,347.0,7.750e-02,4.819e-02,1.246e-01,5.429e-02,2.168e-02,1.360e-01,7.629e-01,2.522e-02
CDCP2,27297,,,,nan,nan,,,,,,,,
CDHR1,14550,photoreceptor cell morphogenesis,GO:0008594,biological process,6.0,2.0,6.690e-02,9.786e-04,4.574e+00,3.706e-02,3.316e-04,4.142e+00,7.361e-01,1.175e-01
CDHR1,14550,cell adhesion,GO:0007155,biological process,6.0,13.0,7.209e-02,1.310e-03,3.965e+00,4.389e-02,8.821e-04,2.183e+00,7.358e-01,1.246e-01
CDHR1,14550,photoreceptor cell outer segment organization,GO:0035845,biological process,6.0,2.0,7.730e-02,1.251e-03,4.777e+00,7.103e-02,8.970e-04,5.625e+00,6.447e-01,1.617e-01
CDHR1,14550,photoreceptor cell maintenance,GO:0045494,biological process,6.0,2.0,8.344e-02,2.291e-03,3.039e+00,6.550e-02,2.069e-03,2.074e+00,6.937e-01,1.271e-01
CDHR1,14550,integral component of plasma membrane,GO:0005887,cellular component,6.0,28.0,6.690e-02,9.786e-04,4.574e+00,1.807e-02,4.705e-04,6.943e-01,8.387e-01,7.749e-02
CDKN1A,1784,negative regulation of phosphorylation,GO:0042326,biological process,51.0,8.0,1.517e-01,1.441e-01,1.596e-01,3.063e-02,1.038e-02,9.039e-02,8.253e-01,2.767e-02
CDKN1A,1784,positive regulation of protein kinase activity,GO:0045860,biological process,51.0,12.0,1.528e-01,1.487e-01,1.570e-01,3.328e-02,1.155e-02,9.592e-02,8.168e-01,2.662e-02
CDKN1A,1784,negative regulation of cyclin-dependent protein kinase activity,GO:1904030,biological process,51.0,4.0,1.563e-01,1.355e-01,1.803e-01,2.770e-02,1.037e-02,7.399e-02,8.360e-01,2.378e-02
CDKN1A,1784,positive regulation of fibroblast proliferation,GO:0048146,biological process,51.0,6.0,1.583e-01,1.436e-01,1.746e-01,2.798e-02,1.123e-02,6.974e-02,8.353e-01,2.271e-02
CDKN1A,1784,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",GO:0006977,biological process,51.0,4.0,1.614e-01,1.429e-01,1.823e-01,6.841e-02,2.231e-02,2.098e-01,7.336e-01,3.326e-02
CDKN1A,1784,cellular response to amino acid starvation,GO:0034198,biological process,51.0,6.0,1.620e-01,1.363e-01,1.925e-01,5.058e-02,4.615e-03,5.544e-01,7.597e-01,6.192e-02
CDKN1A,1784,negative regulation of G1/S transition of mitotic cell cycle,GO:2000134,biological process,51.0,10.0,1.704e-01,1.373e-01,2.115e-01,6.607e-02,4.625e-02,9.440e-02,7.416e-01,1.043e-02
CDKN1A,1784,Ras protein signal transduction,GO:0007265,biological process,51.0,10.0,1.715e-01,1.257e-01,2.341e-01,7.298e-02,1.453e-02,3.667e-01,7.215e-01,4.738e-02
CDKN1A,1784,cellular response to ionizing radiation,GO:0071479,biological process,51.0,6.0,1.746e-01,1.264e-01,2.412e-01,6.974e-02,1.603e-02,3.034e-01,7.278e-01,4.607e-02
CDKN1A,1784,negative regulation of vascular smooth muscle cell proliferation,GO:1904706,biological process,51.0,3.0,1.777e-01,1.364e-01,2.314e-01,5.678e-02,7.768e-03,4.151e-01,7.509e-01,5.369e-02
CDKN1A,1784,negative regulation of cell growth,GO:0030308,biological process,51.0,19.0,1.927e-01,1.302e-01,2.851e-01,7.471e-02,4.099e-03,1.362e+00,7.021e-01,8.245e-02
CDKN1A,1784,negative regulation of cell population proliferation,GO:0008285,biological process,51.0,36.0,2.008e-01,1.248e-01,3.232e-01,5.949e-02,9.913e-04,3.569e+00,7.033e-01,1.011e-01
CDKN1A,1784,cellular response to extracellular stimulus,GO:0031668,biological process,51.0,13.0,2.068e-01,1.384e-01,3.090e-01,1.642e-01,8.117e-02,3.321e-01,6.095e-01,2.805e-02
CDKN1A,1784,cellular response to DNA damage stimulus,GO:0006974,biological process,51.0,13.0,2.110e-01,1.836e-01,2.425e-01,1.423e-01,7.669e-02,2.642e-01,6.338e-01,2.343e-02
CDKN1A,1784,positive regulation of reactive oxygen species metabolic process,GO:2000379,biological process,51.0,10.0,2.113e-01,1.831e-01,2.440e-01,1.377e-01,6.327e-02,2.998e-01,6.376e-01,3.021e-02
CDKN1A,1784,cell cycle arrest,GO:0007050,biological process,51.0,7.0,2.123e-01,2.064e-01,2.183e-01,1.616e-01,1.484e-01,1.759e-01,6.149e-01,3.348e-03
CDKN1A,1784,G1/S transition of mitotic cell cycle,GO:0000082,biological process,51.0,3.0,2.132e-01,1.892e-01,2.402e-01,1.566e-01,1.067e-01,2.298e-01,6.194e-01,1.489e-02
CDKN1A,1784,G2/M transition of mitotic cell cycle,GO:0000086,biological process,51.0,4.0,2.138e-01,1.899e-01,2.407e-01,1.619e-01,1.053e-01,2.490e-01,6.135e-01,1.739e-02
CDKN1A,1784,cellular senescence,GO:0090398,biological process,51.0,6.0,2.247e-01,1.785e-01,2.829e-01,1.760e-01,9.581e-02,3.234e-01,5.982e-01,2.575e-02
CDKN1A,1784,PCNA-p21 complex,GO:0070557,cellular component,51.0,2.0,8.148e-02,2.427e-02,2.736e-01,6.016e-03,1.070e-04,3.381e-01,8.993e-01,6.196e-02
CDKN1A,1784,nucleolus,GO:0005730,cellular component,51.0,18.0,1.728e-01,1.334e-01,2.239e-01,8.433e-02,5.201e-02,1.367e-01,7.100e-01,1.579e-02
CDKN1A,1784,nucleus,GO:0005634,cellular component,51.0,81.0,1.748e-01,1.390e-01,2.198e-01,7.831e-02,4.858e-02,1.262e-01,7.200e-01,1.451e-02
CDKN1A,1784,nucleoplasm,GO:0005654,cellular component,51.0,51.0,1.760e-01,1.368e-01,2.265e-01,9.775e-02,5.929e-02,1.612e-01,6.900e-01,1.666e-02
CDKN1A,1784,nuclear body,GO:0016604,cellular component,51.0,17.0,2.113e-01,1.831e-01,2.440e-01,1.319e-01,5.149e-02,3.379e-01,6.431e-01,3.525e-02
CDKN1A,1784,protein-containing complex,GO:0032991,cellular component,51.0,483.0,2.367e-01,1.007e-01,5.564e-01,1.723e-01,3.238e-02,9.167e-01,5.883e-01,6.681e-02
CDKN1A,1784,cyclin-dependent protein kinase holoenzyme complex,GO:0000307,cellular component,51.0,23.0,3.590e-01,6.595e-02,1.954e+00,2.624e-01,1.834e-02,3.755e+00,4.435e-01,1.509e-01
CDKN1A,1784,cyclin-dependent protein kinase activating kinase activity,GO:0019912,molecular function,51.0,3.0,1.517e-01,1.441e-01,1.596e-01,3.317e-02,1.070e-02,1.028e-01,8.166e-01,2.914e-02
CDKN1A,1784,ubiquitin protein ligase binding,GO:0031625,molecular function,51.0,9.0,1.657e-01,1.441e-01,1.905e-01,4.471e-02,2.431e-02,8.226e-02,7.860e-01,1.583e-02
CDKN1A,1784,protein binding,GO:0005515,molecular function,51.0,347.0,1.724e-01,1.433e-01,2.073e-01,7.140e-02,4.260e-02,1.197e-01,7.316e-01,1.538e-02
CDKN1A,1784,protein kinase binding,GO:0019901,molecular function,51.0,16.0,1.978e-01,1.243e-01,3.147e-01,1.031e-01,1.957e-02,5.436e-01,6.724e-01,5.494e-02
CDKN1A,1784,protein kinase inhibitor activity,GO:0004860,molecular function,51.0,6.0,2.442e-01,1.104e-01,5.400e-01,1.856e-01,4.113e-02,8.373e-01,5.783e-01,5.948e-02
CDKN1A,1784,protein-containing complex binding,GO:0044877,molecular function,51.0,75.0,2.792e-01,1.670e-01,4.669e-01,2.642e-01,1.427e-01,4.894e-01,5.213e-01,3.038e-02
CDKN2B,1788,negative regulation of phosphorylation,GO:0042326,biological process,21.0,8.0,1.119e-01,2.316e-02,5.404e-01,1.816e-02,4.134e-04,7.975e-01,8.338e-01,9.200e-02
CDKN2B,1788,regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000079,biological process,21.0,6.0,1.327e-01,2.815e-02,6.253e-01,2.317e-02,8.391e-04,6.397e-01,8.221e-01,7.094e-02
CDKN2B,1788,negative regulation of cell population proliferation,GO:0008285,biological process,21.0,36.0,1.596e-01,6.908e-02,3.686e-01,4.814e-02,6.371e-03,3.638e-01,7.703e-01,5.251e-02
CDKN2B,1788,negative regulation of epithelial cell proliferation,GO:0050680,biological process,21.0,16.0,1.640e-01,6.521e-02,4.122e-01,6.385e-02,2.321e-02,1.756e-01,7.431e-01,2.877e-02
CDKN2B,1788,positive regulation of transforming growth factor beta receptor signaling pathway,GO:0030511,biological process,21.0,5.0,1.640e-01,6.521e-02,4.122e-01,9.694e-02,3.567e-02,2.635e-01,6.881e-01,3.211e-02
CDKN2B,1788,cellular response to extracellular stimulus,GO:0031668,biological process,21.0,13.0,1.640e-01,6.521e-02,4.122e-01,1.182e-01,4.913e-02,2.843e-01,6.604e-01,3.206e-02
CDKN2B,1788,cellular response to nutrient,GO:0031670,biological process,21.0,15.0,1.659e-01,6.634e-02,4.150e-01,1.279e-01,7.257e-02,2.254e-01,6.507e-01,2.034e-02
CDKN2B,1788,mitotic cell cycle checkpoint,GO:0007093,biological process,21.0,12.0,1.712e-01,5.932e-02,4.940e-01,7.779e-02,7.459e-03,8.112e-01,7.019e-01,7.630e-02
CDKN2B,1788,cell cycle arrest,GO:0007050,biological process,21.0,7.0,1.712e-01,5.932e-02,4.940e-01,9.242e-02,1.556e-02,5.490e-01,6.851e-01,6.363e-02
CDKN2B,1788,G2/M transition of mitotic cell cycle,GO:0000086,biological process,21.0,4.0,1.868e-01,4.869e-02,7.169e-01,9.566e-02,8.077e-03,1.133e+00,6.633e-01,9.716e-02
CDKN2B,1788,cellular senescence,GO:0090398,biological process,21.0,6.0,1.868e-01,4.869e-02,7.169e-01,9.853e-02,9.756e-03,9.951e-01,6.626e-01,9.157e-02
CDKN2B,1788,megakaryocyte differentiation,GO:0030219,biological process,21.0,2.0,1.891e-01,4.980e-02,7.182e-01,1.804e-01,4.651e-02,6.994e-01,5.837e-01,6.096e-02
CDKN2B,1788,nucleus,GO:0005634,cellular component,21.0,81.0,1.640e-01,6.521e-02,4.122e-01,1.010e-01,5.632e-02,1.811e-01,6.850e-01,2.011e-02
CDKN2B,1788,cytoplasm,GO:0005737,cellular component,21.0,78.0,1.641e-01,6.528e-02,4.123e-01,1.363e-01,7.389e-02,2.515e-01,6.405e-01,2.315e-02
CDKN2B,1788,cyclin-dependent protein serine/threonine kinase inhibitor activity,GO:0004861,molecular function,21.0,3.0,1.640e-01,6.521e-02,4.122e-01,8.722e-02,2.306e-02,3.298e-01,7.002e-01,4.187e-02
CDKN2B,1788,protein binding,GO:0005515,molecular function,21.0,347.0,1.641e-01,6.528e-02,4.123e-01,1.232e-01,7.717e-02,1.967e-01,6.567e-01,1.676e-02
CDKN2B,1788,protein kinase binding,GO:0019901,molecular function,21.0,16.0,1.657e-01,6.776e-02,4.052e-01,1.238e-01,8.408e-02,1.821e-01,6.561e-01,1.421e-02
CDO1,1795,L-cysteine catabolic process,GO:0019448,biological process,7.0,7.0,1.005e-01,3.784e-02,2.671e-01,5.701e-02,3.607e-02,9.012e-02,7.590e-01,1.271e-02
CDO1,1795,cysteine dioxygenase activity,GO:0017172,molecular function,7.0,2.0,8.516e-02,2.278e-02,3.184e-01,3.743e-02,2.617e-03,5.355e-01,7.891e-01,7.816e-02
CDO1,1795,ferrous iron binding,GO:0008198,molecular function,7.0,2.0,9.444e-02,2.904e-02,3.072e-01,5.900e-02,1.288e-02,2.702e-01,7.497e-01,4.154e-02
CDO1,1795,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen",GO:0016702,molecular function,7.0,111.0,2.269e-01,7.307e-02,7.043e-01,2.061e-01,5.383e-02,7.892e-01,5.577e-01,6.545e-02
CDR2,1799,protein binding,GO:0005515,molecular function,4.0,347.0,2.038e-02,1.087e-02,3.819e-02,2.038e-02,1.087e-02,3.819e-02,8.670e-01,1.459e-02
CERS4,23747,ceramide biosynthetic process,GO:0046513,biological process,8.0,9.0,6.852e-02,2.726e-02,1.723e-01,3.922e-02,1.044e-02,1.473e-01,7.978e-01,3.512e-02
CERS4,23747,endoplasmic reticulum,GO:0005783,cellular component,8.0,34.0,1.013e-01,4.499e-02,2.280e-01,1.013e-01,4.499e-02,2.280e-01,6.833e-01,2.649e-02
CERS4,23747,sphingosine N-acyltransferase activity,GO:0050291,molecular function,8.0,2.0,2.611e-02,1.156e-02,5.899e-02,6.814e-03,2.614e-03,1.776e-02,9.387e-01,1.079e-02
CERS4,23747,N-acyltransferase activity,GO:0016410,molecular function,8.0,29.0,5.161e-02,1.815e-02,1.467e-01,3.626e-02,7.304e-03,1.800e-01,8.051e-01,3.906e-02
CFH,4883,complement activation,GO:0006956,biological process,16.0,8.0,9.631e-02,7.762e-02,1.195e-01,5.512e-02,2.150e-02,1.413e-01,7.611e-01,2.598e-02
CFH,4883,regulation of complement activation,GO:0030449,biological process,16.0,9.0,1.004e-01,5.260e-02,1.916e-01,6.623e-02,1.340e-02,3.272e-01,7.344e-01,4.480e-02
CFH,4883,regulation of complement-dependent cytotoxicity,GO:1903659,biological process,16.0,4.0,1.034e-01,6.132e-02,1.744e-01,7.039e-02,2.505e-02,1.978e-01,7.310e-01,2.961e-02
CFH,4883,blood microparticle,GO:0072562,cellular component,16.0,8.0,9.631e-02,7.762e-02,1.195e-01,5.298e-02,2.011e-02,1.396e-01,7.654e-01,2.687e-02
CFH,4883,extracellular exosome,GO:0070062,cellular component,16.0,77.0,1.015e-01,6.870e-02,1.501e-01,7.083e-02,4.395e-02,1.141e-01,7.328e-01,1.445e-02
CFH,4883,heparin binding,GO:0008201,molecular function,16.0,6.0,8.896e-02,5.658e-02,1.399e-01,3.012e-02,9.010e-03,1.007e-01,8.266e-01,2.886e-02
CFH,4883,heparan sulfate proteoglycan binding,GO:0043395,molecular function,16.0,4.0,8.896e-02,5.658e-02,1.399e-01,3.551e-02,1.191e-02,1.059e-01,8.101e-01,2.739e-02
CFH,4883,protein binding,GO:0005515,molecular function,16.0,347.0,1.177e-01,6.476e-02,2.138e-01,1.114e-01,5.218e-02,2.379e-01,6.699e-01,2.631e-02
CIB2,24579,,,,nan,nan,,,,,,,,
CISD3,27578,protein maturation by [2Fe-2S] cluster transfer,GO:0106034,biological process,6.0,2.0,3.696e-02,2.125e-02,6.430e-02,2.934e-02,1.188e-02,7.248e-02,8.304e-01,2.214e-02
CISD3,27578,mitochondrion,GO:0005739,cellular component,6.0,35.0,2.738e-02,1.168e-02,6.418e-02,1.956e-02,7.432e-03,5.149e-02,8.686e-01,2.117e-02
CISD3,27578,"2 iron, 2 sulfur cluster binding",GO:0051537,molecular function,6.0,3.0,2.757e-02,7.635e-03,9.957e-02,1.441e-02,1.201e-03,1.729e-01,8.770e-01,4.981e-02
CISD3,27578,metal ion binding,GO:0046872,molecular function,6.0,9.0,2.788e-02,1.191e-02,6.527e-02,2.108e-02,9.760e-03,4.553e-02,8.626e-01,1.730e-02
CLDN22,2044,,,,nan,nan,,,,,,,,
CLOCK,2082,DNA damage checkpoint,GO:0000077,biological process,22.0,6.0,1.615e-01,7.667e-02,3.404e-01,4.790e-02,1.983e-02,1.157e-01,7.773e-01,2.454e-02
CLOCK,2082,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,22.0,35.0,1.654e-01,8.051e-02,3.396e-01,5.361e-02,1.176e-02,2.444e-01,7.601e-01,4.348e-02
CLOCK,2082,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,22.0,62.0,1.744e-01,9.605e-02,3.167e-01,7.177e-02,3.968e-02,1.298e-01,7.306e-01,1.772e-02
CLOCK,2082,response to redox state,GO:0051775,biological process,22.0,6.0,1.891e-01,7.111e-02,5.030e-01,8.313e-02,5.178e-03,1.334e+00,6.861e-01,8.925e-02
CLOCK,2082,regulation of hair cycle,GO:0042634,biological process,22.0,8.0,1.918e-01,1.169e-01,3.147e-01,1.241e-01,7.475e-02,2.061e-01,6.553e-01,1.883e-02
CLOCK,2082,circadian regulation of gene expression,GO:0032922,biological process,22.0,5.0,2.055e-01,1.193e-01,3.540e-01,1.507e-01,8.000e-02,2.838e-01,6.243e-01,2.471e-02
CLOCK,2082,protein acetylation,GO:0006473,biological process,22.0,9.0,2.068e-01,1.099e-01,3.892e-01,1.538e-01,5.100e-02,4.639e-01,6.168e-01,4.262e-02
CLOCK,2082,cellular response to ionizing radiation,GO:0071479,biological process,22.0,6.0,2.209e-01,1.326e-01,3.682e-01,1.309e-01,3.477e-02,4.924e-01,6.396e-01,5.075e-02
CLOCK,2082,transcription factor complex,GO:0005667,cellular component,22.0,8.0,1.529e-01,6.746e-02,3.466e-01,3.997e-02,1.326e-02,1.205e-01,7.966e-01,2.901e-02
CLOCK,2082,intracellular membrane-bounded organelle,GO:0043231,cellular component,22.0,48.0,1.794e-01,8.663e-02,3.717e-01,7.943e-02,1.976e-02,3.193e-01,7.122e-01,4.114e-02
CLOCK,2082,nucleus,GO:0005634,cellular component,22.0,81.0,1.918e-01,1.169e-01,3.147e-01,1.084e-01,7.678e-02,1.530e-01,6.760e-01,1.222e-02
CLOCK,2082,nucleoplasm,GO:0005654,cellular component,22.0,51.0,1.974e-01,1.194e-01,3.265e-01,1.265e-01,5.540e-02,2.889e-01,6.507e-01,2.923e-02
CLOCK,2082,cytosol,GO:0005829,cellular component,22.0,76.0,1.974e-01,1.194e-01,3.265e-01,1.338e-01,5.034e-02,3.556e-01,6.407e-01,3.475e-02
CLOCK,2082,chromosome,GO:0005694,cellular component,22.0,9.0,2.732e-01,2.180e-01,3.424e-01,2.528e-01,1.640e-01,3.895e-01,5.322e-01,2.082e-02
CLOCK,2082,E-box binding,GO:0070888,molecular function,22.0,3.0,1.507e-01,6.474e-02,3.508e-01,1.623e-02,8.136e-03,3.237e-02,8.868e-01,1.431e-02
CLOCK,2082,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,22.0,16.0,1.507e-01,6.474e-02,3.508e-01,3.002e-02,6.110e-03,1.475e-01,8.251e-01,4.162e-02
CLOCK,2082,DNA binding,GO:0003677,molecular function,22.0,27.0,1.744e-01,9.605e-02,3.167e-01,6.523e-02,3.507e-02,1.213e-01,7.424e-01,1.827e-02
CLOCK,2082,protein binding,GO:0005515,molecular function,22.0,347.0,2.037e-01,1.359e-01,3.054e-01,1.750e-01,1.241e-01,2.469e-01,6.010e-01,1.407e-02
CLOCK,2082,histone acetyltransferase activity,GO:0004402,molecular function,22.0,6.0,2.561e-01,1.137e-01,5.769e-01,2.380e-01,8.956e-02,6.326e-01,5.377e-01,4.544e-02
CNR1,2159,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,GO:0007188,biological process,8.0,5.0,7.396e-02,4.153e-02,1.317e-01,2.144e-02,1.244e-02,3.697e-02,8.623e-01,1.295e-02
CNR1,2159,cannabinoid signaling pathway,GO:0038171,biological process,8.0,3.0,7.396e-02,4.153e-02,1.317e-01,2.105e-02,3.844e-03,1.152e-01,8.565e-01,3.722e-02
CNR1,2159,actin cytoskeleton,GO:0015629,cellular component,8.0,9.0,7.396e-02,4.153e-02,1.317e-01,4.335e-02,3.109e-02,6.043e-02,7.902e-01,8.638e-03
CNR1,2159,plasma membrane,GO:0005886,cellular component,8.0,61.0,7.404e-02,4.149e-02,1.321e-01,5.470e-02,3.437e-02,8.706e-02,7.638e-01,1.265e-02
CNR1,2159,identical protein binding,GO:0042802,molecular function,8.0,35.0,7.396e-02,4.153e-02,1.317e-01,4.847e-02,3.627e-02,6.478e-02,7.779e-01,7.938e-03
CNR1,2159,cannabinoid receptor activity,GO:0004949,molecular function,8.0,2.0,9.412e-02,3.347e-02,2.647e-01,8.444e-02,2.160e-02,3.301e-01,7.042e-01,4.184e-02
CNR1,2159,protein binding,GO:0005515,molecular function,8.0,347.0,9.986e-02,8.084e-02,1.234e-01,9.486e-02,7.709e-02,1.167e-01,6.952e-01,6.976e-03
COL18A1,2195,extracellular matrix organization,GO:0030198,biological process,18.0,19.0,1.554e-02,1.234e-02,1.957e-02,7.841e-03,3.223e-03,1.908e-02,9.331e-01,9.607e-03
COL18A1,2195,angiogenesis,GO:0001525,biological process,18.0,9.0,1.987e-02,1.099e-02,3.592e-02,1.516e-02,3.370e-03,6.823e-02,8.836e-01,2.505e-02
COL18A1,2195,endothelial cell morphogenesis,GO:0001886,biological process,18.0,3.0,2.501e-02,1.317e-02,4.749e-02,2.400e-02,1.124e-02,5.125e-02,8.507e-01,1.818e-02
COL18A1,2195,extracellular matrix,GO:0031012,cellular component,18.0,17.0,1.450e-02,1.258e-02,1.670e-02,4.513e-03,2.599e-03,7.838e-03,9.560e-01,4.239e-03
COL18A1,2195,collagen-containing extracellular matrix,GO:0062023,cellular component,18.0,36.0,1.450e-02,1.258e-02,1.670e-02,4.548e-03,2.701e-03,7.657e-03,9.559e-01,4.296e-03
COL18A1,2195,extracellular space,GO:0005615,cellular component,18.0,43.0,1.588e-02,1.245e-02,2.026e-02,8.648e-03,3.072e-03,2.434e-02,9.266e-01,1.386e-02
COL18A1,2195,extracellular region,GO:0005576,cellular component,18.0,17.0,1.953e-02,1.393e-02,2.739e-02,1.517e-02,8.311e-03,2.769e-02,8.928e-01,1.216e-02
COL18A1,2195,extracellular exosome,GO:0070062,cellular component,18.0,77.0,2.046e-02,1.645e-02,2.543e-02,1.622e-02,1.388e-02,1.895e-02,8.894e-01,3.190e-03
COL18A1,2195,extracellular matrix structural constituent,GO:0005201,molecular function,18.0,12.0,1.479e-02,1.292e-02,1.693e-02,6.719e-03,4.245e-03,1.064e-02,9.415e-01,4.415e-03
COL4A1,2202,branching involved in blood vessel morphogenesis,GO:0001569,biological process,24.0,2.0,2.290e-02,8.923e-03,5.876e-02,7.677e-03,3.366e-03,1.751e-02,9.339e-01,9.877e-03
COL4A1,2202,extracellular matrix organization,GO:0030198,biological process,24.0,19.0,2.304e-02,8.810e-03,6.027e-02,1.186e-02,3.802e-03,3.698e-02,9.064e-01,1.896e-02
COL4A1,2202,retinal blood vessel morphogenesis,GO:0061304,biological process,24.0,3.0,2.371e-02,1.035e-02,5.429e-02,9.976e-03,4.352e-03,2.287e-02,9.205e-01,1.096e-02
COL4A1,2202,basement membrane organization,GO:0071711,biological process,24.0,4.0,2.454e-02,1.110e-02,5.429e-02,1.626e-02,6.446e-03,4.099e-02,8.850e-01,2.013e-02
COL4A1,2202,blood vessel morphogenesis,GO:0048514,biological process,24.0,7.0,3.086e-02,2.126e-02,4.480e-02,2.453e-02,1.623e-02,3.709e-02,8.492e-01,1.003e-02
COL4A1,2202,renal tubule morphogenesis,GO:0061333,biological process,24.0,4.0,3.374e-02,1.825e-02,6.238e-02,2.772e-02,1.404e-02,5.473e-02,8.367e-01,1.661e-02
COL4A1,2202,brain development,GO:0007420,biological process,24.0,6.0,6.590e-02,1.790e-02,2.426e-01,6.347e-02,1.616e-02,2.493e-01,7.404e-01,4.272e-02
COL4A1,2202,extracellular matrix,GO:0031012,cellular component,24.0,17.0,1.470e-02,1.568e-03,1.378e-01,3.055e-03,4.781e-05,1.952e-01,9.421e-01,2.278e-02
COL4A1,2202,collagen-containing extracellular matrix,GO:0062023,cellular component,24.0,36.0,2.212e-02,8.491e-03,5.762e-02,5.719e-03,3.342e-03,9.786e-03,9.477e-01,4.781e-03
COL4A1,2202,collagen type IV trimer,GO:0005587,cellular component,24.0,4.0,2.226e-02,8.375e-03,5.916e-02,7.485e-03,3.149e-03,1.779e-02,9.349e-01,1.046e-02
COL4A1,2202,extracellular space,GO:0005615,cellular component,24.0,43.0,2.573e-02,1.188e-02,5.576e-02,1.494e-02,8.530e-03,2.617e-02,8.945e-01,1.005e-02
COL4A1,2202,extracellular matrix structural constituent conferring tensile strength,GO:0030020,molecular function,24.0,4.0,1.608e-02,2.375e-03,1.089e-01,2.475e-03,3.227e-04,1.899e-02,9.650e-01,1.015e-02
COL4A1,2202,extracellular matrix structural constituent,GO:0005201,molecular function,24.0,12.0,1.675e-02,2.375e-03,1.181e-01,6.688e-03,2.874e-04,1.556e-01,9.162e-01,3.106e-02
COL4A1,2202,platelet-derived growth factor binding,GO:0048407,molecular function,24.0,4.0,3.172e-02,1.387e-02,7.255e-02,2.532e-02,9.492e-03,6.755e-02,8.446e-01,2.287e-02
COL4A1,2202,protein binding,GO:0005515,molecular function,24.0,347.0,8.356e-02,3.005e-02,2.323e-01,8.166e-02,3.095e-02,2.155e-01,7.120e-01,2.954e-02
COL4A2,2203,extracellular matrix organization,GO:0030198,biological process,24.0,19.0,3.259e-02,1.910e-02,5.561e-02,1.810e-02,6.518e-03,5.025e-02,8.740e-01,2.008e-02
COL4A2,2203,endodermal cell differentiation,GO:0035987,biological process,24.0,3.0,3.265e-02,2.337e-02,4.560e-02,1.839e-02,6.975e-03,4.850e-02,8.737e-01,2.018e-02
COL4A2,2203,collagen-activated tyrosine kinase receptor signaling pathway,GO:0038063,biological process,24.0,3.0,4.864e-02,2.194e-02,1.078e-01,3.884e-02,1.521e-02,9.919e-02,8.004e-01,2.438e-02
COL4A2,2203,negative regulation of angiogenesis,GO:0016525,biological process,24.0,7.0,9.529e-02,1.845e-02,4.920e-01,8.967e-02,1.413e-02,5.690e-01,6.909e-01,5.609e-02
COL4A2,2203,collagen-containing extracellular matrix,GO:0062023,cellular component,24.0,36.0,2.976e-02,1.990e-02,4.452e-02,5.918e-03,2.322e-03,1.508e-02,9.453e-01,8.853e-03
COL4A2,2203,extracellular matrix,GO:0031012,cellular component,24.0,17.0,2.976e-02,1.990e-02,4.452e-02,7.585e-03,4.025e-03,1.430e-02,9.355e-01,7.323e-03
COL4A2,2203,collagen type IV trimer,GO:0005587,cellular component,24.0,4.0,3.315e-02,2.123e-02,5.178e-02,1.504e-02,8.859e-03,2.554e-02,8.939e-01,1.084e-02
COL4A2,2203,extracellular space,GO:0005615,cellular component,24.0,43.0,3.316e-02,2.122e-02,5.183e-02,1.570e-02,1.423e-02,1.731e-02,8.924e-01,1.919e-03
COL4A2,2203,extracellular exosome,GO:0070062,cellular component,24.0,77.0,3.567e-02,2.269e-02,5.608e-02,2.771e-02,1.614e-02,4.756e-02,8.369e-01,1.328e-02
COL4A2,2203,extracellular matrix structural constituent conferring tensile strength,GO:0030020,molecular function,24.0,4.0,2.976e-02,1.990e-02,4.452e-02,6.885e-03,3.428e-03,1.383e-02,9.400e-01,6.573e-03
COL4A2,2203,extracellular matrix structural constituent,GO:0005201,molecular function,24.0,12.0,3.280e-02,1.903e-02,5.652e-02,1.856e-02,5.164e-03,6.669e-02,8.696e-01,2.488e-02
COL4A2,2203,protein binding,GO:0005515,molecular function,24.0,347.0,9.522e-02,3.568e-02,2.542e-01,8.986e-02,3.710e-02,2.176e-01,6.994e-01,2.770e-02
COL5A3,14864,extracellular matrix organization,GO:0030198,biological process,13.0,19.0,1.781e-02,1.693e-02,1.874e-02,1.117e-02,2.822e-03,4.423e-02,9.089e-01,1.827e-02
COL5A3,14864,collagen type IX trimer,GO:0005594,cellular component,13.0,2.0,1.443e-02,7.845e-03,2.656e-02,8.690e-03,4.312e-03,1.751e-02,9.285e-01,9.204e-03
COL5A3,14864,collagen-containing extracellular matrix,GO:0062023,cellular component,13.0,36.0,1.443e-02,7.845e-03,2.656e-02,8.837e-03,4.434e-03,1.761e-02,9.277e-01,9.202e-03
COL5A3,14864,extracellular matrix,GO:0031012,cellular component,13.0,17.0,1.471e-02,7.728e-03,2.799e-02,7.141e-03,2.534e-03,2.012e-02,9.360e-01,1.235e-02
COL5A3,14864,extracellular space,GO:0005615,cellular component,13.0,43.0,1.471e-02,7.728e-03,2.799e-02,1.112e-02,4.659e-03,2.652e-02,9.138e-01,1.174e-02
COL5A3,14864,extracellular matrix structural constituent conferring tensile strength,GO:0030020,molecular function,13.0,4.0,1.443e-02,7.845e-03,2.656e-02,4.877e-03,1.823e-03,1.305e-02,9.519e-01,7.496e-03
COL5A3,14864,extracellular matrix structural constituent,GO:0005201,molecular function,13.0,12.0,1.731e-02,6.908e-03,4.340e-02,1.645e-02,5.512e-03,4.908e-02,8.819e-01,2.000e-02
COL6A1,2211,osteoblast differentiation,GO:0001649,biological process,22.0,3.0,3.634e-02,2.233e-02,5.913e-02,1.290e-02,2.380e-03,6.995e-02,8.946e-01,3.020e-02
COL6A1,2211,endodermal cell differentiation,GO:0035987,biological process,22.0,3.0,3.634e-02,2.233e-02,5.913e-02,1.370e-02,2.845e-03,6.598e-02,8.919e-01,3.094e-02
COL6A1,2211,growth plate cartilage chondrocyte morphogenesis,GO:0003429,biological process,22.0,4.0,3.649e-02,2.232e-02,5.966e-02,1.646e-02,9.526e-03,2.843e-02,8.865e-01,1.148e-02
COL6A1,2211,collagen-containing extracellular matrix,GO:0062023,cellular component,22.0,36.0,3.634e-02,2.233e-02,5.913e-02,9.890e-03,8.492e-03,1.152e-02,9.234e-01,1.998e-03
COL6A1,2211,extracellular matrix,GO:0031012,cellular component,22.0,17.0,3.649e-02,2.232e-02,5.966e-02,1.327e-02,4.377e-03,4.023e-02,8.990e-01,1.730e-02
COL6A1,2211,extracellular space,GO:0005615,cellular component,22.0,43.0,3.685e-02,2.329e-02,5.830e-02,1.885e-02,1.436e-02,2.473e-02,8.756e-01,6.381e-03
COL6A1,2211,extracellular region,GO:0005576,cellular component,22.0,17.0,3.685e-02,2.329e-02,5.830e-02,2.414e-02,1.530e-02,3.808e-02,8.509e-01,1.109e-02
COL6A1,2211,extracellular exosome,GO:0070062,cellular component,22.0,77.0,3.774e-02,2.584e-02,5.514e-02,2.711e-02,2.077e-02,3.539e-02,8.390e-01,6.497e-03
COL6A1,2211,lysosomal membrane,GO:0005765,cellular component,22.0,10.0,5.234e-02,1.673e-02,1.637e-01,3.202e-02,3.480e-03,2.946e-01,8.105e-01,4.962e-02
COL6A1,2211,membrane,GO:0016020,cellular component,22.0,58.0,7.045e-02,3.003e-02,1.653e-01,6.503e-02,2.772e-02,1.526e-01,7.418e-01,2.422e-02
COL6A1,2211,protein-containing complex,GO:0032991,cellular component,22.0,483.0,2.984e-01,4.955e-02,1.797e+00,2.984e-01,4.955e-02,1.797e+00,4.666e-01,8.926e-02
COL6A1,2211,platelet-derived growth factor binding,GO:0048407,molecular function,22.0,4.0,3.685e-02,2.329e-02,5.830e-02,2.484e-02,1.281e-02,4.817e-02,8.475e-01,1.607e-02
COL6A1,2211,collagen binding,GO:0005518,molecular function,22.0,7.0,3.960e-02,3.169e-02,4.950e-02,2.381e-02,1.555e-02,3.647e-02,8.523e-01,1.035e-02
COLCA2,26978,,,,nan,nan,,,,,,,,
COLQ,2226,extracellular matrix organization,GO:0030198,biological process,13.0,19.0,2.929e-02,1.344e-02,6.384e-02,1.769e-02,4.841e-03,6.465e-02,8.734e-01,2.442e-02
COLQ,2226,collagen-containing extracellular matrix,GO:0062023,cellular component,13.0,36.0,2.781e-02,1.394e-02,5.548e-02,6.331e-03,4.674e-03,8.576e-03,9.440e-01,2.841e-03
COLQ,2226,extracellular matrix,GO:0031012,cellular component,13.0,17.0,2.781e-02,1.394e-02,5.548e-02,7.965e-03,3.859e-03,1.644e-02,9.329e-01,8.252e-03
COLQ,2226,extracellular space,GO:0005615,cellular component,13.0,43.0,3.062e-02,2.120e-02,4.422e-02,1.460e-02,9.780e-03,2.179e-02,8.972e-01,7.092e-03
COLQ,2226,plasma membrane,GO:0005886,cellular component,13.0,61.0,3.683e-02,1.623e-02,8.357e-02,2.873e-02,1.166e-02,7.078e-02,8.324e-01,2.241e-02
COLQ,2226,cell junction,GO:0030054,cellular component,13.0,10.0,4.158e-02,2.176e-02,7.948e-02,3.696e-02,1.934e-02,7.065e-02,8.065e-01,1.633e-02
COLQ,2226,heparin binding,GO:0008201,molecular function,13.0,6.0,2.832e-02,1.510e-02,5.312e-02,1.634e-02,6.454e-03,4.137e-02,8.846e-01,1.982e-02
COLQ,2226,extracellular matrix structural constituent,GO:0005201,molecular function,13.0,12.0,2.904e-02,1.355e-02,6.222e-02,1.155e-02,2.859e-03,4.663e-02,9.061e-01,2.015e-02
COLQ,2226,protein binding,GO:0005515,molecular function,13.0,347.0,5.283e-02,2.486e-02,1.122e-01,5.283e-02,2.486e-02,1.122e-01,7.668e-01,2.043e-02
COMT,2228,dopamine metabolic process,GO:0042417,biological process,47.0,6.0,7.906e-02,2.308e-02,2.708e-01,4.964e-02,8.586e-03,2.869e-01,7.687e-01,4.754e-02
COMT,2228,catecholamine catabolic process,GO:0042424,biological process,47.0,7.0,8.915e-02,3.824e-02,2.078e-01,6.450e-02,2.706e-02,1.537e-01,7.427e-01,2.473e-02
COMT,2228,developmental process,GO:0032502,biological process,47.0,25.0,7.515e-01,4.092e-01,1.380e+00,7.280e-01,3.559e-01,1.489e+00,1.774e-01,8.210e-02
COMT,2228,axon,GO:0030424,cellular component,47.0,9.0,4.465e-02,3.298e-02,6.046e-02,1.430e-02,7.227e-03,2.831e-02,8.967e-01,1.361e-02
COMT,2228,intracellular membrane-bounded organelle,GO:0043231,cellular component,47.0,48.0,5.319e-02,2.910e-02,9.720e-02,1.360e-02,2.358e-03,7.845e-02,8.901e-01,3.057e-02
COMT,2228,dendrite,GO:0030425,cellular component,47.0,11.0,5.564e-02,1.965e-02,1.576e-01,2.431e-02,5.936e-03,9.959e-02,8.456e-01,3.237e-02
COMT,2228,extracellular exosome,GO:0070062,cellular component,47.0,77.0,5.964e-02,2.922e-02,1.217e-01,2.700e-02,1.539e-02,4.737e-02,8.393e-01,1.379e-02
COMT,2228,membrane,GO:0016020,cellular component,47.0,58.0,6.629e-02,2.552e-02,1.722e-01,3.730e-02,1.584e-02,8.783e-02,8.052e-01,2.175e-02
COMT,2228,catechol O-methyltransferase activity,GO:0016206,molecular function,47.0,3.0,5.824e-02,2.860e-02,1.186e-01,1.712e-02,1.524e-03,1.923e-01,8.658e-01,5.424e-02
COMT,2228,protein binding,GO:0005515,molecular function,47.0,347.0,7.987e-02,2.310e-02,2.762e-01,5.198e-02,1.037e-02,2.605e-01,7.646e-01,4.309e-02
COMT,2228,O-methyltransferase activity,GO:0008171,molecular function,47.0,31.0,2.974e-01,8.241e-02,1.073e+00,2.791e-01,6.980e-02,1.116e+00,4.893e-01,8.129e-02
CPA3,2298,proteolysis,GO:0006508,biological process,6.0,14.0,3.970e-02,2.450e-02,6.431e-02,2.276e-02,1.416e-02,3.656e-02,8.568e-01,1.149e-02
CPA3,2298,collagen-containing extracellular matrix,GO:0062023,cellular component,6.0,36.0,3.970e-02,2.450e-02,6.431e-02,2.156e-02,1.160e-02,4.006e-02,8.621e-01,1.499e-02
CPA3,2298,extracellular space,GO:0005615,cellular component,6.0,43.0,3.970e-02,2.450e-02,6.431e-02,2.645e-02,2.010e-02,3.480e-02,8.416e-01,6.661e-03
CPA3,2298,extracellular region,GO:0005576,cellular component,6.0,17.0,4.965e-02,3.140e-02,7.853e-02,4.965e-02,3.140e-02,7.853e-02,7.747e-01,1.214e-02
CPA3,2298,metallocarboxypeptidase activity,GO:0004181,molecular function,6.0,7.0,4.083e-02,2.302e-02,7.239e-02,3.464e-02,1.947e-02,6.164e-02,8.136e-01,1.430e-02
CPEB2,21745,negative regulation of cytoplasmic translation,GO:2000766,biological process,15.0,6.0,6.361e-02,4.738e-02,8.539e-02,2.426e-02,8.674e-03,6.782e-02,8.495e-01,2.515e-02
CPEB2,21745,cellular response to hypoxia,GO:0071456,biological process,15.0,5.0,7.132e-02,4.065e-02,1.251e-01,3.432e-02,6.915e-03,1.704e-01,8.106e-01,4.012e-02
CPEB2,21745,cellular response to insulin stimulus,GO:0032869,biological process,15.0,4.0,9.322e-02,4.673e-02,1.860e-01,6.028e-02,1.659e-02,2.190e-01,7.481e-01,3.697e-02
CPEB2,21745,messenger ribonucleoprotein complex,GO:1990124,cellular component,15.0,3.0,5.043e-02,2.218e-02,1.147e-01,1.856e-02,5.905e-03,5.832e-02,8.712e-01,2.283e-02
CPEB2,21745,nucleus,GO:0005634,cellular component,15.0,81.0,1.012e-01,9.317e-02,1.099e-01,7.756e-02,6.325e-02,9.511e-02,7.219e-01,6.260e-03
CPEB2,21745,cytoplasm,GO:0005737,cellular component,15.0,78.0,1.182e-01,9.951e-02,1.404e-01,9.972e-02,8.870e-02,1.121e-01,6.885e-01,4.033e-03
CPEB2,21745,neuron projection,GO:0043005,cellular component,15.0,22.0,1.422e-01,3.438e-02,5.879e-01,1.126e-01,1.439e-02,8.814e-01,6.527e-01,7.081e-02
CPEB2,21745,synapse,GO:0045202,cellular component,15.0,21.0,1.919e-01,9.221e-02,3.992e-01,1.868e-01,8.978e-02,3.887e-01,5.868e-01,3.139e-02
CPEB2,21745,"translation factor activity, RNA binding",GO:0008135,molecular function,15.0,6.0,4.880e-02,2.096e-02,1.136e-01,7.813e-03,3.242e-03,1.882e-02,9.333e-01,9.193e-03
CPEB2,21745,mRNA 3'-UTR binding,GO:0003730,molecular function,15.0,3.0,4.880e-02,2.096e-02,1.136e-01,1.031e-02,2.240e-03,4.748e-02,9.117e-01,2.204e-02
CPEB2,21745,"translation repressor activity, mRNA regulatory element binding",GO:0000900,molecular function,15.0,3.0,5.043e-02,2.218e-02,1.147e-01,2.212e-02,7.998e-03,6.119e-02,8.566e-01,2.222e-02
CPEB2,21745,RNA binding,GO:0003723,molecular function,15.0,60.0,5.292e-02,2.201e-02,1.273e-01,2.496e-02,5.979e-03,1.042e-01,8.425e-01,3.127e-02
CPEB2,21745,ribosome binding,GO:0043022,molecular function,15.0,4.0,6.784e-02,4.807e-02,9.575e-02,3.998e-02,2.100e-02,7.614e-02,7.983e-01,1.623e-02
CRB2,18688,,,,nan,nan,,,,,,,,
CRYAB,2389,cellular response to gamma radiation,GO:0071480,biological process,24.0,3.0,6.150e-02,2.380e-02,1.589e-01,7.405e-03,1.865e-03,2.940e-02,9.317e-01,1.730e-02
CRYAB,2389,protein homooligomerization,GO:0051260,biological process,24.0,5.0,1.112e-01,6.026e-02,2.053e-01,3.492e-02,7.074e-03,1.724e-01,8.087e-01,4.228e-02
CRYAB,2389,protein stabilization,GO:0050821,biological process,24.0,4.0,1.139e-01,6.141e-02,2.112e-01,3.092e-02,1.701e-02,5.620e-02,8.253e-01,1.483e-02
CRYAB,2389,regulation of cell death,GO:0010941,biological process,24.0,8.0,1.140e-01,6.130e-02,2.121e-01,4.136e-02,1.819e-02,9.409e-02,7.940e-01,2.167e-02
CRYAB,2389,negative regulation of amyloid fibril formation,GO:1905907,biological process,24.0,4.0,1.233e-01,8.745e-02,1.738e-01,6.941e-02,9.541e-03,5.050e-01,7.246e-01,5.628e-02
CRYAB,2389,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,24.0,31.0,1.338e-01,1.085e-01,1.650e-01,8.649e-02,7.439e-02,1.006e-01,7.079e-01,4.680e-03
CRYAB,2389,negative regulation of apoptotic process,GO:0043066,biological process,24.0,29.0,1.353e-01,7.219e-02,2.537e-01,7.193e-02,6.187e-03,8.362e-01,7.143e-01,7.106e-02
CRYAB,2389,negative regulation of protein-containing complex assembly,GO:0031333,biological process,24.0,36.0,1.426e-01,3.882e-02,5.241e-01,7.979e-02,8.450e-03,7.534e-01,6.980e-01,7.808e-02
CRYAB,2389,negative regulation of intracellular transport,GO:0032387,biological process,24.0,17.0,1.810e-01,2.244e-02,1.460e+00,1.058e-01,4.895e-03,2.289e+00,6.228e-01,1.350e-01
CRYAB,2389,extracellular exosome,GO:0070062,cellular component,24.0,77.0,1.340e-01,6.874e-02,2.610e-01,7.992e-02,2.840e-02,2.249e-01,7.139e-01,3.384e-02
CRYAB,2389,nucleus,GO:0005634,cellular component,24.0,81.0,1.458e-01,8.839e-02,2.406e-01,1.152e-01,6.242e-02,2.127e-01,6.662e-01,2.242e-02
CRYAB,2389,cytoplasm,GO:0005737,cellular component,24.0,78.0,1.608e-01,8.778e-02,2.945e-01,1.428e-01,7.739e-02,2.634e-01,6.330e-01,2.388e-02
CRYAB,2389,protein-containing complex,GO:0032991,cellular component,24.0,483.0,3.427e-01,8.156e-02,1.440e+00,2.613e-01,2.525e-02,2.704e+00,4.788e-01,1.107e-01
CRYAB,2389,unfolded protein binding,GO:0051082,molecular function,24.0,2.0,5.757e-02,2.122e-02,1.562e-01,3.569e-03,8.345e-04,1.527e-02,9.589e-01,1.086e-02
CRYAB,2389,amyloid-beta binding,GO:0001540,molecular function,24.0,3.0,1.228e-01,8.321e-02,1.812e-01,5.979e-02,4.028e-02,8.876e-02,7.535e-01,1.108e-02
CRYAB,2389,identical protein binding,GO:0042802,molecular function,24.0,35.0,1.229e-01,8.301e-02,1.821e-01,6.357e-02,3.174e-02,1.273e-01,7.451e-01,2.070e-02
CRYAB,2389,protein homodimerization activity,GO:0042803,molecular function,24.0,21.0,1.229e-01,8.301e-02,1.821e-01,7.265e-02,4.733e-02,1.115e-01,7.298e-01,1.308e-02
CRYAB,2389,protein-containing complex binding,GO:0044877,molecular function,24.0,75.0,1.360e-01,7.057e-02,2.619e-01,8.892e-02,3.124e-02,2.532e-01,6.996e-01,3.453e-02
CRYAB,2389,protein binding,GO:0005515,molecular function,24.0,347.0,1.458e-01,8.839e-02,2.406e-01,1.145e-01,6.962e-02,1.883e-01,6.676e-01,1.811e-02
CTSC,2528,proteolysis,GO:0006508,biological process,14.0,14.0,6.746e-02,3.512e-02,1.296e-01,3.078e-02,6.796e-03,1.394e-01,8.225e-01,3.719e-02
CTSC,2528,proteolysis involved in cellular protein catabolic process,GO:0051603,biological process,14.0,12.0,7.917e-02,3.211e-02,1.952e-01,3.044e-02,4.476e-03,2.071e-01,8.192e-01,4.447e-02
CTSC,2528,extracellular exosome,GO:0070062,cellular component,14.0,77.0,7.018e-02,4.125e-02,1.194e-01,2.733e-02,2.008e-02,3.720e-02,8.381e-01,7.558e-03
CTSC,2528,collagen-containing extracellular matrix,GO:0062023,cellular component,14.0,36.0,7.111e-02,4.347e-02,1.163e-01,2.664e-02,1.600e-02,4.436e-02,8.407e-01,1.251e-02
CTSC,2528,extracellular space,GO:0005615,cellular component,14.0,43.0,7.111e-02,4.347e-02,1.163e-01,2.798e-02,2.008e-02,3.898e-02,8.360e-01,8.171e-03
CTSC,2528,intracellular membrane-bounded organelle,GO:0043231,cellular component,14.0,48.0,8.322e-02,2.978e-02,2.326e-01,5.049e-02,5.257e-03,4.849e-01,7.615e-01,5.966e-02
CTSC,2528,membrane,GO:0016020,cellular component,14.0,58.0,8.346e-02,4.021e-02,1.732e-01,6.901e-02,3.635e-02,1.310e-01,7.355e-01,1.855e-02
CTSC,2528,centrosome,GO:0005813,cellular component,14.0,9.0,8.390e-02,4.113e-02,1.712e-01,6.047e-02,5.023e-02,7.279e-02,7.526e-01,5.297e-03
CTSC,2528,nucleoplasm,GO:0005654,cellular component,14.0,51.0,8.773e-02,3.701e-02,2.079e-01,7.733e-02,2.916e-02,2.051e-01,7.192e-01,2.930e-02
CTSC,2528,lysosome,GO:0005764,cellular component,14.0,13.0,8.862e-02,3.363e-02,2.335e-01,6.224e-02,1.024e-02,3.783e-01,7.400e-01,5.218e-02
CTSC,2528,cysteine-type endopeptidase activity,GO:0004197,molecular function,14.0,6.0,6.501e-02,3.399e-02,1.243e-01,1.021e-02,2.920e-03,3.568e-02,9.162e-01,1.539e-02
CTSC,2528,cysteine-type peptidase activity,GO:0008234,molecular function,14.0,5.0,7.111e-02,4.347e-02,1.163e-01,3.888e-02,1.187e-02,1.273e-01,8.000e-01,3.005e-02
CTSC,2528,protein binding,GO:0005515,molecular function,14.0,347.0,8.773e-02,3.701e-02,2.079e-01,7.133e-02,2.809e-02,1.811e-01,7.292e-01,2.940e-02
CTSD,2529,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043280,biological process,31.0,8.0,9.521e-02,7.450e-02,1.217e-01,2.101e-02,4.700e-03,9.395e-02,8.600e-01,3.529e-02
CTSD,2529,protein catabolic process,GO:0030163,biological process,31.0,13.0,1.023e-01,6.322e-02,1.654e-01,3.934e-02,2.647e-02,5.847e-02,8.003e-01,1.008e-02
CTSD,2529,proteolysis,GO:0006508,biological process,31.0,14.0,1.058e-01,5.834e-02,1.919e-01,4.985e-02,1.895e-02,1.311e-01,7.723e-01,2.731e-02
CTSD,2529,lipoprotein catabolic process,GO:0042159,biological process,31.0,5.0,1.268e-01,7.246e-02,2.219e-01,4.855e-02,7.905e-03,2.982e-01,7.705e-01,4.971e-02
CTSD,2529,regulation of establishment of protein localization,GO:0070201,biological process,31.0,7.0,2.015e-01,1.633e-02,2.487e+00,7.181e-02,1.020e-03,5.057e+00,6.108e-01,2.096e-01
CTSD,2529,positive regulation of apoptotic process,GO:0043065,biological process,31.0,26.0,2.289e-01,1.311e-01,3.997e-01,2.195e-01,1.099e-01,4.386e-01,5.575e-01,3.061e-02
CTSD,2529,extracellular space,GO:0005615,cellular component,31.0,43.0,1.023e-01,6.322e-02,1.654e-01,3.800e-02,2.357e-02,6.126e-02,8.041e-01,1.212e-02
CTSD,2529,collagen-containing extracellular matrix,GO:0062023,cellular component,31.0,36.0,1.023e-01,6.322e-02,1.654e-01,4.661e-02,2.202e-02,9.866e-02,7.811e-01,1.969e-02
CTSD,2529,membrane raft,GO:0045121,cellular component,31.0,8.0,1.058e-01,5.834e-02,1.919e-01,5.936e-02,2.939e-02,1.199e-01,7.535e-01,1.970e-02
CTSD,2529,extracellular exosome,GO:0070062,cellular component,31.0,77.0,1.124e-01,7.163e-02,1.763e-01,5.354e-02,3.179e-02,9.015e-02,7.661e-01,1.427e-02
CTSD,2529,extracellular region,GO:0005576,cellular component,31.0,17.0,1.335e-01,8.710e-02,2.047e-01,9.179e-02,6.891e-02,1.223e-01,6.996e-01,9.565e-03
CTSD,2529,lysosomal membrane,GO:0005765,cellular component,31.0,10.0,1.369e-01,7.064e-02,2.654e-01,9.283e-02,2.224e-02,3.875e-01,6.905e-01,4.437e-02
CTSD,2529,lysosome,GO:0005764,cellular component,31.0,13.0,1.422e-01,8.353e-02,2.421e-01,1.148e-01,6.618e-02,1.992e-01,6.668e-01,1.944e-02
CTSD,2529,endosome membrane,GO:0010008,cellular component,31.0,12.0,1.829e-01,5.604e-02,5.968e-01,1.298e-01,1.513e-02,1.113e+00,6.295e-01,7.386e-02
CTSD,2529,aspartic-type endopeptidase activity,GO:0004190,molecular function,31.0,5.0,9.521e-02,7.450e-02,1.217e-01,1.517e-02,4.188e-03,5.494e-02,8.875e-01,2.649e-02
CTSD,2529,protein binding,GO:0005515,molecular function,31.0,347.0,1.366e-01,7.077e-02,2.638e-01,1.017e-01,4.814e-02,2.150e-01,6.831e-01,2.460e-02
CTSD,2529,peptidase activity,GO:0008233,molecular function,31.0,7.0,1.995e-01,1.311e-01,3.034e-01,1.700e-01,8.118e-02,3.558e-01,6.037e-01,2.881e-02
CXCR4,2561,chemotaxis,GO:0006935,biological process,41.0,12.0,1.084e-01,2.757e-02,4.265e-01,1.788e-02,2.883e-03,1.109e-01,8.688e-01,3.667e-02
CXCR4,2561,neurogenesis,GO:0022008,biological process,41.0,4.0,1.084e-01,2.757e-02,4.265e-01,2.698e-02,4.117e-03,1.768e-01,8.337e-01,4.804e-02
CXCR4,2561,cell chemotaxis,GO:0060326,biological process,41.0,19.0,1.084e-01,2.757e-02,4.265e-01,3.164e-02,8.986e-03,1.114e-01,8.214e-01,3.142e-02
CXCR4,2561,response to hypoxia,GO:0001666,biological process,41.0,7.0,1.084e-01,2.757e-02,4.265e-01,2.924e-02,2.632e-03,3.248e-01,8.164e-01,5.097e-02
CXCR4,2561,cellular response to cytokine stimulus,GO:0071345,biological process,41.0,31.0,1.084e-01,2.757e-02,4.265e-01,3.507e-02,1.130e-02,1.088e-01,8.112e-01,2.852e-02
CXCR4,2561,positive regulation of macrophage migration inhibitory factor signaling pathway,GO:2000448,biological process,41.0,3.0,1.084e-01,2.757e-02,4.265e-01,4.368e-02,3.904e-03,4.887e-01,7.760e-01,5.907e-02
CXCR4,2561,regulation of chemotaxis,GO:0050920,biological process,41.0,20.0,1.143e-01,3.465e-02,3.772e-01,6.614e-02,2.475e-02,1.767e-01,7.391e-01,2.783e-02
CXCR4,2561,immune response,GO:0006955,biological process,41.0,11.0,1.185e-01,2.436e-02,5.762e-01,5.421e-02,4.518e-03,6.505e-01,7.492e-01,7.061e-02
CXCR4,2561,G protein-coupled receptor signaling pathway,GO:0007186,biological process,41.0,43.0,1.198e-01,4.233e-02,3.388e-01,6.413e-02,3.479e-02,1.182e-01,7.443e-01,1.743e-02
CXCR4,2561,CXCL12-activated CXCR4 signaling pathway,GO:0038160,biological process,41.0,3.0,1.336e-01,2.397e-02,7.447e-01,8.341e-02,6.274e-03,1.109e+00,6.918e-01,7.691e-02
CXCR4,2561,regulation of cell adhesion,GO:0030155,biological process,41.0,11.0,1.419e-01,3.048e-02,6.603e-01,1.023e-01,1.626e-02,6.443e-01,6.718e-01,5.810e-02
CXCR4,2561,positive regulation of cytosolic calcium ion concentration,GO:0007204,biological process,41.0,11.0,1.488e-01,5.229e-02,4.237e-01,1.218e-01,4.110e-02,3.608e-01,6.538e-01,4.159e-02
CXCR4,2561,calcium-mediated signaling,GO:0019722,biological process,41.0,13.0,1.737e-01,6.156e-02,4.902e-01,1.465e-01,4.525e-02,4.742e-01,6.231e-01,4.854e-02
CXCR4,2561,brain development,GO:0007420,biological process,41.0,6.0,2.200e-01,4.497e-02,1.077e+00,2.085e-01,3.897e-02,1.115e+00,5.509e-01,7.344e-02
CXCR4,2561,late endosome,GO:0005770,cellular component,41.0,4.0,1.084e-01,2.757e-02,4.265e-01,2.249e-02,2.423e-03,2.088e-01,8.424e-01,4.242e-02
CXCR4,2561,cytoplasmic vesicle,GO:0031410,cellular component,41.0,28.0,1.084e-01,2.757e-02,4.265e-01,3.457e-02,9.424e-03,1.268e-01,8.122e-01,3.227e-02
CXCR4,2561,early endosome,GO:0005769,cellular component,41.0,7.0,1.084e-01,2.757e-02,4.265e-01,3.971e-02,2.802e-03,5.628e-01,7.825e-01,6.153e-02
CXCR4,2561,cell surface,GO:0009986,cellular component,41.0,11.0,1.125e-01,3.229e-02,3.917e-01,6.411e-02,1.483e-02,2.772e-01,7.397e-01,4.068e-02
CXCR4,2561,plasma membrane,GO:0005886,cellular component,41.0,61.0,1.198e-01,4.237e-02,3.387e-01,7.465e-02,3.281e-02,1.698e-01,7.242e-01,2.584e-02
CXCR4,2561,extracellular exosome,GO:0070062,cellular component,41.0,77.0,1.198e-01,4.237e-02,3.387e-01,8.031e-02,3.603e-02,1.790e-01,7.152e-01,2.421e-02
CXCR4,2561,external side of plasma membrane,GO:0009897,cellular component,41.0,8.0,1.438e-01,2.755e-02,7.505e-01,9.696e-02,8.165e-03,1.151e+00,6.708e-01,7.681e-02
CXCR4,2561,lysosome,GO:0005764,cellular component,41.0,13.0,1.567e-01,2.628e-02,9.342e-01,1.142e-01,1.003e-02,1.301e+00,6.454e-01,7.914e-02
CXCR4,2561,cell leading edge,GO:0031252,cellular component,41.0,4.0,1.820e-01,2.522e-02,1.314e+00,1.522e-01,1.276e-02,1.815e+00,5.942e-01,8.985e-02
CXCR4,2561,protein-containing complex,GO:0032991,cellular component,41.0,483.0,2.547e-01,5.517e-02,1.175e+00,2.446e-01,5.061e-02,1.182e+00,5.204e-01,7.252e-02
CXCR4,2561,C-C chemokine binding,GO:0019957,molecular function,41.0,8.0,1.084e-01,2.757e-02,4.265e-01,1.759e-02,1.411e-02,2.195e-02,8.820e-01,4.813e-03
CXCR4,2561,chemokine binding,GO:0019956,molecular function,41.0,5.0,1.084e-01,2.757e-02,4.265e-01,4.032e-02,1.559e-03,1.043e+00,7.696e-01,7.250e-02
CXCR4,2561,myosin light chain binding,GO:0032027,molecular function,41.0,5.0,1.125e-01,3.229e-02,3.917e-01,5.456e-02,1.335e-02,2.230e-01,7.593e-01,3.943e-02
CXCR4,2561,actin binding,GO:0003779,molecular function,41.0,5.0,1.143e-01,3.465e-02,3.772e-01,2.709e-02,1.818e-02,4.036e-02,8.392e-01,9.856e-03
CXCR4,2561,C-X-C motif chemokine 12 receptor activity,GO:0038147,molecular function,41.0,2.0,1.143e-01,3.465e-02,3.772e-01,5.706e-02,1.690e-02,1.927e-01,7.548e-01,3.569e-02
CXCR4,2561,C-C chemokine receptor activity,GO:0016493,molecular function,41.0,6.0,1.198e-01,4.237e-02,3.387e-01,6.049e-02,2.021e-02,1.810e-01,7.485e-01,3.302e-02
CXCR4,2561,identical protein binding,GO:0042802,molecular function,41.0,35.0,1.198e-01,4.237e-02,3.387e-01,7.828e-02,3.771e-02,1.625e-01,7.186e-01,2.256e-02
CXCR4,2561,ubiquitin binding,GO:0043130,molecular function,41.0,3.0,1.202e-01,4.238e-02,3.411e-01,8.263e-02,4.063e-02,1.680e-01,7.119e-01,2.158e-02
CXCR4,2561,ubiquitin protein ligase binding,GO:0031625,molecular function,41.0,9.0,1.461e-01,5.123e-02,4.164e-01,1.112e-01,4.839e-02,2.555e-01,6.697e-01,2.817e-02
CXCR4,2561,protein binding,GO:0005515,molecular function,41.0,347.0,1.738e-01,7.468e-02,4.045e-01,1.473e-01,8.016e-02,2.707e-01,6.283e-01,2.302e-02
CYB5B,24374,membrane,GO:0016020,cellular component,8.0,58.0,8.681e-02,2.168e-02,3.476e-01,5.348e-02,1.341e-02,2.133e-01,7.616e-01,3.886e-02
CYB5B,24374,heme binding,GO:0020037,molecular function,8.0,4.0,8.286e-02,2.030e-02,3.383e-01,4.986e-02,6.521e-03,3.812e-01,7.625e-01,6.166e-02
CYB5B,24374,protein binding,GO:0005515,molecular function,8.0,347.0,9.866e-02,4.014e-02,2.425e-01,7.529e-02,4.405e-02,1.287e-01,7.248e-01,1.676e-02
CYP2R1,20580,exogenous drug catabolic process,GO:0042738,biological process,15.0,3.0,1.554e-01,1.013e-01,2.385e-01,2.007e-02,1.694e-02,2.378e-02,8.694e-01,4.087e-03
CYP2R1,20580,oxidation-reduction process,GO:0055114,biological process,15.0,42.0,1.554e-01,1.013e-01,2.385e-01,3.505e-02,1.400e-02,8.775e-02,8.116e-01,2.349e-02
CYP2R1,20580,xenobiotic metabolic process,GO:0006805,biological process,15.0,47.0,1.584e-01,1.091e-01,2.298e-01,7.526e-02,5.021e-02,1.128e-01,7.254e-01,1.257e-02
CYP2R1,20580,organic acid metabolic process,GO:0006082,biological process,15.0,19.0,1.751e-01,1.052e-01,2.914e-01,8.332e-02,2.430e-02,2.856e-01,7.071e-01,3.715e-02
CYP2R1,20580,calcitriol biosynthetic process from calciol,GO:0036378,biological process,15.0,7.0,1.753e-01,1.218e-01,2.522e-01,1.060e-01,6.992e-02,1.607e-01,6.789e-01,1.425e-02
CYP2R1,20580,intracellular membrane-bounded organelle,GO:0043231,cellular component,15.0,48.0,1.680e-01,1.104e-01,2.556e-01,9.318e-02,4.715e-02,1.841e-01,6.957e-01,2.302e-02
CYP2R1,20580,cytoplasm,GO:0005737,cellular component,15.0,78.0,2.607e-01,1.805e-01,3.765e-01,2.502e-01,1.856e-01,3.373e-01,5.350e-01,1.419e-02
CYP2R1,20580,steroid hydroxylase activity,GO:0008395,molecular function,15.0,22.0,1.726e-01,9.073e-02,3.282e-01,1.059e-01,5.366e-02,2.088e-01,6.781e-01,2.426e-02
CYP2R1,20580,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen",GO:0016712,molecular function,15.0,11.0,1.837e-01,7.861e-02,4.293e-01,1.148e-01,3.601e-02,3.658e-01,6.618e-01,4.379e-02
CYP2R1,20580,vitamin D3 25-hydroxylase activity,GO:0030343,molecular function,15.0,2.0,1.970e-01,8.772e-02,4.422e-01,1.599e-01,4.698e-02,5.442e-01,6.083e-01,4.984e-02
CYP2R1,20580,heme binding,GO:0020037,molecular function,15.0,4.0,2.449e-01,1.374e-01,4.364e-01,2.268e-01,1.236e-01,4.162e-01,5.522e-01,2.692e-02
DAPK1,2674,protein autophosphorylation,GO:0046777,biological process,26.0,12.0,1.092e-01,7.745e-02,1.539e-01,2.245e-02,5.002e-03,1.008e-01,8.537e-01,3.571e-02
DAPK1,2674,intracellular signal transduction,GO:0035556,biological process,26.0,30.0,1.167e-01,6.754e-02,2.016e-01,2.481e-02,1.243e-02,4.950e-02,8.480e-01,1.687e-02
DAPK1,2674,cellular response to interferon-gamma,GO:0071346,biological process,26.0,4.0,1.167e-01,6.754e-02,2.016e-01,2.898e-02,1.039e-02,8.088e-02,8.314e-01,2.493e-02
DAPK1,2674,cellular response to hydroperoxide,GO:0071447,biological process,26.0,6.0,1.190e-01,6.937e-02,2.040e-01,5.382e-02,1.555e-02,1.863e-01,7.625e-01,3.330e-02
DAPK1,2674,apoptotic signaling pathway,GO:0097190,biological process,26.0,6.0,1.227e-01,6.033e-02,2.497e-01,4.455e-02,9.032e-03,2.197e-01,7.806e-01,4.546e-02
DAPK1,2674,positive regulation of autophagy,GO:0010508,biological process,26.0,10.0,1.334e-01,8.901e-02,1.999e-01,5.114e-02,5.263e-03,4.968e-01,7.588e-01,6.487e-02
DAPK1,2674,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043280,biological process,26.0,8.0,1.366e-01,1.017e-01,1.835e-01,6.989e-02,2.649e-02,1.844e-01,7.318e-01,2.993e-02
DAPK1,2674,protein phosphorylation,GO:0006468,biological process,26.0,30.0,1.495e-01,8.022e-02,2.787e-01,1.089e-01,5.153e-02,2.303e-01,6.734e-01,2.523e-02
DAPK1,2674,negative regulation of translation,GO:0017148,biological process,26.0,18.0,2.158e-01,1.336e-01,3.487e-01,1.880e-01,8.497e-02,4.160e-01,5.854e-01,3.232e-02
DAPK1,2674,apoptotic process,GO:0006915,biological process,26.0,21.0,2.549e-01,4.448e-02,1.461e+00,1.961e-01,1.406e-02,2.737e+00,5.388e-01,1.046e-01
DAPK1,2674,actin cytoskeleton,GO:0015629,cellular component,26.0,9.0,1.227e-01,6.033e-02,2.497e-01,6.356e-02,1.935e-02,2.087e-01,7.418e-01,3.603e-02
DAPK1,2674,plasma membrane,GO:0005886,cellular component,26.0,61.0,1.548e-01,7.685e-02,3.117e-01,1.171e-01,4.403e-02,3.117e-01,6.612e-01,3.330e-02
DAPK1,2674,nucleus,GO:0005634,cellular component,26.0,81.0,1.577e-01,8.327e-02,2.986e-01,1.152e-01,5.374e-02,2.471e-01,6.652e-01,2.751e-02
DAPK1,2674,cytoplasm,GO:0005737,cellular component,26.0,78.0,1.745e-01,1.109e-01,2.744e-01,1.480e-01,8.959e-02,2.444e-01,6.280e-01,1.916e-02
DAPK1,2674,calmodulin binding,GO:0005516,molecular function,26.0,3.0,1.092e-01,7.745e-02,1.539e-01,1.183e-02,5.953e-03,2.353e-02,9.107e-01,1.087e-02
DAPK1,2674,syntaxin-1 binding,GO:0017075,molecular function,26.0,2.0,1.167e-01,6.754e-02,2.016e-01,3.971e-02,1.107e-02,1.425e-01,7.966e-01,3.387e-02
DAPK1,2674,calmodulin-dependent protein kinase activity,GO:0004683,molecular function,26.0,5.0,1.167e-01,6.754e-02,2.016e-01,4.449e-02,1.938e-02,1.021e-01,7.860e-01,2.159e-02
DAPK1,2674,protein serine/threonine kinase activity,GO:0004674,molecular function,26.0,31.0,1.167e-01,6.754e-02,2.016e-01,4.945e-02,3.015e-02,8.108e-02,7.753e-01,1.353e-02
DAPK1,2674,protein kinase activity,GO:0004672,molecular function,26.0,33.0,1.217e-01,7.788e-02,1.902e-01,4.876e-02,2.138e-02,1.112e-01,7.759e-01,2.168e-02
DAPK1,2674,identical protein binding,GO:0042802,molecular function,26.0,35.0,1.333e-01,7.130e-02,2.494e-01,7.791e-02,3.537e-02,1.716e-01,7.191e-01,2.414e-02
DAPK1,2674,protein binding,GO:0005515,molecular function,26.0,347.0,1.645e-01,9.558e-02,2.831e-01,1.347e-01,7.100e-02,2.555e-01,6.423e-01,2.335e-02
DAPK1,2674,ATP binding,GO:0005524,molecular function,26.0,10.0,1.841e-01,1.054e-01,3.218e-01,1.701e-01,9.246e-02,3.131e-01,6.040e-01,2.531e-02
DCTN3,2713,cytoskeleton-dependent cytokinesis,GO:0061640,biological process,14.0,4.0,3.701e-02,2.670e-02,5.130e-02,2.451e-02,1.802e-02,3.334e-02,8.493e-01,7.446e-03
DCTN3,2713,centrosome,GO:0005813,cellular component,14.0,9.0,2.854e-02,1.122e-02,7.258e-02,6.423e-03,1.140e-03,3.618e-02,9.364e-01,1.605e-02
DCTN3,2713,nucleolus,GO:0005730,cellular component,14.0,18.0,3.688e-02,2.661e-02,5.113e-02,1.677e-02,8.680e-03,3.241e-02,8.843e-01,1.420e-02
DCTN3,2713,dynactin complex,GO:0005869,cellular component,14.0,2.0,3.688e-02,2.661e-02,5.113e-02,2.287e-02,1.121e-02,4.663e-02,8.555e-01,1.679e-02
DCTN3,2713,cytosol,GO:0005829,cellular component,14.0,76.0,3.701e-02,2.670e-02,5.130e-02,2.966e-02,2.721e-02,3.234e-02,8.300e-01,2.081e-03
DCTN3,2713,perinuclear region of cytoplasm,GO:0048471,cellular component,14.0,11.0,3.712e-02,2.654e-02,5.191e-02,3.186e-02,2.173e-02,4.671e-02,8.224e-01,9.429e-03
DCTN3,2713,protein binding,GO:0005515,molecular function,14.0,347.0,3.877e-02,2.426e-02,6.195e-02,3.875e-02,2.423e-02,6.199e-02,8.019e-01,1.209e-02
DCUN1D3,28734,protein neddylation,GO:0045116,biological process,17.0,3.0,6.884e-02,1.582e-02,2.996e-01,2.577e-02,3.030e-03,2.191e-01,8.316e-01,4.391e-02
DCUN1D3,28734,response to UV-C,GO:0010225,biological process,17.0,3.0,1.379e-01,7.974e-02,2.386e-01,7.677e-02,3.068e-02,1.921e-01,7.200e-01,2.859e-02
DCUN1D3,28734,response to gamma radiation,GO:0010332,biological process,17.0,3.0,1.635e-01,5.471e-02,4.889e-01,1.007e-01,1.623e-02,6.244e-01,6.745e-01,5.725e-02
DCUN1D3,28734,positive regulation of ubiquitin-protein transferase activity,GO:0051443,biological process,17.0,5.0,1.753e-01,7.147e-02,4.301e-01,1.245e-01,4.555e-02,3.406e-01,6.513e-01,3.823e-02
DCUN1D3,28734,negative regulation of G1/S transition of mitotic cell cycle,GO:2000134,biological process,17.0,10.0,1.854e-01,7.339e-02,4.682e-01,1.597e-01,5.525e-02,4.614e-01,6.112e-01,4.121e-02
DCUN1D3,28734,negative regulation of cell growth,GO:0030308,biological process,17.0,19.0,2.435e-01,8.861e-02,6.690e-01,2.039e-01,4.925e-02,8.438e-01,5.593e-01,6.672e-02
DCUN1D3,28734,positive regulation of apoptotic process,GO:0043065,biological process,17.0,26.0,2.989e-01,9.923e-02,9.001e-01,2.623e-01,6.341e-02,1.085e+00,5.081e-01,6.881e-02
DCUN1D3,28734,ubiquitin ligase complex,GO:0000151,cellular component,17.0,14.0,6.152e-02,1.719e-02,2.201e-01,1.441e-02,2.367e-03,8.770e-02,8.847e-01,3.013e-02
DCUN1D3,28734,perinuclear region of cytoplasm,GO:0048471,cellular component,17.0,11.0,1.803e-01,8.482e-02,3.831e-01,1.427e-01,8.162e-02,2.493e-01,6.337e-01,2.105e-02
DCUN1D3,28734,cullin family protein binding,GO:0097602,molecular function,17.0,3.0,6.152e-02,1.719e-02,2.201e-01,1.662e-02,4.653e-03,5.940e-02,8.793e-01,2.394e-02
DCUN1D3,28734,ubiquitin-like protein binding,GO:0032182,molecular function,17.0,4.0,6.152e-02,1.719e-02,2.201e-01,1.739e-02,5.382e-03,5.620e-02,8.766e-01,2.279e-02
DCUN1D3,28734,ubiquitin conjugating enzyme binding,GO:0031624,molecular function,17.0,2.0,1.005e-01,8.015e-02,1.261e-01,3.485e-02,2.786e-02,4.358e-02,8.134e-01,5.579e-03
DCUN1D3,28734,protein binding,GO:0005515,molecular function,17.0,347.0,1.457e-01,9.968e-02,2.130e-01,9.910e-02,6.956e-02,1.412e-01,6.887e-01,1.223e-02
DDX1,2734,protein localization to cytoplasmic stress granule,GO:1903608,biological process,30.0,2.0,6.106e-02,3.494e-02,1.067e-01,1.556e-02,2.889e-03,8.383e-02,8.819e-01,3.558e-02
DDX1,2734,"tRNA splicing, via endonucleolytic cleavage and ligation",GO:0006388,biological process,30.0,3.0,6.346e-02,3.211e-02,1.255e-01,2.056e-02,3.318e-03,1.274e-01,8.589e-01,4.318e-02
DDX1,2734,double-strand break repair,GO:0006302,biological process,30.0,7.0,6.566e-02,3.682e-02,1.171e-01,2.044e-02,1.738e-02,2.404e-02,8.677e-01,3.887e-03
DDX1,2734,nucleic acid phosphodiester bond hydrolysis,GO:0090305,biological process,30.0,11.0,7.575e-02,3.845e-02,1.492e-01,5.031e-02,1.608e-02,1.574e-01,7.705e-01,3.105e-02
DDX1,2734,DNA duplex unwinding,GO:0032508,biological process,30.0,5.0,8.127e-02,5.083e-02,1.299e-01,5.132e-02,1.896e-02,1.389e-01,7.689e-01,2.817e-02
DDX1,2734,multicellular organism development,GO:0007275,biological process,30.0,16.0,9.373e-02,4.878e-02,1.801e-01,8.451e-02,3.232e-02,2.210e-01,7.074e-01,2.963e-02
DDX1,2734,cleavage body,GO:0071920,cellular component,30.0,2.0,6.106e-02,3.494e-02,1.067e-01,1.128e-02,1.769e-03,7.185e-02,9.025e-01,2.485e-02
DDX1,2734,tRNA-splicing ligase complex,GO:0072669,cellular component,30.0,2.0,6.346e-02,3.211e-02,1.255e-01,1.702e-02,1.409e-03,2.056e-01,8.650e-01,5.575e-02
DDX1,2734,cytoplasmic stress granule,GO:0010494,cellular component,30.0,2.0,6.773e-02,3.652e-02,1.256e-01,1.844e-02,7.349e-03,4.629e-02,8.749e-01,2.076e-02
DDX1,2734,ribonucleoprotein complex,GO:1990904,cellular component,30.0,27.0,6.919e-02,3.397e-02,1.409e-01,2.516e-02,2.729e-03,2.321e-01,8.358e-01,5.458e-02
DDX1,2734,cytosol,GO:0005829,cellular component,30.0,76.0,8.846e-02,6.276e-02,1.247e-01,6.726e-02,5.164e-02,8.761e-02,7.395e-01,7.668e-03
DDX1,2734,nucleus,GO:0005634,cellular component,30.0,81.0,8.871e-02,6.353e-02,1.239e-01,7.325e-02,5.899e-02,9.096e-02,7.292e-01,6.592e-03
DDX1,2734,membrane,GO:0016020,cellular component,30.0,58.0,8.871e-02,6.353e-02,1.239e-01,7.508e-02,4.303e-02,1.310e-01,7.251e-01,1.720e-02
DDX1,2734,cytoplasm,GO:0005737,cellular component,30.0,78.0,8.871e-02,6.353e-02,1.239e-01,7.788e-02,5.652e-02,1.073e-01,7.211e-01,9.926e-03
DDX1,2734,nucleoplasm,GO:0005654,cellular component,30.0,51.0,8.928e-02,6.357e-02,1.254e-01,7.826e-02,5.431e-02,1.128e-01,7.205e-01,1.122e-02
DDX1,2734,poly(A) binding,GO:0008143,molecular function,30.0,2.0,6.106e-02,3.494e-02,1.067e-01,1.058e-02,2.434e-03,4.601e-02,9.097e-01,2.543e-02
DDX1,2734,helicase activity,GO:0004386,molecular function,30.0,5.0,6.773e-02,3.652e-02,1.256e-01,2.642e-02,1.756e-02,3.975e-02,8.416e-01,1.004e-02
DDX1,2734,RNA helicase activity,GO:0003724,molecular function,30.0,5.0,6.810e-02,3.641e-02,1.274e-01,2.375e-02,9.560e-03,5.902e-02,8.520e-01,2.227e-02
DDX1,2734,DNA/RNA helicase activity,GO:0033677,molecular function,30.0,6.0,7.001e-02,3.564e-02,1.375e-01,3.028e-02,1.202e-02,7.633e-02,8.271e-01,2.303e-02
DDX1,2734,nuclease activity,GO:0004518,molecular function,30.0,7.0,7.023e-02,3.553e-02,1.388e-01,3.233e-02,1.158e-02,9.031e-02,8.197e-01,2.630e-02
DDX1,2734,RNA binding,GO:0003723,molecular function,30.0,60.0,7.129e-02,4.450e-02,1.142e-01,3.562e-02,2.890e-02,4.391e-02,8.111e-01,5.202e-03
DDX1,2734,chromatin binding,GO:0003682,molecular function,30.0,9.0,7.740e-02,5.525e-02,1.084e-01,4.262e-02,2.429e-02,7.479e-02,7.915e-01,1.457e-02
DDX1,2734,transcription coregulator activity,GO:0003712,molecular function,30.0,5.0,7.933e-02,3.950e-02,1.593e-01,4.637e-02,1.066e-02,2.016e-01,7.771e-01,4.173e-02
DDX1,2734,protein binding,GO:0005515,molecular function,30.0,347.0,8.871e-02,6.353e-02,1.239e-01,6.946e-02,4.820e-02,1.001e-01,7.355e-01,1.097e-02
DEGS1,13709,ceramide biosynthetic process,GO:0046513,biological process,13.0,9.0,4.003e-02,2.769e-02,5.787e-02,1.778e-02,1.320e-02,2.393e-02,8.809e-01,6.886e-03
DEGS1,13709,myelin maintenance,GO:0043217,biological process,13.0,4.0,1.172e-01,4.931e-02,2.787e-01,9.872e-02,3.232e-02,3.015e-01,6.845e-01,3.665e-02
DEGS1,13709,mitochondrion,GO:0005739,cellular component,13.0,35.0,4.003e-02,2.769e-02,5.787e-02,1.879e-02,1.049e-02,3.366e-02,8.744e-01,1.244e-02
DEGS1,13709,sphingolipid delta-4 desaturase activity,GO:0042284,molecular function,13.0,2.0,1.332e-01,9.595e-02,1.848e-01,1.210e-01,9.601e-02,1.525e-01,6.599e-01,8.415e-03
DERA,24269,carbohydrate catabolic process,GO:0016052,biological process,11.0,10.0,5.523e-02,1.192e-02,2.559e-01,1.565e-02,1.956e-03,1.252e-01,8.768e-01,4.480e-02
DERA,24269,deoxyribonucleotide catabolic process,GO:0009264,biological process,11.0,6.0,6.149e-02,1.013e-02,3.732e-01,3.867e-02,3.437e-03,4.351e-01,7.887e-01,7.036e-02
DERA,24269,deoxyribonucleoside catabolic process,GO:0046121,biological process,11.0,5.0,6.149e-02,1.013e-02,3.732e-01,4.946e-02,1.072e-02,2.282e-01,7.697e-01,4.329e-02
DERA,24269,nucleoplasm,GO:0005654,cellular component,11.0,51.0,6.001e-02,1.524e-02,2.363e-01,3.521e-02,2.164e-02,5.730e-02,8.121e-01,1.211e-02
DERA,24269,deoxyribose-phosphate aldolase activity,GO:0004139,molecular function,11.0,2.0,6.149e-02,1.013e-02,3.732e-01,4.772e-02,5.088e-03,4.476e-01,7.658e-01,6.726e-02
DGAT2,16940,diacylglycerol metabolic process,GO:0046339,biological process,16.0,5.0,2.252e-02,6.497e-03,7.805e-02,6.566e-03,1.253e-03,3.441e-02,9.353e-01,1.804e-02
DGAT2,16940,long-chain fatty-acyl-CoA metabolic process,GO:0035336,biological process,16.0,4.0,2.540e-02,9.633e-03,6.696e-02,9.565e-03,3.611e-03,2.534e-02,9.216e-01,1.387e-02
DGAT2,16940,triglyceride biosynthetic process,GO:0019432,biological process,16.0,4.0,3.283e-02,1.370e-02,7.869e-02,1.693e-02,5.498e-03,5.215e-02,8.790e-01,2.113e-02
DGAT2,16940,perinuclear endoplasmic reticulum membrane,GO:1990578,cellular component,16.0,2.0,5.755e-03,1.229e-03,2.696e-02,7.655e-04,9.326e-05,6.284e-03,9.824e-01,4.723e-03
DGAT2,16940,integral component of membrane,GO:0016021,cellular component,16.0,12.0,4.569e-02,2.897e-02,7.206e-02,3.484e-02,1.461e-02,8.311e-02,8.123e-01,2.229e-02
DGAT2,16940,lipid droplet,GO:0005811,cellular component,16.0,10.0,5.679e-02,5.036e-02,6.405e-02,4.748e-02,3.761e-02,5.994e-02,7.801e-01,6.213e-03
DGAT2,16940,endoplasmic reticulum membrane,GO:0005789,cellular component,16.0,12.0,5.711e-02,5.147e-02,6.337e-02,5.395e-02,4.883e-02,5.961e-02,7.658e-01,2.755e-03
DGAT2,16940,endoplasmic reticulum,GO:0005783,cellular component,16.0,34.0,6.034e-02,4.545e-02,8.012e-02,5.603e-02,3.610e-02,8.698e-02,7.610e-01,1.242e-02
DGAT2,16940,diacylglycerol O-acyltransferase activity,GO:0004144,molecular function,16.0,2.0,3.347e-02,1.520e-02,7.368e-02,1.603e-02,9.323e-03,2.755e-02,8.886e-01,1.049e-02
DHCR7,2860,cholesterol biosynthetic process,GO:0006695,biological process,20.0,11.0,5.506e-02,1.630e-02,1.859e-01,1.616e-02,3.697e-03,7.061e-02,8.812e-01,3.079e-02
DHCR7,2860,sterol biosynthetic process,GO:0016126,biological process,20.0,9.0,6.116e-02,2.221e-02,1.684e-01,2.357e-02,1.437e-02,3.867e-02,8.531e-01,1.202e-02
DHCR7,2860,brassinosteroid biosynthetic process,GO:0016132,biological process,20.0,4.0,6.235e-02,2.121e-02,1.832e-01,2.548e-02,6.868e-03,9.452e-02,8.431e-01,3.248e-02
DHCR7,2860,nuclear outer membrane,GO:0005640,cellular component,20.0,3.0,3.441e-02,2.752e-03,4.302e-01,4.138e-03,1.143e-04,1.497e-01,9.285e-01,3.797e-02
DHCR7,2860,integral component of endoplasmic reticulum membrane,GO:0030176,cellular component,20.0,10.0,7.139e-02,2.487e-02,2.049e-01,4.499e-02,1.022e-02,1.981e-01,7.816e-01,4.019e-02
DHCR7,2860,endoplasmic reticulum,GO:0005783,cellular component,20.0,34.0,8.742e-02,4.428e-02,1.726e-01,5.051e-02,3.280e-02,7.777e-02,7.730e-01,1.159e-02
DHCR7,2860,membrane,GO:0016020,cellular component,20.0,58.0,9.711e-02,5.525e-02,1.707e-01,7.273e-02,4.317e-02,1.225e-01,7.293e-01,1.612e-02
DHCR7,2860,cytosol,GO:0005829,cellular component,20.0,76.0,1.118e-01,7.872e-02,1.587e-01,8.800e-02,6.870e-02,1.127e-01,7.053e-01,7.946e-03
DHCR7,2860,sterol delta7 reductase activity,GO:0009918,molecular function,20.0,2.0,3.713e-02,1.961e-02,7.032e-02,5.744e-03,1.689e-03,1.953e-02,9.445e-01,1.283e-02
DHCR7,2860,7-dehydrocholesterol reductase activity,GO:0047598,molecular function,20.0,2.0,9.677e-02,4.226e-02,2.216e-01,7.433e-02,1.787e-02,3.092e-01,7.207e-01,4.134e-02
DHCR7,2860,"oxidoreductase activity, acting on the CH-CH group of donors",GO:0016627,molecular function,20.0,48.0,1.127e-01,3.195e-02,3.977e-01,8.994e-02,1.731e-02,4.671e-01,6.916e-01,5.571e-02
DHCR7,2860,protein binding,GO:0005515,molecular function,20.0,347.0,1.218e-01,1.001e-01,1.483e-01,1.169e-01,9.989e-02,1.368e-01,6.652e-01,5.628e-03
DHX32,16717,,,,nan,nan,,,,,,,,
DLAT,2896,mitochondrion,GO:0005739,cellular component,24.0,35.0,2.594e-02,1.643e-02,4.094e-02,8.051e-03,2.462e-03,2.633e-02,9.299e-01,1.274e-02
DLAT,2896,pyruvate dehydrogenase complex,GO:0045254,cellular component,24.0,7.0,2.627e-02,1.646e-02,4.193e-02,1.490e-02,3.835e-03,5.790e-02,8.870e-01,2.250e-02
DLAT,2896,pyruvate dehydrogenase (NAD+) activity,GO:0034604,molecular function,24.0,3.0,2.627e-02,1.646e-02,4.193e-02,9.713e-03,5.297e-03,1.781e-02,9.230e-01,7.813e-03
DLAT,2896,identical protein binding,GO:0042802,molecular function,24.0,35.0,2.647e-02,1.693e-02,4.136e-02,1.619e-02,1.188e-02,2.208e-02,8.891e-01,6.625e-03
DLAT,2896,protein binding,GO:0005515,molecular function,24.0,347.0,3.096e-02,2.104e-02,4.553e-02,2.602e-02,1.808e-02,3.744e-02,8.432e-01,9.015e-03
DLAT,2896,dihydrolipoyllysine-residue acetyltransferase activity,GO:0004742,molecular function,24.0,4.0,4.360e-02,1.603e-02,1.186e-01,4.360e-02,1.603e-02,1.186e-01,7.876e-01,2.640e-02
DNAJC25,34187,,,,nan,nan,,,,,,,,
DOC2B,2986,,,,nan,nan,,,,,,,,
DOCK5,23476,positive regulation of substrate adhesion-dependent cell spreading,GO:1900026,biological process,8.0,5.0,2.359e-01,1.068e-01,5.210e-01,6.069e-02,1.039e-02,3.543e-01,7.430e-01,5.204e-02
DOCK5,23476,positive regulation of epithelial cell migration,GO:0010634,biological process,8.0,8.0,2.463e-01,1.223e-01,4.960e-01,7.520e-02,5.620e-02,1.006e-01,7.257e-01,8.788e-03
DOCK5,23476,positive regulation of vascular associated smooth muscle cell migration,GO:1904754,biological process,8.0,4.0,2.613e-01,1.063e-01,6.423e-01,1.694e-01,2.780e-02,1.032e+00,5.881e-01,7.287e-02
DOCK5,23476,negative regulation of vascular smooth muscle contraction,GO:1904694,biological process,8.0,6.0,3.377e-01,1.403e-01,8.133e-01,3.236e-01,1.170e-01,8.955e-01,4.687e-01,5.497e-02
DOCK5,23476,plasma membrane,GO:0005886,cellular component,8.0,61.0,2.817e-01,1.577e-01,5.033e-01,1.886e-01,9.585e-02,3.713e-01,5.858e-01,2.792e-02
DOCK5,23476,cytosol,GO:0005829,cellular component,8.0,76.0,2.817e-01,1.577e-01,5.033e-01,2.238e-01,1.485e-01,3.372e-01,5.562e-01,1.845e-02
DOCK5,23476,protein binding,GO:0005515,molecular function,8.0,347.0,2.817e-01,1.577e-01,5.033e-01,2.089e-01,1.297e-01,3.365e-01,5.687e-01,2.050e-02
DPEP1,3002,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043154,biological process,22.0,8.0,1.725e-01,8.344e-02,3.567e-01,3.106e-02,5.936e-03,1.625e-01,8.211e-01,4.345e-02
DPEP1,3002,homocysteine metabolic process,GO:0050667,biological process,22.0,6.0,1.725e-01,8.344e-02,3.567e-01,7.613e-02,5.274e-02,1.099e-01,7.240e-01,1.133e-02
DPEP1,3002,negative regulation of apoptotic process,GO:0043066,biological process,22.0,29.0,1.751e-01,8.361e-02,3.669e-01,1.042e-01,4.811e-02,2.257e-01,6.795e-01,2.628e-02
DPEP1,3002,negative regulation of cell migration,GO:0030336,biological process,22.0,31.0,2.017e-01,1.502e-01,2.708e-01,1.311e-01,6.192e-02,2.777e-01,6.457e-01,2.687e-02
DPEP1,3002,antibiotic metabolic process,GO:0016999,biological process,22.0,59.0,2.273e-01,4.825e-02,1.071e+00,1.386e-01,1.176e-02,1.633e+00,5.998e-01,1.101e-01
DPEP1,3002,cellular response to drug,GO:0035690,biological process,22.0,91.0,3.016e-01,9.552e-02,9.522e-01,2.253e-01,4.110e-02,1.235e+00,5.302e-01,8.581e-02
DPEP1,3002,apical part of cell,GO:0045177,cellular component,22.0,2.0,1.725e-01,8.344e-02,3.567e-01,6.552e-02,1.052e-02,4.082e-01,7.309e-01,5.934e-02
DPEP1,3002,extracellular exosome,GO:0070062,cellular component,22.0,77.0,1.725e-01,8.344e-02,3.567e-01,7.483e-02,2.329e-02,2.404e-01,7.220e-01,3.496e-02
DPEP1,3002,nucleoplasm,GO:0005654,cellular component,22.0,51.0,1.725e-01,8.344e-02,3.567e-01,1.086e-01,3.232e-02,3.648e-01,6.700e-01,4.043e-02
DPEP1,3002,plasma membrane,GO:0005886,cellular component,22.0,61.0,1.761e-01,8.553e-02,3.624e-01,1.346e-01,5.501e-02,3.294e-01,6.406e-01,3.213e-02
DPEP1,3002,cell junction,GO:0030054,cellular component,22.0,10.0,1.860e-01,7.334e-02,4.719e-01,1.236e-01,2.797e-02,5.463e-01,6.461e-01,5.674e-02
DPEP1,3002,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,GO:0043027,molecular function,22.0,3.0,1.725e-01,8.344e-02,3.567e-01,5.833e-02,1.348e-02,2.524e-01,7.516e-01,3.972e-02
DPEP1,3002,zinc ion binding,GO:0008270,molecular function,22.0,8.0,1.761e-01,8.361e-02,3.707e-01,1.065e-01,3.932e-02,2.886e-01,6.748e-01,3.584e-02
DPEP1,3002,metallodipeptidase activity,GO:0070573,molecular function,22.0,3.0,1.790e-01,9.745e-02,3.288e-01,1.040e-01,5.316e-02,2.033e-01,6.805e-01,2.339e-02
DPEP1,3002,protein binding,GO:0005515,molecular function,22.0,347.0,2.066e-01,1.533e-01,2.784e-01,1.805e-01,1.245e-01,2.616e-01,5.956e-01,1.522e-02
DPEP1,3002,modified amino acid binding,GO:0072341,molecular function,22.0,9.0,3.091e-01,6.146e-02,1.555e+00,1.059e-01,1.737e-03,6.458e+00,5.781e-01,1.790e-01
DPT,3011,collagen fibril organization,GO:0030199,biological process,5.0,3.0,2.437e-02,1.381e-02,4.301e-02,1.117e-02,5.374e-03,2.320e-02,9.140e-01,1.180e-02
DPT,3011,collagen-containing extracellular matrix,GO:0062023,cellular component,5.0,36.0,2.437e-02,1.381e-02,4.301e-02,1.309e-02,1.003e-02,1.708e-02,9.057e-01,4.500e-03
DPT,3011,extracellular space,GO:0005615,cellular component,5.0,43.0,2.462e-02,1.349e-02,4.494e-02,1.838e-02,9.981e-03,3.385e-02,8.767e-01,1.424e-02
DPT,3011,protein binding,GO:0005515,molecular function,5.0,347.0,7.754e-02,4.727e-02,1.272e-01,7.754e-02,4.727e-02,1.272e-01,7.213e-01,1.482e-02
DSE,21144,dermatan sulfate metabolic process,GO:0030205,biological process,9.0,7.0,2.282e-01,8.941e-02,5.823e-01,4.687e-02,2.127e-02,1.032e-01,7.801e-01,2.156e-02
DSE,21144,dermatan sulfate biosynthetic process,GO:0030208,biological process,9.0,5.0,2.341e-01,8.620e-02,6.359e-01,7.158e-02,2.286e-02,2.241e-01,7.274e-01,3.594e-02
DSE,21144,chondroitin sulfate metabolic process,GO:0030204,biological process,9.0,8.0,2.341e-01,8.620e-02,6.359e-01,1.119e-01,2.654e-02,4.718e-01,6.630e-01,4.899e-02
DSE,21144,endoplasmic reticulum,GO:0005783,cellular component,9.0,34.0,2.524e-01,1.181e-01,5.395e-01,2.098e-01,6.143e-02,7.168e-01,5.593e-01,5.295e-02
DSE,21144,cytosol,GO:0005829,cellular component,9.0,76.0,2.620e-01,1.374e-01,4.996e-01,2.174e-01,1.222e-01,3.868e-01,5.604e-01,2.654e-02
DSE,21144,nucleoplasm,GO:0005654,cellular component,9.0,51.0,2.620e-01,1.374e-01,4.996e-01,2.351e-01,1.144e-01,4.835e-01,5.437e-01,3.467e-02
DSE,21144,Golgi apparatus,GO:0005794,cellular component,9.0,16.0,2.620e-01,1.374e-01,4.996e-01,2.532e-01,1.458e-01,4.396e-01,5.309e-01,2.640e-02
DSE,21144,chondroitin-glucuronate 5-epimerase activity,GO:0047757,molecular function,9.0,2.0,2.382e-01,9.279e-02,6.116e-01,1.852e-01,3.444e-02,9.959e-01,5.749e-01,6.783e-02
DTX4,29151,,,,nan,nan,,,,,,,,
DUOXA1,26507,,,,nan,nan,,,,,,,,
ECHDC1,21489,,,,nan,nan,,,,,,,,
EDA,3157,positive regulation of NF-kappaB transcription factor activity,GO:0051092,biological process,8.0,3.0,1.397e-01,2.337e-02,8.356e-01,8.881e-02,1.799e-02,4.383e-01,6.948e-01,4.947e-02
EDA,3157,odontogenesis of dentin-containing tooth,GO:0042475,biological process,8.0,4.0,3.383e-01,1.265e-02,9.046e+00,3.215e-01,1.012e-02,1.022e+01,3.164e-01,1.967e-01
EDA,3157,intracellular membrane-bounded organelle,GO:0043231,cellular component,8.0,48.0,1.289e-01,2.476e-02,6.713e-01,5.792e-02,3.331e-02,1.007e-01,7.568e-01,1.580e-02
EDA,3157,lipid droplet,GO:0005811,cellular component,8.0,10.0,1.397e-01,2.337e-02,8.356e-01,7.443e-02,6.950e-03,7.971e-01,7.109e-01,6.821e-02
EDA,3157,protein binding,GO:0005515,molecular function,8.0,347.0,1.289e-01,2.476e-02,6.713e-01,4.665e-02,1.467e-02,1.484e-01,7.797e-01,2.997e-02
EDA,3157,signaling receptor binding,GO:0005102,molecular function,8.0,61.0,1.920e-01,1.879e-02,1.962e+00,1.700e-01,2.045e-02,1.413e+00,5.826e-01,7.952e-02
EDN1,3176,positive regulation of smooth muscle cell proliferation,GO:0048661,biological process,63.0,4.0,1.403e-01,6.808e-02,2.892e-01,7.620e-03,6.214e-03,9.345e-03,9.366e-01,2.103e-03
EDN1,3176,positive regulation of JUN kinase activity,GO:0043507,biological process,63.0,7.0,1.403e-01,6.808e-02,2.892e-01,1.371e-02,5.939e-03,3.164e-02,8.988e-01,1.637e-02
EDN1,3176,phosphatidylinositol 3-kinase signaling,GO:0014065,biological process,63.0,2.0,1.403e-01,6.808e-02,2.892e-01,1.705e-02,1.212e-02,2.397e-02,8.846e-01,7.541e-03
EDN1,3176,positive regulation of DNA-binding transcription factor activity,GO:0051091,biological process,63.0,8.0,1.453e-01,7.452e-02,2.833e-01,3.045e-02,5.628e-03,1.647e-01,8.217e-01,3.912e-02
EDN1,3176,G protein-coupled receptor signaling pathway,GO:0007186,biological process,63.0,43.0,1.457e-01,7.505e-02,2.830e-01,3.483e-02,1.588e-02,7.641e-02,8.130e-01,1.950e-02
EDN1,3176,positive regulation of mitotic nuclear division,GO:0045840,biological process,63.0,8.0,1.484e-01,7.811e-02,2.820e-01,3.849e-02,1.241e-02,1.194e-01,8.013e-01,2.851e-02
EDN1,3176,positive regulation of cell growth involved in cardiac muscle cell development,GO:0061051,biological process,63.0,7.0,1.487e-01,7.722e-02,2.865e-01,2.677e-02,6.257e-03,1.146e-01,8.359e-01,3.247e-02
EDN1,3176,positive regulation of MAP kinase activity,GO:0043406,biological process,63.0,10.0,1.487e-01,7.722e-02,2.865e-01,2.752e-02,9.072e-03,8.349e-02,8.358e-01,2.609e-02
EDN1,3176,endothelin receptor signaling pathway,GO:0086100,biological process,63.0,3.0,1.533e-01,8.627e-02,2.722e-01,3.114e-02,1.018e-02,9.529e-02,8.236e-01,2.814e-02
EDN1,3176,positive regulation of heart rate,GO:0010460,biological process,63.0,7.0,1.542e-01,8.343e-02,2.852e-01,4.896e-02,7.778e-03,3.081e-01,7.693e-01,5.056e-02
EDN1,3176,positive regulation of sarcomere organization,GO:0060298,biological process,63.0,7.0,1.565e-01,8.112e-02,3.020e-01,5.616e-02,2.087e-02,1.511e-01,7.587e-01,2.692e-02
EDN1,3176,inositol phosphate-mediated signaling,GO:0048016,biological process,63.0,3.0,1.565e-01,8.112e-02,3.020e-01,5.665e-02,1.942e-02,1.652e-01,7.571e-01,2.981e-02
EDN1,3176,regulation of systemic arterial blood pressure by endothelin,GO:0003100,biological process,63.0,2.0,1.646e-01,9.458e-02,2.863e-01,8.156e-02,2.312e-02,2.877e-01,7.099e-01,3.873e-02
EDN1,3176,positive regulation of prostaglandin-endoperoxide synthase activity,GO:0060585,biological process,63.0,3.0,1.649e-01,8.695e-02,3.127e-01,7.796e-02,1.161e-02,5.233e-01,7.096e-01,5.553e-02
EDN1,3176,cell surface receptor signaling pathway,GO:0007166,biological process,63.0,32.0,1.658e-01,8.391e-02,3.276e-01,5.454e-02,1.172e-02,2.538e-01,7.577e-01,4.487e-02
EDN1,3176,positive regulation of cell population proliferation,GO:0008284,biological process,63.0,40.0,1.667e-01,8.334e-02,3.335e-01,6.761e-02,1.157e-02,3.953e-01,7.303e-01,4.991e-02
EDN1,3176,positive regulation of hormone secretion,GO:0046887,biological process,63.0,19.0,1.720e-01,1.143e-01,2.590e-01,8.347e-02,4.731e-02,1.473e-01,7.111e-01,1.841e-02
EDN1,3176,negative regulation of nitric-oxide synthase biosynthetic process,GO:0051771,biological process,63.0,3.0,1.728e-01,1.131e-01,2.641e-01,8.674e-02,6.750e-02,1.115e-01,7.073e-01,7.782e-03
EDN1,3176,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,63.0,62.0,1.737e-01,1.048e-01,2.881e-01,8.998e-02,4.513e-02,1.794e-01,7.006e-01,2.220e-02
EDN1,3176,protein kinase C deactivation,GO:0042313,biological process,63.0,2.0,1.741e-01,9.678e-02,3.132e-01,7.745e-02,2.237e-02,2.681e-01,7.168e-01,3.767e-02
EDN1,3176,positive regulation of cardiac muscle hypertrophy,GO:0010613,biological process,63.0,5.0,1.779e-01,1.102e-01,2.870e-01,1.055e-01,5.526e-02,2.013e-01,6.785e-01,2.197e-02
EDN1,3176,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,63.0,43.0,1.795e-01,1.109e-01,2.905e-01,1.157e-01,6.303e-02,2.124e-01,6.655e-01,2.189e-02
EDN1,3176,positive regulation of cell migration,GO:0030335,biological process,63.0,33.0,1.837e-01,7.877e-02,4.284e-01,8.732e-02,7.655e-03,9.960e-01,6.869e-01,7.370e-02
EDN1,3176,vasoconstriction,GO:0042310,biological process,63.0,9.0,1.838e-01,8.240e-02,4.098e-01,8.027e-02,6.632e-03,9.714e-01,6.967e-01,7.808e-02
EDN1,3176,positive regulation of cytosolic calcium ion concentration,GO:0007204,biological process,63.0,11.0,1.875e-01,1.101e-01,3.191e-01,1.065e-01,3.976e-02,2.853e-01,6.750e-01,3.431e-02
EDN1,3176,calcium-mediated signaling,GO:0019722,biological process,63.0,13.0,1.909e-01,8.027e-02,4.538e-01,1.142e-01,2.122e-02,6.141e-01,6.552e-01,6.357e-02
EDN1,3176,positive regulation of receptor biosynthetic process,GO:0010870,biological process,63.0,6.0,2.026e-01,1.645e-01,2.495e-01,1.513e-01,1.307e-01,1.753e-01,6.254e-01,5.646e-03
EDN1,3176,vein smooth muscle contraction,GO:0014826,biological process,63.0,3.0,2.041e-01,1.282e-01,3.249e-01,1.414e-01,3.888e-02,5.144e-01,6.289e-01,4.626e-02
EDN1,3176,artery smooth muscle contraction,GO:0014824,biological process,63.0,4.0,2.084e-01,1.404e-01,3.095e-01,1.566e-01,5.997e-02,4.088e-01,6.158e-01,3.613e-02
EDN1,3176,negative regulation of cellular protein metabolic process,GO:0032269,biological process,63.0,9.0,2.390e-01,1.594e-01,3.583e-01,2.128e-01,1.495e-01,3.028e-01,5.662e-01,1.589e-02
EDN1,3176,positive regulation of cell size,GO:0045793,biological process,63.0,3.0,2.408e-01,9.569e-02,6.061e-01,1.876e-01,4.207e-02,8.368e-01,5.765e-01,5.923e-02
EDN1,3176,cell-cell signaling,GO:0007267,biological process,63.0,35.0,2.440e-01,9.370e-02,6.352e-01,1.953e-01,4.528e-02,8.423e-01,5.696e-01,5.948e-02
EDN1,3176,prostaglandin biosynthetic process,GO:0001516,biological process,63.0,4.0,2.574e-01,9.025e-02,7.339e-01,2.061e-01,3.855e-02,1.102e+00,5.547e-01,6.929e-02
EDN1,3176,nitric oxide transport,GO:0030185,biological process,63.0,4.0,2.721e-01,9.501e-02,7.794e-01,2.396e-01,6.987e-02,8.217e-01,5.299e-01,6.297e-02
EDN1,3176,peptide hormone secretion,GO:0030072,biological process,63.0,20.0,4.241e-01,1.104e-01,1.629e+00,4.108e-01,9.608e-02,1.757e+00,3.875e-01,8.839e-02
EDN1,3176,extracellular space,GO:0005615,cellular component,63.0,43.0,1.677e-01,1.086e-01,2.592e-01,6.403e-02,4.229e-02,9.696e-02,7.452e-01,1.210e-02
EDN1,3176,cytoplasm,GO:0005737,cellular component,63.0,78.0,2.160e-01,1.379e-01,3.384e-01,1.824e-01,1.187e-01,2.802e-01,5.935e-01,1.747e-02
EDN1,3176,cytokine activity,GO:0005125,molecular function,63.0,3.0,1.626e-01,8.061e-02,3.279e-01,6.594e-02,9.126e-03,4.764e-01,7.312e-01,5.699e-02
EDN1,3176,hormone activity,GO:0005179,molecular function,63.0,17.0,1.634e-01,7.989e-02,3.342e-01,7.208e-02,1.219e-02,4.260e-01,7.209e-01,5.348e-02
EDN1,3176,protein binding,GO:0005515,molecular function,63.0,347.0,1.952e-01,1.224e-01,3.115e-01,1.378e-01,8.918e-02,2.129e-01,6.395e-01,1.642e-02
EDN1,3176,endothelin A receptor binding,GO:0031707,molecular function,63.0,2.0,2.012e-01,1.182e-01,3.425e-01,1.553e-01,8.342e-02,2.890e-01,6.197e-01,2.368e-02
EDN1,3176,endothelin B receptor binding,GO:0031708,molecular function,63.0,2.0,2.012e-01,1.182e-01,3.425e-01,1.583e-01,9.049e-02,2.768e-01,6.169e-01,2.139e-02
EEF1AKMT4,53611,,,,nan,nan,,,,,,,,
EEF1E1,3212,positive regulation of cellular senescence,GO:2000774,biological process,13.0,4.0,8.412e-02,1.630e-02,4.340e-01,8.412e-02,1.630e-02,4.340e-01,7.005e-01,5.677e-02
EEF1E1,3212,cytosol,GO:0005829,cellular component,13.0,76.0,2.202e-02,1.402e-02,3.459e-02,9.666e-03,3.144e-03,2.971e-02,9.204e-01,1.345e-02
EEF1E1,3212,nucleoplasm,GO:0005654,cellular component,13.0,51.0,2.279e-02,1.295e-02,4.011e-02,1.580e-02,7.878e-03,3.168e-02,8.889e-01,1.488e-02
EEF1E1,3212,aminoacyl-tRNA synthetase multienzyme complex,GO:0017101,cellular component,13.0,2.0,2.298e-02,1.589e-02,3.324e-02,1.239e-02,6.636e-03,2.314e-02,9.078e-01,1.056e-02
EEF1E1,3212,nucleolus,GO:0005730,cellular component,13.0,18.0,2.519e-02,1.451e-02,4.372e-02,1.723e-02,5.124e-03,5.793e-02,8.766e-01,2.274e-02
EEF1E1,3212,protein binding,GO:0005515,molecular function,13.0,347.0,2.202e-02,1.402e-02,3.459e-02,1.128e-02,8.825e-03,1.441e-02,9.155e-01,3.569e-03
EEF2K,24615,protein autophosphorylation,GO:0046777,biological process,5.0,12.0,1.610e-02,1.367e-02,1.897e-02,1.610e-02,1.367e-02,1.897e-02,8.900e-01,3.486e-03
EEF2K,24615,elongation factor-2 kinase activity,GO:0004686,molecular function,5.0,2.0,1.581e-02,1.299e-02,1.924e-02,9.446e-03,4.432e-03,2.013e-02,9.239e-01,9.667e-03
EEF2K,24615,calmodulin binding,GO:0005516,molecular function,5.0,3.0,1.581e-02,1.299e-02,1.924e-02,1.158e-02,6.891e-03,1.945e-02,9.130e-01,8.193e-03
EGFR,3236,peptidyl-tyrosine autophosphorylation,GO:0038083,biological process,140.0,3.0,9.229e-02,7.128e-02,1.195e-01,8.776e-03,2.391e-03,3.221e-02,9.247e-01,1.428e-02
EGFR,3236,positive regulation of phosphorylation,GO:0042327,biological process,140.0,8.0,9.229e-02,7.128e-02,1.195e-01,1.045e-02,4.044e-03,2.700e-02,9.169e-01,1.260e-02
EGFR,3236,protein autophosphorylation,GO:0046777,biological process,140.0,12.0,9.229e-02,7.128e-02,1.195e-01,1.629e-02,8.277e-03,3.207e-02,8.863e-01,1.311e-02
EGFR,3236,positive regulation of ERK1 and ERK2 cascade,GO:0070374,biological process,140.0,5.0,9.229e-02,7.128e-02,1.195e-01,1.606e-02,3.781e-03,6.824e-02,8.815e-01,2.910e-02
EGFR,3236,regulation of ERK1 and ERK2 cascade,GO:0070372,biological process,140.0,4.0,9.229e-02,7.128e-02,1.195e-01,1.784e-02,1.066e-02,2.985e-02,8.798e-01,1.167e-02
EGFR,3236,positive regulation of MAP kinase activity,GO:0043406,biological process,140.0,10.0,9.229e-02,7.128e-02,1.195e-01,1.819e-02,9.740e-03,3.397e-02,8.771e-01,1.346e-02
EGFR,3236,regulation of JNK cascade,GO:0046328,biological process,140.0,5.0,9.229e-02,7.128e-02,1.195e-01,2.005e-02,7.429e-03,5.410e-02,8.671e-01,2.295e-02
EGFR,3236,positive regulation of protein kinase C activity,GO:1900020,biological process,140.0,3.0,9.229e-02,7.128e-02,1.195e-01,2.033e-02,6.811e-03,6.067e-02,8.657e-01,2.569e-02
EGFR,3236,positive regulation of peptidyl-serine phosphorylation,GO:0033138,biological process,140.0,4.0,9.229e-02,7.128e-02,1.195e-01,2.334e-02,9.993e-03,5.451e-02,8.536e-01,2.060e-02
EGFR,3236,positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045737,biological process,140.0,6.0,9.229e-02,7.128e-02,1.195e-01,2.687e-02,6.351e-03,1.137e-01,8.376e-01,3.650e-02
EGFR,3236,transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007169,biological process,140.0,24.0,9.229e-02,7.128e-02,1.195e-01,2.863e-02,1.054e-02,7.779e-02,8.327e-01,2.516e-02
EGFR,3236,regulation of phosphatidylinositol 3-kinase signaling,GO:0014066,biological process,140.0,4.0,9.308e-02,7.274e-02,1.191e-01,2.953e-02,7.154e-03,1.219e-01,8.273e-01,3.472e-02
EGFR,3236,positive regulation of kinase activity,GO:0033674,biological process,140.0,15.0,9.316e-02,7.293e-02,1.190e-01,3.526e-02,1.942e-02,6.403e-02,8.115e-01,1.514e-02
EGFR,3236,positive regulation of DNA repair,GO:0045739,biological process,140.0,13.0,9.380e-02,7.430e-02,1.184e-01,3.636e-02,1.293e-02,1.022e-01,8.076e-01,2.592e-02
EGFR,3236,positive regulation of protein phosphorylation,GO:0001934,biological process,140.0,17.0,9.456e-02,7.493e-02,1.193e-01,2.603e-02,5.652e-03,1.198e-01,8.379e-01,3.357e-02
EGFR,3236,peptidyl-tyrosine phosphorylation,GO:0018108,biological process,140.0,9.0,9.460e-02,7.620e-02,1.174e-01,3.035e-02,1.890e-02,4.873e-02,8.273e-01,1.167e-02
EGFR,3236,cell surface receptor signaling pathway,GO:0007166,biological process,140.0,32.0,9.554e-02,7.609e-02,1.200e-01,4.196e-02,2.162e-02,8.144e-02,7.930e-01,1.730e-02
EGFR,3236,regulation of peptidyl-tyrosine phosphorylation,GO:0050730,biological process,140.0,8.0,9.847e-02,7.655e-02,1.267e-01,3.773e-02,1.085e-02,1.312e-01,8.031e-01,3.135e-02
EGFR,3236,positive regulation of nitric oxide mediated signal transduction,GO:0010750,biological process,140.0,3.0,9.855e-02,7.683e-02,1.264e-01,3.397e-02,1.119e-02,1.031e-01,8.142e-01,2.864e-02
EGFR,3236,positive regulation of NIK/NF-kappaB signaling,GO:1901224,biological process,140.0,4.0,9.860e-02,7.681e-02,1.266e-01,3.136e-02,8.118e-03,1.211e-01,8.217e-01,3.476e-02
EGFR,3236,positive regulation of protein kinase B signaling,GO:0051897,biological process,140.0,8.0,9.958e-02,8.223e-02,1.206e-01,3.661e-02,1.610e-02,8.321e-02,8.077e-01,2.048e-02
EGFR,3236,signal transduction,GO:0007165,biological process,140.0,48.0,1.046e-01,5.506e-02,1.989e-01,4.247e-02,6.427e-03,2.806e-01,7.836e-01,5.406e-02
EGFR,3236,positive regulation of DNA replication,GO:0045740,biological process,140.0,5.0,1.052e-01,1.014e-01,1.091e-01,5.969e-02,3.869e-02,9.208e-02,7.534e-01,1.258e-02
EGFR,3236,positive regulation of cell migration,GO:0030335,biological process,140.0,33.0,1.061e-01,9.725e-02,1.158e-01,6.631e-02,4.056e-02,1.084e-01,7.408e-01,1.437e-02
EGFR,3236,positive regulation of G1/S transition of mitotic cell cycle,GO:1900087,biological process,140.0,7.0,1.071e-01,1.008e-01,1.137e-01,7.031e-02,4.111e-02,1.202e-01,7.334e-01,1.567e-02
EGFR,3236,positive regulation of production of miRNAs involved in gene silencing by miRNA,GO:1903800,biological process,140.0,7.0,1.080e-01,7.169e-02,1.626e-01,6.458e-02,2.750e-02,1.516e-01,7.424e-01,2.563e-02
EGFR,3236,cellular response to cadmium ion,GO:0071276,biological process,140.0,3.0,1.081e-01,6.983e-02,1.672e-01,6.499e-02,1.903e-02,2.220e-01,7.394e-01,3.487e-02
EGFR,3236,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,140.0,62.0,1.084e-01,1.019e-01,1.154e-01,7.066e-02,5.053e-02,9.883e-02,7.335e-01,1.012e-02
EGFR,3236,positive regulation of canonical Wnt signaling pathway,GO:0090263,biological process,140.0,8.0,1.089e-01,7.917e-02,1.499e-01,6.175e-02,2.289e-02,1.666e-01,7.468e-01,2.999e-02
EGFR,3236,positive regulation of epithelial cell proliferation,GO:0050679,biological process,140.0,18.0,1.103e-01,9.637e-02,1.263e-01,6.673e-02,3.093e-02,1.440e-01,7.391e-01,2.279e-02
EGFR,3236,response to UV-A,GO:0070141,biological process,140.0,3.0,1.110e-01,6.379e-02,1.930e-01,6.502e-02,1.649e-02,2.564e-01,7.380e-01,3.975e-02
EGFR,3236,epidermal growth factor receptor signaling pathway,GO:0007173,biological process,140.0,10.0,1.126e-01,8.263e-02,1.535e-01,7.661e-02,4.824e-02,1.217e-01,7.229e-01,1.444e-02
EGFR,3236,positive regulation of cell population proliferation,GO:0008284,biological process,140.0,40.0,1.127e-01,8.296e-02,1.532e-01,7.549e-02,4.496e-02,1.268e-01,7.246e-01,1.599e-02
EGFR,3236,cellular response to reactive oxygen species,GO:0034614,biological process,140.0,11.0,1.192e-01,4.578e-02,3.104e-01,6.622e-02,1.050e-02,4.177e-01,7.295e-01,6.004e-02
EGFR,3236,positive regulation of protein localization to plasma membrane,GO:1903078,biological process,140.0,7.0,1.241e-01,4.649e-02,3.311e-01,6.248e-02,5.919e-03,6.595e-01,7.319e-01,7.267e-02
EGFR,3236,positive regulation of cell growth,GO:0030307,biological process,140.0,14.0,1.253e-01,7.427e-02,2.113e-01,7.784e-02,1.970e-02,3.075e-01,7.146e-01,4.357e-02
EGFR,3236,multicellular organism development,GO:0007275,biological process,140.0,16.0,1.254e-01,9.740e-02,1.615e-01,9.574e-02,5.825e-02,1.574e-01,6.929e-01,1.697e-02
EGFR,3236,regulation of nitric-oxide synthase activity,GO:0050999,biological process,140.0,5.0,1.353e-01,3.965e-02,4.619e-01,7.443e-02,6.979e-03,7.939e-01,7.059e-01,8.009e-02
EGFR,3236,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,140.0,35.0,1.391e-01,1.002e-01,1.931e-01,1.190e-01,7.816e-02,1.812e-01,6.620e-01,1.491e-02
EGFR,3236,negative regulation of apoptotic process,GO:0043066,biological process,140.0,29.0,1.455e-01,8.422e-02,2.515e-01,1.253e-01,6.747e-02,2.327e-01,6.535e-01,2.321e-02
EGFR,3236,negative regulation of protein catabolic process,GO:0042177,biological process,140.0,8.0,1.481e-01,1.058e-01,2.075e-01,1.278e-01,7.899e-02,2.069e-01,6.510e-01,1.788e-02
EGFR,3236,cellular response to estradiol stimulus,GO:0071392,biological process,140.0,6.0,1.505e-01,3.434e-02,6.592e-01,9.572e-02,9.709e-03,9.438e-01,6.688e-01,8.769e-02
EGFR,3236,cell-cell adhesion,GO:0098609,biological process,140.0,23.0,1.626e-01,1.482e-01,1.784e-01,1.482e-01,1.408e-01,1.559e-01,6.289e-01,1.972e-03
EGFR,3236,cell population proliferation,GO:0008283,biological process,140.0,35.0,2.313e-01,7.921e-02,6.756e-01,1.991e-01,4.512e-02,8.784e-01,5.652e-01,6.137e-02
EGFR,3236,negative regulation of cardiocyte differentiation,GO:1905208,biological process,140.0,10.0,3.140e-01,4.864e-02,2.027e+00,2.963e-01,4.127e-02,2.127e+00,4.159e-01,1.586e-01
EGFR,3236,cell differentiation,GO:0030154,biological process,140.0,86.0,3.357e-01,6.105e-02,1.846e+00,2.976e-01,3.733e-02,2.374e+00,4.506e-01,1.129e-01
EGFR,3236,integral component of plasma membrane,GO:0005887,cellular component,140.0,28.0,9.229e-02,7.128e-02,1.195e-01,1.884e-02,1.599e-02,2.220e-02,8.757e-01,3.792e-03
EGFR,3236,early endosome membrane,GO:0031901,cellular component,140.0,3.0,9.237e-02,7.145e-02,1.194e-01,1.909e-02,9.709e-03,3.755e-02,8.724e-01,1.476e-02
EGFR,3236,focal adhesion,GO:0005925,cellular component,140.0,6.0,9.380e-02,7.430e-02,1.184e-01,3.144e-02,9.658e-03,1.024e-01,8.227e-01,2.857e-02
EGFR,3236,basal plasma membrane,GO:0009925,cellular component,140.0,3.0,9.847e-02,7.655e-02,1.267e-01,3.461e-02,1.121e-02,1.069e-01,8.122e-01,2.912e-02
EGFR,3236,receptor complex,GO:0043235,cellular component,140.0,29.0,9.849e-02,6.128e-02,1.583e-01,3.602e-02,7.179e-03,1.808e-01,8.051e-01,4.322e-02
EGFR,3236,membrane raft,GO:0045121,cellular component,140.0,8.0,9.855e-02,7.683e-02,1.264e-01,3.021e-02,7.140e-03,1.278e-01,8.247e-01,3.490e-02
EGFR,3236,plasma membrane,GO:0005886,cellular component,140.0,61.0,9.855e-02,7.683e-02,1.264e-01,4.869e-02,3.003e-02,7.893e-02,7.770e-01,1.284e-02
EGFR,3236,cell surface,GO:0009986,cellular component,140.0,11.0,1.010e-01,8.181e-02,1.246e-01,4.696e-02,1.965e-02,1.122e-01,7.796e-01,2.386e-02
EGFR,3236,endosome,GO:0005768,cellular component,140.0,15.0,1.055e-01,7.147e-02,1.558e-01,5.262e-02,1.161e-02,2.384e-01,7.639e-01,4.012e-02
EGFR,3236,nucleus,GO:0005634,cellular component,140.0,81.0,1.061e-01,9.725e-02,1.158e-01,6.348e-02,3.843e-02,1.049e-01,7.461e-01,1.439e-02
EGFR,3236,cytoplasm,GO:0005737,cellular component,140.0,78.0,1.080e-01,9.706e-02,1.201e-01,7.466e-02,5.740e-02,9.711e-02,7.267e-01,8.031e-03
EGFR,3236,cell junction,GO:0030054,cellular component,140.0,10.0,1.129e-01,8.325e-02,1.531e-01,8.038e-02,5.231e-02,1.235e-01,7.167e-01,1.369e-02
EGFR,3236,membrane,GO:0016020,cellular component,140.0,58.0,1.130e-01,8.518e-02,1.499e-01,5.921e-02,1.545e-02,2.268e-01,7.498e-01,3.900e-02
EGFR,3236,"multivesicular body, internal vesicle lumen",GO:0097489,cellular component,140.0,3.0,1.193e-01,9.714e-02,1.465e-01,8.171e-02,3.121e-02,2.139e-01,7.120e-01,2.917e-02
EGFR,3236,perinuclear region of cytoplasm,GO:0048471,cellular component,140.0,11.0,1.211e-01,9.884e-02,1.483e-01,8.960e-02,4.207e-02,1.909e-01,7.006e-01,2.373e-02
EGFR,3236,endosome membrane,GO:0010008,cellular component,140.0,12.0,1.235e-01,9.658e-02,1.580e-01,6.112e-02,6.535e-03,5.715e-01,7.387e-01,6.130e-02
EGFR,3236,basolateral plasma membrane,GO:0016323,cellular component,140.0,5.0,1.357e-01,9.582e-02,1.922e-01,1.136e-01,6.852e-02,1.883e-01,6.687e-01,1.778e-02
EGFR,3236,protein-containing complex,GO:0032991,cellular component,140.0,483.0,1.920e-01,7.576e-02,4.867e-01,1.750e-01,6.101e-02,5.022e-01,5.943e-01,4.606e-02
EGFR,3236,epidermal growth factor-activated receptor activity,GO:0005006,molecular function,140.0,3.0,9.229e-02,7.128e-02,1.195e-01,1.154e-02,6.483e-03,2.053e-02,9.132e-01,8.400e-03
EGFR,3236,protein tyrosine kinase activity,GO:0004713,molecular function,140.0,6.0,9.229e-02,7.128e-02,1.195e-01,1.205e-02,6.122e-03,2.372e-02,9.098e-01,9.985e-03
EGFR,3236,identical protein binding,GO:0042802,molecular function,140.0,35.0,9.316e-02,7.293e-02,1.190e-01,2.944e-02,2.113e-02,4.102e-02,8.305e-01,8.145e-03
EGFR,3236,transmembrane receptor protein tyrosine kinase activity,GO:0004714,molecular function,140.0,21.0,9.387e-02,7.411e-02,1.189e-01,3.188e-02,2.353e-02,4.318e-02,8.224e-01,7.485e-03
EGFR,3236,ubiquitin protein ligase binding,GO:0031625,molecular function,140.0,9.0,9.464e-02,7.516e-02,1.192e-01,4.373e-02,2.452e-02,7.800e-02,7.886e-01,1.549e-02
EGFR,3236,cadherin binding,GO:0045296,molecular function,140.0,13.0,9.589e-02,6.779e-02,1.356e-01,3.730e-02,1.133e-02,1.228e-01,8.038e-01,3.144e-02
EGFR,3236,protein binding,GO:0005515,molecular function,140.0,347.0,1.036e-01,9.538e-02,1.125e-01,5.752e-02,5.092e-02,6.498e-02,7.584e-01,3.402e-03
EGFR,3236,protein heterodimerization activity,GO:0046982,molecular function,140.0,8.0,1.052e-01,1.014e-01,1.091e-01,6.163e-02,4.079e-02,9.311e-02,7.498e-01,1.198e-02
EGFR,3236,actin filament binding,GO:0051015,molecular function,140.0,6.0,1.054e-01,7.537e-02,1.474e-01,6.236e-02,3.523e-02,1.104e-01,7.481e-01,1.647e-02
EGFR,3236,epidermal growth factor binding,GO:0048408,molecular function,140.0,3.0,1.118e-01,8.078e-02,1.547e-01,6.539e-02,3.019e-02,1.416e-01,7.411e-01,2.337e-02
EGFR,3236,protein phosphatase binding,GO:0019903,molecular function,140.0,7.0,1.219e-01,5.075e-02,2.930e-01,7.361e-02,1.319e-02,4.108e-01,7.180e-01,5.477e-02
EGFR,3236,enzyme binding,GO:0019899,molecular function,140.0,35.0,1.252e-01,4.765e-02,3.292e-01,7.598e-02,1.100e-02,5.247e-01,7.109e-01,6.298e-02
EGFR,3236,transmembrane signaling receptor activity,GO:0004888,molecular function,140.0,39.0,1.334e-01,9.731e-02,1.830e-01,1.090e-01,6.310e-02,1.883e-01,6.747e-01,1.961e-02
EGFR,3236,chromatin binding,GO:0003682,molecular function,140.0,9.0,1.524e-01,8.388e-02,2.770e-01,1.336e-01,6.348e-02,2.812e-01,6.428e-01,2.766e-02
EGFR,3236,nitric-oxide synthase regulator activity,GO:0030235,molecular function,140.0,3.0,1.651e-01,8.151e-02,3.345e-01,1.490e-01,5.993e-02,3.705e-01,6.244e-01,3.397e-02
EHD3,3244,,,,nan,nan,,,,,,,,
EIF2S1,3265,response to endoplasmic reticulum stress,GO:0034976,biological process,25.0,13.0,4.694e-02,1.133e-02,1.944e-01,3.781e-02,7.881e-03,1.814e-01,7.998e-01,4.277e-02
EIF2S1,3265,positive regulation of neuron death,GO:1901216,biological process,25.0,5.0,4.934e-02,1.522e-02,1.599e-01,2.793e-02,6.288e-03,1.241e-01,8.332e-01,3.780e-02
EIF2S1,3265,eukaryotic translation initiation factor 2B complex,GO:0005851,cellular component,25.0,2.0,4.073e-02,1.512e-02,1.097e-01,1.332e-02,1.086e-03,1.634e-01,8.823e-01,4.477e-02
EIF2S1,3265,eukaryotic translation initiation factor 2 complex,GO:0005850,cellular component,25.0,2.0,4.073e-02,1.512e-02,1.097e-01,1.415e-02,1.139e-03,1.758e-01,8.778e-01,4.622e-02
EIF2S1,3265,extracellular exosome,GO:0070062,cellular component,25.0,77.0,4.073e-02,1.512e-02,1.097e-01,2.007e-02,6.902e-03,5.838e-02,8.668e-01,2.474e-02
EIF2S1,3265,cytosol,GO:0005829,cellular component,25.0,76.0,4.073e-02,1.512e-02,1.097e-01,2.459e-02,8.044e-03,7.519e-02,8.478e-01,2.722e-02
EIF2S1,3265,multi-eIF complex,GO:0043614,cellular component,25.0,2.0,4.084e-02,1.516e-02,1.100e-01,1.941e-02,5.362e-03,7.027e-02,8.657e-01,2.578e-02
EIF2S1,3265,membrane,GO:0016020,cellular component,25.0,58.0,4.415e-02,1.293e-02,1.508e-01,2.811e-02,5.576e-03,1.417e-01,8.320e-01,4.160e-02
EIF2S1,3265,eukaryotic 48S preinitiation complex,GO:0033290,cellular component,25.0,2.0,4.520e-02,1.588e-02,1.286e-01,2.850e-02,8.456e-03,9.605e-02,8.319e-01,2.856e-02
EIF2S1,3265,protein binding,GO:0005515,molecular function,25.0,347.0,4.073e-02,1.512e-02,1.097e-01,2.131e-02,4.327e-03,1.049e-01,8.560e-01,3.467e-02
EIF2S1,3265,RNA binding,GO:0003723,molecular function,25.0,60.0,4.520e-02,1.588e-02,1.286e-01,2.099e-02,5.127e-03,8.593e-02,8.605e-01,3.261e-02
EIF2S1,3265,translation initiation factor activity,GO:0003743,molecular function,25.0,2.0,4.520e-02,1.588e-02,1.286e-01,2.851e-02,1.234e-02,6.585e-02,8.335e-01,2.060e-02
EIF2S1,3265,ribosome binding,GO:0043022,molecular function,25.0,4.0,6.909e-02,1.972e-02,2.421e-01,6.909e-02,1.972e-02,2.421e-01,7.315e-01,3.622e-02
ELL2,17064,,,,nan,nan,,,,,,,,
EPHB2,3393,transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007169,biological process,12.0,24.0,1.252e-01,8.378e-02,1.872e-01,4.683e-02,1.109e-02,1.978e-01,7.764e-01,4.082e-02
EPHB2,3393,positive regulation of kinase activity,GO:0033674,biological process,12.0,15.0,1.428e-01,9.353e-02,2.181e-01,7.989e-02,4.140e-02,1.542e-01,7.165e-01,2.031e-02
EPHB2,3393,multicellular organism development,GO:0007275,biological process,12.0,16.0,2.560e-01,1.330e-01,4.930e-01,2.295e-01,1.059e-01,4.973e-01,5.478e-01,3.732e-02
EPHB2,3393,central nervous system projection neuron axonogenesis,GO:0021952,biological process,12.0,17.0,3.670e-01,1.765e-01,7.631e-01,3.544e-01,1.608e-01,7.810e-01,4.488e-01,5.149e-02
EPHB2,3393,integral component of plasma membrane,GO:0005887,cellular component,12.0,28.0,1.252e-01,8.378e-02,1.872e-01,3.242e-02,2.519e-02,4.172e-02,8.207e-01,6.176e-03
EPHB2,3393,receptor complex,GO:0043235,cellular component,12.0,29.0,1.382e-01,8.069e-02,2.365e-01,6.613e-02,1.655e-02,2.642e-01,7.352e-01,4.264e-02
EPHB2,3393,plasma membrane,GO:0005886,cellular component,12.0,61.0,1.763e-01,1.312e-01,2.368e-01,1.047e-01,7.591e-02,1.444e-01,6.812e-01,1.120e-02
EPHB2,3393,nucleoplasm,GO:0005654,cellular component,12.0,51.0,2.373e-01,1.154e-01,4.883e-01,1.651e-01,4.085e-02,6.673e-01,6.012e-01,5.286e-02
EPHB2,3393,transmembrane receptor protein tyrosine kinase activity,GO:0004714,molecular function,12.0,21.0,1.252e-01,8.378e-02,1.872e-01,4.794e-02,2.113e-02,1.087e-01,7.774e-01,2.264e-02
EPHB2,3393,protein binding,GO:0005515,molecular function,12.0,347.0,2.096e-01,1.258e-01,3.492e-01,1.397e-01,7.104e-02,2.747e-01,6.365e-01,2.482e-02
ERGIC1,29205,endoplasmic reticulum to Golgi vesicle-mediated transport,GO:0006888,biological process,12.0,5.0,2.054e-01,5.463e-02,7.722e-01,1.345e-01,1.800e-02,1.005e+00,6.263e-01,6.933e-02
ERGIC1,29205,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum",GO:0006890,biological process,12.0,3.0,2.070e-01,5.432e-02,7.891e-01,1.310e-01,1.232e-02,1.393e+00,6.235e-01,8.142e-02
ERGIC1,29205,endoplasmic reticulum-Golgi intermediate compartment,GO:0005793,cellular component,12.0,3.0,1.828e-01,5.648e-02,5.918e-01,4.406e-02,3.004e-02,6.463e-02,7.882e-01,1.022e-02
ERGIC1,29205,integral component of endoplasmic reticulum membrane,GO:0030176,cellular component,12.0,10.0,1.828e-01,5.648e-02,5.918e-01,5.554e-02,1.774e-02,1.740e-01,7.586e-01,3.376e-02
ERGIC1,29205,integral component of Golgi membrane,GO:0030173,cellular component,12.0,7.0,2.109e-01,5.361e-02,8.293e-01,1.310e-01,7.799e-03,2.199e+00,6.140e-01,9.541e-02
ERGIC1,29205,endoplasmic reticulum,GO:0005783,cellular component,12.0,34.0,2.174e-01,7.008e-02,6.742e-01,1.164e-01,3.864e-02,3.509e-01,6.610e-01,3.724e-02
ERGIC1,29205,intracellular membrane-bounded organelle,GO:0043231,cellular component,12.0,48.0,2.231e-01,7.860e-02,6.333e-01,1.198e-01,5.631e-02,2.548e-01,6.593e-01,2.601e-02
ERGIC1,29205,membrane,GO:0016020,cellular component,12.0,58.0,2.281e-01,8.668e-02,6.004e-01,1.604e-01,1.108e-01,2.322e-01,6.156e-01,1.425e-02
ERGIC1,29205,nucleoplasm,GO:0005654,cellular component,12.0,51.0,2.281e-01,8.668e-02,6.004e-01,1.804e-01,1.015e-01,3.207e-01,5.946e-01,2.307e-02
ERGIC1,29205,COPII-coated ER to Golgi transport vesicle,GO:0030134,cellular component,12.0,3.0,2.338e-01,8.493e-02,6.437e-01,2.179e-01,8.424e-02,5.635e-01,5.561e-01,4.177e-02
ERGIC1,29205,protein binding,GO:0005515,molecular function,12.0,347.0,2.281e-01,8.668e-02,6.004e-01,1.800e-01,9.355e-02,3.462e-01,5.943e-01,2.643e-02
EYA2,3520,histone dephosphorylation,GO:0016576,biological process,19.0,3.0,7.580e-02,5.603e-02,1.025e-01,4.027e-02,2.436e-02,6.659e-02,7.976e-01,1.319e-02
EYA2,3520,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,GO:2001240,biological process,19.0,4.0,1.295e-01,6.961e-02,2.410e-01,8.161e-02,3.929e-02,1.695e-01,7.135e-01,2.228e-02
EYA2,3520,positive regulation of DNA repair,GO:0045739,biological process,19.0,13.0,1.354e-01,7.930e-02,2.314e-01,9.008e-02,5.536e-02,1.466e-01,7.014e-01,1.572e-02
EYA2,3520,cell differentiation,GO:0030154,biological process,19.0,86.0,3.015e-01,2.643e-02,3.439e+00,1.847e-01,4.426e-03,7.708e+00,5.057e-01,1.502e-01
EYA2,3520,anatomical structure development,GO:0048856,biological process,19.0,197.0,5.827e-01,1.580e-01,2.149e+00,5.757e-01,1.499e-01,2.210e+00,2.353e-01,1.301e-01
EYA2,3520,cytosol,GO:0005829,cellular component,19.0,76.0,7.580e-02,5.603e-02,1.025e-01,2.527e-02,1.164e-02,5.484e-02,8.456e-01,1.851e-02
EYA2,3520,nucleus,GO:0005634,cellular component,19.0,81.0,7.580e-02,5.603e-02,1.025e-01,2.994e-02,2.068e-02,4.336e-02,8.288e-01,9.042e-03
EYA2,3520,protein binding,GO:0005515,molecular function,19.0,347.0,7.580e-02,5.603e-02,1.025e-01,2.339e-02,1.479e-02,3.698e-02,8.541e-01,1.108e-02
EYA2,3520,magnesium ion binding,GO:0000287,molecular function,19.0,5.0,1.047e-01,3.582e-02,3.062e-01,5.813e-02,1.040e-02,3.249e-01,7.479e-01,5.244e-02
EYA2,3520,protein tyrosine phosphatase activity,GO:0004725,molecular function,19.0,8.0,2.468e-01,1.795e-01,3.394e-01,2.127e-01,1.282e-01,3.528e-01,5.652e-01,2.262e-02
F13A1,3531,"blood coagulation, fibrin clot formation",GO:0072378,biological process,7.0,3.0,1.128e-01,3.323e-02,3.829e-01,6.508e-02,1.062e-02,3.986e-01,7.348e-01,5.063e-02
F13A1,3531,peptide cross-linking,GO:0018149,biological process,7.0,37.0,5.165e-01,2.290e-01,1.165e+00,5.165e-01,2.290e-01,1.165e+00,3.371e-01,6.029e-02
F13A1,3531,collagen-containing extracellular matrix,GO:0062023,cellular component,7.0,36.0,1.128e-01,3.323e-02,3.829e-01,3.364e-02,1.263e-02,8.958e-02,8.164e-01,2.417e-02
F13A1,3531,blood microparticle,GO:0072562,cellular component,7.0,8.0,1.221e-01,4.662e-02,3.197e-01,6.986e-02,2.939e-02,1.661e-01,7.329e-01,2.518e-02
F13A1,3531,protein-glutamine gamma-glutamyltransferase activity,GO:0003810,molecular function,7.0,2.0,2.209e-01,6.295e-02,7.754e-01,1.693e-01,4.385e-02,6.539e-01,5.950e-01,6.009e-02
FAAP24,28467,nucleoplasm,GO:0005654,cellular component,6.0,51.0,7.421e-02,4.440e-02,1.240e-01,5.381e-02,3.739e-02,7.745e-02,7.659e-01,1.001e-02
FAAP24,28467,Fanconi anaemia nuclear complex,GO:0043240,cellular component,6.0,2.0,9.111e-02,3.386e-02,2.451e-01,4.849e-02,4.964e-03,4.737e-01,7.651e-01,6.412e-02
FAAP24,28467,intracellular membrane-bounded organelle,GO:0043231,cellular component,6.0,48.0,9.513e-02,5.689e-02,1.591e-01,8.832e-02,4.491e-02,1.737e-01,7.032e-01,2.238e-02
FAAP24,28467,chromatin binding,GO:0003682,molecular function,6.0,9.0,7.421e-02,4.440e-02,1.240e-01,3.289e-02,1.919e-02,5.638e-02,8.191e-01,1.326e-02
FAAP24,28467,protein binding,GO:0005515,molecular function,6.0,347.0,7.421e-02,4.440e-02,1.240e-01,5.441e-02,3.283e-02,9.016e-02,7.644e-01,1.422e-02
FAH,3579,homogentisate catabolic process,GO:1902000,biological process,10.0,4.0,5.569e-02,2.599e-02,1.193e-01,2.104e-02,3.539e-03,1.251e-01,8.561e-01,3.975e-02
FAH,3579,tyrosine catabolic process,GO:0006572,biological process,10.0,6.0,5.588e-02,2.623e-02,1.191e-01,1.602e-02,6.273e-03,4.089e-02,8.856e-01,1.746e-02
FAH,3579,extracellular exosome,GO:0070062,cellular component,10.0,77.0,5.588e-02,2.623e-02,1.191e-01,3.649e-02,1.929e-02,6.903e-02,8.080e-01,1.608e-02
FAH,3579,fumarylacetoacetase activity,GO:0004334,molecular function,10.0,2.0,7.535e-02,1.686e-02,3.367e-01,6.497e-02,1.063e-02,3.970e-01,7.328e-01,5.729e-02
FAH,3579,protein binding,GO:0005515,molecular function,10.0,347.0,8.190e-02,3.531e-02,1.900e-01,7.603e-02,3.259e-02,1.774e-01,7.217e-01,2.668e-02
FAM110C,33340,regulation of cell projection assembly,GO:0060491,biological process,7.0,6.0,9.688e-02,6.496e-02,1.445e-01,6.133e-02,3.558e-02,1.057e-01,7.501e-01,1.577e-02
FAM110C,33340,positive regulation of protein kinase B signaling,GO:0051897,biological process,7.0,8.0,9.741e-02,6.433e-02,1.475e-01,6.925e-02,4.276e-02,1.121e-01,7.354e-01,1.396e-02
FAM110C,33340,positive regulation of cell migration,GO:0030335,biological process,7.0,33.0,1.292e-01,5.158e-02,3.236e-01,1.006e-01,1.735e-02,5.828e-01,6.754e-01,5.564e-02
FAM110C,33340,cell cortex,GO:0005938,cellular component,7.0,3.0,3.509e-02,1.263e-02,9.752e-02,6.944e-03,2.325e-03,2.074e-02,9.379e-01,1.043e-02
FAM110C,33340,alpha-tubulin binding,GO:0043014,molecular function,7.0,2.0,4.733e-02,1.991e-02,1.125e-01,1.806e-02,4.895e-03,6.663e-02,8.740e-01,2.907e-02
FAM110C,33340,protein binding,GO:0005515,molecular function,7.0,347.0,1.480e-01,1.134e-01,1.932e-01,1.311e-01,8.370e-02,2.053e-01,6.472e-01,1.675e-02
FAM131B,22202,cytosol,GO:0005829,cellular component,6.0,76.0,7.291e-02,4.548e-02,1.169e-01,4.866e-02,2.714e-02,8.725e-02,7.769e-01,1.589e-02
FAM131B,22202,nucleoplasm,GO:0005654,cellular component,6.0,51.0,7.291e-02,4.548e-02,1.169e-01,6.369e-02,2.889e-02,1.404e-01,7.446e-01,2.316e-02
FAM131B,22202,protein binding,GO:0005515,molecular function,6.0,347.0,7.303e-02,4.567e-02,1.168e-01,4.757e-02,2.707e-02,8.359e-02,7.795e-01,1.526e-02
FAM49A,25373,intracellular,GO:0005622,cellular component,2.0,8.0,8.235e-02,4.155e-02,1.632e-01,8.235e-02,4.155e-02,1.632e-01,7.122e-01,2.211e-02
FAM49B,25216,positive regulation of T cell activation,GO:0050870,biological process,5.0,14.0,1.269e-01,3.524e-02,4.570e-01,7.686e-02,8.892e-03,6.643e-01,7.042e-01,7.490e-02
FAM49B,25216,extracellular exosome,GO:0070062,cellular component,5.0,77.0,1.066e-01,6.227e-02,1.825e-01,5.055e-02,1.118e-02,2.286e-01,7.668e-01,4.350e-02
FAM49B,25216,protein binding,GO:0005515,molecular function,5.0,347.0,1.346e-01,6.833e-02,2.653e-01,1.176e-01,8.847e-02,1.564e-01,6.641e-01,1.019e-02
FASN,3594,osteoblast differentiation,GO:0001649,biological process,50.0,3.0,1.838e-02,1.428e-02,2.365e-02,1.434e-02,6.067e-03,3.390e-02,8.956e-01,1.511e-02
FASN,3594,extracellular exosome,GO:0070062,cellular component,50.0,77.0,1.351e-02,7.850e-03,2.324e-02,6.189e-03,3.020e-03,1.268e-02,9.439e-01,7.256e-03
FASN,3594,membrane,GO:0016020,cellular component,50.0,58.0,1.351e-02,7.850e-03,2.324e-02,7.073e-03,6.001e-03,8.338e-03,9.397e-01,1.678e-03
FASN,3594,cytosol,GO:0005829,cellular component,50.0,76.0,1.351e-02,7.850e-03,2.324e-02,7.285e-03,5.227e-03,1.015e-02,9.384e-01,3.556e-03
FASN,3594,Golgi apparatus,GO:0005794,cellular component,50.0,16.0,1.351e-02,7.850e-03,2.324e-02,7.493e-03,3.978e-03,1.411e-02,9.361e-01,6.867e-03
FASN,3594,plasma membrane,GO:0005886,cellular component,50.0,61.0,1.446e-02,6.661e-03,3.141e-02,9.481e-03,3.056e-03,2.942e-02,9.203e-01,1.702e-02
FASN,3594,cadherin binding,GO:0045296,molecular function,50.0,13.0,1.446e-02,6.661e-03,3.141e-02,8.022e-03,1.577e-03,4.081e-02,9.243e-01,2.310e-02
FASN,3594,protein binding,GO:0005515,molecular function,50.0,347.0,1.656e-02,1.087e-02,2.523e-02,1.224e-02,9.052e-03,1.654e-02,9.103e-01,4.597e-03
FASN,3594,RNA binding,GO:0003723,molecular function,50.0,60.0,2.399e-02,9.211e-03,6.245e-02,2.303e-02,8.439e-03,6.286e-02,8.547e-01,2.442e-02
FBLN1,3600,negative regulation of ERK1 and ERK2 cascade,GO:0070373,biological process,26.0,4.0,3.685e-02,1.664e-02,8.162e-02,1.255e-02,6.045e-03,2.605e-02,9.059e-01,1.326e-02
FBLN1,3600,negative regulation of protein phosphorylation,GO:0001933,biological process,26.0,19.0,3.685e-02,1.664e-02,8.162e-02,1.652e-02,1.292e-02,2.112e-02,8.877e-01,5.286e-03
FBLN1,3600,negative regulation of cell adhesion,GO:0007162,biological process,26.0,10.0,3.911e-02,1.901e-02,8.044e-02,2.422e-02,2.255e-02,2.601e-02,8.504e-01,1.752e-03
FBLN1,3600,negative regulation of substrate adhesion-dependent cell spreading,GO:1900025,biological process,26.0,4.0,4.023e-02,1.990e-02,8.132e-02,2.337e-02,9.642e-03,5.665e-02,8.525e-01,2.055e-02
FBLN1,3600,"blood coagulation, fibrin clot formation",GO:0072378,biological process,26.0,3.0,4.426e-02,1.073e-02,1.827e-01,2.235e-02,1.697e-03,2.943e-01,8.421e-01,6.395e-02
FBLN1,3600,negative regulation of stem cell proliferation,GO:2000647,biological process,26.0,6.0,4.789e-02,1.347e-02,1.703e-01,3.371e-02,9.738e-03,1.167e-01,8.148e-01,3.172e-02
FBLN1,3600,negative regulation of cell motility,GO:2000146,biological process,26.0,8.0,4.797e-02,3.060e-02,7.521e-02,3.373e-02,1.702e-02,6.684e-02,8.161e-01,1.732e-02
FBLN1,3600,elastic fiber,GO:0071953,cellular component,26.0,3.0,3.685e-02,1.664e-02,8.162e-02,1.536e-02,1.112e-02,2.124e-02,8.934e-01,6.568e-03
FBLN1,3600,collagen-containing extracellular matrix,GO:0062023,cellular component,26.0,36.0,4.046e-02,1.330e-02,1.231e-01,1.606e-02,2.905e-03,8.884e-02,8.794e-01,3.611e-02
FBLN1,3600,extracellular matrix,GO:0031012,cellular component,26.0,17.0,4.426e-02,1.073e-02,1.827e-01,1.880e-02,1.049e-03,3.371e-01,8.508e-01,6.735e-02
FBLN1,3600,extracellular space,GO:0005615,cellular component,26.0,43.0,4.426e-02,1.073e-02,1.827e-01,2.089e-02,1.820e-03,2.396e-01,8.499e-01,5.882e-02
FBLN1,3600,extracellular exosome,GO:0070062,cellular component,26.0,77.0,4.793e-02,1.297e-02,1.772e-01,3.930e-02,1.126e-02,1.372e-01,7.975e-01,3.363e-02
FBLN1,3600,extracellular region,GO:0005576,cellular component,26.0,17.0,4.914e-02,1.362e-02,1.772e-01,3.750e-02,7.648e-03,1.839e-01,8.014e-01,4.140e-02
FBLN1,3600,fibrinogen binding,GO:0070051,molecular function,26.0,2.0,3.685e-02,1.664e-02,8.162e-02,5.435e-03,3.245e-03,9.102e-03,9.496e-01,4.529e-03
FBLN1,3600,protein C-terminus binding,GO:0008022,molecular function,26.0,3.0,3.759e-02,1.749e-02,8.080e-02,1.889e-02,9.794e-03,3.644e-02,8.737e-01,1.476e-02
FBLN1,3600,calcium ion binding,GO:0005509,molecular function,26.0,6.0,3.911e-02,1.901e-02,8.044e-02,2.157e-02,1.712e-02,2.716e-02,8.622e-01,5.635e-03
FBLN1,3600,fibronectin binding,GO:0001968,molecular function,26.0,5.0,4.046e-02,1.330e-02,1.231e-01,1.252e-02,1.572e-03,9.965e-02,8.918e-01,4.039e-02
FBLN1,3600,protein-containing complex binding,GO:0044877,molecular function,26.0,75.0,4.376e-02,1.218e-02,1.572e-01,2.943e-02,9.391e-03,9.222e-02,8.292e-01,2.872e-02
FBLN1,3600,extracellular matrix structural constituent,GO:0005201,molecular function,26.0,12.0,4.426e-02,1.073e-02,1.827e-01,1.785e-02,1.031e-03,3.089e-01,8.555e-01,6.397e-02
FBLN1,3600,identical protein binding,GO:0042802,molecular function,26.0,35.0,5.989e-02,2.393e-02,1.499e-01,5.294e-02,2.881e-02,9.730e-02,7.670e-01,1.706e-02
FBXW8,13597,protein ubiquitination,GO:0016567,biological process,15.0,10.0,9.396e-02,7.735e-02,1.141e-01,3.287e-02,1.507e-02,7.170e-02,8.184e-01,1.983e-02
FBXW8,13597,Golgi organization,GO:0007030,biological process,15.0,7.0,1.148e-01,8.323e-02,1.585e-01,6.531e-02,3.029e-02,1.408e-01,7.416e-01,2.294e-02
FBXW8,13597,positive regulation of dendrite morphogenesis,GO:0050775,biological process,15.0,5.0,1.670e-01,5.130e-02,5.440e-01,8.389e-02,3.030e-03,2.323e+00,6.762e-01,9.695e-02
FBXW8,13597,cell population proliferation,GO:0008283,biological process,15.0,35.0,2.355e-01,8.527e-02,6.505e-01,2.026e-01,4.515e-02,9.089e-01,5.611e-01,6.380e-02
FBXW8,13597,3M complex,GO:1990393,cellular component,15.0,2.0,9.396e-02,7.735e-02,1.141e-01,2.597e-02,1.337e-02,5.043e-02,8.433e-01,1.635e-02
FBXW8,13597,Cul7-RING ubiquitin ligase complex,GO:0031467,cellular component,15.0,2.0,1.046e-01,6.396e-02,1.711e-01,3.630e-02,8.387e-03,1.572e-01,8.057e-01,3.807e-02
FBXW8,13597,Golgi apparatus,GO:0005794,cellular component,15.0,16.0,1.322e-01,7.819e-02,2.237e-01,1.007e-01,4.725e-02,2.147e-01,6.846e-01,2.628e-02
FBXW8,13597,cytosol,GO:0005829,cellular component,15.0,76.0,1.381e-01,9.911e-02,1.923e-01,1.027e-01,7.977e-02,1.323e-01,6.840e-01,8.865e-03
FBXW8,13597,perinuclear region of cytoplasm,GO:0048471,cellular component,15.0,11.0,1.402e-01,7.819e-02,2.514e-01,1.116e-01,4.979e-02,2.502e-01,6.694e-01,2.725e-02
FBXW8,13597,ubiquitin-protein transferase activity,GO:0004842,molecular function,15.0,7.0,9.396e-02,7.735e-02,1.141e-01,2.103e-02,7.916e-03,5.585e-02,8.635e-01,2.340e-02
FBXW8,13597,protein binding,GO:0005515,molecular function,15.0,347.0,1.366e-01,7.371e-02,2.531e-01,1.042e-01,3.648e-02,2.975e-01,6.777e-01,3.707e-02
FDPS,3631,farnesyl diphosphate biosynthetic process,GO:0045337,biological process,14.0,5.0,4.173e-02,2.287e-02,7.616e-02,1.610e-02,4.886e-03,5.307e-02,8.837e-01,2.559e-02
FDPS,3631,cytosol,GO:0005829,cellular component,14.0,76.0,4.173e-02,2.287e-02,7.616e-02,1.919e-02,1.823e-02,2.019e-02,8.740e-01,1.240e-03
FDPS,3631,cytoplasm,GO:0005737,cellular component,14.0,78.0,4.173e-02,2.287e-02,7.616e-02,2.184e-02,1.558e-02,3.061e-02,8.609e-01,8.187e-03
FDPS,3631,nucleoplasm,GO:0005654,cellular component,14.0,51.0,4.173e-02,2.287e-02,7.616e-02,2.190e-02,1.699e-02,2.824e-02,8.608e-01,6.128e-03
FDPS,3631,RNA binding,GO:0003723,molecular function,14.0,60.0,5.212e-02,1.997e-02,1.360e-01,3.065e-02,3.288e-03,2.858e-01,8.146e-01,5.060e-02
FDPS,3631,geranyltranstransferase activity,GO:0004337,molecular function,14.0,4.0,1.343e-01,5.259e-02,3.427e-01,1.253e-01,5.290e-02,2.969e-01,6.518e-01,3.032e-02
FDPS,3631,dimethylallyltranstransferase activity,GO:0004161,molecular function,14.0,2.0,1.343e-01,5.259e-02,3.427e-01,1.267e-01,4.115e-02,3.902e-01,6.479e-01,3.976e-02
FGF18,3674,positive regulation of blood vessel endothelial cell migration,GO:0043536,biological process,14.0,6.0,2.267e-02,1.295e-02,3.967e-02,1.325e-02,9.201e-03,1.909e-02,9.047e-01,6.106e-03
FGF18,3674,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,GO:2000546,biological process,14.0,4.0,2.374e-02,1.229e-02,4.586e-02,1.543e-02,8.058e-03,2.956e-02,8.912e-01,1.333e-02
FGF18,3674,positive regulation of MAP kinase activity,GO:0043406,biological process,14.0,10.0,2.396e-02,1.230e-02,4.667e-02,1.440e-02,3.982e-03,5.206e-02,8.911e-01,2.320e-02
FGF18,3674,positive regulation of angiogenesis,GO:0045766,biological process,14.0,12.0,3.508e-02,1.965e-02,6.263e-02,2.804e-02,9.431e-03,8.337e-02,8.344e-01,2.652e-02
FGF18,3674,nucleolus,GO:0005730,cellular component,14.0,18.0,4.721e-02,2.610e-02,8.539e-02,4.484e-02,2.339e-02,8.595e-02,7.857e-01,1.749e-02
FGF18,3674,type 2 fibroblast growth factor receptor binding,GO:0005111,molecular function,14.0,2.0,1.765e-02,8.712e-03,3.575e-02,6.339e-03,1.129e-03,3.558e-02,9.354e-01,2.150e-02
FGF18,3674,type 1 fibroblast growth factor receptor binding,GO:0005105,molecular function,14.0,2.0,1.765e-02,8.712e-03,3.575e-02,6.415e-03,9.928e-04,4.145e-02,9.331e-01,2.348e-02
FHL1,3702,negative regulation of G1/S transition of mitotic cell cycle,GO:2000134,biological process,17.0,10.0,2.012e-01,1.636e-01,2.476e-01,1.100e-01,4.822e-02,2.511e-01,6.715e-01,2.992e-02
FHL1,3702,negative regulation of cell growth,GO:0030308,biological process,17.0,19.0,2.149e-01,9.656e-02,4.784e-01,1.055e-01,5.796e-03,1.921e+00,6.475e-01,9.634e-02
FHL1,3702,positive regulation of potassium ion transport,GO:0043268,biological process,17.0,4.0,2.213e-01,7.014e-02,6.980e-01,6.245e-02,2.485e-03,1.569e+00,7.104e-01,1.113e-01
FHL1,3702,regulation of membrane depolarization,GO:0003254,biological process,17.0,10.0,2.213e-01,7.014e-02,6.980e-01,9.280e-02,8.977e-03,9.594e-01,6.721e-01,8.919e-02
FHL1,3702,negative regulation of G2/M transition of mitotic cell cycle,GO:0010972,biological process,17.0,8.0,2.296e-01,1.284e-01,4.105e-01,1.571e-01,5.421e-02,4.552e-01,6.126e-01,4.507e-02
FHL1,3702,regulation of potassium ion transmembrane transporter activity,GO:1901016,biological process,17.0,13.0,2.488e-01,1.071e-01,5.777e-01,1.599e-01,3.229e-02,7.920e-01,5.996e-01,7.174e-02
FHL1,3702,focal adhesion,GO:0005925,cellular component,17.0,6.0,1.633e-01,9.661e-02,2.760e-01,5.638e-02,1.190e-02,2.671e-01,7.529e-01,4.736e-02
FHL1,3702,nucleus,GO:0005634,cellular component,17.0,81.0,2.012e-01,1.636e-01,2.476e-01,1.416e-01,1.084e-01,1.850e-01,6.358e-01,1.019e-02
FHL1,3702,plasma membrane,GO:0005886,cellular component,17.0,61.0,2.012e-01,1.636e-01,2.476e-01,1.436e-01,1.211e-01,1.702e-01,6.337e-01,6.438e-03
FHL1,3702,cytosol,GO:0005829,cellular component,17.0,76.0,2.012e-01,1.636e-01,2.476e-01,1.575e-01,1.391e-01,1.783e-01,6.191e-01,4.873e-03
FHL1,3702,cytoplasm,GO:0005737,cellular component,17.0,78.0,2.099e-01,1.548e-01,2.846e-01,1.819e-01,1.737e-01,1.905e-01,5.952e-01,1.934e-03
FHL1,3702,ion channel binding,GO:0044325,molecular function,17.0,6.0,1.633e-01,9.661e-02,2.760e-01,2.593e-02,2.281e-02,2.948e-02,8.435e-01,3.156e-03
FHL1,3702,protein binding,GO:0005515,molecular function,17.0,347.0,2.012e-01,1.636e-01,2.476e-01,1.360e-01,1.157e-01,1.599e-01,6.422e-01,5.976e-03
FIBIN,33747,,,,nan,nan,,,,,,,,
FKBP5,3721,chaperone-mediated protein folding,GO:0061077,biological process,14.0,7.0,1.026e-01,3.307e-02,3.183e-01,6.383e-02,9.569e-03,4.258e-01,7.366e-01,5.279e-02
FKBP5,3721,protein peptidyl-prolyl isomerization,GO:0000413,biological process,14.0,3.0,1.337e-01,4.070e-02,4.391e-01,1.337e-01,4.070e-02,4.391e-01,6.384e-01,4.429e-02
FKBP5,3721,extracellular exosome,GO:0070062,cellular component,14.0,77.0,8.574e-02,3.779e-02,1.945e-01,3.884e-02,1.563e-02,9.653e-02,8.007e-01,2.339e-02
FKBP5,3721,cytoplasm,GO:0005737,cellular component,14.0,78.0,8.574e-02,3.779e-02,1.945e-01,5.368e-02,3.667e-02,7.860e-02,7.663e-01,1.042e-02
FKBP5,3721,nucleoplasm,GO:0005654,cellular component,14.0,51.0,8.987e-02,3.615e-02,2.234e-01,6.102e-02,3.422e-02,1.088e-01,7.506e-01,1.681e-02
FKBP5,3721,membrane,GO:0016020,cellular component,14.0,58.0,1.046e-01,3.282e-02,3.333e-01,7.850e-02,1.339e-02,4.601e-01,7.100e-01,5.168e-02
FKBP5,3721,heat shock protein binding,GO:0031072,molecular function,14.0,6.0,5.939e-02,2.127e-02,1.658e-01,6.648e-03,2.322e-03,1.904e-02,9.393e-01,1.197e-02
FKBP5,3721,protein binding,GO:0005515,molecular function,14.0,347.0,8.574e-02,3.779e-02,1.945e-01,4.535e-02,3.196e-02,6.434e-02,7.851e-01,9.368e-03
FKBP5,3721,peptidyl-prolyl cis-trans isomerase activity,GO:0003755,molecular function,14.0,3.0,9.240e-02,3.504e-02,2.436e-01,5.335e-02,1.876e-02,1.517e-01,7.642e-01,2.904e-02
FMO1,3769,NADPH oxidation,GO:0070995,biological process,11.0,3.0,1.424e-01,8.093e-02,2.505e-01,3.641e-02,5.599e-03,2.368e-01,8.017e-01,5.118e-02
FMO1,3769,organic acid metabolic process,GO:0006082,biological process,11.0,19.0,2.149e-01,1.273e-01,3.629e-01,1.145e-01,5.525e-02,2.375e-01,6.664e-01,2.667e-02
FMO1,3769,toxin metabolic process,GO:0009404,biological process,11.0,14.0,2.932e-01,1.916e-01,4.487e-01,2.443e-01,1.596e-01,3.739e-01,5.391e-01,2.042e-02
FMO1,3769,"N,N-dimethylaniline monooxygenase activity",GO:0004499,molecular function,11.0,2.0,2.149e-01,1.273e-01,3.629e-01,1.048e-01,3.243e-02,3.388e-01,6.755e-01,4.155e-02
FMO1,3769,protein binding,GO:0005515,molecular function,11.0,347.0,2.863e-01,1.186e-01,6.915e-01,2.501e-01,6.693e-02,9.347e-01,5.213e-01,6.158e-02
FMO1,3769,monooxygenase activity,GO:0004497,molecular function,11.0,58.0,2.962e-01,9.308e-02,9.423e-01,1.794e-01,2.286e-02,1.408e+00,5.617e-01,1.034e-01
FMOD,3774,,,,nan,nan,,,,,,,,
FOLH1,3788,proteolysis,GO:0006508,biological process,10.0,14.0,4.741e-02,3.211e-02,7.001e-02,2.512e-02,1.298e-02,4.861e-02,8.467e-01,1.614e-02
FOLH1,3788,C-terminal protein deglutamylation,GO:0035609,biological process,10.0,3.0,5.938e-02,2.979e-02,1.184e-01,5.504e-02,2.187e-02,1.385e-01,7.613e-01,2.539e-02
FOLH1,3788,extracellular exosome,GO:0070062,cellular component,10.0,77.0,4.862e-02,3.546e-02,6.667e-02,3.301e-02,2.675e-02,4.074e-02,8.190e-01,5.176e-03
FOLH1,3788,cell surface,GO:0009986,cellular component,10.0,11.0,4.862e-02,3.546e-02,6.667e-02,3.719e-02,3.519e-02,3.929e-02,8.067e-01,1.414e-03
FOLH1,3788,plasma membrane,GO:0005886,cellular component,10.0,61.0,5.834e-02,5.082e-02,6.699e-02,5.418e-02,5.294e-02,5.544e-02,7.652e-01,6.288e-04
FOLH1,3788,carboxypeptidase activity,GO:0004180,molecular function,10.0,5.0,4.682e-02,3.052e-02,7.183e-02,5.836e-03,3.226e-03,1.056e-02,9.469e-01,5.081e-03
FOLH1,3788,Ac-Asp-Glu binding,GO:1904492,molecular function,10.0,3.0,4.741e-02,3.211e-02,7.001e-02,2.232e-02,8.952e-03,5.566e-02,8.578e-01,2.200e-02
FOLH1,3788,metallocarboxypeptidase activity,GO:0004181,molecular function,10.0,7.0,4.741e-02,3.211e-02,7.001e-02,2.474e-02,1.285e-02,4.765e-02,8.479e-01,1.591e-02
FOLH1,3788,tetrahydrofolyl-poly(glutamate) polymer binding,GO:1904493,molecular function,10.0,2.0,4.800e-02,3.137e-02,7.344e-02,3.269e-02,1.310e-02,8.159e-02,8.189e-01,2.327e-02
FOSL2,3798,,,,nan,nan,,,,,,,,
FSTL3,3973,regulation of BMP signaling pathway,GO:0030510,biological process,19.0,8.0,1.284e-01,5.622e-02,2.932e-01,2.700e-02,1.460e-02,4.993e-02,8.394e-01,1.499e-02
FSTL3,3973,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0090101,biological process,19.0,9.0,1.284e-01,5.622e-02,2.932e-01,3.747e-02,7.105e-03,1.976e-01,8.013e-01,4.086e-02
FSTL3,3973,hematopoietic progenitor cell differentiation,GO:0002244,biological process,19.0,6.0,1.284e-01,5.622e-02,2.932e-01,5.129e-02,3.882e-02,6.776e-02,7.716e-01,7.689e-03
FSTL3,3973,regulation of transcription by RNA polymerase II,GO:0006357,biological process,19.0,46.0,1.390e-01,4.710e-02,4.102e-01,6.576e-02,1.752e-02,2.468e-01,7.374e-01,3.735e-02
FSTL3,3973,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,19.0,62.0,1.487e-01,5.857e-02,3.777e-01,9.379e-02,5.454e-02,1.613e-01,6.956e-01,1.775e-02
FSTL3,3973,multicellular organism development,GO:0007275,biological process,19.0,16.0,1.556e-01,3.635e-02,6.658e-01,9.981e-02,2.025e-02,4.919e-01,6.773e-01,5.623e-02
FSTL3,3973,negative regulation of BMP signaling pathway,GO:0030514,biological process,19.0,9.0,1.586e-01,3.477e-02,7.231e-01,7.630e-02,6.557e-03,8.878e-01,6.984e-01,8.876e-02
FSTL3,3973,negative regulation of activin receptor signaling pathway,GO:0032926,biological process,19.0,4.0,1.667e-01,3.094e-02,8.978e-01,7.625e-02,4.161e-03,1.397e+00,6.858e-01,1.100e-01
FSTL3,3973,positive regulation of cell-cell adhesion,GO:0022409,biological process,19.0,13.0,1.704e-01,4.332e-02,6.701e-01,1.146e-01,1.716e-02,7.648e-01,6.503e-01,7.408e-02
FSTL3,3973,negative regulation of osteoclast differentiation,GO:0045671,biological process,19.0,4.0,2.835e-01,8.250e-02,9.744e-01,2.741e-01,7.366e-02,1.020e+00,4.962e-01,7.586e-02
FSTL3,3973,cell differentiation,GO:0030154,biological process,19.0,86.0,3.380e-01,4.839e-02,2.361e+00,3.024e-01,3.538e-02,2.584e+00,4.291e-01,1.358e-01
FSTL3,3973,extracellular space,GO:0005615,cellular component,19.0,43.0,1.390e-01,4.710e-02,4.102e-01,6.441e-02,1.964e-02,2.112e-01,7.406e-01,3.407e-02
FSTL3,3973,nucleoplasm,GO:0005654,cellular component,19.0,51.0,1.672e-01,4.534e-02,6.163e-01,1.266e-01,3.882e-02,4.131e-01,6.466e-01,4.649e-02
FSTL3,3973,nucleus,GO:0005634,cellular component,19.0,81.0,1.767e-01,5.153e-02,6.061e-01,1.306e-01,4.851e-02,3.517e-01,6.441e-01,3.740e-02
FSTL3,3973,fibronectin binding,GO:0001968,molecular function,19.0,5.0,1.187e-01,4.178e-02,3.375e-01,1.336e-02,1.710e-03,1.043e-01,8.871e-01,3.152e-02
FSTL3,3973,activin binding,GO:0048185,molecular function,19.0,3.0,1.334e-01,6.433e-02,2.767e-01,6.175e-02,5.230e-02,7.291e-02,7.501e-01,4.794e-03
FSTL3,3973,protein binding,GO:0005515,molecular function,19.0,347.0,2.191e-01,1.018e-01,4.715e-01,1.702e-01,1.517e-01,1.910e-01,6.064e-01,4.618e-03
GABRQ,14454,,,,nan,nan,,,,,,,,
GALE,4116,galactose catabolic process via UDP-galactose,GO:0033499,biological process,9.0,2.0,4.311e-02,2.818e-02,6.593e-02,9.186e-03,8.756e-03,9.637e-03,9.275e-01,6.760e-04
GALE,4116,galactose catabolic process,GO:0019388,biological process,9.0,7.0,4.756e-02,2.240e-02,1.010e-01,3.300e-02,8.172e-03,1.333e-01,8.159e-01,3.650e-02
GALE,4116,cytosol,GO:0005829,cellular component,9.0,76.0,4.756e-02,2.240e-02,1.010e-01,4.607e-02,2.414e-02,8.790e-02,7.827e-01,1.750e-02
GALE,4116,protein homodimerization activity,GO:0042803,molecular function,9.0,21.0,4.756e-02,2.240e-02,1.010e-01,2.839e-02,1.846e-02,4.368e-02,8.343e-01,1.067e-02
GALE,4116,UDP-glucose 4-epimerase activity,GO:0003978,molecular function,9.0,2.0,4.756e-02,2.240e-02,1.010e-01,3.394e-02,2.783e-02,4.141e-02,8.160e-01,4.993e-03
GALE,4116,identical protein binding,GO:0042802,molecular function,9.0,35.0,4.756e-02,2.240e-02,1.010e-01,3.657e-02,1.814e-02,7.371e-02,8.073e-01,1.806e-02
GAMT,4136,creatine biosynthetic process,GO:0006601,biological process,9.0,4.0,1.797e-01,9.219e-02,3.503e-01,1.039e-01,3.211e-02,3.363e-01,6.764e-01,4.270e-02
GAMT,4136,nucleus,GO:0005634,cellular component,9.0,81.0,1.797e-01,9.219e-02,3.503e-01,1.001e-01,6.254e-02,1.601e-01,6.870e-01,1.579e-02
GAMT,4136,cytoplasm,GO:0005737,cellular component,9.0,78.0,1.894e-01,9.758e-02,3.677e-01,1.299e-01,5.609e-02,3.007e-01,6.466e-01,2.975e-02
GAMT,4136,guanidinoacetate N-methyltransferase activity,GO:0030731,molecular function,9.0,2.0,8.574e-02,1.162e-02,6.325e-01,2.722e-02,8.294e-04,8.935e-01,8.051e-01,9.367e-02
GAMT,4136,S-adenosylmethionine-dependent methyltransferase activity,GO:0008757,molecular function,9.0,134.0,4.055e-01,3.012e-01,5.458e-01,4.055e-01,3.012e-01,5.458e-01,4.232e-01,1.888e-02
GAPDH,4141,cellular response to interferon-gamma,GO:0071346,biological process,67.0,4.0,5.008e-02,3.452e-02,7.264e-02,1.777e-02,3.149e-03,1.002e-01,8.680e-01,3.101e-02
GAPDH,4141,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,GO:0052501,biological process,67.0,3.0,5.008e-02,3.452e-02,7.264e-02,2.148e-02,1.159e-02,3.980e-02,8.622e-01,1.469e-02
GAPDH,4141,killing by host of symbiont cells,GO:0051873,biological process,67.0,5.0,5.008e-02,3.452e-02,7.264e-02,3.320e-02,2.215e-02,4.975e-02,8.182e-01,1.005e-02
GAPDH,4141,antimicrobial humoral immune response mediated by antimicrobial peptide,GO:0061844,biological process,67.0,2.0,5.208e-02,3.147e-02,8.621e-02,2.795e-02,9.647e-03,8.101e-02,8.350e-01,2.675e-02
GAPDH,4141,defense response to fungus,GO:0050832,biological process,67.0,6.0,5.236e-02,3.107e-02,8.825e-02,3.262e-02,1.031e-02,1.032e-01,8.186e-01,2.895e-02
GAPDH,4141,negative regulation of endopeptidase activity,GO:0010951,biological process,67.0,9.0,5.469e-02,3.505e-02,8.533e-02,4.542e-02,2.999e-02,6.878e-02,7.848e-01,1.118e-02
GAPDH,4141,killing of cells of other organism,GO:0031640,biological process,67.0,5.0,5.500e-02,2.765e-02,1.094e-01,4.397e-02,1.616e-02,1.196e-01,7.862e-01,2.737e-02
GAPDH,4141,negative regulation of translation,GO:0017148,biological process,67.0,18.0,5.507e-02,2.757e-02,1.100e-01,3.500e-02,6.610e-03,1.853e-01,8.080e-01,4.292e-02
GAPDH,4141,glycolytic process,GO:0006096,biological process,67.0,13.0,7.156e-02,2.887e-02,1.774e-01,6.239e-02,1.886e-02,2.063e-01,7.445e-01,3.424e-02
GAPDH,4141,positive regulation of cytokine secretion,GO:0050715,biological process,67.0,24.0,8.191e-02,8.060e-02,8.325e-02,7.887e-02,7.424e-02,8.379e-02,7.198e-01,1.775e-03
GAPDH,4141,vesicle,GO:0031982,cellular component,67.0,6.0,5.008e-02,3.452e-02,7.264e-02,1.882e-02,1.059e-02,3.347e-02,8.741e-01,1.255e-02
GAPDH,4141,extracellular exosome,GO:0070062,cellular component,67.0,77.0,5.008e-02,3.452e-02,7.264e-02,1.918e-02,1.043e-02,3.527e-02,8.723e-01,1.361e-02
GAPDH,4141,plasma membrane,GO:0005886,cellular component,67.0,61.0,5.008e-02,3.452e-02,7.264e-02,2.371e-02,8.197e-03,6.856e-02,8.500e-01,2.383e-02
GAPDH,4141,cytosol,GO:0005829,cellular component,67.0,76.0,5.008e-02,3.452e-02,7.264e-02,2.531e-02,1.685e-02,3.802e-02,8.460e-01,9.996e-03
GAPDH,4141,nucleus,GO:0005634,cellular component,67.0,81.0,5.008e-02,3.452e-02,7.264e-02,2.681e-02,1.303e-02,5.516e-02,8.398e-01,1.750e-02
GAPDH,4141,cytoplasm,GO:0005737,cellular component,67.0,78.0,5.008e-02,3.452e-02,7.264e-02,2.967e-02,1.805e-02,4.878e-02,8.299e-01,1.225e-02
GAPDH,4141,membrane,GO:0016020,cellular component,67.0,58.0,5.008e-02,3.452e-02,7.264e-02,3.224e-02,2.165e-02,4.800e-02,8.213e-01,9.777e-03
GAPDH,4141,intracellular membrane-bounded organelle,GO:0043231,cellular component,67.0,48.0,5.041e-02,3.500e-02,7.260e-02,2.328e-02,7.043e-03,7.694e-02,8.508e-01,2.625e-02
GAPDH,4141,GAIT complex,GO:0097452,cellular component,67.0,2.0,5.340e-02,4.081e-02,6.989e-02,4.155e-02,3.503e-02,4.928e-02,7.949e-01,4.343e-03
GAPDH,4141,lipid droplet,GO:0005811,cellular component,67.0,10.0,5.624e-02,3.631e-02,8.711e-02,2.831e-02,7.733e-03,1.036e-01,8.328e-01,3.263e-02
GAPDH,4141,nuclear membrane,GO:0031965,cellular component,67.0,6.0,5.640e-02,4.049e-02,7.855e-02,3.106e-02,1.071e-02,9.006e-02,8.238e-01,2.720e-02
GAPDH,4141,ribonucleoprotein complex,GO:1990904,cellular component,67.0,27.0,6.972e-02,5.853e-02,8.304e-02,6.452e-02,5.730e-02,7.264e-02,7.449e-01,3.477e-03
GAPDH,4141,identical protein binding,GO:0042802,molecular function,67.0,35.0,5.008e-02,3.452e-02,7.264e-02,1.777e-02,1.144e-02,2.760e-02,8.804e-01,9.578e-03
GAPDH,4141,disordered domain specific binding,GO:0097718,molecular function,67.0,2.0,5.008e-02,3.452e-02,7.264e-02,1.862e-02,1.084e-02,3.198e-02,8.757e-01,1.255e-02
GAPDH,4141,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,GO:0004365,molecular function,67.0,2.0,5.008e-02,3.452e-02,7.264e-02,1.944e-02,8.119e-03,4.656e-02,8.691e-01,1.835e-02
GAPDH,4141,protein binding,GO:0005515,molecular function,67.0,347.0,5.008e-02,3.452e-02,7.264e-02,2.831e-02,1.330e-02,6.027e-02,8.344e-01,1.846e-02
GAPDH,4141,aspartic-type endopeptidase inhibitor activity,GO:0019828,molecular function,67.0,2.0,5.008e-02,3.452e-02,7.264e-02,2.853e-02,1.371e-02,5.940e-02,8.336e-01,1.820e-02
GATAD1,29941,,,,nan,nan,,,,,,,,
GATB,8849,glutaminyl-tRNAGln biosynthesis via transamidation,GO:0070681,biological process,10.0,2.0,3.531e-02,2.387e-02,5.224e-02,9.669e-03,2.808e-03,3.330e-02,9.195e-01,1.526e-02
GATB,8849,mitochondrial translation,GO:0032543,biological process,10.0,2.0,3.794e-02,2.901e-02,4.962e-02,2.436e-02,2.000e-02,2.968e-02,8.498e-01,4.899e-03
GATB,8849,mitochondrion,GO:0005739,cellular component,10.0,35.0,3.689e-02,2.837e-02,4.797e-02,2.199e-02,9.770e-03,4.949e-02,8.597e-01,1.967e-02
GATB,8849,glutamyl-tRNA(Gln) amidotransferase complex,GO:0030956,cellular component,10.0,2.0,4.405e-02,4.041e-02,4.802e-02,3.698e-02,2.703e-02,5.058e-02,8.071e-01,7.879e-03
GATB,8849,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,GO:0050567,molecular function,10.0,3.0,3.689e-02,2.837e-02,4.797e-02,1.843e-02,1.715e-02,1.980e-02,8.780e-01,1.669e-03
GATB,8849,protein binding,GO:0005515,molecular function,10.0,347.0,5.737e-02,2.918e-02,1.128e-01,5.737e-02,2.918e-02,1.128e-01,7.575e-01,1.948e-02
GBE1,4180,glycogen biosynthetic process,GO:0005978,biological process,8.0,3.0,7.118e-02,3.576e-02,1.417e-01,1.464e-02,7.831e-03,2.736e-02,8.956e-01,1.115e-02
GBE1,4180,carbohydrate metabolic process,GO:0005975,biological process,8.0,12.0,7.118e-02,3.576e-02,1.417e-01,2.703e-02,9.944e-03,7.350e-02,8.384e-01,2.420e-02
GBE1,4180,extracellular exosome,GO:0070062,cellular component,8.0,77.0,8.451e-02,2.940e-02,2.429e-01,5.119e-02,2.256e-02,1.161e-01,7.702e-01,2.177e-02
GBE1,4180,cytoplasm,GO:0005737,cellular component,8.0,78.0,1.221e-01,6.290e-02,2.372e-01,1.099e-01,6.711e-02,1.800e-01,6.733e-01,1.692e-02
GBE1,4180,"1,4-alpha-glucan branching enzyme activity",GO:0003844,molecular function,8.0,2.0,8.562e-02,2.809e-02,2.610e-01,5.855e-02,1.157e-02,2.964e-01,7.479e-01,4.958e-02
GBE1,4180,protein binding,GO:0005515,molecular function,8.0,347.0,1.221e-01,6.290e-02,2.372e-01,1.100e-01,5.874e-02,2.059e-01,6.727e-01,2.202e-02
GCSH,4208,protein lipoylation,GO:0009249,biological process,8.0,4.0,3.583e-02,2.515e-02,5.104e-02,2.577e-02,2.076e-02,3.197e-02,8.443e-01,5.221e-03
GCSH,4208,protein binding,GO:0005515,molecular function,8.0,347.0,3.583e-02,2.515e-02,5.104e-02,3.071e-02,1.284e-02,7.344e-02,8.258e-01,2.141e-02
GFM1,13780,mitochondrial translational elongation,GO:0070125,biological process,7.0,2.0,9.291e-02,3.481e-02,2.480e-01,6.141e-02,1.135e-02,3.321e-01,7.410e-01,5.314e-02
GFM1,13780,mitochondrion,GO:0005739,cellular component,7.0,35.0,7.470e-02,5.854e-02,9.533e-02,5.250e-02,3.736e-02,7.379e-02,7.688e-01,9.262e-03
GFM1,13780,translation elongation factor activity,GO:0003746,molecular function,7.0,2.0,7.002e-02,6.686e-02,7.332e-02,2.339e-02,1.792e-02,3.055e-02,8.540e-01,6.516e-03
GFM1,13780,RNA binding,GO:0003723,molecular function,7.0,60.0,7.002e-02,6.686e-02,7.332e-02,3.387e-02,9.209e-03,1.245e-01,8.143e-01,3.189e-02
GFM1,13780,GTPase activity,GO:0003924,molecular function,7.0,7.0,7.752e-02,5.363e-02,1.121e-01,3.530e-02,1.280e-02,9.735e-02,8.102e-01,2.635e-02
GFM1,13780,protein binding,GO:0005515,molecular function,7.0,347.0,1.181e-01,8.667e-02,1.609e-01,1.111e-01,8.036e-02,1.537e-01,6.725e-01,1.163e-02
GFPT2,4242,fructose 6-phosphate metabolic process,GO:0006002,biological process,17.0,5.0,2.781e-02,1.829e-02,4.230e-02,8.405e-03,3.068e-03,2.303e-02,9.287e-01,1.221e-02
GFPT2,4242,UDP-N-acetylglucosamine metabolic process,GO:0006047,biological process,17.0,6.0,2.781e-02,1.829e-02,4.230e-02,9.016e-03,5.920e-03,1.373e-02,9.279e-01,5.222e-03
GFPT2,4242,protein N-linked glycosylation,GO:0006487,biological process,17.0,7.0,3.697e-02,1.989e-02,6.872e-02,3.336e-02,1.522e-02,7.312e-02,8.171e-01,1.986e-02
GFPT2,4242,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,GO:0004360,molecular function,17.0,2.0,3.192e-02,1.821e-02,5.593e-02,2.499e-02,1.130e-02,5.525e-02,8.467e-01,1.901e-02
GFPT2,4242,protein binding,GO:0005515,molecular function,17.0,347.0,3.412e-02,2.306e-02,5.049e-02,2.452e-02,1.172e-02,5.131e-02,8.489e-01,1.790e-02
GHR,4263,,,,nan,nan,,,,,,,,
GJB4,4286,nucleolus,GO:0005730,cellular component,4.0,18.0,7.013e-02,4.222e-02,1.165e-01,3.252e-02,1.521e-02,6.956e-02,8.199e-01,1.921e-02
GJB4,4286,nucleoplasm,GO:0005654,cellular component,4.0,51.0,7.249e-02,4.002e-02,1.313e-01,5.793e-02,3.229e-02,1.039e-01,7.567e-01,1.683e-02
GJB4,4286,cell junction,GO:0030054,cellular component,4.0,10.0,8.415e-02,3.709e-02,1.909e-01,7.659e-02,2.468e-02,2.376e-01,7.192e-01,3.359e-02
GLRX,4330,positive regulation of membrane potential,GO:0045838,biological process,9.0,3.0,6.082e-02,1.933e-03,1.914e+00,4.851e-02,1.534e-03,1.535e+00,7.376e-01,1.184e-01
GLRX,4330,positive regulation of sodium ion transmembrane transporter activity,GO:2000651,biological process,9.0,9.0,8.017e-02,1.559e-03,4.122e+00,6.853e-02,9.672e-04,4.855e+00,6.303e-01,1.946e-01
GLRX,4330,extracellular exosome,GO:0070062,cellular component,9.0,77.0,3.947e-02,5.446e-03,2.860e-01,1.479e-02,5.394e-03,4.056e-02,8.916e-01,1.980e-02
GLRX,4330,glutathione disulfide oxidoreductase activity,GO:0015038,molecular function,9.0,4.0,4.303e-02,4.427e-03,4.183e-01,2.943e-02,7.409e-03,1.169e-01,8.285e-01,3.527e-02
GLRX,4330,protein N-terminus binding,GO:0047485,molecular function,9.0,3.0,5.074e-02,2.983e-03,8.631e-01,2.909e-02,1.580e-03,5.358e-01,8.116e-01,8.030e-02
GLUD1,4335,substantia nigra development,GO:0021762,biological process,28.0,3.0,8.226e-02,2.753e-02,2.459e-01,4.865e-02,6.332e-03,3.738e-01,7.678e-01,5.642e-02
GLUD1,4335,positive regulation of insulin secretion,GO:0032024,biological process,28.0,5.0,8.653e-02,2.976e-02,2.517e-01,4.692e-02,3.462e-03,6.359e-01,7.648e-01,6.523e-02
GLUD1,4335,glutamate catabolic process,GO:0006538,biological process,28.0,16.0,9.163e-02,2.164e-02,3.880e-01,6.961e-02,1.039e-02,4.664e-01,7.230e-01,6.040e-02
GLUD1,4335,glutamate biosynthetic process,GO:0006537,biological process,28.0,5.0,9.807e-02,2.138e-02,4.498e-01,8.342e-02,1.242e-02,5.600e-01,6.978e-01,6.502e-02
GLUD1,4335,mitochondrion,GO:0005739,cellular component,28.0,35.0,6.061e-02,3.642e-02,1.009e-01,3.191e-02,1.192e-02,8.541e-02,8.216e-01,2.447e-02
GLUD1,4335,cytoplasm,GO:0005737,cellular component,28.0,78.0,7.027e-02,4.156e-02,1.188e-01,4.752e-02,2.120e-02,1.065e-01,7.784e-01,2.240e-02
GLUD1,4335,glutamate dehydrogenase (NAD+) activity,GO:0004352,molecular function,28.0,2.0,4.959e-02,3.117e-02,7.890e-02,7.077e-03,1.496e-03,3.349e-02,9.336e-01,1.556e-02
GLUD1,4335,glutamate dehydrogenase [NAD(P)+] activity,GO:0004353,molecular function,28.0,4.0,5.511e-02,4.571e-02,6.645e-02,1.474e-02,5.896e-03,3.686e-02,8.929e-01,1.695e-02
GLUD1,4335,NAD+ binding,GO:0070403,molecular function,28.0,3.0,5.511e-02,4.571e-02,6.645e-02,1.658e-02,5.740e-03,4.791e-02,8.814e-01,1.967e-02
GLUD1,4335,ADP binding,GO:0043531,molecular function,28.0,3.0,5.511e-02,4.571e-02,6.645e-02,2.740e-02,1.326e-02,5.662e-02,8.377e-01,1.780e-02
GLUD1,4335,leucine binding,GO:0070728,molecular function,28.0,3.0,6.061e-02,3.642e-02,1.009e-01,3.423e-02,1.681e-02,6.971e-02,8.145e-01,1.797e-02
GLUD1,4335,protein binding,GO:0005515,molecular function,28.0,347.0,6.680e-02,4.209e-02,1.060e-01,3.970e-02,1.863e-02,8.460e-02,7.987e-01,1.926e-02
GLUD1,4335,GTP binding,GO:0005525,molecular function,28.0,9.0,7.976e-02,5.066e-02,1.256e-01,6.565e-02,5.464e-02,7.888e-02,7.428e-01,5.357e-03
GNPTAB,29670,,,,nan,nan,,,,,,,,
GPD1,4455,glycerol-3-phosphate metabolic process,GO:0006072,biological process,14.0,4.0,2.736e-02,2.514e-02,2.978e-02,1.292e-02,7.096e-03,2.352e-02,9.053e-01,9.502e-03
GPD1,4455,NADH oxidation,GO:0006116,biological process,14.0,5.0,3.389e-02,1.515e-02,7.581e-02,1.679e-02,3.812e-03,7.395e-02,8.782e-01,3.214e-02
GPD1,4455,extracellular exosome,GO:0070062,cellular component,14.0,77.0,3.389e-02,1.515e-02,7.581e-02,2.233e-02,6.334e-03,7.872e-02,8.565e-01,3.049e-02
GPD1,4455,cytosol,GO:0005829,cellular component,14.0,76.0,3.807e-02,2.038e-02,7.111e-02,3.534e-02,1.692e-02,7.381e-02,8.109e-01,1.895e-02
GPD1,4455,glycerol-3-phosphate dehydrogenase [NAD+] activity,GO:0004367,molecular function,14.0,2.0,3.429e-02,1.600e-02,7.347e-02,2.345e-02,5.113e-03,1.076e-01,8.488e-01,3.560e-02
GPR155,22951,,,,nan,nan,,,,,,,,
GRAMD1B,29214,,,,nan,nan,,,,,,,,
GSDME,2810,necrotic cell death,GO:0070265,biological process,14.0,3.0,1.646e-01,7.343e-02,3.689e-01,2.411e-02,1.500e-02,3.877e-02,8.509e-01,1.166e-02
GSDME,2810,positive regulation of MAPK cascade,GO:0043410,biological process,14.0,13.0,1.646e-01,7.343e-02,3.689e-01,2.978e-02,1.749e-02,5.071e-02,8.295e-01,1.310e-02
GSDME,2810,cell death,GO:0008219,biological process,14.0,6.0,2.053e-01,6.263e-02,6.730e-01,9.163e-02,2.963e-02,2.834e-01,6.950e-01,3.528e-02
GSDME,2810,pyroptosis,GO:0070269,biological process,14.0,2.0,2.080e-01,6.181e-02,7.000e-01,1.265e-01,1.872e-02,8.552e-01,6.379e-01,6.484e-02
GSDME,2810,negative regulation of cell population proliferation,GO:0008285,biological process,14.0,36.0,2.092e-01,6.796e-02,6.438e-01,1.106e-01,3.692e-02,3.314e-01,6.686e-01,3.651e-02
GSDME,2810,cellular response to tumor necrosis factor,GO:0071356,biological process,14.0,4.0,2.161e-01,7.831e-02,5.961e-01,9.092e-02,6.195e-02,1.334e-01,7.005e-01,1.237e-02
GSDME,2810,cellular response to virus,GO:0098586,biological process,14.0,6.0,2.170e-01,8.344e-02,5.644e-01,1.179e-01,2.960e-02,4.693e-01,6.554e-01,5.033e-02
GSDME,2810,positive regulation of intrinsic apoptotic signaling pathway,GO:2001244,biological process,14.0,10.0,2.190e-01,6.018e-02,7.967e-01,1.367e-01,1.153e-02,1.621e+00,6.142e-01,8.511e-02
GSDME,2810,plasma membrane,GO:0005886,cellular component,14.0,61.0,2.215e-01,8.736e-02,5.618e-01,1.382e-01,9.762e-02,1.958e-01,6.393e-01,1.325e-02
GSDME,2810,membrane,GO:0016020,cellular component,14.0,58.0,2.227e-01,8.322e-02,5.959e-01,1.820e-01,7.443e-02,4.451e-01,5.902e-01,3.629e-02
GSDME,2810,cytosol,GO:0005829,cellular component,14.0,76.0,2.303e-01,8.211e-02,6.458e-01,1.720e-01,6.807e-02,4.345e-01,5.999e-01,3.711e-02
GSDME,2810,cardiolipin binding,GO:1901612,molecular function,14.0,2.0,2.521e-01,6.281e-02,1.012e+00,1.989e-01,3.757e-02,1.053e+00,5.590e-01,7.530e-02
GSDME,2810,"phosphatidylinositol-4,5-bisphosphate binding",GO:0005546,molecular function,14.0,2.0,2.802e-01,5.042e-02,1.557e+00,2.022e-01,1.204e-02,3.394e+00,5.252e-01,1.138e-01
GSTA3,4628,glutathione metabolic process,GO:0006749,biological process,14.0,9.0,9.872e-02,8.897e-02,1.095e-01,5.451e-02,1.022e-02,2.908e-01,7.586e-01,4.486e-02
GSTA3,4628,xenobiotic metabolic process,GO:0006805,biological process,14.0,47.0,1.126e-01,6.167e-02,2.056e-01,8.871e-02,3.332e-02,2.362e-01,7.004e-01,3.333e-02
GSTA3,4628,extracellular exosome,GO:0070062,cellular component,14.0,77.0,9.068e-02,6.289e-02,1.308e-01,4.085e-02,2.091e-02,7.979e-02,7.958e-01,1.744e-02
GSTA3,4628,cytosol,GO:0005829,cellular component,14.0,76.0,9.500e-02,7.666e-02,1.177e-01,5.306e-02,3.106e-02,9.064e-02,7.671e-01,1.486e-02
GSTA3,4628,glutathione transferase activity,GO:0004364,molecular function,14.0,3.0,1.165e-01,4.685e-02,2.894e-01,7.824e-02,1.191e-02,5.141e-01,7.089e-01,5.783e-02
GSTO1,13312,oxidation-reduction process,GO:0055114,biological process,21.0,42.0,2.750e-01,1.506e-01,5.022e-01,1.223e-01,1.234e-02,1.211e+00,6.366e-01,7.704e-02
GSTO1,13312,cellular response to arsenic-containing substance,GO:0071243,biological process,21.0,5.0,2.866e-01,9.646e-02,8.513e-01,1.397e-01,1.419e-02,1.377e+00,6.041e-01,1.018e-01
GSTO1,13312,L-ascorbic acid metabolic process,GO:0019852,biological process,21.0,8.0,3.219e-01,2.489e-01,4.163e-01,2.244e-01,1.074e-01,4.692e-01,5.529e-01,3.286e-02
GSTO1,13312,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,GO:0010880,biological process,21.0,4.0,3.676e-01,2.119e-01,6.376e-01,2.726e-01,1.242e-01,5.983e-01,5.115e-01,4.272e-02
GSTO1,13312,positive regulation of ryanodine-sensitive calcium-release channel activity,GO:0060316,biological process,21.0,6.0,3.715e-01,2.202e-01,6.269e-01,2.730e-01,1.241e-01,6.004e-01,5.115e-01,4.160e-02
GSTO1,13312,xenobiotic catabolic process,GO:0042178,biological process,21.0,51.0,3.763e-01,9.524e-02,1.487e+00,2.562e-01,2.648e-02,2.478e+00,4.712e-01,1.299e-01
GSTO1,13312,negative regulation of ryanodine-sensitive calcium-release channel activity,GO:0060315,biological process,21.0,6.0,4.117e-01,2.170e-01,7.811e-01,3.183e-01,1.076e-01,9.418e-01,4.691e-01,6.340e-02
GSTO1,13312,extracellular exosome,GO:0070062,cellular component,21.0,77.0,2.294e-01,1.119e-01,4.704e-01,7.268e-02,4.184e-02,1.263e-01,7.292e-01,1.689e-02
GSTO1,13312,cytosol,GO:0005829,cellular component,21.0,76.0,2.582e-01,1.319e-01,5.054e-01,1.205e-01,4.479e-02,3.242e-01,6.568e-01,3.423e-02
GSTO1,13312,cytoplasm,GO:0005737,cellular component,21.0,78.0,2.586e-01,1.319e-01,5.069e-01,1.317e-01,2.537e-02,6.838e-01,6.354e-01,5.763e-02
GSTO1,13312,nucleoplasm,GO:0005654,cellular component,21.0,51.0,2.586e-01,1.319e-01,5.069e-01,1.413e-01,4.391e-02,4.547e-01,6.304e-01,4.208e-02
GSTO1,13312,glutathione dehydrogenase (ascorbate) activity,GO:0045174,molecular function,21.0,4.0,2.294e-01,1.119e-01,4.704e-01,5.881e-02,1.396e-02,2.477e-01,7.490e-01,4.412e-02
GSTO1,13312,protein binding,GO:0005515,molecular function,21.0,347.0,2.586e-01,1.319e-01,5.069e-01,1.308e-01,2.634e-02,6.490e-01,6.375e-01,5.519e-02
GSTO1,13312,oxidoreductase activity,GO:0016491,molecular function,21.0,93.0,3.675e-01,7.120e-02,1.897e+00,2.165e-01,1.624e-02,2.885e+00,4.583e-01,1.828e-01
GSTO1,13312,glutathione transferase activity,GO:0004364,molecular function,21.0,3.0,3.735e-01,2.337e-01,5.968e-01,2.496e-01,7.806e-02,7.981e-01,5.223e-01,6.231e-02
GYPC,4704,plasma membrane,GO:0005886,cellular component,5.0,61.0,1.784e-01,8.173e-02,3.894e-01,1.021e-01,3.419e-02,3.048e-01,6.798e-01,3.930e-02
GYPC,4704,membrane,GO:0016020,cellular component,5.0,58.0,1.784e-01,8.173e-02,3.894e-01,1.114e-01,9.460e-02,1.312e-01,6.723e-01,5.801e-03
GYPC,4704,cortical cytoskeleton,GO:0030863,cellular component,5.0,5.0,1.850e-01,8.882e-02,3.852e-01,1.268e-01,3.418e-02,4.701e-01,6.459e-01,4.579e-02
GYPC,4704,protein binding,GO:0005515,molecular function,5.0,347.0,2.009e-01,1.032e-01,3.913e-01,1.749e-01,5.887e-02,5.199e-01,5.949e-01,4.419e-02
HAS2,4819,cellular response to interleukin-1,GO:0071347,biological process,18.0,3.0,3.546e-01,8.194e-02,1.535e+00,1.096e-01,3.853e-02,3.118e-01,6.702e-01,3.509e-02
HAS2,4819,cellular response to tumor necrosis factor,GO:0071356,biological process,18.0,4.0,3.849e-01,8.002e-02,1.851e+00,1.611e-01,3.331e-02,7.788e-01,6.025e-01,6.033e-02
HAS2,4819,positive regulation of cell population proliferation,GO:0008284,biological process,18.0,40.0,3.890e-01,7.954e-02,1.902e+00,1.811e-01,3.266e-02,1.005e+00,5.792e-01,6.669e-02
HAS2,4819,cellular response to platelet-derived growth factor stimulus,GO:0036120,biological process,18.0,4.0,3.890e-01,7.954e-02,1.902e+00,2.328e-01,3.533e-02,1.534e+00,5.223e-01,8.545e-02
HAS2,4819,positive regulation of cell migration,GO:0030335,biological process,18.0,33.0,3.929e-01,7.890e-02,1.956e+00,1.918e-01,1.007e-02,3.654e+00,5.319e-01,1.172e-01
HAS2,4819,positive regulation of monocyte aggregation,GO:1900625,biological process,18.0,3.0,4.277e-01,7.396e-02,2.474e+00,2.623e-01,9.838e-03,6.994e+00,4.293e-01,1.534e-01
HAS2,4819,extracellular matrix assembly,GO:0085029,biological process,18.0,7.0,4.555e-01,1.492e-01,1.390e+00,3.739e-01,9.507e-02,1.471e+00,4.194e-01,7.937e-02
HAS2,4819,cellular response to fluid shear stress,GO:0071498,biological process,18.0,7.0,5.185e-01,2.705e-01,9.939e-01,3.675e-01,2.574e-01,5.245e-01,4.484e-01,2.083e-02
HAS2,4819,extracellular polysaccharide biosynthetic process,GO:0045226,biological process,18.0,5.0,6.010e-01,5.114e-01,7.063e-01,4.907e-01,3.638e-01,6.620e-01,3.672e-01,2.197e-02
HAS2,4819,hyaluronan biosynthetic process,GO:0030213,biological process,18.0,4.0,6.572e-01,4.650e-01,9.288e-01,6.114e-01,3.970e-01,9.414e-01,2.841e-01,4.448e-02
HAS2,4819,integral component of plasma membrane,GO:0005887,cellular component,18.0,28.0,3.065e-01,7.564e-02,1.242e+00,4.878e-02,6.225e-03,3.822e-01,7.655e-01,6.132e-02
HAS2,4819,identical protein binding,GO:0042802,molecular function,18.0,35.0,3.096e-01,7.647e-02,1.254e+00,7.208e-02,3.050e-02,1.704e-01,7.290e-01,2.509e-02
HAS2,4819,protein binding,GO:0005515,molecular function,18.0,347.0,3.679e-01,1.250e-01,1.083e+00,1.291e-01,5.203e-02,3.203e-01,6.468e-01,3.307e-02
HAS2,4819,hyaluronan synthase activity,GO:0050501,molecular function,18.0,3.0,5.200e-01,2.697e-01,1.003e+00,3.904e-01,2.482e-01,6.140e-01,4.315e-01,2.804e-02
HDLBP,4857,cytosol,GO:0005829,cellular component,10.0,76.0,3.063e-02,1.606e-02,5.842e-02,2.867e-02,1.474e-02,5.575e-02,8.331e-01,1.650e-02
HDLBP,4857,cadherin binding,GO:0045296,molecular function,10.0,13.0,2.511e-02,8.177e-03,7.708e-02,6.405e-03,2.049e-03,2.002e-02,9.411e-01,1.040e-02
HDLBP,4857,RNA binding,GO:0003723,molecular function,10.0,60.0,3.063e-02,1.606e-02,5.842e-02,2.113e-02,6.869e-03,6.503e-02,8.619e-01,2.649e-02
HDLBP,4857,protein binding,GO:0005515,molecular function,10.0,347.0,3.063e-02,1.606e-02,5.842e-02,3.063e-02,1.606e-02,5.842e-02,8.264e-01,1.604e-02
HEATR5B,29273,"retrograde transport, endosome to Golgi",GO:0042147,biological process,7.0,6.0,6.906e-02,3.477e-02,1.372e-01,1.966e-02,6.533e-03,5.916e-02,8.673e-01,2.401e-02
HEATR5B,29273,endocytosis,GO:0006897,biological process,7.0,12.0,1.065e-01,3.044e-02,3.727e-01,6.463e-02,6.728e-03,6.208e-01,7.308e-01,6.510e-02
HEATR5B,29273,protein localization,GO:0008104,biological process,7.0,22.0,1.146e-01,4.107e-02,3.198e-01,8.177e-02,1.700e-02,3.934e-01,7.065e-01,4.775e-02
HEATR5B,29273,endocytic vesicle,GO:0030139,cellular component,7.0,7.0,7.747e-02,4.519e-02,1.328e-01,2.239e-02,4.613e-03,1.087e-01,8.521e-01,3.529e-02
HEATR5B,29273,membrane,GO:0016020,cellular component,7.0,58.0,1.481e-01,9.255e-02,2.368e-01,1.190e-01,6.049e-02,2.342e-01,6.608e-01,2.341e-02
HEATR5B,29273,protein binding,GO:0005515,molecular function,7.0,347.0,1.457e-01,9.029e-02,2.350e-01,1.371e-01,7.840e-02,2.396e-01,6.398e-01,2.146e-02
HGF,4893,hepatocyte growth factor receptor signaling pathway,GO:0048012,biological process,28.0,2.0,5.198e-02,2.850e-02,9.479e-02,3.181e-03,1.423e-03,7.108e-03,9.650e-01,4.274e-03
HGF,4893,positive regulation of peptidyl-tyrosine phosphorylation,GO:0050731,biological process,28.0,8.0,5.745e-02,3.357e-02,9.830e-02,1.077e-02,5.302e-03,2.188e-02,9.164e-01,1.091e-02
HGF,4893,positive regulation of phosphatidylinositol 3-kinase signaling,GO:0014068,biological process,28.0,5.0,5.745e-02,3.357e-02,9.830e-02,1.472e-02,1.007e-02,2.152e-02,8.964e-01,7.515e-03
HGF,4893,positive regulation of protein phosphorylation,GO:0001934,biological process,28.0,17.0,6.250e-02,3.248e-02,1.202e-01,1.692e-02,2.132e-03,1.342e-01,8.679e-01,3.542e-02
HGF,4893,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043154,biological process,28.0,8.0,6.305e-02,3.218e-02,1.235e-01,2.482e-02,6.695e-03,9.204e-02,8.440e-01,2.910e-02
HGF,4893,cellular response to hepatocyte growth factor stimulus,GO:0035729,biological process,28.0,3.0,6.320e-02,3.210e-02,1.244e-01,2.485e-02,7.324e-03,8.433e-02,8.460e-01,2.980e-02
HGF,4893,negative regulation of hydrogen peroxide-mediated programmed cell death,GO:1901299,biological process,28.0,6.0,7.250e-02,2.935e-02,1.791e-01,4.657e-02,1.147e-02,1.890e-01,7.785e-01,3.703e-02
HGF,4893,cell chemotaxis,GO:0060326,biological process,28.0,19.0,7.262e-02,3.643e-02,1.448e-01,4.406e-02,1.739e-02,1.116e-01,7.867e-01,2.456e-02
HGF,4893,positive regulation of DNA biosynthetic process,GO:2000573,biological process,28.0,11.0,8.027e-02,6.729e-02,9.574e-02,4.374e-02,2.504e-02,7.640e-02,7.886e-01,1.442e-02
HGF,4893,negative regulation of release of cytochrome c from mitochondria,GO:0090201,biological process,28.0,4.0,9.074e-02,4.958e-02,1.661e-01,5.016e-02,8.932e-03,2.817e-01,7.678e-01,4.656e-02
HGF,4893,positive regulation of cell migration,GO:0030335,biological process,28.0,33.0,9.188e-02,6.681e-02,1.264e-01,5.996e-02,2.950e-02,1.219e-01,7.522e-01,1.979e-02
HGF,4893,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,GO:0060665,biological process,28.0,3.0,9.192e-02,6.674e-02,1.266e-01,5.670e-02,2.360e-02,1.362e-01,7.581e-01,2.434e-02
HGF,4893,negative regulation of apoptotic process,GO:0043066,biological process,28.0,29.0,1.383e-01,1.126e-01,1.698e-01,1.313e-01,1.079e-01,1.597e-01,6.477e-01,7.230e-03
HGF,4893,membrane,GO:0016020,cellular component,28.0,58.0,1.277e-01,7.072e-02,2.308e-01,1.181e-01,5.763e-02,2.420e-01,6.619e-01,2.622e-02
HGF,4893,chemoattractant activity,GO:0042056,molecular function,28.0,3.0,5.745e-02,3.357e-02,9.830e-02,1.902e-02,1.059e-02,3.415e-02,8.732e-01,1.277e-02
HGF,4893,serine-type endopeptidase activity,GO:0004252,molecular function,28.0,4.0,6.717e-02,2.949e-02,1.530e-01,3.693e-02,9.086e-03,1.501e-01,8.040e-01,3.689e-02
HGF,4893,identical protein binding,GO:0042802,molecular function,28.0,35.0,9.671e-02,7.147e-02,1.309e-01,7.023e-02,4.503e-02,1.095e-01,7.336e-01,1.301e-02
HGF,4893,protein binding,GO:0005515,molecular function,28.0,347.0,1.412e-01,1.171e-01,1.702e-01,1.360e-01,1.243e-01,1.488e-01,6.422e-01,3.354e-03
HHIPL1,19710,,,,nan,nan,,,,,,,,
HIF3A,15825,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,8.0,62.0,1.101e-01,5.730e-02,2.115e-01,5.415e-02,3.096e-02,9.470e-02,7.648e-01,1.523e-02
HIF3A,15825,regulation of transcription by RNA polymerase II,GO:0006357,biological process,8.0,46.0,1.101e-01,5.730e-02,2.115e-01,6.285e-02,3.142e-02,1.257e-01,7.465e-01,2.058e-02
HIF3A,15825,nucleus,GO:0005634,cellular component,8.0,81.0,1.101e-01,5.730e-02,2.115e-01,8.015e-02,4.592e-02,1.399e-01,7.165e-01,1.799e-02
HIF3A,15825,cytosol,GO:0005829,cellular component,8.0,76.0,1.101e-01,5.730e-02,2.115e-01,8.954e-02,3.403e-02,2.356e-01,6.995e-01,3.066e-02
HIF3A,15825,nucleoplasm,GO:0005654,cellular component,8.0,51.0,1.101e-01,5.730e-02,2.115e-01,9.235e-02,3.579e-02,2.383e-01,6.955e-01,3.107e-02
HIF3A,15825,plasma membrane,GO:0005886,cellular component,8.0,61.0,1.364e-01,1.106e-01,1.683e-01,1.355e-01,1.114e-01,1.649e-01,6.428e-01,7.188e-03
HIF3A,15825,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,8.0,9.0,1.101e-01,5.730e-02,2.115e-01,4.025e-02,2.329e-02,6.956e-02,7.978e-01,1.389e-02
HIPK2,14402,peptidyl-threonine phosphorylation,GO:0018107,biological process,30.0,9.0,1.022e-01,2.720e-02,3.838e-01,3.375e-02,7.566e-04,1.505e+00,7.761e-01,7.906e-02
HIPK2,14402,peptidyl-serine phosphorylation,GO:0018105,biological process,30.0,10.0,1.030e-01,2.733e-02,3.879e-01,3.465e-02,6.117e-04,1.963e+00,7.678e-01,8.405e-02
HIPK2,14402,SMAD protein signal transduction,GO:0060395,biological process,30.0,2.0,1.215e-01,6.179e-02,2.390e-01,3.418e-02,1.361e-02,8.582e-02,8.145e-01,2.285e-02
HIPK2,14402,positive regulation of angiogenesis,GO:0045766,biological process,30.0,12.0,1.215e-01,6.179e-02,2.390e-01,4.143e-02,1.494e-02,1.149e-01,7.936e-01,2.616e-02
HIPK2,14402,positive regulation of transforming growth factor beta receptor signaling pathway,GO:0030511,biological process,30.0,5.0,1.251e-01,5.968e-02,2.623e-01,6.489e-02,1.503e-02,2.801e-01,7.373e-01,4.359e-02
HIPK2,14402,positive regulation of JNK cascade,GO:0046330,biological process,30.0,5.0,1.387e-01,8.429e-02,2.282e-01,4.164e-02,1.144e-02,1.516e-01,7.918e-01,3.323e-02
HIPK2,14402,protein phosphorylation,GO:0006468,biological process,30.0,30.0,1.414e-01,8.110e-02,2.464e-01,7.738e-02,3.688e-02,1.624e-01,7.201e-01,2.384e-02
HIPK2,14402,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,30.0,62.0,1.458e-01,8.642e-02,2.460e-01,5.781e-02,1.554e-02,2.150e-01,7.526e-01,3.834e-02
HIPK2,14402,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",GO:0006978,biological process,30.0,3.0,1.465e-01,8.438e-02,2.543e-01,7.100e-02,3.308e-02,1.524e-01,7.316e-01,2.219e-02
HIPK2,14402,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0042771,biological process,30.0,3.0,1.481e-01,8.464e-02,2.590e-01,8.651e-02,3.757e-02,1.992e-01,7.049e-01,2.607e-02
HIPK2,14402,smoothened signaling pathway,GO:0007224,biological process,30.0,9.0,1.515e-01,8.425e-02,2.725e-01,7.915e-02,1.447e-02,4.329e-01,7.098e-01,5.017e-02
HIPK2,14402,negative regulation of BMP signaling pathway,GO:0030514,biological process,30.0,9.0,1.523e-01,1.025e-01,2.264e-01,1.037e-01,4.250e-02,2.532e-01,6.796e-01,3.064e-02
HIPK2,14402,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,30.0,35.0,1.643e-01,7.734e-02,3.489e-01,7.875e-02,1.199e-02,5.174e-01,7.060e-01,6.396e-02
HIPK2,14402,negative regulation of ubiquitin-dependent protein catabolic process,GO:2000059,biological process,30.0,4.0,1.673e-01,5.805e-02,4.821e-01,1.160e-01,1.218e-02,1.104e+00,6.456e-01,7.530e-02
HIPK2,14402,PML body,GO:0016605,cellular component,30.0,3.0,1.024e-01,3.234e-02,3.242e-01,1.313e-02,4.577e-03,3.767e-02,9.003e-01,1.731e-02
HIPK2,14402,nucleus,GO:0005634,cellular component,30.0,81.0,1.626e-01,1.217e-01,2.174e-01,1.211e-01,1.070e-01,1.372e-01,6.599e-01,4.530e-03
HIPK2,14402,cytoplasm,GO:0005737,cellular component,30.0,78.0,1.840e-01,1.431e-01,2.367e-01,1.696e-01,1.312e-01,2.192e-01,6.066e-01,1.039e-02
HIPK2,14402,nuclear body,GO:0016604,cellular component,30.0,17.0,1.855e-01,1.112e-01,3.095e-01,1.565e-01,7.951e-02,3.081e-01,6.175e-01,2.765e-02
HIPK2,14402,SMAD binding,GO:0046332,molecular function,30.0,6.0,1.024e-01,3.234e-02,3.242e-01,1.105e-02,5.992e-03,2.036e-02,9.157e-01,9.214e-03
HIPK2,14402,protein tyrosine kinase activity,GO:0004713,molecular function,30.0,6.0,1.215e-01,6.179e-02,2.390e-01,2.696e-02,1.567e-02,4.640e-02,8.396e-01,1.331e-02
HIPK2,14402,transcription coactivator activity,GO:0003713,molecular function,30.0,5.0,1.326e-01,7.332e-02,2.400e-01,4.728e-02,2.357e-02,9.484e-02,7.796e-01,1.895e-02
HIPK2,14402,protein kinase activity,GO:0004672,molecular function,30.0,33.0,1.458e-01,8.642e-02,2.460e-01,7.272e-02,2.681e-02,1.972e-01,7.262e-01,3.185e-02
HIPK2,14402,transcription corepressor activity,GO:0003714,molecular function,30.0,4.0,1.471e-01,8.450e-02,2.560e-01,7.901e-02,4.141e-02,1.508e-01,7.182e-01,1.933e-02
HIPK2,14402,protein serine/threonine kinase activity,GO:0004674,molecular function,30.0,31.0,1.471e-01,8.450e-02,2.560e-01,8.357e-02,5.845e-02,1.195e-01,7.120e-01,1.110e-02
HIPK2,14402,RNA polymerase II activating transcription factor binding,GO:0001102,molecular function,30.0,3.0,1.671e-01,8.218e-02,3.396e-01,1.219e-01,3.546e-02,4.190e-01,6.519e-01,4.694e-02
HIPK2,14402,protein binding,GO:0005515,molecular function,30.0,347.0,1.839e-01,1.427e-01,2.371e-01,1.601e-01,1.228e-01,2.087e-01,6.162e-01,1.050e-02
HIPK2,14402,virion binding,GO:0046790,molecular function,30.0,2.0,1.916e-01,1.392e-01,2.638e-01,1.784e-01,1.381e-01,2.304e-01,5.980e-01,1.030e-02
HMGCS1,5007,"farnesyl diphosphate biosynthetic process, mevalonate pathway",GO:0010142,biological process,20.0,3.0,3.499e-02,9.298e-03,1.316e-01,2.262e-02,4.750e-03,1.078e-01,8.507e-01,3.415e-02
HMGCS1,5007,acetyl-CoA metabolic process,GO:0006084,biological process,20.0,9.0,6.973e-02,1.257e-02,3.869e-01,6.473e-02,1.195e-02,3.507e-01,7.355e-01,5.054e-02
HMGCS1,5007,cytosol,GO:0005829,cellular component,20.0,76.0,2.320e-02,7.990e-03,6.734e-02,1.338e-02,3.492e-03,5.128e-02,8.959e-01,2.363e-02
HMGCS1,5007,protein homodimerization activity,GO:0042803,molecular function,20.0,21.0,2.277e-02,7.604e-03,6.816e-02,7.014e-03,2.342e-03,2.101e-02,9.373e-01,1.091e-02
HMGCS1,5007,hydroxymethylglutaryl-CoA synthase activity,GO:0004421,molecular function,20.0,2.0,4.987e-02,6.603e-03,3.766e-01,2.972e-02,1.297e-03,6.813e-01,8.022e-01,6.983e-02
HMGN5,8013,positive regulation of gene expression,GO:0010628,biological process,8.0,23.0,1.303e-01,9.215e-02,1.843e-01,6.282e-02,2.723e-02,1.449e-01,7.458e-01,2.505e-02
HMGN5,8013,negative regulation of cell cycle arrest,GO:0071157,biological process,8.0,4.0,1.303e-01,9.215e-02,1.843e-01,7.589e-02,3.951e-02,1.458e-01,7.232e-01,2.073e-02
HMGN5,8013,negative regulation of apoptotic process,GO:0043066,biological process,8.0,29.0,1.303e-01,9.215e-02,1.843e-01,7.223e-02,1.075e-02,4.855e-01,7.200e-01,5.494e-02
HMGN5,8013,positive regulation of cell population proliferation,GO:0008284,biological process,8.0,40.0,1.303e-01,9.215e-02,1.843e-01,8.226e-02,3.383e-02,2.000e-01,7.115e-01,2.747e-02
HMGN5,8013,nucleoplasm,GO:0005654,cellular component,8.0,51.0,1.303e-01,9.215e-02,1.843e-01,9.846e-02,8.208e-02,1.181e-01,6.902e-01,6.292e-03
HMGN5,8013,mitochondrion,GO:0005739,cellular component,8.0,35.0,1.303e-01,9.215e-02,1.843e-01,1.092e-01,5.491e-02,2.174e-01,6.732e-01,2.397e-02
HMGN5,8013,RNA binding,GO:0003723,molecular function,8.0,60.0,1.361e-01,9.393e-02,1.972e-01,1.121e-01,5.845e-02,2.149e-01,6.697e-01,2.227e-02
HOMER1,17512,regulation of store-operated calcium entry,GO:2001256,biological process,14.0,5.0,9.067e-02,6.407e-02,1.283e-01,2.861e-02,1.298e-02,6.306e-02,8.333e-01,1.933e-02
HOMER1,17512,G protein-coupled glutamate receptor signaling pathway,GO:0007216,biological process,14.0,5.0,9.136e-02,6.375e-02,1.309e-01,3.955e-02,1.577e-02,9.924e-02,7.988e-01,2.337e-02
HOMER1,17512,response to calcium ion,GO:0051592,biological process,14.0,5.0,1.094e-01,4.690e-02,2.553e-01,6.458e-02,2.279e-02,1.830e-01,7.410e-01,3.216e-02
HOMER1,17512,dendrite,GO:0030425,cellular component,14.0,11.0,7.696e-02,4.877e-02,1.215e-01,1.116e-02,2.293e-03,5.436e-02,9.052e-01,2.769e-02
HOMER1,17512,postsynaptic density,GO:0014069,cellular component,14.0,4.0,1.017e-01,5.420e-02,1.907e-01,4.678e-02,1.274e-02,1.718e-01,7.785e-01,3.446e-02
HOMER1,17512,plasma membrane,GO:0005886,cellular component,14.0,61.0,1.218e-01,5.087e-02,2.915e-01,1.013e-01,3.712e-02,2.766e-01,6.820e-01,3.414e-02
HOMER1,17512,neuron projection,GO:0043005,cellular component,14.0,22.0,1.396e-01,4.664e-02,4.178e-01,1.093e-01,1.774e-02,6.735e-01,6.620e-01,5.918e-02
HOMER1,17512,cytoplasm,GO:0005737,cellular component,14.0,78.0,1.516e-01,1.167e-01,1.971e-01,1.446e-01,1.057e-01,1.979e-01,6.322e-01,1.202e-02
HOMER1,17512,ion channel binding,GO:0044325,molecular function,14.0,6.0,9.136e-02,6.375e-02,1.309e-01,2.725e-02,6.556e-03,1.132e-01,8.345e-01,3.254e-02
HOMER1,17512,G protein-coupled glutamate receptor binding,GO:0035256,molecular function,14.0,11.0,1.040e-01,5.175e-02,2.092e-01,6.862e-02,2.127e-02,2.214e-01,7.322e-01,3.710e-02
HOMER1,17512,protein binding,GO:0005515,molecular function,14.0,347.0,1.322e-01,7.210e-02,2.423e-01,1.118e-01,5.985e-02,2.088e-01,6.706e-01,2.242e-02
HP,5141,acute inflammatory response,GO:0002526,biological process,26.0,6.0,7.277e-02,3.755e-02,1.410e-01,2.856e-02,1.280e-02,6.372e-02,8.335e-01,1.997e-02
HP,5141,positive regulation of cell death,GO:0010942,biological process,26.0,7.0,7.520e-02,2.769e-02,2.042e-01,2.549e-02,4.434e-03,1.465e-01,8.383e-01,4.045e-02
HP,5141,negative regulation of hydrogen peroxide catabolic process,GO:2000296,biological process,26.0,4.0,8.051e-02,2.807e-02,2.309e-01,3.698e-02,3.524e-03,3.882e-01,7.939e-01,6.101e-02
HP,5141,response to hydrogen peroxide,GO:0042542,biological process,26.0,7.0,9.195e-02,2.312e-02,3.658e-01,3.783e-02,2.232e-03,6.412e-01,7.834e-01,8.032e-02
HP,5141,negative regulation of oxidoreductase activity,GO:0051354,biological process,26.0,18.0,1.058e-01,2.274e-02,4.924e-01,6.923e-02,6.910e-03,6.935e-01,7.161e-01,7.816e-02
HP,5141,response to organic substance,GO:0010033,biological process,26.0,58.0,1.616e-01,1.612e-02,1.620e+00,1.280e-01,6.947e-03,2.358e+00,6.041e-01,1.182e-01
HP,5141,haptoglobin-hemoglobin complex,GO:0031838,cellular component,26.0,2.0,7.520e-02,2.769e-02,2.042e-01,2.586e-02,6.479e-03,1.032e-01,8.415e-01,3.458e-02
HP,5141,extracellular space,GO:0005615,cellular component,26.0,43.0,1.060e-01,5.009e-02,2.243e-01,7.139e-02,1.821e-02,2.799e-01,7.264e-01,3.975e-02
HP,5141,extracellular exosome,GO:0070062,cellular component,26.0,77.0,1.092e-01,5.662e-02,2.108e-01,7.709e-02,3.321e-02,1.790e-01,7.200e-01,2.643e-02
HP,5141,blood microparticle,GO:0072562,cellular component,26.0,8.0,1.287e-01,1.114e-01,1.486e-01,1.035e-01,6.405e-02,1.673e-01,6.821e-01,1.662e-02
HP,5141,hemoglobin binding,GO:0030492,molecular function,26.0,4.0,6.334e-02,4.648e-02,8.631e-02,1.775e-02,5.827e-03,5.408e-02,8.768e-01,2.492e-02
HP,5141,serine-type endopeptidase activity,GO:0004252,molecular function,26.0,4.0,7.490e-02,2.795e-02,2.007e-01,2.479e-02,1.063e-02,5.782e-02,8.478e-01,2.086e-02
HP,5141,protein binding,GO:0005515,molecular function,26.0,347.0,1.202e-01,7.369e-02,1.961e-01,9.703e-02,5.511e-02,1.708e-01,6.907e-01,1.846e-02
HSD11B1,5208,steroid catabolic process,GO:0006706,biological process,16.0,17.0,4.087e-02,2.409e-02,6.934e-02,2.180e-02,3.972e-03,1.196e-01,8.534e-01,3.822e-02
HSD11B1,5208,membrane,GO:0016020,cellular component,16.0,58.0,4.876e-02,2.245e-02,1.059e-01,4.341e-02,2.214e-02,8.511e-02,7.893e-01,1.748e-02
HSD11B1,5208,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,GO:0003845,molecular function,16.0,4.0,3.286e-02,2.297e-02,4.702e-02,1.186e-02,4.742e-03,2.967e-02,9.090e-01,1.342e-02
HSD11B1,5208,steroid binding,GO:0005496,molecular function,16.0,13.0,4.876e-02,2.245e-02,1.059e-01,4.604e-02,2.160e-02,9.810e-02,7.825e-01,2.019e-02
HSD17B12,18646,protein binding,GO:0005515,molecular function,29.0,347.0,1.332e-02,3.823e-03,4.642e-02,1.332e-02,3.823e-03,4.642e-02,8.972e-01,1.923e-02
HSD17B7,5215,cholesterol biosynthetic process,GO:0006695,biological process,38.0,11.0,2.585e-02,1.141e-02,5.855e-02,2.258e-02,6.299e-03,8.093e-02,8.527e-01,2.727e-02
HSD17B7,5215,endoplasmic reticulum,GO:0005783,cellular component,38.0,34.0,2.479e-02,1.163e-02,5.282e-02,1.427e-02,3.637e-03,5.602e-02,8.902e-01,2.228e-02
HSD17B7,5215,3-keto sterol reductase activity,GO:0000253,molecular function,38.0,2.0,3.570e-02,2.153e-02,5.920e-02,2.445e-02,7.694e-03,7.767e-02,8.482e-01,2.835e-02
HSPA12A,19022,extracellular exosome,GO:0070062,cellular component,3.0,77.0,9.862e-02,6.568e-02,1.481e-01,5.976e-02,4.285e-02,8.335e-02,7.537e-01,9.397e-03
HSPA12A,19022,protein binding,GO:0005515,molecular function,3.0,347.0,1.024e-01,6.023e-02,1.742e-01,1.024e-01,6.023e-02,1.742e-01,6.834e-01,1.856e-02
HSPB1,5246,cellular response to vascular endothelial growth factor stimulus,GO:0035924,biological process,44.0,3.0,4.508e-02,2.719e-02,7.474e-02,1.307e-02,6.631e-03,2.574e-02,9.034e-01,1.240e-02
HSPB1,5246,platelet aggregation,GO:0070527,biological process,44.0,3.0,4.508e-02,2.719e-02,7.474e-02,1.175e-02,1.421e-03,9.721e-02,8.962e-01,3.225e-02
HSPB1,5246,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,GO:0038033,biological process,44.0,4.0,4.508e-02,2.719e-02,7.474e-02,1.597e-02,9.093e-03,2.807e-02,8.890e-01,1.206e-02
HSPB1,5246,positive regulation of endothelial cell chemotaxis,GO:2001028,biological process,44.0,7.0,4.508e-02,2.719e-02,7.474e-02,1.969e-02,1.079e-02,3.593e-02,8.700e-01,1.362e-02
HSPB1,5246,positive regulation of blood vessel endothelial cell migration,GO:0043536,biological process,44.0,6.0,4.508e-02,2.719e-02,7.474e-02,2.146e-02,1.227e-02,3.753e-02,8.622e-01,1.330e-02
HSPB1,5246,positive regulation of angiogenesis,GO:0045766,biological process,44.0,12.0,4.508e-02,2.719e-02,7.474e-02,2.422e-02,1.134e-02,5.172e-02,8.498e-01,1.791e-02
HSPB1,5246,anterograde axonal protein transport,GO:0099641,biological process,44.0,6.0,4.508e-02,2.719e-02,7.474e-02,2.772e-02,1.652e-02,4.652e-02,8.368e-01,1.271e-02
HSPB1,5246,intracellular signal transduction,GO:0035556,biological process,44.0,30.0,4.513e-02,2.713e-02,7.508e-02,2.684e-02,7.977e-03,9.030e-02,8.376e-01,2.809e-02
HSPB1,5246,response to virus,GO:0009615,biological process,44.0,6.0,4.658e-02,2.760e-02,7.861e-02,1.856e-02,3.769e-03,9.139e-02,8.693e-01,3.538e-02
HSPB1,5246,chaperone-mediated protein folding,GO:0061077,biological process,44.0,7.0,5.147e-02,2.607e-02,1.016e-01,3.633e-02,9.217e-03,1.432e-01,8.065e-01,3.410e-02
HSPB1,5246,regulation of protein phosphorylation,GO:0001932,biological process,44.0,22.0,5.992e-02,3.420e-02,1.050e-01,4.769e-02,1.862e-02,1.221e-01,7.776e-01,2.586e-02
HSPB1,5246,retina homeostasis,GO:0001895,biological process,44.0,5.0,6.745e-02,2.124e-02,2.142e-01,4.824e-02,4.919e-03,4.730e-01,7.667e-01,5.824e-02
HSPB1,5246,focal adhesion,GO:0005925,cellular component,44.0,6.0,4.508e-02,2.719e-02,7.474e-02,1.637e-02,5.529e-03,4.847e-02,8.834e-01,2.283e-02
HSPB1,5246,extracellular exosome,GO:0070062,cellular component,44.0,77.0,4.508e-02,2.719e-02,7.474e-02,2.847e-02,2.003e-02,4.048e-02,8.340e-01,8.658e-03
HSPB1,5246,nucleus,GO:0005634,cellular component,44.0,81.0,4.984e-02,2.427e-02,1.024e-01,4.030e-02,1.381e-02,1.176e-01,7.963e-01,2.774e-02
HSPB1,5246,extracellular space,GO:0005615,cellular component,44.0,43.0,5.144e-02,4.087e-02,6.476e-02,3.233e-02,1.371e-02,7.621e-02,8.204e-01,2.148e-02
HSPB1,5246,cytoplasm,GO:0005737,cellular component,44.0,78.0,5.204e-02,3.026e-02,8.949e-02,4.449e-02,2.729e-02,7.252e-02,7.869e-01,1.293e-02
HSPB1,5246,identical protein binding,GO:0042802,molecular function,44.0,35.0,4.508e-02,2.719e-02,7.474e-02,1.925e-02,1.588e-02,2.334e-02,8.736e-01,4.566e-03
HSPB1,5246,protein homodimerization activity,GO:0042803,molecular function,44.0,21.0,4.508e-02,2.719e-02,7.474e-02,2.584e-02,1.338e-02,4.990e-02,8.436e-01,1.591e-02
HSPB1,5246,protein folding chaperone,GO:0044183,molecular function,44.0,2.0,4.508e-02,2.719e-02,7.474e-02,2.853e-02,1.692e-02,4.813e-02,8.337e-01,1.294e-02
HSPB1,5246,protein binding,GO:0005515,molecular function,44.0,347.0,4.519e-02,2.724e-02,7.498e-02,3.068e-02,2.250e-02,4.185e-02,8.264e-01,7.572e-03
HSPB1,5246,RNA binding,GO:0003723,molecular function,44.0,60.0,4.849e-02,2.346e-02,1.002e-01,3.579e-02,1.177e-02,1.089e-01,8.082e-01,2.920e-02
HSPB1,5246,protein kinase binding,GO:0019901,molecular function,44.0,16.0,5.232e-02,3.032e-02,9.029e-02,4.389e-02,2.179e-02,8.840e-02,7.879e-01,1.865e-02
HSPB2,5247,nucleus,GO:0005634,cellular component,10.0,81.0,2.713e-02,1.254e-02,5.868e-02,2.317e-02,1.086e-02,4.944e-02,8.546e-01,1.845e-02
HSPB2,5247,cytoplasm,GO:0005737,cellular component,10.0,78.0,2.713e-02,1.254e-02,5.868e-02,2.696e-02,1.236e-02,5.882e-02,8.395e-01,1.935e-02
HSPB2,5247,protein binding,GO:0005515,molecular function,10.0,347.0,2.713e-02,1.254e-02,5.868e-02,2.213e-02,1.346e-02,3.637e-02,8.594e-01,1.198e-02
HSPB7,5249,nucleus,GO:0005634,cellular component,6.0,81.0,1.614e-01,1.223e-01,2.130e-01,8.675e-02,7.610e-02,9.889e-02,7.076e-01,4.128e-03
HSPB7,5249,nucleoplasm,GO:0005654,cellular component,6.0,51.0,1.614e-01,1.223e-01,2.130e-01,9.333e-02,6.321e-02,1.378e-01,6.968e-01,1.247e-02
HSPB7,5249,cytoplasm,GO:0005737,cellular component,6.0,78.0,1.614e-01,1.223e-01,2.130e-01,1.172e-01,9.431e-02,1.457e-01,6.647e-01,7.869e-03
HSPB7,5249,aggresome,GO:0016235,cellular component,6.0,2.0,2.025e-01,1.626e-01,2.522e-01,2.025e-01,1.626e-01,2.522e-01,5.758e-01,9.572e-03
HSPB7,5249,protein binding,GO:0005515,molecular function,6.0,347.0,1.614e-01,1.223e-01,2.130e-01,1.291e-01,9.786e-02,1.704e-01,6.500e-01,1.022e-02
IDE,5381,amyloid-beta clearance by cellular catabolic process,GO:0150094,biological process,43.0,3.0,1.210e-01,4.611e-02,3.175e-01,8.579e-03,5.599e-03,1.315e-02,9.303e-01,4.944e-03
IDE,5381,insulin catabolic process,GO:1901143,biological process,43.0,3.0,1.210e-01,4.611e-02,3.175e-01,1.179e-02,6.503e-03,2.139e-02,9.112e-01,9.860e-03
IDE,5381,insulin metabolic process,GO:1901142,biological process,43.0,4.0,1.223e-01,4.564e-02,3.277e-01,2.891e-02,1.010e-02,8.271e-02,8.315e-01,2.528e-02
IDE,5381,proteolysis,GO:0006508,biological process,43.0,14.0,1.251e-01,4.454e-02,3.514e-01,4.007e-02,7.194e-03,2.232e-01,7.930e-01,4.626e-02
IDE,5381,cellular protein catabolic process,GO:0044257,biological process,43.0,13.0,1.315e-01,4.340e-02,3.984e-01,3.702e-02,5.330e-03,2.571e-01,7.996e-01,4.782e-02
IDE,5381,proteolysis involved in cellular protein catabolic process,GO:0051603,biological process,43.0,12.0,1.318e-01,5.195e-02,3.344e-01,4.081e-02,1.572e-02,1.059e-01,7.952e-01,2.430e-02
IDE,5381,peptide catabolic process,GO:0043171,biological process,43.0,18.0,1.349e-01,4.281e-02,4.252e-01,5.589e-02,7.391e-03,4.226e-01,7.525e-01,5.460e-02
IDE,5381,bradykinin catabolic process,GO:0010815,biological process,43.0,3.0,1.402e-01,8.287e-02,2.373e-01,3.205e-02,1.717e-02,5.985e-02,8.218e-01,1.552e-02
IDE,5381,amyloid-beta clearance,GO:0097242,biological process,43.0,4.0,1.463e-01,8.741e-02,2.450e-01,5.956e-02,2.718e-02,1.305e-01,7.526e-01,2.170e-02
IDE,5381,antigen processing and presentation of endogenous peptide antigen via MHC class I,GO:0019885,biological process,43.0,5.0,1.566e-01,8.215e-02,2.987e-01,8.737e-02,4.224e-02,1.807e-01,7.043e-01,2.259e-02
IDE,5381,hormone catabolic process,GO:0042447,biological process,43.0,26.0,1.630e-01,7.220e-02,3.679e-01,8.259e-02,2.147e-02,3.178e-01,7.073e-01,4.222e-02
IDE,5381,amyloid-beta metabolic process,GO:0050435,biological process,43.0,3.0,1.654e-01,7.691e-02,3.557e-01,9.775e-02,3.393e-02,2.817e-01,6.865e-01,3.387e-02
IDE,5381,determination of adult lifespan,GO:0008340,biological process,43.0,2.0,1.692e-01,1.152e-01,2.486e-01,1.206e-01,7.458e-02,1.952e-01,6.599e-01,1.771e-02
IDE,5381,protein homooligomerization,GO:0051260,biological process,43.0,5.0,1.778e-01,1.307e-01,2.418e-01,7.404e-02,1.474e-02,3.720e-01,7.180e-01,5.373e-02
IDE,5381,positive regulation of protein oligomerization,GO:0032461,biological process,43.0,5.0,2.065e-01,1.176e-01,3.625e-01,9.991e-02,1.660e-02,6.013e-01,6.728e-01,6.777e-02
IDE,5381,regulation of aerobic respiration,GO:1903715,biological process,43.0,2.0,2.122e-01,1.598e-01,2.819e-01,2.043e-01,1.555e-01,2.683e-01,5.740e-01,1.222e-02
IDE,5381,ubiquitin recycling,GO:0010992,biological process,43.0,2.0,2.313e-01,1.572e-01,3.403e-01,2.288e-01,1.573e-01,3.328e-01,5.523e-01,1.694e-02
IDE,5381,peroxisomal matrix,GO:0005782,cellular component,43.0,4.0,1.426e-01,4.051e-02,5.017e-01,7.683e-02,7.207e-03,8.190e-01,7.066e-01,6.868e-02
IDE,5381,extracellular space,GO:0005615,cellular component,43.0,43.0,1.552e-01,8.407e-02,2.866e-01,7.304e-02,5.585e-02,9.552e-02,7.294e-01,8.145e-03
IDE,5381,mitochondrion,GO:0005739,cellular component,43.0,35.0,1.630e-01,7.220e-02,3.679e-01,1.054e-01,2.006e-02,5.535e-01,6.699e-01,5.324e-02
IDE,5381,cell surface,GO:0009986,cellular component,43.0,11.0,1.654e-01,7.691e-02,3.557e-01,1.077e-01,3.480e-02,3.331e-01,6.721e-01,3.786e-02
IDE,5381,cytosol,GO:0005829,cellular component,43.0,76.0,1.654e-01,7.691e-02,3.557e-01,1.100e-01,3.871e-02,3.125e-01,6.699e-01,3.470e-02
IDE,5381,nucleus,GO:0005634,cellular component,43.0,81.0,1.765e-01,9.487e-02,3.283e-01,1.485e-01,6.023e-02,3.662e-01,6.251e-01,3.349e-02
IDE,5381,cytoplasm,GO:0005737,cellular component,43.0,78.0,1.831e-01,1.018e-01,3.292e-01,1.577e-01,6.884e-02,3.614e-01,6.155e-01,3.215e-02
IDE,5381,peroxisome,GO:0005777,cellular component,43.0,16.0,1.834e-01,1.146e-01,2.934e-01,1.453e-01,8.689e-02,2.429e-01,6.308e-01,1.993e-02
IDE,5381,external side of plasma membrane,GO:0009897,cellular component,43.0,8.0,1.880e-01,1.130e-01,3.129e-01,1.551e-01,7.454e-02,3.229e-01,6.184e-01,3.006e-02
IDE,5381,basolateral plasma membrane,GO:0016323,cellular component,43.0,5.0,1.948e-01,1.698e-01,2.235e-01,1.239e-01,5.417e-02,2.833e-01,6.537e-01,2.962e-02
IDE,5381,ubiquitin-dependent protein binding,GO:0140036,molecular function,43.0,3.0,1.210e-01,4.611e-02,3.175e-01,1.729e-02,1.141e-02,2.618e-02,8.829e-01,8.998e-03
IDE,5381,insulin binding,GO:0043559,molecular function,43.0,3.0,1.223e-01,4.564e-02,3.277e-01,2.006e-02,8.899e-03,4.521e-02,8.669e-01,1.767e-02
IDE,5381,metalloendopeptidase activity,GO:0004222,molecular function,43.0,7.0,1.223e-01,4.564e-02,3.277e-01,2.306e-02,1.328e-02,4.004e-02,8.554e-01,1.331e-02
IDE,5381,peptide binding,GO:0042277,molecular function,43.0,14.0,1.404e-01,5.079e-02,3.880e-01,6.822e-02,1.303e-02,3.572e-01,7.300e-01,4.669e-02
IDE,5381,endopeptidase activity,GO:0004175,molecular function,43.0,11.0,1.481e-01,8.389e-02,2.613e-01,5.154e-02,3.543e-02,7.498e-02,7.710e-01,1.041e-02
IDE,5381,protein homodimerization activity,GO:0042803,molecular function,43.0,21.0,1.571e-01,8.321e-02,2.966e-01,8.934e-02,5.614e-02,1.422e-01,7.026e-01,1.486e-02
IDE,5381,zinc ion binding,GO:0008270,molecular function,43.0,8.0,1.659e-01,7.787e-02,3.534e-01,1.251e-01,4.570e-02,3.423e-01,6.509e-01,3.488e-02
IDE,5381,protein binding,GO:0005515,molecular function,43.0,347.0,1.817e-01,1.139e-01,2.899e-01,1.416e-01,8.766e-02,2.288e-01,6.351e-01,1.805e-02
IDE,5381,ATP binding,GO:0005524,molecular function,43.0,10.0,2.155e-01,1.619e-01,2.869e-01,1.964e-01,1.341e-01,2.875e-01,5.806e-01,1.613e-02
IDH3A,5384,tricarboxylic acid cycle,GO:0006099,biological process,23.0,4.0,4.043e-02,1.185e-02,1.379e-01,1.022e-02,2.628e-03,3.976e-02,9.135e-01,2.078e-02
IDH3A,5384,isocitrate metabolic process,GO:0006102,biological process,23.0,3.0,4.101e-02,1.262e-02,1.333e-01,1.813e-02,6.225e-03,5.278e-02,8.745e-01,2.217e-02
IDH3A,5384,mitochondrion,GO:0005739,cellular component,23.0,35.0,4.114e-02,1.174e-02,1.441e-01,1.969e-02,2.971e-03,1.305e-01,8.580e-01,3.551e-02
IDH3A,5384,nucleus,GO:0005634,cellular component,23.0,81.0,5.681e-02,2.957e-02,1.091e-01,4.258e-02,2.254e-02,8.045e-02,7.913e-01,1.641e-02
IDH3A,5384,magnesium ion binding,GO:0000287,molecular function,23.0,5.0,5.669e-02,2.820e-02,1.139e-01,4.499e-02,1.523e-02,1.329e-01,7.834e-01,2.940e-02
IDH3A,5384,isocitrate dehydrogenase (NAD+) activity,GO:0004449,molecular function,23.0,2.0,5.730e-02,2.975e-02,1.103e-01,5.309e-02,3.046e-02,9.252e-02,7.671e-01,1.495e-02
IDI1,5387,isopentenyl diphosphate biosynthetic process,GO:0009240,biological process,9.0,5.0,9.310e-02,3.018e-02,2.872e-01,3.325e-02,6.838e-03,1.617e-01,8.142e-01,4.204e-02
IDI1,5387,peroxisome,GO:0005777,cellular component,9.0,16.0,1.081e-01,3.132e-02,3.733e-01,7.862e-02,1.787e-02,3.459e-01,7.120e-01,4.819e-02
IDI1,5387,cytoplasm,GO:0005737,cellular component,9.0,78.0,1.174e-01,4.983e-02,2.768e-01,8.006e-02,4.872e-02,1.316e-01,7.170e-01,1.589e-02
IDI1,5387,isopentenyl-diphosphate delta-isomerase activity,GO:0004452,molecular function,9.0,2.0,1.061e-01,3.209e-02,3.506e-01,8.047e-02,1.582e-02,4.094e-01,7.082e-01,4.812e-02
IGFBP3,5472,negative regulation of smooth muscle cell proliferation,GO:0048662,biological process,28.0,5.0,4.923e-02,1.555e-02,1.559e-01,1.139e-02,3.610e-03,3.595e-02,9.098e-01,1.548e-02
IGFBP3,5472,negative regulation of protein phosphorylation,GO:0001933,biological process,28.0,19.0,4.923e-02,1.555e-02,1.559e-01,2.685e-02,9.620e-03,7.493e-02,8.392e-01,2.539e-02
IGFBP3,5472,negative regulation of smooth muscle cell migration,GO:0014912,biological process,28.0,5.0,6.235e-02,1.263e-02,3.079e-01,2.641e-02,2.136e-03,3.265e-01,8.241e-01,5.083e-02
IGFBP3,5472,regulation of insulin-like growth factor receptor signaling pathway,GO:0043567,biological process,28.0,5.0,7.378e-02,1.137e-02,4.787e-01,4.194e-02,3.954e-03,4.449e-01,7.812e-01,5.742e-02
IGFBP3,5472,positive regulation of myoblast differentiation,GO:0045663,biological process,28.0,4.0,8.003e-02,1.220e-02,5.251e-01,6.399e-02,6.652e-03,6.155e-01,7.324e-01,6.393e-02
IGFBP3,5472,positive regulation of apoptotic process,GO:0043065,biological process,28.0,26.0,8.047e-02,1.221e-02,5.303e-01,6.803e-02,7.273e-03,6.363e-01,7.248e-01,6.311e-02
IGFBP3,5472,negative regulation of cell population proliferation,GO:0008285,biological process,28.0,36.0,9.953e-02,2.926e-02,3.385e-01,8.660e-02,1.989e-02,3.769e-01,6.997e-01,4.458e-02
IGFBP3,5472,protein phosphorylation,GO:0006468,biological process,28.0,30.0,1.233e-01,8.611e-02,1.766e-01,9.713e-02,6.379e-02,1.479e-01,6.913e-01,1.429e-02
IGFBP3,5472,insulin-like growth factor ternary complex,GO:0042567,cellular component,28.0,2.0,4.804e-02,1.406e-02,1.641e-01,1.684e-02,4.751e-03,5.970e-02,8.798e-01,2.754e-02
IGFBP3,5472,extracellular space,GO:0005615,cellular component,28.0,43.0,7.804e-02,3.841e-02,1.586e-01,3.944e-02,8.884e-03,1.751e-01,7.960e-01,4.022e-02
IGFBP3,5472,nucleus,GO:0005634,cellular component,28.0,81.0,1.373e-01,1.165e-01,1.618e-01,1.223e-01,1.161e-01,1.288e-01,6.585e-01,1.853e-03
IGFBP3,5472,protein tyrosine phosphatase activator activity,GO:0008160,molecular function,28.0,2.0,3.279e-02,2.766e-03,3.888e-01,4.552e-03,1.016e-04,2.040e-01,9.296e-01,2.486e-02
IGFBP3,5472,fibronectin binding,GO:0001968,molecular function,28.0,5.0,4.804e-02,1.406e-02,1.641e-01,1.615e-02,8.118e-03,3.214e-02,8.870e-01,1.303e-02
IGFBP3,5472,insulin-like growth factor II binding,GO:0031995,molecular function,28.0,3.0,4.804e-02,1.406e-02,1.641e-01,2.179e-02,4.324e-03,1.098e-01,8.531e-01,3.388e-02
IGFBP3,5472,insulin-like growth factor I binding,GO:0031994,molecular function,28.0,3.0,4.804e-02,1.406e-02,1.641e-01,2.190e-02,3.842e-03,1.249e-01,8.513e-01,3.642e-02
IGFBP3,5472,protein binding,GO:0005515,molecular function,28.0,347.0,1.367e-01,1.179e-01,1.585e-01,1.094e-01,6.785e-02,1.763e-01,6.744e-01,1.696e-02
IGFBP4,5473,,,,nan,nan,,,,,,,,
IGFBP6,5475,regulation of insulin-like growth factor receptor signaling pathway,GO:0043567,biological process,7.0,5.0,5.512e-02,8.812e-03,3.447e-01,4.815e-02,4.960e-03,4.674e-01,7.667e-01,5.982e-02
IGFBP6,5475,insulin-like growth factor binary complex,GO:0042568,cellular component,7.0,2.0,4.724e-02,1.282e-02,1.741e-01,3.059e-02,8.470e-03,1.105e-01,8.247e-01,3.282e-02
IGFBP6,5475,extracellular space,GO:0005615,cellular component,7.0,43.0,6.733e-02,2.170e-02,2.089e-01,3.328e-02,4.128e-03,2.684e-01,8.087e-01,5.444e-02
IGFBP6,5475,fibronectin binding,GO:0001968,molecular function,7.0,5.0,3.680e-02,7.717e-03,1.755e-01,1.517e-02,4.500e-03,5.111e-02,8.874e-01,2.184e-02
IGFBP6,5475,insulin-like growth factor II binding,GO:0031995,molecular function,7.0,3.0,3.923e-02,6.762e-03,2.275e-01,2.684e-02,3.053e-03,2.360e-01,8.282e-01,4.957e-02
IGFBP6,5475,insulin-like growth factor I binding,GO:0031994,molecular function,7.0,3.0,3.923e-02,6.762e-03,2.275e-01,2.677e-02,2.645e-03,2.710e-01,8.265e-01,5.279e-02
IL17RC,18358,,,,nan,nan,,,,,,,,
IL22RA2,14901,,,,nan,nan,,,,,,,,
ISLR,6133,extracellular exosome,GO:0070062,cellular component,3.0,77.0,8.629e-03,5.460e-03,1.364e-02,8.629e-03,5.460e-03,1.364e-02,9.300e-01,5.692e-03
ISOC1,24254,cytoplasm,GO:0005737,cellular component,3.0,78.0,5.353e-02,3.935e-02,7.281e-02,5.301e-02,3.875e-02,7.253e-02,7.678e-01,8.736e-03
ISOC1,24254,protein binding,GO:0005515,molecular function,3.0,347.0,5.353e-02,3.935e-02,7.281e-02,5.084e-02,3.799e-02,6.805e-02,7.724e-01,7.949e-03
JPT2,14137,plasma membrane,GO:0005886,cellular component,3.0,61.0,5.993e-02,4.206e-02,8.540e-02,4.786e-02,3.082e-02,7.433e-02,7.790e-01,1.171e-02
JPT2,14137,cytosol,GO:0005829,cellular component,3.0,76.0,5.993e-02,4.206e-02,8.540e-02,5.993e-02,4.206e-02,8.540e-02,7.533e-01,9.984e-03
KCNJ15,6261,potassium ion import across plasma membrane,GO:1990573,biological process,5.0,3.0,3.904e-02,9.824e-03,1.551e-01,1.230e-02,1.491e-03,1.014e-01,8.928e-01,3.914e-02
KCNJ15,6261,regulation of ion transmembrane transport,GO:0034765,biological process,5.0,9.0,1.269e-01,7.465e-03,2.157e+00,9.150e-02,2.829e-03,2.959e+00,6.325e-01,1.490e-01
KCNJ15,6261,inward rectifier potassium channel activity,GO:0005242,molecular function,5.0,5.0,5.780e-02,3.342e-02,9.995e-02,2.927e-02,6.396e-03,1.339e-01,8.270e-01,3.554e-02
KCNJ15,6261,protein binding,GO:0005515,molecular function,5.0,347.0,1.184e-01,8.406e-02,1.669e-01,1.076e-01,8.535e-02,1.357e-01,6.773e-01,8.184e-03
KCTD9,22401,cullin family protein binding,GO:0097602,molecular function,7.0,3.0,9.859e-03,3.152e-03,3.084e-02,3.358e-03,6.357e-04,1.773e-02,9.598e-01,8.483e-03
KCTD9,22401,protein self-association,GO:0043621,molecular function,7.0,3.0,1.392e-02,7.326e-03,2.646e-02,8.772e-03,2.224e-03,3.459e-02,9.224e-01,1.997e-02
KCTD9,22401,identical protein binding,GO:0042802,molecular function,7.0,35.0,1.446e-02,8.926e-03,2.341e-02,9.471e-03,4.510e-03,1.989e-02,9.238e-01,1.016e-02
KCTD9,22401,protein binding,GO:0005515,molecular function,7.0,347.0,2.080e-02,1.132e-02,3.820e-02,1.890e-02,8.376e-03,4.263e-02,8.733e-01,1.842e-02
KLB,15527,fibroblast growth factor binding,GO:0017134,molecular function,9.0,2.0,1.599e-02,2.956e-03,8.652e-02,8.461e-03,1.045e-03,6.850e-02,9.150e-01,3.311e-02
KLB,15527,fibroblast growth factor receptor binding,GO:0005104,molecular function,9.0,5.0,1.697e-02,5.031e-03,5.724e-02,8.812e-03,3.412e-03,2.275e-02,9.266e-01,1.157e-02
KLB,15527,protein binding,GO:0005515,molecular function,9.0,347.0,7.047e-02,3.140e-02,1.582e-01,7.047e-02,3.140e-02,1.582e-01,7.316e-01,2.502e-02
KLF13,13672,regulation of transcription by RNA polymerase II,GO:0006357,biological process,5.0,46.0,5.866e-02,3.225e-02,1.067e-01,3.646e-02,2.448e-02,5.430e-02,8.086e-01,9.966e-03
KLF13,13672,nucleus,GO:0005634,cellular component,5.0,81.0,5.866e-02,3.225e-02,1.067e-01,4.591e-02,2.545e-02,8.281e-02,7.833e-01,1.568e-02
KLF13,13672,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,5.0,9.0,5.866e-02,3.225e-02,1.067e-01,2.524e-02,1.722e-02,3.698e-02,8.463e-01,9.382e-03
KLF13,13672,protein binding,GO:0005515,molecular function,5.0,347.0,5.896e-02,3.186e-02,1.091e-01,5.896e-02,3.186e-02,1.091e-01,7.545e-01,1.792e-02
KLHL25,25732,protein ubiquitination,GO:0016567,biological process,9.0,10.0,4.518e-02,2.712e-02,7.526e-02,2.187e-02,1.759e-02,2.717e-02,8.608e-01,5.294e-03
KLHL25,25732,ubiquitin-dependent protein catabolic process,GO:0006511,biological process,9.0,6.0,4.518e-02,2.712e-02,7.526e-02,3.353e-02,2.192e-02,5.127e-02,8.172e-01,1.056e-02
KLHL25,25732,regulation of translational initiation,GO:0006446,biological process,9.0,15.0,7.684e-02,3.559e-02,1.659e-01,6.202e-02,1.958e-02,1.965e-01,7.457e-01,3.231e-02
KLHL25,25732,Cul3-RING ubiquitin ligase complex,GO:0031463,cellular component,9.0,2.0,4.518e-02,2.712e-02,7.526e-02,1.815e-02,1.389e-02,2.371e-02,8.790e-01,6.165e-03
KLHL25,25732,cytoplasm,GO:0005737,cellular component,9.0,78.0,6.261e-02,1.383e-02,2.835e-01,5.684e-02,9.838e-03,3.284e-01,7.505e-01,5.236e-02
KMT5A,29489,peptidyl-lysine monomethylation,GO:0018026,biological process,12.0,3.0,7.736e-02,3.479e-02,1.720e-01,3.896e-02,7.146e-03,2.124e-01,7.968e-01,4.201e-02
KMT5A,29489,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,12.0,31.0,9.360e-02,7.558e-02,1.159e-01,5.146e-02,2.450e-02,1.081e-01,7.698e-01,2.078e-02
KMT5A,29489,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,12.0,43.0,9.360e-02,7.558e-02,1.159e-01,5.433e-02,2.638e-02,1.119e-01,7.638e-01,1.945e-02
KMT5A,29489,"regulation of DNA damage response, signal transduction by p53 class mediator",GO:0043516,biological process,12.0,6.0,1.732e-01,2.437e-02,1.231e+00,1.474e-01,1.584e-02,1.372e+00,5.936e-01,1.064e-01
KMT5A,29489,nucleoplasm,GO:0005654,cellular component,12.0,51.0,8.071e-02,3.275e-02,1.989e-01,5.094e-02,1.010e-02,2.569e-01,7.659e-01,4.546e-02
KMT5A,29489,cytosol,GO:0005829,cellular component,12.0,76.0,8.071e-02,3.275e-02,1.989e-01,5.924e-02,1.053e-02,3.333e-01,7.474e-01,4.794e-02
KMT5A,29489,p53 binding,GO:0002039,molecular function,12.0,2.0,5.103e-02,2.554e-02,1.019e-01,7.413e-03,1.403e-03,3.918e-02,9.290e-01,2.083e-02
KMT5A,29489,transcription corepressor activity,GO:0003714,molecular function,12.0,4.0,7.736e-02,3.479e-02,1.720e-01,3.172e-02,1.726e-02,5.827e-02,8.228e-01,1.506e-02
KMT5A,29489,histone-lysine N-methyltransferase activity,GO:0018024,molecular function,12.0,10.0,9.360e-02,7.558e-02,1.159e-01,4.396e-02,1.498e-02,1.290e-01,7.868e-01,2.762e-02
KMT5A,29489,protein-lysine N-methyltransferase activity,GO:0016279,molecular function,12.0,7.0,9.360e-02,7.558e-02,1.159e-01,7.479e-02,6.933e-02,8.068e-02,7.264e-01,2.380e-03
KMT5A,29489,protein binding,GO:0005515,molecular function,12.0,347.0,1.106e-01,6.823e-02,1.792e-01,9.034e-02,2.827e-02,2.887e-01,6.968e-01,3.618e-02
KRT36,6454,extracellular exosome,GO:0070062,cellular component,2.0,77.0,1.563e-02,1.336e-02,1.828e-02,1.563e-02,1.336e-02,1.828e-02,8.927e-01,3.211e-03
LACC1,26789,peroxisome,GO:0005777,cellular component,5.0,16.0,1.562e-01,9.566e-02,2.550e-01,1.379e-01,5.889e-02,3.229e-01,6.372e-01,3.159e-02
LACC1,26789,protein binding,GO:0005515,molecular function,5.0,347.0,1.248e-01,8.652e-02,1.800e-01,7.570e-02,3.332e-02,1.720e-01,7.223e-01,2.580e-02
LACC1,26789,copper ion binding,GO:0005507,molecular function,5.0,7.0,1.248e-01,8.652e-02,1.800e-01,1.067e-01,4.486e-02,2.536e-01,6.756e-01,2.897e-02
LACTB2,18512,"RNA phosphodiester bond hydrolysis, endonucleolytic",GO:0090502,biological process,8.0,5.0,5.781e-02,2.410e-02,1.387e-01,2.974e-02,8.445e-03,1.047e-01,8.275e-01,3.031e-02
LACTB2,18512,mitochondrial matrix,GO:0005759,cellular component,8.0,6.0,6.492e-02,3.485e-02,1.210e-01,3.738e-02,3.187e-02,4.384e-02,8.061e-01,4.062e-03
LACTB2,18512,single-stranded RNA binding,GO:0003727,molecular function,8.0,7.0,5.387e-02,2.795e-02,1.039e-01,1.618e-02,1.058e-02,2.473e-02,8.884e-01,8.234e-03
LACTB2,18512,endoribonuclease activity,GO:0004521,molecular function,8.0,6.0,6.150e-02,2.101e-02,1.801e-01,3.654e-02,7.134e-03,1.872e-01,8.033e-01,4.408e-02
LACTB2,18512,zinc ion binding,GO:0008270,molecular function,8.0,8.0,8.243e-02,5.728e-02,1.186e-01,6.377e-02,4.747e-02,8.565e-02,7.459e-01,8.611e-03
LACTB2,18512,protein binding,GO:0005515,molecular function,8.0,347.0,1.242e-01,7.780e-02,1.982e-01,1.242e-01,7.780e-02,1.982e-01,6.555e-01,1.732e-02
LARGE1,6511,protein O-linked mannosylation,GO:0035269,biological process,7.0,3.0,3.509e-01,2.173e-01,5.664e-01,2.659e-01,8.833e-02,8.007e-01,5.129e-01,5.188e-02
LARGE1,6511,Golgi apparatus,GO:0005794,cellular component,7.0,16.0,3.509e-01,2.173e-01,5.664e-01,2.371e-01,8.183e-02,6.869e-01,5.379e-01,4.727e-02
LARGE1,6511,manganese ion binding,GO:0030145,molecular function,7.0,3.0,3.509e-01,2.173e-01,5.664e-01,1.608e-01,5.873e-02,4.404e-01,6.105e-01,3.975e-02
LARGE1,6511,xylosyltransferase activity,GO:0042285,molecular function,7.0,5.0,3.707e-01,2.621e-01,5.243e-01,2.331e-01,1.516e-01,3.583e-01,5.482e-01,1.996e-02
LARGE1,6511,"transferase activity, transferring glycosyl groups",GO:0016757,molecular function,7.0,9.0,3.707e-01,2.621e-01,5.243e-01,2.928e-01,2.486e-01,3.450e-01,5.028e-01,8.461e-03
LARGE1,6511,glucuronosyltransferase activity,GO:0015020,molecular function,7.0,15.0,3.707e-01,2.621e-01,5.243e-01,3.444e-01,2.078e-01,5.708e-01,4.625e-01,3.009e-02
LBX1,16960,nucleus,GO:0005634,cellular component,4.0,81.0,4.142e-02,1.513e-02,1.134e-01,4.072e-02,1.420e-02,1.168e-01,7.949e-01,2.776e-02
LBX1,16960,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,4.0,9.0,2.977e-02,1.901e-02,4.664e-02,2.037e-02,9.807e-03,4.232e-02,8.658e-01,1.612e-02
LCOR,29503,nucleoplasm,GO:0005654,cellular component,8.0,51.0,5.561e-02,4.011e-02,7.710e-02,4.887e-02,2.618e-02,9.125e-02,7.761e-01,1.680e-02
LCOR,29503,protein binding,GO:0005515,molecular function,8.0,347.0,5.561e-02,4.011e-02,7.710e-02,4.918e-02,3.867e-02,6.253e-02,7.761e-01,6.532e-03
LDHA,6535,extracellular exosome,GO:0070062,cellular component,36.0,77.0,1.128e-02,7.565e-03,1.682e-02,3.347e-03,1.257e-03,8.909e-03,9.630e-01,5.930e-03
LDHA,6535,membrane,GO:0016020,cellular component,36.0,58.0,1.372e-02,7.635e-03,2.467e-02,8.738e-03,3.769e-03,2.026e-02,9.277e-01,1.026e-02
LDHA,6535,nucleus,GO:0005634,cellular component,36.0,81.0,1.372e-02,7.635e-03,2.467e-02,1.249e-02,5.592e-03,2.788e-02,9.063e-01,1.274e-02
LDHA,6535,protein binding,GO:0005515,molecular function,36.0,347.0,1.372e-02,7.635e-03,2.467e-02,1.265e-02,5.416e-03,2.953e-02,9.051e-01,1.331e-02
LDHA,6535,cadherin binding,GO:0045296,molecular function,36.0,13.0,1.715e-02,1.245e-02,2.362e-02,1.172e-02,4.868e-03,2.821e-02,9.094e-01,1.527e-02
LDLR,6547,cholesterol import,GO:0070508,biological process,30.0,3.0,1.460e-01,2.167e-02,9.832e-01,2.766e-02,5.753e-03,1.329e-01,8.324e-01,3.769e-02
LDLR,6547,intestinal cholesterol absorption,GO:0030299,biological process,30.0,3.0,1.460e-01,2.167e-02,9.832e-01,3.539e-02,9.710e-03,1.290e-01,8.092e-01,3.353e-02
LDLR,6547,cholesterol transport,GO:0030301,biological process,30.0,8.0,1.460e-01,2.167e-02,9.832e-01,5.172e-02,1.711e-02,1.564e-01,7.673e-01,3.183e-02
LDLR,6547,response to caloric restriction,GO:0061771,biological process,30.0,4.0,1.519e-01,2.184e-02,1.056e+00,7.402e-02,1.997e-02,2.744e-01,7.216e-01,4.175e-02
LDLR,6547,cholesterol homeostasis,GO:0042632,biological process,30.0,3.0,1.597e-01,2.361e-02,1.080e+00,8.485e-02,2.644e-02,2.723e-01,7.051e-01,3.778e-02
LDLR,6547,cellular response to low-density lipoprotein particle stimulus,GO:0071404,biological process,30.0,3.0,1.660e-01,2.173e-02,1.267e+00,9.942e-02,5.878e-03,1.681e+00,6.499e-01,1.088e-01
LDLR,6547,long-term memory,GO:0007616,biological process,30.0,2.0,1.830e-01,3.262e-02,1.026e+00,1.022e-01,8.876e-03,1.176e+00,6.581e-01,8.894e-02
LDLR,6547,receptor-mediated endocytosis involved in cholesterol transport,GO:0090118,biological process,30.0,3.0,1.931e-01,1.973e-02,1.891e+00,1.545e-01,1.072e-02,2.228e+00,5.681e-01,1.286e-01
LDLR,6547,low-density lipoprotein particle clearance,GO:0034383,biological process,30.0,2.0,2.173e-01,4.904e-02,9.626e-01,1.259e-01,2.482e-02,6.384e-01,6.429e-01,5.594e-02
LDLR,6547,regulation of protein metabolic process,GO:0051246,biological process,30.0,22.0,3.085e-01,7.609e-02,1.251e+00,2.874e-01,7.552e-02,1.093e+00,4.900e-01,6.456e-02
LDLR,6547,late endosome,GO:0005770,cellular component,30.0,4.0,1.460e-01,2.167e-02,9.832e-01,3.243e-02,4.559e-03,2.307e-01,8.132e-01,5.106e-02
LDLR,6547,PCSK9-LDLR complex,GO:1990666,cellular component,30.0,2.0,1.460e-01,2.167e-02,9.832e-01,4.398e-02,8.381e-03,2.308e-01,7.833e-01,4.455e-02
LDLR,6547,receptor complex,GO:0043235,cellular component,30.0,29.0,1.507e-01,2.155e-02,1.053e+00,5.148e-02,7.173e-03,3.695e-01,7.615e-01,5.595e-02
LDLR,6547,early endosome,GO:0005769,cellular component,30.0,7.0,1.541e-01,1.916e-02,1.239e+00,6.621e-02,9.952e-03,4.405e-01,7.290e-01,6.140e-02
LDLR,6547,cell surface,GO:0009986,cellular component,30.0,11.0,1.796e-01,2.402e-02,1.342e+00,1.327e-01,1.340e-02,1.315e+00,6.189e-01,8.830e-02
LDLR,6547,external side of plasma membrane,GO:0009897,cellular component,30.0,8.0,1.796e-01,2.402e-02,1.342e+00,1.275e-01,8.714e-03,1.866e+00,6.146e-01,1.045e-01
LDLR,6547,Golgi apparatus,GO:0005794,cellular component,30.0,16.0,1.819e-01,2.633e-02,1.257e+00,1.240e-01,2.476e-02,6.210e-01,6.437e-01,6.124e-02
LDLR,6547,lysosome,GO:0005764,cellular component,30.0,13.0,1.866e-01,2.491e-02,1.398e+00,1.177e-01,4.788e-03,2.891e+00,6.184e-01,1.151e-01
LDLR,6547,membrane,GO:0016020,cellular component,30.0,58.0,2.072e-01,4.248e-02,1.011e+00,1.573e-01,4.390e-02,5.639e-01,6.096e-01,5.426e-02
LDLR,6547,clathrin-coated pit,GO:0005905,cellular component,30.0,2.0,2.452e-01,4.006e-02,1.501e+00,2.259e-01,3.243e-02,1.574e+00,5.227e-01,9.557e-02
LDLR,6547,low-density lipoprotein particle binding,GO:0030169,molecular function,30.0,2.0,1.460e-01,2.167e-02,9.832e-01,4.647e-02,1.709e-02,1.264e-01,7.802e-01,2.759e-02
LDLR,6547,low-density lipoprotein particle receptor activity,GO:0005041,molecular function,30.0,2.0,1.541e-01,1.916e-02,1.239e+00,7.363e-02,3.210e-03,1.689e+00,6.853e-01,1.182e-01
LDLR,6547,very-low-density lipoprotein particle receptor activity,GO:0030229,molecular function,30.0,2.0,1.541e-01,1.916e-02,1.239e+00,7.254e-02,2.841e-03,1.852e+00,6.837e-01,1.232e-01
LDLR,6547,identical protein binding,GO:0042802,molecular function,30.0,35.0,1.579e-01,2.003e-02,1.244e+00,8.530e-02,1.135e-02,6.411e-01,6.925e-01,7.126e-02
LDLR,6547,protein binding,GO:0005515,molecular function,30.0,347.0,1.819e-01,2.633e-02,1.257e+00,1.401e-01,2.198e-02,8.934e-01,6.184e-01,7.536e-02
LDLR,6547,protease binding,GO:0002020,molecular function,30.0,6.0,1.866e-01,2.491e-02,1.398e+00,1.162e-01,8.975e-03,1.504e+00,6.391e-01,8.650e-02
LEO1,30401,positive regulation of transcription elongation from RNA polymerase II promoter,GO:0032968,biological process,16.0,4.0,4.177e-01,2.563e-01,6.810e-01,1.163e-01,4.222e-02,3.206e-01,6.616e-01,3.806e-02
LEO1,30401,mRNA polyadenylation,GO:0006378,biological process,16.0,4.0,4.177e-01,2.563e-01,6.810e-01,1.430e-01,4.252e-02,4.811e-01,6.265e-01,5.029e-02
LEO1,30401,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,16.0,62.0,4.177e-01,2.563e-01,6.810e-01,1.567e-01,1.259e-01,1.950e-01,6.198e-01,8.521e-03
LEO1,30401,stem cell population maintenance,GO:0019827,biological process,16.0,7.0,4.177e-01,2.563e-01,6.810e-01,2.774e-01,1.949e-01,3.949e-01,5.134e-01,1.811e-02
LEO1,30401,histone monoubiquitination,GO:0010390,biological process,16.0,4.0,4.195e-01,2.543e-01,6.917e-01,3.036e-01,1.267e-01,7.277e-01,4.871e-01,4.516e-02
LEO1,30401,histone H2B ubiquitination,GO:0033523,biological process,16.0,3.0,4.195e-01,2.543e-01,6.917e-01,3.152e-01,1.213e-01,8.193e-01,4.765e-01,5.061e-02
LEO1,30401,positive regulation of mRNA 3'-end processing,GO:0031442,biological process,16.0,4.0,5.097e-01,3.673e-01,7.072e-01,3.675e-01,1.839e-01,7.344e-01,4.421e-01,4.516e-02
LEO1,30401,negative regulation of myeloid cell differentiation,GO:0045638,biological process,16.0,8.0,5.259e-01,3.809e-01,7.260e-01,4.900e-01,3.159e-01,7.600e-01,3.648e-01,3.531e-02
LEO1,30401,centrosome,GO:0005813,cellular component,16.0,9.0,4.177e-01,2.563e-01,6.810e-01,1.558e-01,1.107e-01,2.191e-01,6.204e-01,1.346e-02
LEO1,30401,nucleus,GO:0005634,cellular component,16.0,81.0,4.177e-01,2.563e-01,6.810e-01,2.123e-01,1.363e-01,3.307e-01,5.660e-01,2.031e-02
LEO1,30401,nucleoplasm,GO:0005654,cellular component,16.0,51.0,4.177e-01,2.563e-01,6.810e-01,2.448e-01,1.258e-01,4.763e-01,5.366e-01,3.169e-02
LEO1,30401,fibrillar center,GO:0001650,cellular component,16.0,6.0,4.195e-01,2.543e-01,6.917e-01,2.438e-01,5.434e-02,1.093e+00,5.230e-01,6.883e-02
LEO1,30401,Cdc73/Paf1 complex,GO:0016593,cellular component,16.0,2.0,5.574e-01,5.074e-01,6.123e-01,5.447e-01,4.752e-01,6.245e-01,3.344e-01,1.146e-02
LEO1,30401,RNA polymerase II C-terminal domain phosphoserine binding,GO:1990269,molecular function,16.0,3.0,4.177e-01,2.563e-01,6.810e-01,2.395e-01,2.145e-01,2.675e-01,5.442e-01,5.165e-03
LEO1,30401,protein binding,GO:0005515,molecular function,16.0,347.0,4.359e-01,3.023e-01,6.285e-01,3.116e-01,2.500e-01,3.883e-01,4.887e-01,1.209e-02
LEP,6553,tyrosine phosphorylation of STAT protein,GO:0007260,biological process,57.0,2.0,7.195e-02,4.612e-02,1.122e-01,6.291e-03,3.308e-03,1.196e-02,9.439e-01,5.760e-03
LEP,6553,positive regulation of MAPK cascade,GO:0043410,biological process,57.0,13.0,7.195e-02,4.612e-02,1.122e-01,9.359e-03,3.646e-03,2.403e-02,9.231e-01,1.305e-02
LEP,6553,positive regulation of phosphatidylinositol 3-kinase signaling,GO:0014068,biological process,57.0,5.0,7.195e-02,4.612e-02,1.122e-01,1.024e-02,6.651e-03,1.577e-02,9.209e-01,5.742e-03
LEP,6553,positive regulation of receptor signaling pathway via JAK-STAT,GO:0046427,biological process,57.0,5.0,7.195e-02,4.612e-02,1.122e-01,1.541e-02,6.321e-03,3.756e-02,8.894e-01,1.879e-02
LEP,6553,prostaglandin secretion,GO:0032310,biological process,57.0,5.0,7.195e-02,4.612e-02,1.122e-01,2.154e-02,7.025e-03,6.602e-02,8.601e-01,2.642e-02
LEP,6553,activation of protein kinase C activity,GO:1990051,biological process,57.0,2.0,7.252e-02,4.763e-02,1.104e-01,2.016e-02,6.043e-03,6.728e-02,8.631e-01,2.455e-02
LEP,6553,regulation of endothelial cell proliferation,GO:0001936,biological process,57.0,6.0,7.311e-02,4.476e-02,1.194e-01,1.033e-02,2.691e-03,3.966e-02,9.137e-01,1.888e-02
LEP,6553,positive regulation of p38MAPK cascade,GO:1900745,biological process,57.0,4.0,7.479e-02,4.280e-02,1.307e-01,2.264e-02,1.289e-02,3.977e-02,8.571e-01,1.369e-02
LEP,6553,negative regulation of autophagy,GO:0010507,biological process,57.0,8.0,7.956e-02,4.583e-02,1.381e-01,3.896e-02,2.244e-02,6.765e-02,8.009e-01,1.439e-02
LEP,6553,regulation of natural killer cell proliferation,GO:0032817,biological process,57.0,6.0,7.980e-02,3.728e-02,1.708e-01,3.484e-02,1.081e-02,1.123e-01,8.118e-01,2.934e-02
LEP,6553,positive regulation of TOR signaling,GO:0032008,biological process,57.0,5.0,8.017e-02,3.690e-02,1.742e-01,2.718e-02,6.596e-03,1.120e-01,8.364e-01,3.569e-02
LEP,6553,regulation of angiogenesis,GO:0045765,biological process,57.0,8.0,8.435e-02,4.294e-02,1.657e-01,4.215e-02,1.529e-02,1.162e-01,7.916e-01,2.604e-02
LEP,6553,interleukin-8 secretion,GO:0072606,biological process,57.0,2.0,8.639e-02,5.691e-02,1.312e-01,4.982e-02,2.246e-02,1.105e-01,7.732e-01,2.212e-02
LEP,6553,interleukin-6 secretion,GO:0072604,biological process,57.0,2.0,8.697e-02,5.648e-02,1.339e-01,5.225e-02,2.654e-02,1.029e-01,7.683e-01,1.905e-02
LEP,6553,regulation of cell cycle,GO:0051726,biological process,57.0,9.0,8.755e-02,5.213e-02,1.470e-01,5.159e-02,4.350e-02,6.118e-02,7.709e-01,4.678e-03
LEP,6553,response to insulin,GO:0032868,biological process,57.0,3.0,8.836e-02,3.096e-02,2.522e-01,4.950e-02,1.561e-02,1.570e-01,7.721e-01,3.261e-02
LEP,6553,regulation of cytokine production involved in inflammatory response,GO:1900015,biological process,57.0,5.0,8.955e-02,2.870e-02,2.794e-01,4.298e-02,6.092e-03,3.032e-01,7.819e-01,5.579e-02
LEP,6553,positive regulation of T cell proliferation,GO:0042102,biological process,57.0,10.0,8.955e-02,2.870e-02,2.794e-01,4.514e-02,5.999e-03,3.396e-01,7.757e-01,5.806e-02
LEP,6553,cellular response to leptin stimulus,GO:0044320,biological process,57.0,3.0,9.027e-02,2.946e-02,2.765e-01,4.953e-02,7.941e-03,3.089e-01,7.660e-01,5.415e-02
LEP,6553,negative regulation of appetite by leptin-mediated signaling pathway,GO:0038108,biological process,57.0,3.0,9.314e-02,2.620e-02,3.311e-01,2.692e-02,1.127e-03,6.427e-01,8.138e-01,8.522e-02
LEP,6553,regulation of nitric-oxide synthase activity,GO:0050999,biological process,57.0,5.0,9.317e-02,3.652e-02,2.377e-01,4.201e-02,6.330e-03,2.788e-01,7.866e-01,4.942e-02
LEP,6553,regulation of natural killer cell activation,GO:0032814,biological process,57.0,7.0,9.526e-02,3.246e-02,2.795e-01,6.372e-02,1.341e-02,3.026e-01,7.385e-01,4.722e-02
LEP,6553,intestinal absorption,GO:0050892,biological process,57.0,6.0,9.834e-02,3.390e-02,2.853e-01,6.609e-02,1.496e-02,2.920e-01,7.350e-01,4.400e-02
LEP,6553,negative regulation of glucose import,GO:0046325,biological process,57.0,3.0,1.085e-01,4.845e-02,2.431e-01,8.467e-02,4.206e-02,1.704e-01,7.085e-01,2.282e-02
LEP,6553,regulation of natural killer cell mediated cytotoxicity,GO:0042269,biological process,57.0,7.0,1.139e-01,2.928e-02,4.428e-01,9.215e-02,1.563e-02,5.432e-01,6.871e-01,5.846e-02
LEP,6553,angiogenesis,GO:0001525,biological process,57.0,9.0,1.148e-01,5.164e-02,2.552e-01,9.066e-02,4.262e-02,1.928e-01,6.991e-01,2.380e-02
LEP,6553,positive regulation of developmental growth,GO:0048639,biological process,57.0,23.0,1.223e-01,3.539e-02,4.224e-01,6.085e-02,5.482e-03,6.754e-01,7.312e-01,7.950e-02
LEP,6553,energy reserve metabolic process,GO:0006112,biological process,57.0,3.0,1.494e-01,6.078e-02,3.671e-01,1.388e-01,5.242e-02,3.676e-01,6.344e-01,3.892e-02
LEP,6553,sexual reproduction,GO:0019953,biological process,57.0,5.0,1.661e-01,8.646e-02,3.191e-01,1.525e-01,7.564e-02,3.073e-01,6.220e-01,2.703e-02
LEP,6553,lipid metabolic process,GO:0006629,biological process,57.0,13.0,1.746e-01,3.784e-02,8.059e-01,1.623e-01,3.071e-02,8.576e-01,5.950e-01,7.615e-02
LEP,6553,placenta development,GO:0001890,biological process,57.0,3.0,2.076e-01,1.071e-01,4.025e-01,1.902e-01,8.284e-02,4.366e-01,5.823e-01,3.713e-02
LEP,6553,extracellular space,GO:0005615,cellular component,57.0,43.0,8.836e-02,3.096e-02,2.522e-01,4.207e-02,9.976e-03,1.774e-01,7.888e-01,3.978e-02
LEP,6553,hormone activity,GO:0005179,molecular function,57.0,17.0,8.364e-02,6.470e-02,1.081e-01,3.689e-02,1.207e-02,1.128e-01,8.053e-01,2.928e-02
LEP,6553,peptide hormone receptor binding,GO:0051428,molecular function,57.0,6.0,1.083e-01,6.246e-02,1.880e-01,7.044e-02,3.164e-02,1.568e-01,7.321e-01,2.405e-02
LETM1,6556,,,,nan,nan,,,,,,,,
LGALS1,6561,positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043123,biological process,22.0,6.0,9.953e-02,6.889e-02,1.438e-01,5.330e-02,3.238e-02,8.775e-02,7.667e-01,1.348e-02
LGALS1,6561,positive regulation of viral entry into host cell,GO:0046598,biological process,22.0,4.0,1.001e-01,6.997e-02,1.433e-01,6.138e-02,1.745e-02,2.158e-01,7.467e-01,3.459e-02
LGALS1,6561,collagen-containing extracellular matrix,GO:0062023,cellular component,22.0,36.0,5.994e-02,1.399e-02,2.568e-01,1.948e-02,2.099e-03,1.808e-01,8.575e-01,4.790e-02
LGALS1,6561,extracellular space,GO:0005615,cellular component,22.0,43.0,5.994e-02,1.399e-02,2.568e-01,2.030e-02,1.514e-03,2.722e-01,8.497e-01,6.120e-02
LGALS1,6561,extracellular exosome,GO:0070062,cellular component,22.0,77.0,7.269e-02,2.755e-02,1.918e-01,3.471e-02,7.212e-03,1.671e-01,8.095e-01,4.196e-02
LGALS1,6561,extracellular region,GO:0005576,cellular component,22.0,17.0,7.996e-02,3.008e-02,2.126e-01,5.126e-02,9.060e-03,2.901e-01,7.641e-01,4.901e-02
LGALS1,6561,intracellular,GO:0005622,cellular component,22.0,8.0,9.953e-02,6.889e-02,1.438e-01,9.192e-02,6.770e-02,1.248e-01,6.992e-01,1.010e-02
LGALS1,6561,laminin binding,GO:0043236,molecular function,22.0,6.0,5.043e-02,1.062e-02,2.395e-01,4.585e-03,9.653e-04,2.178e-02,9.510e-01,1.100e-02
LGALS1,6561,protein binding,GO:0005515,molecular function,22.0,347.0,9.953e-02,6.889e-02,1.438e-01,6.945e-02,2.774e-02,1.739e-01,7.327e-01,2.857e-02
LGALS1,6561,RNA binding,GO:0003723,molecular function,22.0,60.0,9.953e-02,6.889e-02,1.438e-01,8.058e-02,7.380e-02,8.799e-02,7.170e-01,2.660e-03
LGALS1,6561,carbohydrate binding,GO:0030246,molecular function,22.0,6.0,9.953e-02,6.889e-02,1.438e-01,8.998e-02,5.681e-02,1.425e-01,7.014e-01,1.531e-02
LGALSL,25012,cytoplasm,GO:0005737,cellular component,4.0,78.0,1.645e-01,8.523e-02,3.173e-01,1.248e-01,9.124e-02,1.708e-01,6.551e-01,1.151e-02
LGALSL,25012,intracellular,GO:0005622,cellular component,4.0,8.0,1.734e-01,7.727e-02,3.892e-01,1.734e-01,7.727e-02,3.892e-01,5.993e-01,3.344e-02
LGALSL,25012,protein binding,GO:0005515,molecular function,4.0,347.0,1.645e-01,8.523e-02,3.173e-01,1.135e-01,9.451e-02,1.364e-01,6.695e-01,6.552e-03
LGR4,13299,adenylate cyclase-activating G protein-coupled receptor signaling pathway,GO:0007189,biological process,15.0,8.0,6.540e-02,3.378e-02,1.266e-01,1.792e-02,7.506e-03,4.276e-02,8.766e-01,1.795e-02
LGR4,13299,positive regulation of canonical Wnt signaling pathway,GO:0090263,biological process,15.0,8.0,6.983e-02,3.310e-02,1.473e-01,3.829e-02,1.949e-02,7.522e-02,8.029e-01,1.696e-02
LGR4,13299,hormone-mediated signaling pathway,GO:0009755,biological process,15.0,15.0,7.209e-02,3.278e-02,1.586e-01,3.979e-02,1.227e-02,1.291e-01,7.965e-01,3.148e-02
LGR4,13299,activation of adenylate cyclase activity,GO:0007190,biological process,15.0,2.0,8.922e-02,5.859e-02,1.359e-01,4.055e-02,3.986e-03,4.126e-01,7.854e-01,5.618e-02
LGR4,13299,integral component of plasma membrane,GO:0005887,cellular component,15.0,28.0,6.665e-02,3.274e-02,1.357e-01,1.994e-02,3.449e-03,1.153e-01,8.599e-01,3.607e-02
LGR4,13299,transmembrane signaling receptor activity,GO:0004888,molecular function,15.0,39.0,7.354e-02,3.075e-02,1.759e-01,4.988e-02,2.072e-02,1.201e-01,7.728e-01,2.438e-02
LGR4,13299,protein binding,GO:0005515,molecular function,15.0,347.0,7.937e-02,2.901e-02,2.171e-01,6.285e-02,1.902e-02,2.076e-01,7.437e-01,3.420e-02
LGR4,13299,G protein-coupled peptide receptor activity,GO:0008528,molecular function,15.0,28.0,1.758e-01,2.668e-02,1.158e+00,1.724e-01,2.522e-02,1.178e+00,5.746e-01,9.495e-02
LOX,6664,peptidyl-lysine oxidation,GO:0018057,biological process,8.0,3.0,4.660e-02,1.722e-02,1.261e-01,1.938e-02,2.176e-03,1.727e-01,8.555e-01,3.981e-02
LOX,6664,extracellular space,GO:0005615,cellular component,8.0,43.0,4.860e-02,2.067e-02,1.143e-01,1.829e-02,1.348e-02,2.483e-02,8.783e-01,7.117e-03
LOX,6664,collagen binding,GO:0005518,molecular function,8.0,7.0,4.860e-02,2.067e-02,1.143e-01,2.230e-02,1.351e-02,3.681e-02,8.588e-01,1.213e-02
LOX,6664,protein-lysine 6-oxidase activity,GO:0004720,molecular function,8.0,3.0,6.204e-02,3.745e-02,1.028e-01,5.346e-02,3.825e-02,7.472e-02,7.667e-01,9.270e-03
LOX,6664,protein binding,GO:0005515,molecular function,8.0,347.0,7.744e-02,2.455e-02,2.442e-01,7.188e-02,1.789e-02,2.888e-01,7.253e-01,4.072e-02
LPCAT3,30244,membrane,GO:0016020,cellular component,12.0,58.0,3.477e-02,1.406e-02,8.596e-02,2.943e-02,7.283e-03,1.189e-01,8.276e-01,3.376e-02
LPCAT3,30244,1-acylglycerophosphocholine O-acyltransferase activity,GO:0047184,molecular function,12.0,2.0,1.874e-02,9.167e-03,3.832e-02,1.181e-02,3.270e-03,4.263e-02,9.052e-01,2.110e-02
LPGAT1,28985,positive regulation of fatty acid biosynthetic process,GO:0045723,biological process,13.0,9.0,1.819e-01,1.076e-01,3.076e-01,5.856e-02,1.169e-02,2.934e-01,7.491e-01,4.601e-02
LPGAT1,28985,phosphatidylinositol acyl-chain remodeling,GO:0036149,biological process,13.0,2.0,1.975e-01,1.106e-01,3.527e-01,1.256e-01,3.869e-02,4.078e-01,6.488e-01,4.100e-02
LPGAT1,28985,endoplasmic reticulum,GO:0005783,cellular component,13.0,34.0,1.975e-01,1.106e-01,3.527e-01,1.140e-01,2.445e-02,5.319e-01,6.597e-01,5.074e-02
LPGAT1,28985,membrane,GO:0016020,cellular component,13.0,58.0,1.975e-01,1.106e-01,3.527e-01,1.201e-01,3.577e-02,4.035e-01,6.551e-01,4.164e-02
LPGAT1,28985,cytoplasm,GO:0005737,cellular component,13.0,78.0,1.975e-01,1.106e-01,3.527e-01,1.496e-01,5.207e-02,4.301e-01,6.223e-01,3.891e-02
LPGAT1,28985,endomembrane system,GO:0012505,cellular component,13.0,4.0,1.988e-01,1.138e-01,3.472e-01,1.846e-01,1.099e-01,3.101e-01,5.907e-01,2.200e-02
LPGAT1,28985,"transferase activity, transferring acyl groups",GO:0016746,molecular function,13.0,5.0,1.988e-01,1.138e-01,3.472e-01,1.621e-01,9.288e-02,2.828e-01,6.125e-01,2.287e-02
LRP11,16936,,,,nan,nan,,,,,,,,
LRPAP1,6701,regulation of receptor-mediated endocytosis,GO:0048259,biological process,25.0,8.0,8.668e-02,4.309e-02,1.744e-01,3.556e-02,1.124e-02,1.125e-01,8.094e-01,2.948e-02
LRPAP1,6701,negative regulation of receptor internalization,GO:0002091,biological process,25.0,6.0,9.706e-02,4.712e-02,1.999e-01,4.618e-02,7.007e-03,3.044e-01,7.759e-01,5.058e-02
LRPAP1,6701,negative regulation of protein binding,GO:0032091,biological process,25.0,13.0,1.025e-01,5.976e-02,1.758e-01,5.222e-02,2.588e-02,1.054e-01,7.683e-01,1.986e-02
LRPAP1,6701,negative regulation of cell death,GO:0060548,biological process,25.0,8.0,1.133e-01,3.708e-02,3.464e-01,6.896e-02,1.013e-02,4.692e-01,7.260e-01,5.580e-02
LRPAP1,6701,amyloid-beta clearance by transcytosis,GO:0150093,biological process,25.0,3.0,1.258e-01,5.149e-02,3.072e-01,7.270e-02,1.246e-02,4.242e-01,7.185e-01,5.792e-02
LRPAP1,6701,negative regulation of amyloid-beta clearance,GO:1900222,biological process,25.0,3.0,1.302e-01,3.060e-02,5.537e-01,5.479e-02,3.182e-03,9.436e-01,7.377e-01,9.292e-02
LRPAP1,6701,negative regulation of very-low-density lipoprotein particle clearance,GO:0010916,biological process,25.0,3.0,1.336e-01,5.994e-02,2.977e-01,1.003e-01,2.798e-02,3.594e-01,6.804e-01,4.616e-02
LRPAP1,6701,rough endoplasmic reticulum lumen,GO:0048237,cellular component,25.0,2.0,7.445e-02,3.030e-02,1.829e-01,2.317e-02,6.285e-03,8.546e-02,8.509e-01,2.932e-02
LRPAP1,6701,cis-Golgi network,GO:0005801,cellular component,25.0,2.0,7.861e-02,3.320e-02,1.861e-01,1.846e-02,4.759e-03,7.162e-02,8.717e-01,2.979e-02
LRPAP1,6701,endoplasmic reticulum-Golgi intermediate compartment,GO:0005793,cellular component,25.0,3.0,1.067e-01,5.465e-02,2.083e-01,5.585e-02,2.198e-02,1.419e-01,7.596e-01,2.573e-02
LRPAP1,6701,endosome,GO:0005768,cellular component,25.0,15.0,1.348e-01,6.560e-02,2.770e-01,1.067e-01,3.853e-02,2.955e-01,6.742e-01,3.691e-02
LRPAP1,6701,plasma membrane,GO:0005886,cellular component,25.0,61.0,1.476e-01,8.598e-02,2.534e-01,1.153e-01,7.980e-02,1.666e-01,6.669e-01,1.323e-02
LRPAP1,6701,endoplasmic reticulum,GO:0005783,cellular component,25.0,34.0,1.528e-01,8.679e-02,2.689e-01,1.370e-01,7.609e-02,2.467e-01,6.398e-01,2.249e-02
LRPAP1,6701,Golgi apparatus,GO:0005794,cellular component,25.0,16.0,1.619e-01,9.057e-02,2.894e-01,1.304e-01,5.978e-02,2.845e-01,6.464e-01,2.787e-02
LRPAP1,6701,low-density lipoprotein particle receptor binding,GO:0050750,molecular function,25.0,2.0,7.445e-02,3.030e-02,1.829e-01,1.722e-02,3.794e-03,7.817e-02,8.758e-01,3.191e-02
LRPAP1,6701,very-low-density lipoprotein particle receptor binding,GO:0070326,molecular function,25.0,2.0,7.445e-02,3.030e-02,1.829e-01,1.820e-02,3.916e-03,8.461e-02,8.712e-01,3.356e-02
LRPAP1,6701,receptor antagonist activity,GO:0048019,molecular function,25.0,7.0,1.034e-01,3.195e-02,3.348e-01,5.701e-02,7.985e-03,4.070e-01,7.469e-01,6.161e-02
LRPAP1,6701,protein binding,GO:0005515,molecular function,25.0,347.0,1.555e-01,9.046e-02,2.672e-01,1.305e-01,9.129e-02,1.866e-01,6.484e-01,1.295e-02
LRRC59,28817,mitochondrial nucleoid,GO:0042645,cellular component,10.0,4.0,3.894e-02,2.875e-02,5.275e-02,2.726e-02,1.732e-02,4.290e-02,8.385e-01,1.109e-02
LRRC59,28817,endoplasmic reticulum,GO:0005783,cellular component,10.0,34.0,3.894e-02,2.875e-02,5.275e-02,2.927e-02,1.366e-02,6.273e-02,8.311e-01,1.860e-02
LRRC59,28817,membrane,GO:0016020,cellular component,10.0,58.0,3.906e-02,2.854e-02,5.347e-02,3.326e-02,1.778e-02,6.223e-02,8.177e-01,1.564e-02
LRRC59,28817,cadherin binding,GO:0045296,molecular function,10.0,13.0,3.785e-02,2.622e-02,5.463e-02,1.025e-02,4.684e-03,2.241e-02,9.191e-01,9.961e-03
LRRC59,28817,RNA binding,GO:0003723,molecular function,10.0,60.0,3.894e-02,2.875e-02,5.275e-02,3.022e-02,1.934e-02,4.721e-02,8.279e-01,1.101e-02
LRRN4CL,33724,,,,nan,nan,,,,,,,,
LSS,6708,cholesterol biosynthetic process,GO:0006695,biological process,10.0,11.0,1.635e-01,4.136e-02,6.463e-01,2.725e-02,6.894e-03,1.077e-01,8.365e-01,3.482e-02
LSS,6708,steroid biosynthetic process,GO:0006694,biological process,10.0,13.0,2.585e-01,9.548e-02,7.001e-01,1.543e-01,1.022e-01,2.331e-01,6.217e-01,1.566e-02
LSS,6708,regulation of protein stability,GO:0031647,biological process,10.0,5.0,2.690e-01,7.026e-02,1.030e+00,1.911e-01,2.000e-02,1.827e+00,5.529e-01,9.452e-02
LSS,6708,lipid droplet,GO:0005811,cellular component,10.0,10.0,2.474e-01,7.885e-02,7.762e-01,1.226e-01,3.152e-02,4.769e-01,6.495e-01,5.085e-02
LSS,6708,membrane,GO:0016020,cellular component,10.0,58.0,2.646e-01,1.056e-01,6.633e-01,1.958e-01,1.271e-01,3.017e-01,5.808e-01,1.852e-02
LSS,6708,lanosterol synthase activity,GO:0000250,molecular function,10.0,2.0,2.701e-01,7.147e-02,1.021e+00,2.352e-01,4.039e-02,1.369e+00,5.237e-01,8.028e-02
LURAP1L,31452,,,,nan,nan,,,,,,,,
LVRN,26904,,,,nan,nan,,,,,,,,
LYNX1,29604,,,,nan,nan,,,,,,,,
LYPLA1,6737,protein depalmitoylation,GO:0002084,biological process,8.0,4.0,4.666e-02,2.232e-02,9.756e-02,2.470e-02,5.114e-03,1.193e-01,8.437e-01,3.757e-02
LYPLA1,6737,extracellular exosome,GO:0070062,cellular component,8.0,77.0,8.210e-02,5.726e-02,1.177e-01,5.468e-02,2.422e-02,1.235e-01,7.625e-01,2.261e-02
LYPLA1,6737,cytoplasm,GO:0005737,cellular component,8.0,78.0,8.210e-02,5.726e-02,1.177e-01,6.816e-02,4.709e-02,9.865e-02,7.378e-01,1.105e-02
LYPLA1,6737,lipase activity,GO:0016298,molecular function,8.0,7.0,4.548e-02,2.126e-02,9.733e-02,1.309e-02,3.504e-03,4.888e-02,8.977e-01,2.310e-02
LYPLA1,6737,palmitoyl-(protein) hydrolase activity,GO:0008474,molecular function,8.0,4.0,4.548e-02,2.126e-02,9.733e-02,1.828e-02,8.758e-03,3.814e-02,8.765e-01,1.659e-02
LYPLA1,6737,carboxylic ester hydrolase activity,GO:0052689,molecular function,8.0,116.0,1.124e-01,4.128e-02,3.060e-01,1.124e-01,4.128e-02,3.060e-01,6.668e-01,3.667e-02
LYVE1,14687,,,,nan,nan,,,,,,,,
MAP3K6,6858,cellular response to stress,GO:0033554,biological process,8.0,38.0,6.355e-02,1.403e-02,2.879e-01,2.467e-02,1.453e-03,4.189e-01,8.286e-01,7.312e-02
MAP3K6,6858,activation of MAPKK activity,GO:0000186,biological process,8.0,7.0,6.355e-02,1.403e-02,2.879e-01,3.417e-02,6.347e-03,1.840e-01,8.106e-01,4.398e-02
MAP3K6,6858,protein phosphorylation,GO:0006468,biological process,8.0,30.0,6.509e-02,1.478e-02,2.867e-01,5.627e-02,9.703e-03,3.263e-01,7.517e-01,5.258e-02
MAP3K6,6858,MAP kinase kinase kinase activity,GO:0004709,molecular function,8.0,3.0,6.355e-02,1.403e-02,2.879e-01,2.677e-02,4.968e-03,1.442e-01,8.364e-01,4.281e-02
MAP3K6,6858,protein kinase activity,GO:0004672,molecular function,8.0,33.0,6.394e-02,1.433e-02,2.853e-01,3.723e-02,1.284e-02,1.079e-01,8.043e-01,2.809e-02
MAP3K6,6858,magnesium ion binding,GO:0000287,molecular function,8.0,5.0,6.469e-02,1.446e-02,2.894e-01,3.782e-02,1.069e-02,1.339e-01,8.025e-01,3.238e-02
MAP3K6,6858,ATP binding,GO:0005524,molecular function,8.0,10.0,7.950e-02,2.169e-02,2.913e-01,7.254e-02,2.515e-02,2.093e-01,7.266e-01,3.127e-02
MASP1,6901,,,,nan,nan,,,,,,,,
MATN2,6908,growth plate cartilage chondrocyte morphogenesis,GO:0003429,biological process,8.0,4.0,1.748e-02,8.381e-03,3.647e-02,1.271e-02,4.407e-03,3.664e-02,9.029e-01,1.581e-02
MATN2,6908,collagen-containing extracellular matrix,GO:0062023,cellular component,8.0,36.0,1.329e-02,5.379e-03,3.283e-02,4.546e-03,2.732e-03,7.566e-03,9.559e-01,4.136e-03
MATN2,6908,extracellular matrix,GO:0031012,cellular component,8.0,17.0,1.329e-02,5.379e-03,3.283e-02,6.606e-03,1.836e-03,2.377e-02,9.383e-01,1.423e-02
MATN2,6908,extracellular space,GO:0005615,cellular component,8.0,43.0,2.014e-02,1.595e-02,2.543e-02,1.360e-02,1.272e-02,1.454e-02,9.034e-01,1.156e-03
MATN2,6908,protein binding,GO:0005515,molecular function,8.0,347.0,7.626e-02,3.532e-02,1.646e-01,7.626e-02,3.532e-02,1.646e-01,7.222e-01,2.300e-02
MC5R,6933,adenylate cyclase-activating G protein-coupled receptor signaling pathway,GO:0007189,biological process,3.0,8.0,2.867e-02,2.236e-02,3.677e-02,1.434e-02,1.118e-02,1.838e-02,8.992e-01,4.666e-03
MC5R,6933,protein binding,GO:0005515,molecular function,3.0,347.0,5.385e-02,3.130e-02,9.263e-02,5.385e-02,3.130e-02,9.263e-02,7.653e-01,1.493e-02
MDH1,6970,NADH metabolic process,GO:0006734,biological process,28.0,6.0,2.115e-02,1.497e-02,2.990e-02,5.082e-03,1.523e-03,1.695e-02,9.493e-01,9.857e-03
MDH1,6970,tricarboxylic acid cycle,GO:0006099,biological process,28.0,4.0,2.136e-02,1.478e-02,3.088e-02,7.883e-03,5.105e-03,1.217e-02,9.346e-01,4.586e-03
MDH1,6970,malate metabolic process,GO:0006108,biological process,28.0,3.0,2.136e-02,1.478e-02,3.088e-02,1.048e-02,2.614e-03,4.206e-02,9.129e-01,1.819e-02
MDH1,6970,oxaloacetate metabolic process,GO:0006107,biological process,28.0,6.0,2.136e-02,1.478e-02,3.088e-02,1.308e-02,5.151e-03,3.321e-02,9.017e-01,1.500e-02
MDH1,6970,extracellular exosome,GO:0070062,cellular component,28.0,77.0,2.810e-02,1.571e-02,5.026e-02,1.560e-02,4.159e-03,5.850e-02,8.851e-01,2.825e-02
MDH1,6970,extracellular space,GO:0005615,cellular component,28.0,43.0,2.810e-02,1.571e-02,5.026e-02,1.852e-02,6.361e-03,5.391e-02,8.731e-01,2.328e-02
MDH1,6970,cytosol,GO:0005829,cellular component,28.0,76.0,3.190e-02,2.219e-02,4.586e-02,2.836e-02,1.973e-02,4.076e-02,8.343e-01,8.870e-03
MDH1,6970,L-malate dehydrogenase activity,GO:0030060,molecular function,28.0,3.0,2.975e-02,1.836e-02,4.820e-02,2.258e-02,1.512e-02,3.372e-02,8.576e-01,9.790e-03
MDH1,6970,protein binding,GO:0005515,molecular function,28.0,347.0,4.848e-02,3.621e-02,6.492e-02,4.848e-02,3.621e-02,6.492e-02,7.777e-01,7.833e-03
ME1,6983,malate metabolic process,GO:0006108,biological process,25.0,3.0,2.088e-02,1.146e-02,3.806e-02,5.722e-03,2.061e-03,1.589e-02,9.462e-01,8.559e-03
ME1,6983,pyruvate metabolic process,GO:0006090,biological process,25.0,14.0,2.149e-02,1.001e-02,4.615e-02,9.634e-03,2.263e-03,4.102e-02,9.181e-01,1.700e-02
ME1,6983,regulation of NADP metabolic process,GO:1902031,biological process,25.0,3.0,5.995e-02,5.740e-03,6.260e-01,5.359e-02,3.518e-03,8.162e-01,7.476e-01,7.057e-02
ME1,6983,mitochondrion,GO:0005739,cellular component,25.0,35.0,2.250e-02,1.543e-02,3.281e-02,1.277e-02,5.360e-03,3.041e-02,9.041e-01,1.403e-02
ME1,6983,manganese ion binding,GO:0030145,molecular function,25.0,3.0,2.336e-02,1.376e-02,3.964e-02,1.559e-02,1.161e-02,2.091e-02,8.924e-01,5.757e-03
ME1,6983,malic enzyme activity,GO:0004470,molecular function,25.0,4.0,2.512e-02,9.729e-03,6.486e-02,1.755e-02,4.924e-03,6.254e-02,8.746e-01,2.407e-02
ME1,6983,malate dehydrogenase (decarboxylating) (NADP+) activity,GO:0004473,molecular function,25.0,3.0,2.881e-02,5.316e-03,1.561e-01,1.258e-02,6.976e-04,2.270e-01,8.800e-01,5.580e-02
MEGF9,3234,,,,nan,nan,,,,,,,,
MET,7029,positive regulation of endothelial cell chemotaxis,GO:2001028,biological process,39.0,7.0,1.616e-01,1.156e-01,2.259e-01,2.549e-02,1.213e-02,5.359e-02,8.449e-01,1.782e-02
MET,7029,transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007169,biological process,39.0,24.0,1.653e-01,1.253e-01,2.180e-01,4.108e-02,1.391e-02,1.213e-01,7.943e-01,2.765e-02
MET,7029,negative regulation of Rho protein signal transduction,GO:0035024,biological process,39.0,3.0,1.836e-01,1.092e-01,3.087e-01,6.714e-02,1.462e-02,3.084e-01,7.332e-01,4.281e-02
MET,7029,positive regulation of protein kinase B signaling,GO:0051897,biological process,39.0,8.0,1.846e-01,1.082e-01,3.149e-01,6.792e-02,1.031e-02,4.473e-01,7.282e-01,5.459e-02
MET,7029,positive regulation of kinase activity,GO:0033674,biological process,39.0,15.0,1.846e-01,1.082e-01,3.149e-01,8.569e-02,3.012e-02,2.438e-01,7.045e-01,3.420e-02
MET,7029,negative regulation of thrombin-activated receptor signaling pathway,GO:0070495,biological process,39.0,3.0,1.938e-01,1.085e-01,3.462e-01,8.666e-02,1.874e-02,4.008e-01,6.990e-01,4.747e-02
MET,7029,negative regulation of hydrogen peroxide-mediated programmed cell death,GO:1901299,biological process,39.0,6.0,2.074e-01,1.638e-01,2.627e-01,8.745e-02,2.502e-02,3.057e-01,6.998e-01,4.268e-02
MET,7029,semaphorin-plexin signaling pathway,GO:0071526,biological process,39.0,6.0,2.078e-01,1.421e-01,3.041e-01,7.109e-02,9.851e-03,5.131e-01,7.178e-01,6.681e-02
MET,7029,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,39.0,62.0,2.212e-01,1.328e-01,3.687e-01,1.390e-01,5.382e-02,3.588e-01,6.351e-01,3.465e-02
MET,7029,positive chemotaxis,GO:0050918,biological process,39.0,11.0,2.266e-01,1.698e-01,3.023e-01,1.316e-01,5.557e-02,3.119e-01,6.441e-01,3.329e-02
MET,7029,multicellular organism development,GO:0007275,biological process,39.0,16.0,2.311e-01,1.222e-01,4.372e-01,1.685e-01,5.580e-02,5.088e-01,6.008e-01,4.606e-02
MET,7029,negative regulation of guanyl-nucleotide exchange factor activity,GO:1905098,biological process,39.0,6.0,2.317e-01,8.773e-02,6.118e-01,5.176e-02,9.682e-04,2.767e+00,7.141e-01,1.243e-01
MET,7029,establishment of skin barrier,GO:0061436,biological process,39.0,2.0,2.328e-01,1.642e-01,3.299e-01,1.599e-01,6.113e-02,4.182e-01,6.115e-01,3.922e-02
MET,7029,endothelial cell morphogenesis,GO:0001886,biological process,39.0,3.0,2.373e-01,1.320e-01,4.265e-01,1.766e-01,5.336e-02,5.843e-01,5.923e-01,4.679e-02
MET,7029,neuron differentiation,GO:0030182,biological process,39.0,20.0,2.376e-01,1.319e-01,4.281e-01,2.003e-01,8.611e-02,4.657e-01,5.734e-01,3.501e-02
MET,7029,negative regulation of stress fiber assembly,GO:0051497,biological process,39.0,3.0,2.405e-01,2.112e-01,2.739e-01,1.724e-01,1.017e-01,2.924e-01,6.023e-01,2.201e-02
MET,7029,branching morphogenesis of an epithelial tube,GO:0048754,biological process,39.0,9.0,2.506e-01,1.265e-01,4.965e-01,2.015e-01,6.539e-02,6.209e-01,5.688e-01,4.705e-02
MET,7029,liver development,GO:0001889,biological process,39.0,3.0,2.681e-01,1.081e-01,6.653e-01,2.214e-01,6.549e-02,7.483e-01,5.476e-01,5.721e-02
MET,7029,positive regulation of microtubule polymerization,GO:0031116,biological process,39.0,6.0,2.730e-01,2.416e-01,3.085e-01,2.235e-01,1.889e-01,2.644e-01,5.576e-01,7.709e-03
MET,7029,pancreas development,GO:0031016,biological process,39.0,2.0,3.050e-01,1.015e-01,9.169e-01,2.417e-01,3.792e-02,1.540e+00,5.148e-01,8.562e-02
MET,7029,integral component of plasma membrane,GO:0005887,cellular component,39.0,28.0,1.684e-01,1.188e-01,2.388e-01,4.338e-02,2.119e-02,8.880e-02,7.893e-01,1.861e-02
MET,7029,basal plasma membrane,GO:0009925,cellular component,39.0,3.0,1.752e-01,1.163e-01,2.639e-01,6.757e-02,2.567e-02,1.779e-01,7.360e-01,2.999e-02
MET,7029,receptor complex,GO:0043235,cellular component,39.0,29.0,1.779e-01,1.538e-01,2.057e-01,5.386e-02,1.334e-02,2.175e-01,7.604e-01,4.093e-02
MET,7029,cell surface,GO:0009986,cellular component,39.0,11.0,2.102e-01,1.024e-01,4.317e-01,1.196e-01,2.584e-02,5.538e-01,6.523e-01,5.126e-02
MET,7029,hepatocyte growth factor-activated receptor activity,GO:0005008,molecular function,39.0,2.0,1.616e-01,1.156e-01,2.259e-01,1.660e-02,1.069e-02,2.575e-02,8.862e-01,8.848e-03
MET,7029,transmembrane receptor protein tyrosine kinase activity,GO:0004714,molecular function,39.0,21.0,1.687e-01,1.185e-01,2.403e-01,5.219e-02,3.331e-02,8.176e-02,7.693e-01,1.245e-02
MET,7029,identical protein binding,GO:0042802,molecular function,39.0,35.0,1.846e-01,1.082e-01,3.149e-01,9.471e-02,3.159e-02,2.839e-01,6.907e-01,3.551e-02
MET,7029,protein phosphatase binding,GO:0019903,molecular function,39.0,7.0,2.281e-01,1.540e-01,3.377e-01,1.184e-01,2.621e-02,5.349e-01,6.527e-01,5.620e-02
MET,7029,protein binding,GO:0005515,molecular function,39.0,347.0,2.328e-01,1.326e-01,4.087e-01,1.798e-01,8.309e-02,3.889e-01,5.936e-01,3.111e-02
METTL21C,33717,protein methylation,GO:0006479,biological process,7.0,12.0,3.028e-01,3.796e-02,2.415e+00,1.732e-01,5.277e-03,5.686e+00,5.350e-01,1.330e-01
METTL21C,33717,nucleus,GO:0005634,cellular component,7.0,81.0,1.773e-01,9.662e-02,3.252e-01,9.378e-02,6.079e-02,1.447e-01,6.961e-01,1.426e-02
METTL21C,33717,protein-containing complex,GO:0032991,cellular component,7.0,483.0,5.509e-01,3.548e-01,8.555e-01,5.509e-01,3.548e-01,8.555e-01,3.255e-01,3.623e-02
METTL21C,33717,heat shock protein binding,GO:0031072,molecular function,7.0,6.0,1.575e-01,5.849e-02,4.243e-01,5.174e-02,1.900e-02,1.409e-01,7.682e-01,2.714e-02
METTL21C,33717,protein binding,GO:0005515,molecular function,7.0,347.0,1.773e-01,9.662e-02,3.252e-01,9.016e-02,7.073e-02,1.149e-01,7.020e-01,8.002e-03
METTL21C,33717,protein-lysine N-methyltransferase activity,GO:0016279,molecular function,7.0,7.0,2.926e-01,1.457e-01,5.876e-01,2.101e-01,1.312e-01,3.365e-01,5.677e-01,2.105e-02
MFAP4,7035,elastic fiber assembly,GO:0048251,biological process,11.0,3.0,5.151e-02,1.817e-02,1.461e-01,7.185e-03,1.695e-03,3.045e-02,9.340e-01,1.355e-02
MFAP4,7035,UV protection,GO:0009650,biological process,11.0,2.0,6.688e-02,3.652e-02,1.225e-01,2.602e-02,5.659e-03,1.196e-01,8.384e-01,3.556e-02
MFAP4,7035,supramolecular fiber organization,GO:0097435,biological process,11.0,14.0,8.196e-02,4.178e-02,1.608e-01,6.038e-02,2.477e-02,1.472e-01,7.504e-01,2.647e-02
MFAP4,7035,cellular response to UV-B,GO:0071493,biological process,11.0,3.0,8.200e-02,4.185e-02,1.607e-01,5.987e-02,2.358e-02,1.520e-01,7.511e-01,2.741e-02
MFAP4,7035,regulation of collagen metabolic process,GO:0010712,biological process,11.0,6.0,1.304e-01,5.529e-02,3.076e-01,1.169e-01,3.985e-02,3.428e-01,6.605e-01,3.785e-02
MFAP4,7035,elastic fiber,GO:0071953,cellular component,11.0,3.0,6.594e-02,3.761e-02,1.156e-01,2.273e-02,1.125e-02,4.596e-02,8.560e-01,1.635e-02
MFAP4,7035,collagen-containing extracellular matrix,GO:0062023,cellular component,11.0,36.0,7.383e-02,5.332e-02,1.022e-01,2.707e-02,1.086e-02,6.749e-02,8.387e-01,2.255e-02
MFAP4,7035,microfibril,GO:0001527,cellular component,11.0,2.0,7.383e-02,5.332e-02,1.022e-01,3.849e-02,2.382e-02,6.218e-02,8.028e-01,1.205e-02
MFAP4,7035,extracellular region,GO:0005576,cellular component,11.0,17.0,8.636e-02,4.983e-02,1.497e-01,5.691e-02,2.123e-02,1.525e-01,7.570e-01,2.890e-02
MFAP4,7035,protein binding,GO:0005515,molecular function,11.0,347.0,1.543e-01,1.028e-01,2.317e-01,1.490e-01,8.809e-02,2.520e-01,6.270e-01,1.968e-02
MFSD8,28486,,,,nan,nan,,,,,,,,
MIGA2,23621,mitochondrial fusion,GO:0008053,biological process,7.0,4.0,4.152e-02,2.212e-02,7.797e-02,1.453e-02,9.320e-03,2.266e-02,8.972e-01,8.346e-03
MIGA2,23621,integral component of plasma membrane,GO:0005887,cellular component,7.0,28.0,4.152e-02,2.212e-02,7.797e-02,1.754e-02,7.918e-03,3.885e-02,8.791e-01,1.576e-02
MIGA2,23621,protein heterodimerization activity,GO:0046982,molecular function,7.0,8.0,4.494e-02,3.067e-02,6.583e-02,2.725e-02,1.803e-02,4.116e-02,8.385e-01,1.019e-02
MIGA2,23621,protein homodimerization activity,GO:0042803,molecular function,7.0,21.0,5.456e-02,2.697e-02,1.104e-01,4.508e-02,2.023e-02,1.005e-01,7.846e-01,2.143e-02
MIGA2,23621,protein binding,GO:0005515,molecular function,7.0,347.0,6.681e-02,5.070e-02,8.803e-02,6.681e-02,5.070e-02,8.803e-02,7.404e-01,8.248e-03
MKKS,7108,cilium assembly,GO:0060271,biological process,13.0,7.0,2.185e-01,5.698e-02,8.382e-01,1.012e-01,2.476e-02,4.134e-01,6.785e-01,4.560e-02
MKKS,7108,chaperone-mediated protein complex assembly,GO:0051131,biological process,13.0,2.0,2.261e-01,6.004e-02,8.511e-01,1.113e-01,5.940e-03,2.087e+00,6.368e-01,1.007e-01
MKKS,7108,intracellular transport,GO:0046907,biological process,13.0,33.0,3.171e-01,8.269e-02,1.216e+00,3.081e-01,8.009e-02,1.185e+00,4.677e-01,8.028e-02
MKKS,7108,developmental process,GO:0032502,biological process,13.0,25.0,3.353e-01,8.948e-02,1.256e+00,3.025e-01,6.743e-02,1.357e+00,4.725e-01,7.591e-02
MKKS,7108,kinociliary basal body,GO:1902636,cellular component,13.0,2.0,2.006e-01,4.728e-02,8.514e-01,1.839e-02,3.262e-03,1.037e-01,8.687e-01,3.890e-02
MKKS,7108,ciliary basal body,GO:0036064,cellular component,13.0,11.0,2.038e-01,4.968e-02,8.360e-01,5.320e-02,1.653e-02,1.712e-01,7.634e-01,3.409e-02
MKKS,7108,centrosome,GO:0005813,cellular component,13.0,9.0,2.038e-01,4.968e-02,8.360e-01,5.743e-02,1.557e-02,2.119e-01,7.533e-01,3.839e-02
MKKS,7108,nucleus,GO:0005634,cellular component,13.0,81.0,2.386e-01,7.641e-02,7.452e-01,1.347e-01,4.664e-02,3.892e-01,6.383e-01,4.199e-02
MKKS,7108,cytoplasm,GO:0005737,cellular component,13.0,78.0,2.386e-01,7.641e-02,7.452e-01,1.765e-01,5.597e-02,5.567e-01,5.909e-01,5.159e-02
MKKS,7108,intracellular,GO:0005622,cellular component,13.0,8.0,2.395e-01,7.732e-02,7.421e-01,1.754e-01,4.361e-02,7.058e-01,5.884e-01,6.122e-02
MKKS,7108,RNA polymerase II repressing transcription factor binding,GO:0001103,molecular function,13.0,3.0,2.260e-01,6.403e-02,7.978e-01,1.534e-01,2.732e-02,8.611e-01,6.054e-01,7.274e-02
MKKS,7108,protein binding,GO:0005515,molecular function,13.0,347.0,2.386e-01,7.641e-02,7.452e-01,1.749e-01,4.724e-02,6.475e-01,5.894e-01,5.983e-02
MLX,11645,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,21.0,62.0,3.996e-02,2.650e-02,6.024e-02,2.555e-02,1.806e-02,3.612e-02,8.451e-01,8.480e-03
MLX,11645,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,21.0,43.0,4.732e-02,2.364e-02,9.473e-02,3.877e-02,1.726e-02,8.707e-02,8.012e-01,2.057e-02
MLX,11645,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,21.0,31.0,5.001e-02,2.298e-02,1.088e-01,4.249e-02,1.124e-02,1.606e-01,7.896e-01,3.393e-02
MLX,11645,regulation of transcription by RNA polymerase II,GO:0006357,biological process,21.0,46.0,5.331e-02,3.581e-02,7.936e-02,4.872e-02,3.204e-02,7.409e-02,7.771e-01,1.139e-02
MLX,11645,nucleus,GO:0005634,cellular component,21.0,81.0,3.981e-02,2.648e-02,5.985e-02,1.862e-02,7.773e-03,4.459e-02,8.734e-01,1.864e-02
MLX,11645,nucleoplasm,GO:0005654,cellular component,21.0,51.0,3.981e-02,2.648e-02,5.985e-02,2.183e-02,9.171e-03,5.198e-02,8.604e-01,2.103e-02
MLX,11645,cytosol,GO:0005829,cellular component,21.0,76.0,3.981e-02,2.648e-02,5.985e-02,2.336e-02,1.129e-02,4.835e-02,8.537e-01,1.753e-02
MLX,11645,cytoplasm,GO:0005737,cellular component,21.0,78.0,4.192e-02,2.542e-02,6.914e-02,2.774e-02,1.129e-02,6.817e-02,8.363e-01,2.195e-02
MLX,11645,nuclear membrane,GO:0031965,cellular component,21.0,6.0,5.564e-02,3.963e-02,7.812e-02,4.278e-02,1.571e-02,1.165e-01,7.899e-01,2.596e-02
MLX,11645,"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,molecular function,21.0,5.0,3.981e-02,2.648e-02,5.985e-02,6.237e-03,1.384e-03,2.811e-02,9.386e-01,1.756e-02
MLX,11645,DNA-binding transcription factor activity,GO:0003700,molecular function,21.0,12.0,3.981e-02,2.648e-02,5.985e-02,1.311e-02,7.988e-03,2.151e-02,9.048e-01,7.834e-03
MLX,11645,RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000977,molecular function,21.0,9.0,3.981e-02,2.648e-02,5.985e-02,1.422e-02,5.807e-03,3.482e-02,8.957e-01,1.499e-02
MLX,11645,protein homodimerization activity,GO:0042803,molecular function,21.0,21.0,3.981e-02,2.648e-02,5.985e-02,2.107e-02,1.198e-02,3.705e-02,8.644e-01,1.357e-02
MLX,11645,protein heterodimerization activity,GO:0046982,molecular function,21.0,8.0,3.996e-02,2.650e-02,6.024e-02,1.849e-02,1.099e-02,3.111e-02,8.764e-01,1.209e-02
MLX,11645,transcription factor binding,GO:0008134,molecular function,21.0,9.0,4.148e-02,3.140e-02,5.480e-02,2.634e-02,1.557e-02,4.455e-02,8.420e-01,1.276e-02
MLX,11645,protein binding,GO:0005515,molecular function,21.0,347.0,4.190e-02,2.605e-02,6.737e-02,3.123e-02,2.301e-02,4.240e-02,8.245e-01,7.513e-03
MLX,11645,DNA binding,GO:0003677,molecular function,21.0,27.0,4.494e-02,2.378e-02,8.494e-02,2.930e-02,7.811e-03,1.099e-01,8.288e-01,3.244e-02
MMAB,19331,cobalamin binding,GO:0031419,molecular function,4.0,5.0,6.363e-02,2.089e-02,1.938e-01,2.672e-02,1.344e-02,5.314e-02,8.402e-01,1.682e-02
MMAB,19331,"cob(I)yrinic acid a,c-diamide adenosyltransferase activity",GO:0008817,molecular function,4.0,2.0,8.268e-02,1.797e-02,3.805e-01,6.856e-02,9.043e-03,5.198e-01,7.249e-01,6.099e-02
MMAB,19331,protein binding,GO:0005515,molecular function,4.0,347.0,8.543e-02,2.489e-02,2.932e-01,7.463e-02,3.175e-02,1.754e-01,7.245e-01,2.566e-02
MMGT1,28100,integral component of membrane,GO:0016021,cellular component,9.0,12.0,7.463e-02,6.681e-02,8.337e-02,1.939e-02,6.469e-03,5.812e-02,8.698e-01,2.538e-02
MMGT1,28100,ER membrane protein complex,GO:0072546,cellular component,9.0,2.0,7.993e-02,7.073e-02,9.034e-02,4.069e-02,1.311e-02,1.263e-01,7.950e-01,2.943e-02
MMGT1,28100,early endosome,GO:0005769,cellular component,9.0,7.0,8.383e-02,5.287e-02,1.329e-01,3.897e-02,1.498e-02,1.014e-01,8.002e-01,2.464e-02
MMGT1,28100,Golgi apparatus,GO:0005794,cellular component,9.0,16.0,1.029e-01,7.443e-02,1.423e-01,9.247e-02,7.244e-02,1.180e-01,6.987e-01,8.195e-03
MMGT1,28100,membrane,GO:0016020,cellular component,9.0,58.0,1.029e-01,7.443e-02,1.423e-01,9.354e-02,6.580e-02,1.330e-01,6.967e-01,1.124e-02
MMGT1,28100,plasma membrane,GO:0005886,cellular component,9.0,61.0,1.032e-01,7.405e-02,1.440e-01,9.690e-02,5.679e-02,1.653e-01,6.911e-01,1.750e-02
MMGT1,28100,inorganic cation transmembrane transporter activity,GO:0022890,molecular function,9.0,10.0,8.207e-02,5.551e-02,1.213e-01,3.506e-02,2.364e-02,5.200e-02,8.126e-01,9.909e-03
MMP19,7165,extracellular matrix organization,GO:0030198,biological process,5.0,19.0,2.002e-02,8.292e-03,4.834e-02,1.583e-02,5.720e-03,4.380e-02,8.864e-01,2.148e-02
MMP19,7165,collagen catabolic process,GO:0030574,biological process,5.0,5.0,2.124e-02,8.100e-03,5.571e-02,2.051e-02,7.879e-03,5.341e-02,8.636e-01,2.045e-02
MMP19,7165,extracellular space,GO:0005615,cellular component,5.0,43.0,2.002e-02,8.292e-03,4.834e-02,1.796e-02,8.073e-03,3.996e-02,8.773e-01,1.730e-02
MMP19,7165,metalloendopeptidase activity,GO:0004222,molecular function,5.0,7.0,1.733e-02,9.257e-03,3.243e-02,4.624e-03,3.068e-03,6.968e-03,9.554e-01,3.340e-03
MMP28,14366,collagen catabolic process,GO:0030574,biological process,7.0,5.0,2.529e-02,9.784e-03,6.535e-02,1.824e-02,7.253e-03,4.587e-02,8.749e-01,1.929e-02
MMP28,14366,extracellular matrix organization,GO:0030198,biological process,7.0,19.0,2.529e-02,9.784e-03,6.535e-02,1.763e-02,4.073e-03,7.630e-02,8.718e-01,2.696e-02
MMP28,14366,extracellular space,GO:0005615,cellular component,7.0,43.0,2.529e-02,9.784e-03,6.535e-02,1.709e-02,7.630e-03,3.830e-02,8.812e-01,1.613e-02
MMP28,14366,collagen-containing extracellular matrix,GO:0062023,cellular component,7.0,36.0,2.529e-02,9.784e-03,6.535e-02,2.028e-02,8.385e-03,4.903e-02,8.652e-01,1.891e-02
MMP28,14366,metalloendopeptidase activity,GO:0004222,molecular function,7.0,7.0,2.453e-02,9.883e-03,6.088e-02,4.831e-03,2.850e-03,8.189e-03,9.538e-01,4.362e-03
MMP28,14366,protein binding,GO:0005515,molecular function,7.0,347.0,9.106e-02,6.992e-02,1.186e-01,9.106e-02,6.992e-02,1.186e-01,7.007e-01,8.725e-03
MMP3,7173,collagen catabolic process,GO:0030574,biological process,23.0,5.0,3.908e-02,2.629e-02,5.811e-02,2.274e-02,8.691e-03,5.949e-02,8.553e-01,2.251e-02
MMP3,7173,proteolysis,GO:0006508,biological process,23.0,14.0,4.135e-02,3.165e-02,5.401e-02,2.455e-02,1.264e-02,4.771e-02,8.487e-01,1.612e-02
MMP3,7173,extracellular matrix organization,GO:0030198,biological process,23.0,19.0,4.374e-02,3.458e-02,5.533e-02,3.383e-02,2.511e-02,4.557e-02,8.164e-01,7.439e-03
MMP3,7173,negative regulation of hydrogen peroxide metabolic process,GO:0010727,biological process,23.0,6.0,4.374e-02,3.458e-02,5.533e-02,3.495e-02,2.736e-02,4.465e-02,8.131e-01,6.101e-03
MMP3,7173,positive regulation of protein-containing complex assembly,GO:0031334,biological process,23.0,36.0,9.988e-02,3.808e-03,2.620e+00,6.326e-02,1.106e-03,3.619e+00,6.643e-01,1.709e-01
MMP3,7173,metalloendopeptidase activity,GO:0004222,molecular function,23.0,7.0,3.908e-02,2.629e-02,5.811e-02,9.617e-03,4.965e-03,1.863e-02,9.234e-01,8.929e-03
MMP3,7173,endopeptidase activity,GO:0004175,molecular function,23.0,11.0,3.908e-02,2.629e-02,5.811e-02,1.704e-02,5.061e-03,5.738e-02,8.774e-01,2.259e-02
MMP3,7173,metallopeptidase activity,GO:0008237,molecular function,23.0,4.0,3.908e-02,2.629e-02,5.811e-02,1.838e-02,1.065e-02,3.170e-02,8.768e-01,1.251e-02
MMP3,7173,protein binding,GO:0005515,molecular function,23.0,347.0,8.040e-02,5.248e-02,1.232e-01,7.730e-02,4.430e-02,1.349e-01,7.215e-01,1.673e-02
MORC4,23485,,,,nan,nan,,,,,,,,
MPC1,21606,mitochondrial pyruvate transmembrane transport,GO:0006850,biological process,7.0,3.0,6.649e-02,3.130e-02,1.412e-01,4.186e-02,9.145e-03,1.916e-01,7.897e-01,4.058e-02
MPC1,21606,integral component of mitochondrial inner membrane,GO:0031305,cellular component,7.0,5.0,5.893e-02,3.372e-02,1.030e-01,3.770e-02,1.954e-02,7.273e-02,8.046e-01,1.637e-02
MPC1,21606,mitochondrion,GO:0005739,cellular component,7.0,35.0,5.893e-02,3.372e-02,1.030e-01,4.426e-02,2.895e-02,6.766e-02,7.875e-01,1.129e-02
MPC1,21606,pyruvate transmembrane transporter activity,GO:0050833,molecular function,7.0,3.0,6.388e-02,2.912e-02,1.402e-01,5.433e-02,2.048e-02,1.442e-01,7.624e-01,2.822e-02
MPDZ,7208,apicolateral plasma membrane,GO:0016327,cellular component,5.0,2.0,1.605e-01,4.804e-02,5.361e-01,1.205e-01,1.875e-02,7.747e-01,6.440e-01,6.982e-02
MPDZ,7208,cytoplasm,GO:0005737,cellular component,5.0,78.0,1.727e-01,1.026e-01,2.909e-01,1.569e-01,1.254e-01,1.964e-01,6.194e-01,8.663e-03
MPDZ,7208,protein C-terminus binding,GO:0008022,molecular function,5.0,3.0,1.247e-01,3.871e-02,4.015e-01,3.659e-02,6.838e-03,1.958e-01,8.031e-01,4.496e-02
MPDZ,7208,protein binding,GO:0005515,molecular function,5.0,347.0,1.656e-01,9.320e-02,2.941e-01,1.146e-01,8.173e-02,1.607e-01,6.679e-01,1.227e-02
MRAP,1304,negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,GO:0106072,biological process,16.0,6.0,1.893e-01,6.926e-02,5.176e-01,5.024e-02,1.915e-02,1.318e-01,7.716e-01,2.703e-02
MRAP,1304,regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,GO:0106070,biological process,16.0,7.0,1.893e-01,6.926e-02,5.176e-01,5.078e-02,2.387e-02,1.080e-01,7.713e-01,2.120e-02
MRAP,1304,positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,GO:0106071,biological process,16.0,5.0,2.042e-01,5.971e-02,6.985e-01,5.353e-02,2.604e-02,1.100e-01,7.653e-01,1.980e-02
MRAP,1304,protein localization to plasma membrane,GO:0072659,biological process,16.0,7.0,2.125e-01,5.535e-02,8.160e-01,8.843e-02,7.677e-03,1.019e+00,6.765e-01,9.271e-02
MRAP,1304,negative regulation of protein localization to plasma membrane,GO:1903077,biological process,16.0,7.0,2.224e-01,5.057e-02,9.780e-01,7.841e-02,3.087e-03,1.992e+00,6.726e-01,1.245e-01
MRAP,1304,plasma membrane,GO:0005886,cellular component,16.0,61.0,2.541e-01,1.016e-01,6.358e-01,1.645e-01,6.187e-02,4.373e-01,6.065e-01,4.038e-02
MRAP,1304,endoplasmic reticulum,GO:0005783,cellular component,16.0,34.0,2.683e-01,1.263e-01,5.700e-01,2.216e-01,1.308e-01,3.754e-01,5.573e-01,2.428e-02
MRAP,1304,receptor regulator activity,GO:0030545,molecular function,16.0,5.0,2.166e-01,5.333e-02,8.796e-01,6.598e-02,2.775e-03,1.569e+00,7.004e-01,1.165e-01
MRAP,1304,identical protein binding,GO:0042802,molecular function,16.0,35.0,2.541e-01,1.016e-01,6.358e-01,1.295e-01,7.542e-02,2.225e-01,6.488e-01,1.953e-02
MRAP,1304,type 3 melanocortin receptor binding,GO:0031781,molecular function,16.0,2.0,2.541e-01,1.016e-01,6.358e-01,2.030e-01,9.680e-02,4.257e-01,5.719e-01,3.094e-02
MRAP,1304,type 4 melanocortin receptor binding,GO:0031782,molecular function,16.0,2.0,2.541e-01,1.016e-01,6.358e-01,2.079e-01,9.412e-02,4.591e-01,5.669e-01,3.340e-02
MRAP,1304,corticotropin hormone receptor binding,GO:0031780,molecular function,16.0,2.0,2.541e-01,1.016e-01,6.358e-01,2.092e-01,9.220e-02,4.744e-01,5.655e-01,3.466e-02
MRAP,1304,type 1 melanocortin receptor binding,GO:0070996,molecular function,16.0,2.0,2.541e-01,1.016e-01,6.358e-01,2.096e-01,9.440e-02,4.653e-01,5.653e-01,3.380e-02
MRAP,1304,type 5 melanocortin receptor binding,GO:0031783,molecular function,16.0,2.0,2.541e-01,1.016e-01,6.358e-01,2.127e-01,9.811e-02,4.611e-01,5.629e-01,3.300e-02
MRAP,1304,protein binding,GO:0005515,molecular function,16.0,347.0,2.732e-01,1.356e-01,5.507e-01,2.458e-01,1.519e-01,3.978e-01,5.374e-01,2.320e-02
MRO,24121,,,,nan,nan,,,,,,,,
MRPS22,14508,mitochondrial small ribosomal subunit,GO:0005763,cellular component,4.0,3.0,2.552e-02,1.361e-02,4.784e-02,1.595e-02,1.207e-02,2.106e-02,8.905e-01,5.470e-03
MRPS22,14508,mitochondrion,GO:0005739,cellular component,4.0,35.0,2.805e-02,1.184e-02,6.644e-02,2.539e-02,8.645e-03,7.459e-02,8.439e-01,2.542e-02
MRPS22,14508,structural constituent of ribosome,GO:0003735,molecular function,4.0,2.0,2.552e-02,1.361e-02,4.784e-02,2.226e-02,1.338e-02,3.703e-02,8.589e-01,1.225e-02
MS4A4A,13371,,,,nan,nan,,,,,,,,
MTDH,29608,positive regulation of angiogenesis,GO:0045766,biological process,27.0,12.0,1.344e-01,6.240e-02,2.894e-01,2.686e-02,9.320e-04,7.741e-01,8.082e-01,6.324e-02
MTDH,29608,positive regulation of NF-kappaB transcription factor activity,GO:0051092,biological process,27.0,3.0,1.497e-01,1.098e-01,2.039e-01,4.323e-02,1.558e-02,1.199e-01,7.887e-01,2.649e-02
MTDH,29608,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,27.0,43.0,1.497e-01,1.098e-01,2.039e-01,6.684e-02,4.487e-02,9.955e-02,7.400e-01,1.162e-02
MTDH,29608,lipopolysaccharide-mediated signaling pathway,GO:0031663,biological process,27.0,2.0,1.505e-01,1.268e-01,1.787e-01,3.869e-02,6.420e-03,2.332e-01,7.963e-01,4.754e-02
MTDH,29608,positive regulation of autophagy,GO:0010508,biological process,27.0,10.0,1.505e-01,1.268e-01,1.787e-01,5.407e-02,1.207e-02,2.422e-01,7.585e-01,4.492e-02
MTDH,29608,regulation of transcription by RNA polymerase II,GO:0006357,biological process,27.0,46.0,1.527e-01,1.094e-01,2.132e-01,7.533e-02,6.956e-02,8.158e-02,7.256e-01,2.411e-03
MTDH,29608,positive regulation of protein kinase B signaling,GO:0051897,biological process,27.0,8.0,1.529e-01,1.082e-01,2.160e-01,5.208e-02,3.630e-03,7.470e-01,7.520e-01,6.793e-02
MTDH,29608,positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043123,biological process,27.0,6.0,1.532e-01,1.091e-01,2.151e-01,8.105e-02,2.119e-02,3.101e-01,7.100e-01,4.038e-02
MTDH,29608,negative regulation of apoptotic process,GO:0043066,biological process,27.0,29.0,1.642e-01,1.041e-01,2.592e-01,1.155e-01,3.013e-02,4.425e-01,6.598e-01,4.470e-02
MTDH,29608,nucleus,GO:0005634,cellular component,27.0,81.0,1.527e-01,1.094e-01,2.132e-01,8.519e-02,7.331e-02,9.899e-02,7.099e-01,4.753e-03
MTDH,29608,cytoplasm,GO:0005737,cellular component,27.0,78.0,1.579e-01,1.247e-01,2.000e-01,1.253e-01,1.069e-01,1.468e-01,6.547e-01,5.805e-03
MTDH,29608,perinuclear region of cytoplasm,GO:0048471,cellular component,27.0,11.0,1.622e-01,1.178e-01,2.234e-01,1.338e-01,1.018e-01,1.760e-01,6.445e-01,1.025e-02
MTDH,29608,nuclear body,GO:0016604,cellular component,27.0,17.0,1.624e-01,1.175e-01,2.243e-01,1.405e-01,8.168e-02,2.418e-01,6.360e-01,2.071e-02
MTDH,29608,endoplasmic reticulum membrane,GO:0005789,cellular component,27.0,12.0,1.676e-01,1.023e-01,2.745e-01,1.330e-01,5.500e-02,3.218e-01,6.425e-01,3.202e-02
MTDH,29608,fibrillar center,GO:0001650,cellular component,27.0,6.0,1.676e-01,1.023e-01,2.745e-01,1.387e-01,5.101e-02,3.772e-01,6.350e-01,3.602e-02
MTDH,29608,endoplasmic reticulum,GO:0005783,cellular component,27.0,34.0,1.722e-01,1.152e-01,2.574e-01,1.450e-01,8.833e-02,2.381e-01,6.312e-01,1.900e-02
MTDH,29608,transcription coactivator activity,GO:0003713,molecular function,27.0,5.0,1.465e-01,1.126e-01,1.906e-01,2.556e-02,1.343e-02,4.866e-02,8.448e-01,1.574e-02
MTDH,29608,double-stranded RNA binding,GO:0003725,molecular function,27.0,6.0,1.465e-01,1.126e-01,1.906e-01,3.863e-02,1.595e-02,9.352e-02,8.011e-01,2.299e-02
MTDH,29608,transcription coregulator activity,GO:0003712,molecular function,27.0,5.0,1.465e-01,1.126e-01,1.906e-01,4.634e-02,1.619e-02,1.326e-01,7.804e-01,2.795e-02
MTDH,29608,RNA polymerase II transcription factor binding,GO:0001085,molecular function,27.0,4.0,1.465e-01,1.126e-01,1.906e-01,4.873e-02,3.357e-02,7.072e-02,7.772e-01,1.014e-02
MTDH,29608,protein binding,GO:0005515,molecular function,27.0,347.0,1.574e-01,1.228e-01,2.016e-01,1.086e-01,8.613e-02,1.370e-01,6.760e-01,8.209e-03
MTDH,29608,RNA binding,GO:0003723,molecular function,27.0,60.0,1.574e-01,1.228e-01,2.016e-01,1.212e-01,8.800e-02,1.671e-01,6.596e-01,1.155e-02
MTDH,29608,NF-kappaB binding,GO:0051059,molecular function,27.0,2.0,1.579e-01,1.051e-01,2.372e-01,1.196e-01,5.354e-02,2.671e-01,6.592e-01,2.839e-02
MVD,7529,"isopentenyl diphosphate biosynthetic process, mevalonate pathway",GO:0019287,biological process,14.0,6.0,7.395e-02,2.999e-02,1.824e-01,2.930e-02,2.000e-02,4.293e-02,8.311e-01,9.400e-03
MVD,7529,isoprenoid biosynthetic process,GO:0008299,biological process,14.0,12.0,9.461e-02,4.493e-02,1.992e-01,6.210e-02,2.001e-02,1.927e-01,7.459e-01,3.142e-02
MVD,7529,positive regulation of cell population proliferation,GO:0008284,biological process,14.0,40.0,1.756e-01,9.849e-02,3.129e-01,1.668e-01,7.860e-02,3.538e-01,6.069e-01,2.917e-02
MVD,7529,cytosol,GO:0005829,cellular component,14.0,76.0,7.395e-02,2.999e-02,1.824e-01,4.273e-02,1.395e-02,1.309e-01,7.888e-01,3.048e-02
MVD,7529,Hsp70 protein binding,GO:0030544,molecular function,14.0,2.0,7.395e-02,2.999e-02,1.824e-01,2.358e-02,6.966e-03,7.983e-02,8.502e-01,2.808e-02
MVD,7529,protein homodimerization activity,GO:0042803,molecular function,14.0,21.0,7.395e-02,2.999e-02,1.824e-01,3.976e-02,2.023e-02,7.814e-02,7.987e-01,1.767e-02
MVD,7529,diphosphomevalonate decarboxylase activity,GO:0004163,molecular function,14.0,2.0,1.254e-01,6.420e-02,2.448e-01,1.131e-01,5.045e-02,2.536e-01,6.674e-01,2.822e-02
MVK,7530,"isopentenyl diphosphate biosynthetic process, mevalonate pathway",GO:0019287,biological process,10.0,6.0,8.377e-02,2.436e-02,2.881e-01,2.950e-02,7.272e-03,1.197e-01,8.273e-01,3.250e-02
MVK,7530,cholesterol biosynthetic process,GO:0006695,biological process,10.0,11.0,8.377e-02,2.436e-02,2.881e-01,2.874e-02,5.147e-03,1.605e-01,8.268e-01,3.831e-02
MVK,7530,isoprenoid biosynthetic process,GO:0008299,biological process,10.0,12.0,8.377e-02,2.436e-02,2.881e-01,4.171e-02,6.234e-03,2.791e-01,7.876e-01,4.730e-02
MVK,7530,negative regulation of inflammatory response,GO:0050728,biological process,10.0,13.0,2.271e-01,2.594e-02,1.988e+00,1.256e-01,3.547e-03,4.447e+00,5.627e-01,1.721e-01
MVK,7530,intracellular membrane-bounded organelle,GO:0043231,cellular component,10.0,48.0,1.155e-01,9.119e-02,1.462e-01,4.280e-02,1.316e-02,1.392e-01,7.894e-01,3.015e-02
MVK,7530,cytosol,GO:0005829,cellular component,10.0,76.0,1.363e-01,1.164e-01,1.597e-01,1.068e-01,7.295e-02,1.565e-01,6.781e-01,1.349e-02
MVK,7530,mevalonate kinase activity,GO:0004496,molecular function,10.0,3.0,1.264e-01,3.048e-02,5.245e-01,7.524e-02,7.647e-03,7.404e-01,7.049e-01,7.935e-02
MVK,7530,identical protein binding,GO:0042802,molecular function,10.0,35.0,1.361e-01,1.161e-01,1.597e-01,9.329e-02,5.193e-02,1.676e-01,6.962e-01,1.905e-02
MVK,7530,protein binding,GO:0005515,molecular function,10.0,347.0,1.630e-01,9.918e-02,2.678e-01,1.507e-01,8.049e-02,2.821e-01,6.242e-01,2.499e-02
MYL4,7585,cardiac muscle contraction,GO:0060048,biological process,15.0,3.0,2.655e-02,1.092e-02,6.459e-02,1.461e-02,4.353e-03,4.905e-02,8.908e-01,2.487e-02
MYL4,7585,regulation of the force of heart contraction,GO:0002026,biological process,15.0,7.0,7.854e-02,1.804e-02,3.419e-01,5.029e-02,4.680e-03,5.404e-01,7.591e-01,6.938e-02
MYL4,7585,positive regulation of ATPase activity,GO:0032781,biological process,15.0,10.0,8.846e-02,2.142e-02,3.654e-01,7.728e-02,1.251e-02,4.775e-01,7.111e-01,5.665e-02
MYL4,7585,A band,GO:0031672,cellular component,15.0,3.0,9.557e-02,6.174e-02,1.479e-01,7.964e-02,5.145e-02,1.233e-01,7.180e-01,1.340e-02
MYL4,7585,actin monomer binding,GO:0003785,molecular function,15.0,2.0,2.045e-02,5.988e-03,6.988e-02,5.343e-03,5.813e-04,4.911e-02,9.376e-01,2.362e-02
MYL4,7585,actin filament binding,GO:0051015,molecular function,15.0,6.0,2.433e-02,1.064e-02,5.564e-02,9.817e-03,2.953e-03,3.264e-02,9.174e-01,1.910e-02
MYL7,21719,A band,GO:0031672,cellular component,5.0,3.0,1.243e-01,8.281e-02,1.866e-01,1.154e-01,6.037e-02,2.205e-01,6.655e-01,2.240e-02
MYL7,21719,protein binding,GO:0005515,molecular function,5.0,347.0,1.243e-01,8.281e-02,1.866e-01,1.048e-01,9.295e-02,1.183e-01,6.813e-01,4.268e-03
MYO1H,13879,,,,nan,nan,,,,,,,,
MYRIP,19156,,,,nan,nan,,,,,,,,
NAMPT,30092,positive regulation of nitric-oxide synthase biosynthetic process,GO:0051770,biological process,41.0,3.0,3.197e-02,1.553e-02,6.582e-02,1.653e-02,6.988e-03,3.910e-02,8.842e-01,1.882e-02
NAMPT,30092,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,41.0,62.0,3.937e-02,2.340e-02,6.625e-02,3.430e-02,1.974e-02,5.961e-02,8.147e-01,1.367e-02
NAMPT,30092,extracellular exosome,GO:0070062,cellular component,41.0,77.0,3.197e-02,1.553e-02,6.582e-02,1.453e-02,6.798e-03,3.107e-02,8.951e-01,1.496e-02
NAMPT,30092,cell junction,GO:0030054,cellular component,41.0,10.0,3.531e-02,2.402e-02,5.190e-02,1.641e-02,7.967e-03,3.380e-02,8.853e-01,1.380e-02
NAMPT,30092,nuclear speck,GO:0016607,cellular component,41.0,5.0,4.213e-02,2.268e-02,7.825e-02,4.213e-02,2.268e-02,7.825e-02,7.926e-01,1.589e-02
NAMPT,30092,identical protein binding,GO:0042802,molecular function,41.0,35.0,3.197e-02,1.553e-02,6.582e-02,1.208e-02,2.086e-03,6.992e-02,8.984e-01,2.444e-02
NAMPT,30092,protein binding,GO:0005515,molecular function,41.0,347.0,3.355e-02,1.491e-02,7.550e-02,2.225e-02,7.693e-03,6.432e-02,8.557e-01,2.322e-02
NBL1,7650,,,,nan,nan,,,,,,,,
NDRG2,14460,signal transduction,GO:0007165,biological process,7.0,48.0,1.578e-01,1.085e-01,2.295e-01,5.020e-02,3.808e-02,6.617e-02,7.740e-01,7.555e-03
NDRG2,14460,substantia nigra development,GO:0021762,biological process,7.0,3.0,1.903e-01,7.409e-02,4.886e-01,1.331e-01,1.903e-02,9.306e-01,6.274e-01,7.242e-02
NDRG2,14460,extracellular exosome,GO:0070062,cellular component,7.0,77.0,1.578e-01,1.085e-01,2.295e-01,8.858e-02,4.525e-02,1.734e-01,7.026e-01,2.239e-02
NDRG2,14460,cytoplasm,GO:0005737,cellular component,7.0,78.0,1.681e-01,1.304e-01,2.166e-01,1.294e-01,1.190e-01,1.406e-01,6.499e-01,3.081e-03
NDRG2,14460,Golgi apparatus,GO:0005794,cellular component,7.0,16.0,1.701e-01,1.188e-01,2.437e-01,1.389e-01,7.575e-02,2.549e-01,6.377e-01,2.235e-02
NDRG2,14460,protein binding,GO:0005515,molecular function,7.0,347.0,1.602e-01,1.142e-01,2.249e-01,9.637e-02,9.089e-02,1.022e-01,6.934e-01,1.966e-03
NFIL3,7787,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,20.0,43.0,4.738e-02,2.311e-02,9.713e-02,3.036e-02,1.115e-02,8.269e-02,8.267e-01,2.496e-02
NFIL3,7787,"regulation of transcription, DNA-templated",GO:0006355,biological process,20.0,28.0,1.736e-01,4.729e-02,6.376e-01,1.567e-01,5.044e-02,4.867e-01,6.135e-01,4.364e-02
NFIL3,7787,circadian rhythm,GO:0007623,biological process,20.0,9.0,2.301e-01,2.730e-02,1.939e+00,2.186e-01,2.178e-02,2.193e+00,5.255e-01,9.625e-02
NFIL3,7787,nucleus,GO:0005634,cellular component,20.0,81.0,2.577e-02,1.540e-02,4.314e-02,5.358e-03,3.180e-03,9.028e-03,9.500e-01,4.472e-03
NFIL3,7787,protein binding,GO:0005515,molecular function,20.0,347.0,2.963e-02,1.324e-02,6.631e-02,7.979e-03,2.955e-03,2.155e-02,9.316e-01,1.091e-02
NFIL3,7787,RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000977,molecular function,20.0,9.0,4.738e-02,2.311e-02,9.713e-02,2.627e-02,1.131e-02,6.101e-02,8.418e-01,2.072e-02
NFIL3,7787,"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,molecular function,20.0,5.0,5.039e-02,2.977e-02,8.531e-02,3.049e-02,2.253e-02,4.124e-02,8.270e-01,7.409e-03
NID1,7821,canonical Wnt signaling pathway,GO:0060070,biological process,17.0,21.0,9.189e-02,1.674e-02,5.043e-01,8.159e-02,9.931e-03,6.702e-01,7.012e-01,6.207e-02
NID1,7821,collagen-containing extracellular matrix,GO:0062023,cellular component,17.0,36.0,3.772e-02,1.696e-02,8.388e-02,8.971e-03,3.486e-03,2.308e-02,9.256e-01,1.235e-02
NID1,7821,basement membrane,GO:0005604,cellular component,17.0,4.0,3.772e-02,1.696e-02,8.388e-02,1.026e-02,2.691e-03,3.911e-02,9.149e-01,1.697e-02
NID1,7821,extracellular exosome,GO:0070062,cellular component,17.0,77.0,4.322e-02,2.703e-02,6.910e-02,2.259e-02,6.884e-03,7.412e-02,8.540e-01,2.656e-02
NID1,7821,plasma membrane,GO:0005886,cellular component,17.0,61.0,5.744e-02,3.781e-02,8.727e-02,4.145e-02,1.420e-02,1.209e-01,7.933e-01,2.767e-02
NID1,7821,receptor complex,GO:0043235,cellular component,17.0,29.0,6.106e-02,4.547e-02,8.200e-02,4.870e-02,3.975e-02,5.968e-02,7.773e-01,5.557e-03
NID1,7821,Wnt-protein binding,GO:0017147,molecular function,17.0,2.0,4.142e-02,1.599e-02,1.073e-01,1.746e-02,4.671e-03,6.528e-02,8.755e-01,2.640e-02
NID1,7821,laminin binding,GO:0043236,molecular function,17.0,6.0,4.556e-02,1.405e-02,1.478e-01,1.894e-02,2.303e-03,1.558e-01,8.622e-01,4.749e-02
NID1,7821,collagen binding,GO:0005518,molecular function,17.0,7.0,4.679e-02,2.631e-02,8.322e-02,2.673e-02,1.329e-02,5.377e-02,8.403e-01,1.702e-02
NID1,7821,Wnt-activated receptor activity,GO:0042813,molecular function,17.0,2.0,5.032e-02,3.983e-02,6.357e-02,3.089e-02,9.109e-03,1.048e-01,8.239e-01,3.026e-02
NID1,7821,proteoglycan binding,GO:0043394,molecular function,17.0,6.0,6.191e-02,1.462e-02,2.622e-01,3.789e-02,4.446e-03,3.228e-01,7.944e-01,5.923e-02
NID2,13389,basement membrane,GO:0005604,cellular component,6.0,4.0,1.732e-02,8.309e-03,3.610e-02,6.049e-03,2.264e-03,1.617e-02,9.438e-01,1.003e-02
NID2,13389,collagen-containing extracellular matrix,GO:0062023,cellular component,6.0,36.0,1.732e-02,8.309e-03,3.610e-02,6.480e-03,3.869e-03,1.085e-02,9.429e-01,5.156e-03
NID2,13389,extracellular exosome,GO:0070062,cellular component,6.0,77.0,3.167e-02,2.222e-02,4.513e-02,1.900e-02,1.333e-02,2.708e-02,8.746e-01,8.512e-03
NID2,13389,plasma membrane,GO:0005886,cellular component,6.0,61.0,4.086e-02,2.309e-02,7.231e-02,3.269e-02,1.847e-02,5.785e-02,8.196e-01,1.424e-02
NID2,13389,protein binding,GO:0005515,molecular function,6.0,347.0,6.319e-02,3.694e-02,1.081e-01,6.319e-02,3.694e-02,1.081e-01,7.466e-01,1.545e-02
NINJ1,7824,cell adhesion,GO:0007155,biological process,3.0,13.0,8.506e-02,8.296e-03,8.721e-01,7.168e-02,5.230e-03,9.826e-01,7.033e-01,9.405e-02
NINJ1,7824,protein binding,GO:0005515,molecular function,3.0,347.0,6.924e-02,1.358e-02,3.530e-01,5.495e-02,2.361e-02,1.279e-01,7.618e-01,2.439e-02
NINL,29163,microtubule anchoring at centrosome,GO:0034454,biological process,11.0,2.0,4.874e-02,2.428e-02,9.785e-02,2.543e-02,7.759e-03,8.336e-02,8.428e-01,2.723e-02
NINL,29163,centrosome,GO:0005813,cellular component,11.0,9.0,4.874e-02,2.428e-02,9.785e-02,1.174e-02,4.075e-03,3.379e-02,9.079e-01,1.699e-02
NINL,29163,cytosol,GO:0005829,cellular component,11.0,76.0,6.133e-02,5.730e-02,6.564e-02,5.447e-02,3.876e-02,7.655e-02,7.645e-01,9.403e-03
NINL,29163,intercellular bridge,GO:0045171,cellular component,11.0,4.0,6.240e-02,5.893e-02,6.607e-02,5.792e-02,4.289e-02,7.822e-02,7.575e-01,8.326e-03
NINL,29163,protein binding,GO:0005515,molecular function,11.0,347.0,6.060e-02,5.754e-02,6.383e-02,4.974e-02,4.156e-02,5.953e-02,7.751e-01,4.964e-03
NKD1,17045,negative regulation of Wnt signaling pathway,GO:0030178,biological process,10.0,10.0,2.029e-01,4.603e-02,8.941e-01,6.332e-02,1.638e-02,2.448e-01,7.421e-01,3.745e-02
NKD1,17045,negative regulation of canonical Wnt signaling pathway,GO:0090090,biological process,10.0,11.0,2.029e-01,4.603e-02,8.941e-01,7.582e-02,6.341e-03,9.065e-01,7.067e-01,7.202e-02
NKD1,17045,positive regulation of protein catabolic process,GO:0045732,biological process,10.0,8.0,2.529e-01,1.187e-01,5.391e-01,1.677e-01,1.395e-01,2.015e-01,6.088e-01,7.266e-03
NKD1,17045,cytoplasm,GO:0005737,cellular component,10.0,78.0,2.697e-01,1.060e-01,6.858e-01,2.217e-01,9.735e-02,5.048e-01,5.537e-01,3.999e-02
NKD1,17045,protein phosphatase type 2A complex,GO:0000159,cellular component,10.0,3.0,3.733e-01,9.450e-02,1.474e+00,3.259e-01,5.207e-02,2.040e+00,4.416e-01,9.460e-02
NKD1,17045,protein binding,GO:0005515,molecular function,10.0,347.0,2.703e-01,1.063e-01,6.876e-01,2.189e-01,8.558e-02,5.601e-01,5.549e-01,4.238e-02
NKX2-1,11825,forebrain development,GO:0030900,biological process,43.0,2.0,8.179e-02,2.184e-02,3.063e-01,2.127e-02,1.282e-02,3.529e-02,8.634e-01,1.227e-02
NKX2-1,11825,thyroid gland development,GO:0030878,biological process,43.0,2.0,8.368e-02,2.126e-02,3.293e-01,2.263e-02,1.478e-03,3.464e-01,8.346e-01,5.406e-02
NKX2-1,11825,epithelial tube branching involved in lung morphogenesis,GO:0060441,biological process,43.0,3.0,8.449e-02,2.516e-02,2.838e-01,2.819e-02,1.730e-02,4.595e-02,8.351e-01,1.203e-02
NKX2-1,11825,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,43.0,43.0,8.691e-02,2.023e-02,3.734e-01,3.746e-02,4.044e-03,3.469e-01,7.943e-01,6.001e-02
NKX2-1,11825,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,43.0,62.0,8.691e-02,2.023e-02,3.734e-01,4.773e-02,7.901e-03,2.884e-01,7.714e-01,5.163e-02
NKX2-1,11825,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,43.0,35.0,8.711e-02,2.016e-02,3.763e-01,3.336e-02,3.048e-03,3.651e-01,8.058e-01,6.682e-02
NKX2-1,11825,positive regulation of gene expression,GO:0010628,biological process,43.0,23.0,8.929e-02,1.945e-02,4.099e-01,4.805e-02,5.623e-03,4.106e-01,7.672e-01,6.220e-02
NKX2-1,11825,negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030512,biological process,43.0,7.0,9.688e-02,1.916e-02,4.900e-01,3.186e-02,1.354e-03,7.497e-01,7.946e-01,7.291e-02
NKX2-1,11825,brain development,GO:0007420,biological process,43.0,6.0,1.104e-01,2.289e-02,5.324e-01,8.919e-02,1.560e-02,5.100e-01,6.926e-01,5.416e-02
NKX2-1,11825,lung development,GO:0030324,biological process,43.0,4.0,1.114e-01,2.067e-02,6.002e-01,8.193e-02,1.234e-02,5.438e-01,7.028e-01,5.665e-02
NKX2-1,11825,globus pallidus development,GO:0021759,biological process,43.0,2.0,1.333e-01,1.187e-02,1.497e+00,6.895e-02,2.726e-03,1.744e+00,6.964e-01,1.136e-01
NKX2-1,11825,negative regulation of epithelial to mesenchymal transition,GO:0010719,biological process,43.0,6.0,1.572e-01,1.078e-02,2.291e+00,9.518e-02,3.498e-03,2.590e+00,6.260e-01,1.502e-01
NKX2-1,11825,response to hormone,GO:0009725,biological process,43.0,34.0,2.475e-01,8.025e-02,7.636e-01,1.528e-01,1.446e-02,1.616e+00,5.965e-01,8.553e-02
NKX2-1,11825,negative regulation of cell migration,GO:0030336,biological process,43.0,31.0,2.660e-01,1.077e-01,6.569e-01,2.455e-01,9.944e-02,6.064e-01,5.317e-01,4.636e-02
NKX2-1,11825,cell differentiation,GO:0030154,biological process,43.0,86.0,3.840e-01,7.097e-02,2.077e+00,3.166e-01,3.198e-02,3.134e+00,4.288e-01,1.169e-01
NKX2-1,11825,nucleus,GO:0005634,cellular component,43.0,81.0,8.582e-02,2.101e-02,3.505e-01,4.496e-02,7.240e-03,2.792e-01,7.801e-01,4.718e-02
NKX2-1,11825,RNA polymerase II regulatory region DNA binding,GO:0001012,molecular function,43.0,3.0,8.179e-02,2.184e-02,3.063e-01,1.193e-02,7.983e-03,1.784e-02,9.115e-01,6.478e-03
NKX2-1,11825,intronic transcription regulatory region DNA binding,GO:0044213,molecular function,43.0,3.0,8.179e-02,2.184e-02,3.063e-01,1.562e-02,8.216e-03,2.968e-02,8.902e-01,1.355e-02
NKX2-1,11825,RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000977,molecular function,43.0,9.0,8.211e-02,2.175e-02,3.101e-01,3.027e-02,1.188e-02,7.715e-02,8.273e-01,2.310e-02
NKX2-1,11825,DNA-binding transcription factor activity,GO:0003700,molecular function,43.0,12.0,8.514e-02,2.120e-02,3.419e-01,4.571e-02,1.307e-02,1.599e-01,7.818e-01,3.239e-02
NKX2-1,11825,DNA binding,GO:0003677,molecular function,43.0,27.0,8.514e-02,2.120e-02,3.419e-01,4.615e-02,1.025e-02,2.079e-01,7.793e-01,3.927e-02
NKX2-1,11825,transcription regulatory region DNA binding,GO:0044212,molecular function,43.0,18.0,8.582e-02,2.101e-02,3.505e-01,3.657e-02,3.633e-03,3.681e-01,7.960e-01,5.505e-02
NKX2-1,11825,sequence-specific DNA binding,GO:0043565,molecular function,43.0,10.0,8.941e-02,2.624e-02,3.047e-01,5.332e-02,2.390e-02,1.189e-01,7.657e-01,2.158e-02
NKX2-1,11825,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,43.0,16.0,9.154e-02,2.807e-02,2.985e-01,5.080e-02,2.007e-02,1.286e-01,7.705e-01,2.624e-02
NKX2-1,11825,protein binding,GO:0005515,molecular function,43.0,347.0,9.768e-02,3.284e-02,2.906e-01,7.094e-02,2.988e-02,1.684e-01,7.307e-01,2.584e-02
NKX2-1,11825,enzyme binding,GO:0019899,molecular function,43.0,35.0,1.674e-01,8.616e-02,3.253e-01,1.367e-01,4.290e-02,4.356e-01,6.356e-01,4.189e-02
NME2,7850,negative regulation of apoptotic process,GO:0043066,biological process,44.0,29.0,1.778e-01,1.334e-01,2.369e-01,3.368e-02,8.101e-03,1.400e-01,8.136e-01,3.743e-02
NME2,7850,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,44.0,62.0,1.778e-01,1.334e-01,2.369e-01,8.892e-02,3.275e-02,2.414e-01,7.001e-01,3.097e-02
NME2,7850,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,44.0,35.0,1.799e-01,1.400e-01,2.311e-01,1.045e-01,5.042e-02,2.168e-01,6.793e-01,2.448e-02
NME2,7850,positive regulation of keratinocyte differentiation,GO:0045618,biological process,44.0,6.0,1.950e-01,1.124e-01,3.381e-01,1.059e-01,2.352e-02,4.770e-01,6.710e-01,4.861e-02
NME2,7850,integrin-mediated signaling pathway,GO:0007229,biological process,44.0,2.0,2.058e-01,9.820e-02,4.313e-01,1.470e-01,6.853e-02,3.153e-01,6.273e-01,2.998e-02
NME2,7850,nucleoside triphosphate biosynthetic process,GO:0009142,biological process,44.0,7.0,2.077e-01,9.610e-02,4.491e-01,1.526e-01,6.936e-02,3.357e-01,6.207e-01,3.222e-02
NME2,7850,positive regulation of epithelial cell proliferation,GO:0050679,biological process,44.0,18.0,2.170e-01,8.688e-02,5.421e-01,1.036e-01,9.797e-03,1.096e+00,6.598e-01,8.049e-02
NME2,7850,regulation of apoptotic process,GO:0042981,biological process,44.0,23.0,2.222e-01,9.216e-02,5.356e-01,1.436e-01,2.600e-02,7.935e-01,6.197e-01,6.252e-02
NME2,7850,regulation of epidermis development,GO:0045682,biological process,44.0,6.0,2.308e-01,7.526e-02,7.075e-01,1.193e-01,1.398e-02,1.017e+00,6.382e-01,8.542e-02
NME2,7850,nucleoside diphosphate phosphorylation,GO:0006165,biological process,44.0,14.0,2.368e-01,7.078e-02,7.924e-01,1.749e-01,3.364e-02,9.094e-01,5.823e-01,7.557e-02
NME2,7850,purine nucleotide metabolic process,GO:0006163,biological process,44.0,8.0,2.451e-01,6.787e-02,8.849e-01,2.190e-01,4.869e-02,9.850e-01,5.403e-01,7.795e-02
NME2,7850,pyrimidine nucleotide metabolic process,GO:0006220,biological process,44.0,9.0,2.996e-01,1.170e-01,7.671e-01,2.940e-01,1.147e-01,7.538e-01,4.909e-01,5.484e-02
NME2,7850,nucleus,GO:0005634,cellular component,44.0,81.0,1.778e-01,1.334e-01,2.369e-01,4.908e-02,2.522e-02,9.550e-02,7.755e-01,1.844e-02
NME2,7850,cytoplasm,GO:0005737,cellular component,44.0,78.0,1.778e-01,1.334e-01,2.369e-01,8.691e-02,5.990e-02,1.261e-01,7.064e-01,1.211e-02
NME2,7850,ruffle,GO:0001726,cellular component,44.0,2.0,1.797e-01,1.311e-01,2.462e-01,7.792e-02,4.154e-02,1.461e-01,7.201e-01,1.873e-02
NME2,7850,extracellular exosome,GO:0070062,cellular component,44.0,77.0,1.825e-01,1.274e-01,2.617e-01,9.352e-02,5.950e-02,1.470e-01,6.964e-01,1.471e-02
NME2,7850,lamellipodium,GO:0030027,cellular component,44.0,4.0,1.871e-01,1.244e-01,2.813e-01,1.324e-01,8.409e-02,2.084e-01,6.457e-01,1.675e-02
NME2,7850,cell periphery,GO:0071944,cellular component,44.0,2.0,1.918e-01,1.150e-01,3.197e-01,1.110e-01,4.979e-02,2.476e-01,6.703e-01,2.749e-02
NME2,7850,G-quadruplex DNA binding,GO:0051880,molecular function,44.0,3.0,1.778e-01,1.334e-01,2.369e-01,2.990e-02,1.053e-02,8.491e-02,8.280e-01,2.655e-02
NME2,7850,DNA binding,GO:0003677,molecular function,44.0,27.0,1.778e-01,1.334e-01,2.369e-01,4.840e-02,1.385e-02,1.691e-01,7.740e-01,3.508e-02
NME2,7850,transcription coactivator activity,GO:0003713,molecular function,44.0,5.0,1.778e-01,1.334e-01,2.369e-01,6.043e-02,2.485e-02,1.470e-01,7.504e-01,2.524e-02
NME2,7850,GDP binding,GO:0019003,molecular function,44.0,4.0,1.818e-01,1.374e-01,2.404e-01,1.152e-01,7.726e-02,1.719e-01,6.669e-01,1.423e-02
NME2,7850,protein binding,GO:0005515,molecular function,44.0,347.0,1.825e-01,1.274e-01,2.617e-01,1.200e-01,8.524e-02,1.689e-01,6.611e-01,1.243e-02
NME2,7850,nucleoside diphosphate kinase activity,GO:0004550,molecular function,44.0,3.0,2.213e-01,1.365e-01,3.587e-01,1.192e-01,2.591e-02,5.479e-01,6.507e-01,6.025e-02
NMT1,7857,N-terminal peptidyl-glycine N-myristoylation,GO:0018008,biological process,17.0,3.0,1.484e-01,6.950e-02,3.168e-01,8.702e-02,7.873e-03,9.618e-01,6.882e-01,7.200e-02
NMT1,7857,cellular ketone metabolic process,GO:0042180,biological process,17.0,50.0,1.996e-01,1.523e-01,2.616e-01,1.996e-01,1.523e-01,2.616e-01,5.783e-01,1.192e-02
NMT1,7857,cytosol,GO:0005829,cellular component,17.0,76.0,1.498e-01,7.244e-02,3.098e-01,7.428e-02,5.612e-02,9.831e-02,7.274e-01,8.580e-03
NMT1,7857,cytoplasm,GO:0005737,cellular component,17.0,78.0,1.498e-01,7.244e-02,3.098e-01,9.719e-02,5.459e-02,1.730e-01,6.905e-01,1.888e-02
NMT1,7857,extrinsic component of membrane,GO:0019898,cellular component,17.0,8.0,1.498e-01,7.244e-02,3.098e-01,1.098e-01,6.960e-02,1.733e-01,6.737e-01,1.602e-02
NMT1,7857,plasma membrane,GO:0005886,cellular component,17.0,61.0,1.498e-01,7.244e-02,3.098e-01,1.135e-01,5.846e-02,2.202e-01,6.678e-01,2.298e-02
NMT1,7857,glycylpeptide N-tetradecanoyltransferase activity,GO:0004379,molecular function,17.0,3.0,1.369e-01,6.801e-02,2.754e-01,2.135e-02,1.529e-02,2.981e-02,8.631e-01,8.061e-03
NMT1,7857,myristoyltransferase activity,GO:0019107,molecular function,17.0,6.0,1.382e-01,7.061e-02,2.703e-01,4.463e-02,2.320e-02,8.584e-02,7.863e-01,1.701e-02
NMT1,7857,protein binding,GO:0005515,molecular function,17.0,347.0,1.498e-01,7.244e-02,3.098e-01,1.198e-01,5.343e-02,2.684e-01,6.590e-01,2.778e-02
NOMO1,30060,endoplasmic reticulum membrane,GO:0005789,cellular component,3.0,12.0,5.315e-02,3.792e-02,7.451e-02,3.465e-02,2.985e-02,4.022e-02,8.140e-01,3.645e-03
NOMO1,30060,membrane,GO:0016020,cellular component,3.0,58.0,5.630e-02,3.350e-02,9.463e-02,5.630e-02,3.350e-02,9.463e-02,7.601e-01,1.483e-02
NPHS2,13394,metanephric glomerular visceral epithelial cell development,GO:0072249,biological process,12.0,3.0,2.980e-01,9.661e-02,9.189e-01,2.571e-01,6.933e-02,9.538e-01,5.146e-01,6.394e-02
NPHS2,13394,actin cytoskeleton reorganization,GO:0031532,biological process,12.0,3.0,3.179e-01,1.411e-01,7.165e-01,2.926e-01,1.503e-01,5.697e-01,4.989e-01,3.390e-02
NPHS2,13394,membrane raft,GO:0045121,cellular component,12.0,8.0,2.147e-01,1.213e-01,3.801e-01,3.353e-02,1.350e-02,8.330e-02,8.165e-01,2.266e-02
NPHS2,13394,extracellular exosome,GO:0070062,cellular component,12.0,77.0,2.147e-01,1.213e-01,3.801e-01,7.364e-02,6.021e-02,9.006e-02,7.284e-01,6.134e-03
NPHS2,13394,intrinsic component of the cytoplasmic side of the plasma membrane,GO:0031235,cellular component,12.0,4.0,2.147e-01,1.213e-01,3.801e-01,7.899e-02,4.382e-02,1.424e-01,7.182e-01,1.875e-02
NPHS2,13394,plasma membrane,GO:0005886,cellular component,12.0,61.0,2.147e-01,1.213e-01,3.801e-01,9.332e-02,9.044e-02,9.629e-02,6.979e-01,1.073e-03
NPHS2,13394,cell-cell junction,GO:0005911,cellular component,12.0,17.0,2.928e-01,9.875e-02,8.679e-01,2.247e-01,7.562e-02,6.675e-01,5.475e-01,4.978e-02
NPHS2,13394,slit diaphragm,GO:0036057,cellular component,12.0,2.0,2.928e-01,9.875e-02,8.679e-01,2.307e-01,7.511e-02,7.083e-01,5.417e-01,5.164e-02
NPHS2,13394,protein-containing complex,GO:0032991,cellular component,12.0,483.0,3.577e-01,8.267e-02,1.547e+00,2.473e-01,1.964e-02,3.115e+00,4.827e-01,1.197e-01
NPHS2,13394,protein binding,GO:0005515,molecular function,12.0,347.0,2.553e-01,1.179e-01,5.531e-01,1.553e-01,1.390e-01,1.735e-01,6.214e-01,4.354e-03
NQO2,7856,oxidation-reduction process,GO:0055114,biological process,17.0,42.0,1.691e-01,2.838e-02,1.008e+00,1.226e-01,1.041e-02,1.444e+00,6.287e-01,9.160e-02
NQO2,7856,extracellular exosome,GO:0070062,cellular component,17.0,77.0,1.598e-01,2.711e-02,9.423e-01,9.005e-02,2.265e-02,3.580e-01,6.948e-01,4.659e-02
NQO2,7856,cytosol,GO:0005829,cellular component,17.0,76.0,1.774e-01,3.633e-02,8.667e-01,1.426e-01,3.917e-02,5.193e-01,6.258e-01,5.363e-02
NQO2,7856,nucleoplasm,GO:0005654,cellular component,17.0,51.0,1.927e-01,4.555e-02,8.152e-01,1.714e-01,4.848e-02,6.059e-01,5.941e-01,5.670e-02
NQO2,7856,dihydronicotinamide riboside quinone reductase activity,GO:0001512,molecular function,17.0,2.0,1.147e-01,1.072e-02,1.227e+00,1.653e-02,1.200e-03,2.277e-01,8.650e-01,5.647e-02
NQO2,7856,FAD binding,GO:0071949,molecular function,17.0,2.0,1.147e-01,1.072e-02,1.227e+00,2.897e-02,5.243e-04,1.601e+00,7.842e-01,9.574e-02
NQO2,7856,"oxidoreductase activity, acting on other nitrogenous compounds as donors",GO:0016661,molecular function,17.0,14.0,1.258e-01,1.431e-02,1.106e+00,4.183e-02,3.702e-03,4.725e-01,7.792e-01,7.209e-02
NQO2,7856,electron transfer activity,GO:0009055,molecular function,17.0,13.0,1.258e-01,1.431e-02,1.106e+00,4.465e-02,3.137e-03,6.356e-01,7.674e-01,8.165e-02
NQO2,7856,chloride ion binding,GO:0031404,molecular function,17.0,2.0,1.281e-01,1.510e-02,1.087e+00,6.523e-02,4.249e-03,1.001e+00,7.142e-01,9.564e-02
NQO2,7856,resveratrol binding,GO:1905594,molecular function,17.0,2.0,1.281e-01,1.510e-02,1.087e+00,6.876e-02,4.505e-03,1.049e+00,7.067e-01,9.751e-02
NQO2,7856,melatonin binding,GO:1904408,molecular function,17.0,6.0,1.319e-01,1.621e-02,1.074e+00,6.873e-02,7.353e-03,6.424e-01,7.179e-01,7.594e-02
NQO2,7856,NAD(P)H dehydrogenase (quinone) activity,GO:0003955,molecular function,17.0,2.0,1.337e-01,1.643e-02,1.089e+00,6.948e-02,2.810e-03,1.718e+00,6.975e-01,1.098e-01
NQO2,7856,protein homodimerization activity,GO:0042803,molecular function,17.0,21.0,1.542e-01,2.500e-02,9.514e-01,9.737e-02,1.873e-02,5.061e-01,6.795e-01,5.931e-02
NQO2,7856,zinc ion binding,GO:0008270,molecular function,17.0,8.0,1.592e-01,2.587e-02,9.796e-01,1.218e-01,1.395e-02,1.064e+00,6.316e-01,9.263e-02
NQO2,7856,protein binding,GO:0005515,molecular function,17.0,347.0,1.916e-01,4.484e-02,8.192e-01,1.610e-01,4.613e-02,5.622e-01,6.059e-01,5.360e-02
NQO2,7856,oxidoreductase activity,GO:0016491,molecular function,17.0,93.0,2.000e-01,1.395e-02,2.866e+00,1.510e-01,6.524e-03,3.495e+00,5.012e-01,2.061e-01
NSDHL,13398,cholesterol metabolic process,GO:0008203,biological process,7.0,7.0,1.488e-01,7.530e-02,2.941e-01,4.927e-02,9.878e-03,2.457e-01,7.686e-01,4.720e-02
NSDHL,13398,endoplasmic reticulum,GO:0005783,cellular component,7.0,34.0,1.871e-01,6.718e-02,5.210e-01,9.944e-02,3.574e-02,2.767e-01,6.844e-01,3.555e-02
NSDHL,13398,lipid droplet,GO:0005811,cellular component,7.0,10.0,1.985e-01,6.763e-02,5.826e-01,1.075e-01,2.535e-02,4.556e-01,6.684e-01,5.109e-02
NSDHL,13398,oxidoreductase activity,GO:0016491,molecular function,7.0,93.0,3.491e-01,9.741e-02,1.251e+00,2.657e-01,4.275e-02,1.652e+00,4.807e-01,1.108e-01
NSDHL,13398,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",GO:0016616,molecular function,7.0,347.0,4.843e-01,1.807e-01,1.298e+00,4.742e-01,1.858e-01,1.211e+00,3.613e-01,6.546e-02
NUDT15,23063,,,,nan,nan,,,,,,,,
OGN,8126,extracellular space,GO:0005615,cellular component,7.0,43.0,4.348e-02,2.215e-02,8.535e-02,1.990e-02,1.385e-02,2.859e-02,8.702e-01,8.663e-03
OGN,8126,collagen-containing extracellular matrix,GO:0062023,cellular component,7.0,36.0,4.348e-02,2.215e-02,8.535e-02,2.082e-02,1.431e-02,3.029e-02,8.656e-01,8.972e-03
OGN,8126,extracellular exosome,GO:0070062,cellular component,7.0,77.0,4.383e-02,2.232e-02,8.604e-02,2.444e-02,1.200e-02,4.979e-02,8.491e-01,1.691e-02
OGN,8126,extracellular vesicle,GO:1903561,cellular component,7.0,13.0,4.636e-02,1.940e-02,1.108e-01,2.224e-02,3.888e-03,1.273e-01,8.531e-01,4.232e-02
OGN,8126,extracellular region,GO:0005576,cellular component,7.0,17.0,4.827e-02,2.257e-02,1.033e-01,3.936e-02,2.452e-02,6.320e-02,8.002e-01,1.208e-02
OGN,8126,protein binding,GO:0005515,molecular function,7.0,347.0,5.767e-02,2.001e-02,1.662e-01,5.767e-02,2.001e-02,1.662e-01,7.552e-01,2.882e-02
OLFM1,17187,positive regulation of apoptotic process,GO:0043065,biological process,4.0,26.0,1.657e-01,3.441e-02,7.977e-01,1.469e-01,2.030e-02,1.063e+00,6.118e-01,7.088e-02
OLFM1,17187,protein binding,GO:0005515,molecular function,4.0,347.0,1.304e-01,4.066e-02,4.181e-01,8.214e-02,5.513e-02,1.224e-01,7.142e-01,1.246e-02
OLFML3,24956,extracellular vesicle,GO:1903561,cellular component,2.0,13.0,7.825e-02,1.554e-02,3.941e-01,7.825e-02,1.554e-02,3.941e-01,7.117e-01,4.981e-02
OMD,8134,,,,nan,nan,,,,,,,,
ONECUT3,13399,,,,nan,nan,,,,,,,,
OPA3,8142,visual perception,GO:0007601,biological process,4.0,3.0,4.325e-02,1.305e-02,1.433e-01,2.696e-02,6.478e-03,1.122e-01,8.355e-01,3.199e-02
OPA3,8142,regulation of lipid metabolic process,GO:0019216,biological process,4.0,14.0,1.044e-01,1.373e-02,7.939e-01,1.044e-01,1.373e-02,7.939e-01,6.631e-01,7.459e-02
OPA3,8142,mitochondrion,GO:0005739,cellular component,4.0,35.0,3.952e-02,1.367e-02,1.142e-01,1.849e-02,9.390e-03,3.639e-02,8.759e-01,1.565e-02
ORM1,8498,positive regulation of tumor necrosis factor secretion,GO:1904469,biological process,19.0,4.0,3.318e-02,1.294e-02,8.506e-02,8.444e-03,2.656e-03,2.684e-02,9.267e-01,1.601e-02
ORM1,8498,negative regulation of tumor necrosis factor production,GO:0032720,biological process,19.0,5.0,3.318e-02,1.294e-02,8.506e-02,1.012e-02,3.831e-03,2.675e-02,9.187e-01,1.227e-02
ORM1,8498,positive regulation of interleukin-1 beta secretion,GO:0050718,biological process,19.0,4.0,3.318e-02,1.294e-02,8.506e-02,1.168e-02,4.536e-03,3.010e-02,9.092e-01,1.567e-02
ORM1,8498,positive regulation of interleukin-1 secretion,GO:0050716,biological process,19.0,6.0,3.342e-02,1.303e-02,8.572e-02,1.055e-02,2.205e-03,5.044e-02,9.109e-01,1.976e-02
ORM1,8498,negative regulation of interleukin-6 production,GO:0032715,biological process,19.0,5.0,5.348e-02,2.390e-02,1.197e-01,2.773e-02,4.471e-03,1.720e-01,8.287e-01,3.998e-02
ORM1,8498,collagen-containing extracellular matrix,GO:0062023,cellular component,19.0,36.0,5.348e-02,2.484e-02,1.151e-01,3.248e-02,1.257e-02,8.390e-02,8.201e-01,2.337e-02
ORM1,8498,extracellular space,GO:0005615,cellular component,19.0,43.0,5.679e-02,3.228e-02,9.991e-02,3.211e-02,2.755e-02,3.741e-02,8.219e-01,3.841e-03
ORM1,8498,blood microparticle,GO:0072562,cellular component,19.0,8.0,5.872e-02,3.730e-02,9.243e-02,4.400e-02,3.898e-02,4.966e-02,7.889e-01,3.103e-03
ORM1,8498,extracellular exosome,GO:0070062,cellular component,19.0,77.0,6.100e-02,3.084e-02,1.207e-01,4.991e-02,2.523e-02,9.873e-02,7.736e-01,1.802e-02
ORM1,8498,extracellular region,GO:0005576,cellular component,19.0,17.0,7.213e-02,2.749e-02,1.893e-01,6.296e-02,2.091e-02,1.895e-01,7.444e-01,3.060e-02
ORM1,8498,protein binding,GO:0005515,molecular function,19.0,347.0,9.453e-02,4.313e-02,2.072e-01,9.453e-02,4.313e-02,2.072e-01,6.931e-01,2.507e-02
OSGIN1,30093,,,,nan,nan,,,,,,,,
PABPC1L,15797,,,,nan,nan,,,,,,,,
PAFAH1B2,8575,brain development,GO:0007420,biological process,15.0,6.0,8.283e-02,5.479e-02,1.252e-01,6.695e-02,3.910e-02,1.146e-01,7.394e-01,1.600e-02
PAFAH1B2,8575,positive regulation of macroautophagy,GO:0016239,biological process,15.0,9.0,2.687e-01,5.619e-02,1.285e+00,2.687e-01,5.619e-02,1.285e+00,4.997e-01,7.395e-02
PAFAH1B2,8575,cytosol,GO:0005829,cellular component,15.0,76.0,6.255e-02,3.639e-02,1.075e-01,2.646e-02,1.221e-02,5.737e-02,8.412e-01,1.907e-02
PAFAH1B2,8575,extracellular exosome,GO:0070062,cellular component,15.0,77.0,6.444e-02,4.016e-02,1.034e-01,2.872e-02,1.268e-02,6.504e-02,8.328e-01,2.007e-02
PAFAH1B2,8575,cytoplasm,GO:0005737,cellular component,15.0,78.0,6.631e-02,4.244e-02,1.036e-01,3.842e-02,2.741e-02,5.386e-02,8.030e-01,8.491e-03
PAFAH1B2,8575,nucleolus,GO:0005730,cellular component,15.0,18.0,6.845e-02,3.918e-02,1.196e-01,3.856e-02,1.247e-02,1.193e-01,8.009e-01,2.850e-02
PAFAH1B2,8575,plasma membrane,GO:0005886,cellular component,15.0,61.0,6.893e-02,4.730e-02,1.005e-01,3.855e-02,1.254e-02,1.185e-01,8.011e-01,2.838e-02
PAFAH1B2,8575,fibrillar center,GO:0001650,cellular component,15.0,6.0,7.718e-02,3.597e-02,1.656e-01,4.789e-02,7.677e-03,2.988e-01,7.729e-01,4.780e-02
PAFAH1B2,8575,platelet-activating factor acetyltransferase activity,GO:0047179,molecular function,15.0,2.0,6.436e-02,3.796e-02,1.091e-01,3.391e-02,9.136e-03,1.259e-01,8.137e-01,3.368e-02
PAFAH1B2,8575,protein binding,GO:0005515,molecular function,15.0,347.0,6.531e-02,4.179e-02,1.020e-01,2.919e-02,1.635e-02,5.212e-02,8.315e-01,1.432e-02
PAFAH2,8579,1-alkyl-2-acetylglycerophosphocholine esterase activity,GO:0003847,molecular function,10.0,2.0,1.087e-02,4.324e-03,2.734e-02,1.087e-02,4.324e-03,2.734e-02,9.142e-01,1.403e-02
PAK1IP1,20882,regulation of signal transduction by p53 class mediator,GO:1901796,biological process,5.0,6.0,5.863e-02,8.842e-03,3.888e-01,3.752e-02,2.913e-03,4.831e-01,7.905e-01,7.473e-02
PAK1IP1,20882,ribosomal large subunit biogenesis,GO:0042273,biological process,5.0,2.0,5.863e-02,8.842e-03,3.888e-01,3.880e-02,3.206e-03,4.697e-01,7.870e-01,7.229e-02
PAK1IP1,20882,nucleolus,GO:0005730,cellular component,5.0,18.0,6.026e-02,9.241e-03,3.930e-01,3.995e-02,8.991e-03,1.775e-01,7.949e-01,3.970e-02
PAK1IP1,20882,protein binding,GO:0005515,molecular function,5.0,347.0,7.798e-02,2.056e-02,2.958e-01,6.769e-02,2.851e-02,1.607e-01,7.364e-01,2.650e-02
PAK3,8592,signal transduction by protein phosphorylation,GO:0023014,biological process,12.0,6.0,9.419e-02,3.607e-02,2.459e-01,2.723e-02,5.266e-03,1.408e-01,8.342e-01,4.103e-02
PAK3,8592,regulation of mitotic cell cycle,GO:0007346,biological process,12.0,19.0,9.787e-02,3.431e-02,2.792e-01,2.102e-02,9.821e-03,4.498e-02,8.643e-01,1.838e-02
PAK3,8592,regulation of actin filament polymerization,GO:0030833,biological process,12.0,7.0,9.842e-02,3.403e-02,2.846e-01,3.067e-02,4.872e-03,1.930e-01,8.203e-01,4.709e-02
PAK3,8592,stress-activated protein kinase signaling cascade,GO:0031098,biological process,12.0,4.0,9.842e-02,3.403e-02,2.846e-01,4.751e-02,9.543e-03,2.365e-01,7.742e-01,4.469e-02
PAK3,8592,regulation of axonogenesis,GO:0050770,biological process,12.0,9.0,1.156e-01,6.834e-02,1.956e-01,5.196e-02,3.196e-02,8.448e-02,7.697e-01,1.366e-02
PAK3,8592,activation of protein kinase activity,GO:0032147,biological process,12.0,12.0,1.281e-01,9.284e-02,1.767e-01,6.893e-02,3.570e-02,1.331e-01,7.355e-01,1.934e-02
PAK3,8592,cytoplasm,GO:0005737,cellular component,12.0,78.0,1.428e-01,9.269e-02,2.199e-01,1.362e-01,7.638e-02,2.427e-01,6.410e-01,2.140e-02
PAK3,8592,MAP kinase kinase activity,GO:0004708,molecular function,12.0,3.0,1.322e-01,9.822e-02,1.779e-01,1.135e-01,9.579e-02,1.345e-01,6.696e-01,6.038e-03
PAK3,8592,protein binding,GO:0005515,molecular function,12.0,347.0,1.384e-01,8.892e-02,2.155e-01,1.244e-01,6.648e-02,2.329e-01,6.546e-01,2.321e-02
PAK3,8592,protein serine/threonine kinase activity,GO:0004674,molecular function,12.0,31.0,1.456e-01,1.212e-01,1.749e-01,1.305e-01,9.936e-02,1.713e-01,6.485e-01,1.012e-02
PCCA,8653,mitochondrial matrix,GO:0005759,cellular component,15.0,6.0,1.868e-02,1.149e-02,3.037e-02,8.262e-03,4.783e-03,1.427e-02,9.319e-01,6.122e-03
PCCA,8653,mitochondrion,GO:0005739,cellular component,15.0,35.0,2.069e-02,1.151e-02,3.721e-02,1.208e-02,6.377e-03,2.287e-02,9.093e-01,1.092e-02
PCCA,8653,propionyl-CoA carboxylase activity,GO:0004658,molecular function,15.0,2.0,1.868e-02,1.149e-02,3.037e-02,7.151e-03,4.050e-03,1.263e-02,9.384e-01,6.184e-03
PCCA,8653,protein binding,GO:0005515,molecular function,15.0,347.0,2.660e-02,1.607e-02,4.403e-02,2.225e-02,1.510e-02,3.278e-02,8.590e-01,9.514e-03
PCCA,8653,enzyme binding,GO:0019899,molecular function,15.0,35.0,3.431e-02,9.079e-03,1.296e-01,3.431e-02,9.079e-03,1.296e-01,8.120e-01,3.505e-02
PCDH7,8659,cell adhesion,GO:0007155,biological process,5.0,13.0,7.696e-02,4.860e-03,1.219e+00,6.653e-02,3.084e-03,1.435e+00,7.036e-01,1.103e-01
PCDH7,8659,integral component of plasma membrane,GO:0005887,cellular component,5.0,28.0,5.177e-02,9.140e-03,2.932e-01,2.203e-02,1.916e-03,2.532e-01,8.454e-01,5.989e-02
PCDH7,8659,plasma membrane,GO:0005886,cellular component,5.0,61.0,5.780e-02,1.221e-02,2.736e-01,5.050e-02,1.678e-02,1.520e-01,7.701e-01,3.124e-02
PCDHAC2,8677,cell adhesion,GO:0007155,biological process,6.0,13.0,3.873e-02,4.724e-04,3.176e+00,3.873e-02,4.724e-04,3.176e+00,7.325e-01,1.407e-01
PCDHAC2,8677,integral component of plasma membrane,GO:0005887,cellular component,6.0,28.0,1.793e-02,3.920e-04,8.203e-01,1.029e-02,2.805e-04,3.775e-01,8.786e-01,6.893e-02
PCLO,13406,,,,nan,nan,,,,,,,,
PCTP,8752,phospholipid transport,GO:0015914,biological process,6.0,12.0,2.127e-01,2.483e-02,1.822e+00,1.932e-01,1.759e-02,2.123e+00,5.303e-01,1.275e-01
PCTP,8752,phosphatidylcholine binding,GO:0031210,molecular function,6.0,4.0,8.354e-02,6.358e-02,1.097e-01,2.088e-02,1.590e-02,2.744e-02,8.654e-01,6.588e-03
PCTP,8752,phosphatidylcholine transporter activity,GO:0008525,molecular function,6.0,5.0,1.209e-01,4.701e-02,3.108e-01,7.300e-02,1.997e-02,2.668e-01,7.233e-01,4.215e-02
PCTP,8752,protein binding,GO:0005515,molecular function,6.0,347.0,1.281e-01,9.260e-02,1.771e-01,9.235e-02,4.425e-02,1.927e-01,6.967e-01,2.334e-02
PCYOX1,20588,prenylated protein catabolic process,GO:0030327,biological process,10.0,2.0,1.937e-01,1.861e-02,2.016e+00,1.741e-01,1.948e-02,1.556e+00,5.722e-01,9.154e-02
PCYOX1,20588,extracellular exosome,GO:0070062,cellular component,10.0,77.0,1.874e-01,1.954e-02,1.797e+00,8.087e-02,1.598e-02,4.092e-01,7.076e-01,4.814e-02
PCYOX1,20588,lysosome,GO:0005764,cellular component,10.0,13.0,1.937e-01,1.861e-02,2.016e+00,1.770e-01,1.597e-02,1.961e+00,5.646e-01,9.730e-02
PCYOX1,20588,very-low-density lipoprotein particle,GO:0034361,cellular component,10.0,2.0,1.937e-01,1.861e-02,2.016e+00,1.817e-01,1.535e-02,2.150e+00,5.549e-01,1.053e-01
PCYOX1,20588,prenylcysteine oxidase activity,GO:0001735,molecular function,10.0,2.0,1.874e-01,1.954e-02,1.797e+00,6.804e-02,5.270e-03,8.786e-01,7.200e-01,7.419e-02
PDE7A,8791,"3',5'-cyclic-AMP phosphodiesterase activity",GO:0004115,molecular function,5.0,2.0,1.219e-02,2.555e-03,5.812e-02,1.219e-02,2.555e-03,5.812e-02,8.999e-01,2.563e-02
PDGFRA,8803,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,GO:0038091,biological process,52.0,3.0,8.423e-02,7.031e-02,1.009e-01,8.286e-03,1.992e-03,3.446e-02,9.263e-01,1.693e-02
PDGFRA,8803,platelet-derived growth factor receptor signaling pathway,GO:0048008,biological process,52.0,5.0,8.423e-02,7.031e-02,1.009e-01,8.302e-03,1.145e-03,6.021e-02,9.211e-01,2.038e-02
PDGFRA,8803,protein autophosphorylation,GO:0046777,biological process,52.0,12.0,9.446e-02,6.998e-02,1.275e-01,1.431e-02,5.354e-03,3.823e-02,8.946e-01,1.668e-02
PDGFRA,8803,positive regulation of ERK1 and ERK2 cascade,GO:0070374,biological process,52.0,5.0,9.544e-02,6.850e-02,1.330e-01,1.410e-02,2.080e-03,9.564e-02,8.860e-01,3.704e-02
PDGFRA,8803,peptidyl-tyrosine phosphorylation,GO:0018108,biological process,52.0,9.0,9.544e-02,6.850e-02,1.330e-01,2.714e-02,2.161e-02,3.409e-02,8.390e-01,5.548e-03
PDGFRA,8803,platelet-derived growth factor receptor-alpha signaling pathway,GO:0035790,biological process,52.0,3.0,9.544e-02,6.850e-02,1.330e-01,2.813e-02,2.161e-02,3.663e-02,8.353e-01,6.449e-03
PDGFRA,8803,transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007169,biological process,52.0,24.0,9.544e-02,6.850e-02,1.330e-01,3.156e-02,9.508e-03,1.048e-01,8.218e-01,3.052e-02
PDGFRA,8803,phosphatidylinositol-mediated signaling,GO:0048015,biological process,52.0,3.0,9.919e-02,7.037e-02,1.398e-01,3.771e-02,1.909e-02,7.449e-02,8.041e-01,1.754e-02
PDGFRA,8803,positive regulation of fibroblast proliferation,GO:0048146,biological process,52.0,6.0,1.154e-01,1.132e-01,1.175e-01,4.744e-02,3.034e-02,7.417e-02,7.800e-01,1.189e-02
PDGFRA,8803,positive regulation of kinase activity,GO:0033674,biological process,52.0,15.0,1.199e-01,9.735e-02,1.476e-01,5.954e-02,3.392e-02,1.045e-01,7.537e-01,1.570e-02
PDGFRA,8803,cell chemotaxis,GO:0060326,biological process,52.0,19.0,1.213e-01,1.012e-01,1.453e-01,6.309e-02,4.343e-02,9.167e-02,7.470e-01,1.092e-02
PDGFRA,8803,platelet aggregation,GO:0070527,biological process,52.0,3.0,1.231e-01,1.041e-01,1.456e-01,6.947e-02,4.467e-02,1.081e-01,7.351e-01,1.286e-02
PDGFRA,8803,positive regulation of phospholipase C activity,GO:0010863,biological process,52.0,4.0,1.312e-01,1.026e-01,1.677e-01,6.843e-02,2.565e-02,1.826e-01,7.347e-01,2.842e-02
PDGFRA,8803,hematopoietic progenitor cell differentiation,GO:0002244,biological process,52.0,6.0,1.315e-01,8.361e-02,2.068e-01,7.483e-02,2.318e-02,2.416e-01,7.213e-01,3.789e-02
PDGFRA,8803,regulation of chemotaxis,GO:0050920,biological process,52.0,20.0,1.352e-01,1.029e-01,1.775e-01,8.608e-02,5.277e-02,1.404e-01,7.077e-01,1.523e-02
PDGFRA,8803,positive regulation of phosphatidylinositol 3-kinase activity,GO:0043552,biological process,52.0,5.0,1.395e-01,1.022e-01,1.905e-01,9.875e-02,4.440e-02,2.196e-01,6.872e-01,2.722e-02
PDGFRA,8803,cellular response to reactive oxygen species,GO:0034614,biological process,52.0,11.0,1.416e-01,8.144e-02,2.460e-01,8.423e-02,1.873e-02,3.788e-01,7.026e-01,4.936e-02
PDGFRA,8803,positive regulation of cell migration,GO:0030335,biological process,52.0,33.0,1.418e-01,9.478e-02,2.120e-01,9.667e-02,3.998e-02,2.338e-01,6.895e-01,2.947e-02
PDGFRA,8803,positive regulation of cell population proliferation,GO:0008284,biological process,52.0,40.0,1.504e-01,1.180e-01,1.917e-01,1.136e-01,9.811e-02,1.315e-01,6.695e-01,5.222e-03
PDGFRA,8803,positive regulation of cytosolic calcium ion concentration,GO:0007204,biological process,52.0,11.0,1.654e-01,1.515e-01,1.805e-01,1.424e-01,1.289e-01,1.573e-01,6.350e-01,3.747e-03
PDGFRA,8803,negative regulation of platelet activation,GO:0010544,biological process,52.0,5.0,1.700e-01,1.164e-01,2.483e-01,1.391e-01,6.085e-02,3.179e-01,6.359e-01,3.105e-02
PDGFRA,8803,multicellular organism development,GO:0007275,biological process,52.0,16.0,1.830e-01,8.736e-02,3.832e-01,1.550e-01,5.368e-02,4.478e-01,6.156e-01,4.314e-02
PDGFRA,8803,regulation of mesenchymal stem cell differentiation,GO:2000739,biological process,52.0,5.0,1.946e-01,1.132e-01,3.343e-01,1.770e-01,9.238e-02,3.391e-01,5.971e-01,2.657e-02
PDGFRA,8803,intrinsic component of plasma membrane,GO:0031226,cellular component,52.0,8.0,9.544e-02,6.850e-02,1.330e-01,1.344e-02,1.824e-03,9.899e-02,8.882e-01,3.637e-02
PDGFRA,8803,integral component of plasma membrane,GO:0005887,cellular component,52.0,28.0,9.544e-02,6.850e-02,1.330e-01,2.554e-02,2.150e-02,3.033e-02,8.450e-01,4.242e-03
PDGFRA,8803,receptor complex,GO:0043235,cellular component,52.0,29.0,1.001e-01,6.175e-02,1.621e-01,3.548e-02,5.195e-03,2.423e-01,8.041e-01,5.177e-02
PDGFRA,8803,plasma membrane,GO:0005886,cellular component,52.0,61.0,1.433e-01,1.193e-01,1.721e-01,1.016e-01,8.140e-02,1.268e-01,6.854e-01,7.571e-03
PDGFRA,8803,membrane,GO:0016020,cellular component,52.0,58.0,1.680e-01,7.847e-02,3.595e-01,1.274e-01,3.376e-02,4.805e-01,6.446e-01,4.752e-02
PDGFRA,8803,nucleoplasm,GO:0005654,cellular component,52.0,51.0,1.938e-01,9.276e-02,4.050e-01,1.659e-01,5.112e-02,5.383e-01,6.035e-01,4.508e-02
PDGFRA,8803,cell junction,GO:0030054,cellular component,52.0,10.0,2.003e-01,1.811e-01,2.215e-01,1.866e-01,1.663e-01,2.095e-01,5.907e-01,4.861e-03
PDGFRA,8803,protein-containing complex,GO:0032991,cellular component,52.0,483.0,2.216e-01,1.045e-01,4.700e-01,2.050e-01,8.247e-02,5.094e-01,5.676e-01,4.209e-02
PDGFRA,8803,vascular endothelial growth factor binding,GO:0038085,molecular function,52.0,2.0,9.919e-02,7.037e-02,1.398e-01,2.906e-02,2.090e-02,4.039e-02,8.318e-01,8.056e-03
PDGFRA,8803,transmembrane receptor protein tyrosine kinase activity,GO:0004714,molecular function,52.0,21.0,9.919e-02,7.037e-02,1.398e-01,3.730e-02,2.249e-02,6.189e-02,8.059e-01,1.298e-02
PDGFRA,8803,vascular endothelial growth factor-activated receptor activity,GO:0005021,molecular function,52.0,7.0,1.015e-01,6.991e-02,1.475e-01,3.026e-02,1.370e-02,6.683e-02,8.273e-01,1.974e-02
PDGFRA,8803,growth factor binding,GO:0019838,molecular function,52.0,21.0,1.076e-01,5.217e-02,2.221e-01,3.012e-02,2.008e-03,4.519e-01,8.118e-01,7.452e-02
PDGFRA,8803,platelet-derived growth factor receptor binding,GO:0005161,molecular function,52.0,2.0,1.213e-01,1.012e-01,1.453e-01,4.666e-02,1.511e-02,1.441e-01,7.793e-01,2.978e-02
PDGFRA,8803,protein kinase activity,GO:0004672,molecular function,52.0,33.0,1.295e-01,1.039e-01,1.615e-01,7.319e-02,4.658e-02,1.150e-01,7.287e-01,1.339e-02
PDGFRA,8803,platelet-derived growth factor alpha-receptor activity,GO:0005018,molecular function,52.0,2.0,1.296e-01,1.114e-01,1.507e-01,7.468e-02,6.937e-02,8.040e-02,7.267e-01,2.293e-03
PDGFRA,8803,platelet-derived growth factor binding,GO:0048407,molecular function,52.0,4.0,1.337e-01,9.698e-02,1.843e-01,6.999e-02,3.210e-02,1.526e-01,7.325e-01,2.420e-02
PDGFRA,8803,protein homodimerization activity,GO:0042803,molecular function,52.0,21.0,1.552e-01,1.149e-01,2.096e-01,1.211e-01,7.888e-02,1.861e-01,6.594e-01,1.531e-02
PDGFRA,8803,protein binding,GO:0005515,molecular function,52.0,347.0,1.585e-01,1.262e-01,1.992e-01,1.314e-01,1.046e-01,1.652e-01,6.474e-01,8.349e-03
PDHA1,8806,acetyl-CoA biosynthetic process from pyruvate,GO:0006086,biological process,34.0,4.0,3.055e-02,2.020e-02,4.620e-02,1.829e-02,1.613e-02,2.074e-02,8.786e-01,2.903e-03
PDHA1,8806,mitochondrion,GO:0005739,cellular component,34.0,35.0,3.055e-02,2.020e-02,4.620e-02,9.539e-03,2.431e-03,3.742e-02,9.186e-01,1.779e-02
PDHA1,8806,nucleolus,GO:0005730,cellular component,34.0,18.0,3.055e-02,2.020e-02,4.620e-02,1.621e-02,9.896e-03,2.656e-02,8.880e-01,1.017e-02
PDHA1,8806,nucleus,GO:0005634,cellular component,34.0,81.0,3.182e-02,1.908e-02,5.306e-02,2.376e-02,1.225e-02,4.610e-02,8.519e-01,1.593e-02
PDHA1,8806,pyruvate dehydrogenase complex,GO:0045254,cellular component,34.0,7.0,3.240e-02,1.917e-02,5.474e-02,2.398e-02,6.520e-03,8.822e-02,8.470e-01,2.840e-02
PDHA1,8806,mitochondrial pyruvate dehydrogenase complex,GO:0005967,cellular component,34.0,3.0,4.371e-02,2.952e-02,6.473e-02,4.141e-02,2.997e-02,5.722e-02,7.952e-01,8.165e-03
PDHA1,8806,protein binding,GO:0005515,molecular function,34.0,347.0,3.182e-02,1.908e-02,5.306e-02,2.079e-02,7.888e-03,5.480e-02,8.627e-01,2.099e-02
PDHA1,8806,pyruvate dehydrogenase (acetyl-transferring) activity,GO:0004739,molecular function,34.0,3.0,4.149e-02,2.203e-02,7.814e-02,2.664e-02,6.527e-03,1.087e-01,8.384e-01,3.525e-02
PDHX,21350,pyruvate dehydrogenase complex,GO:0045254,cellular component,16.0,7.0,1.914e-02,1.776e-03,2.064e-01,1.431e-02,9.892e-04,2.071e-01,8.741e-01,4.479e-02
PDHX,21350,pyruvate dehydrogenase (NAD+) activity,GO:0034604,molecular function,16.0,3.0,1.685e-02,1.978e-03,1.436e-01,6.923e-03,1.592e-03,3.010e-02,9.351e-01,1.511e-02
PDHX,21350,protein binding,GO:0005515,molecular function,16.0,347.0,3.825e-02,2.174e-02,6.728e-02,3.825e-02,2.174e-02,6.728e-02,8.030e-01,1.468e-02
PDK4,8812,regulation of acetyl-CoA biosynthetic process from pyruvate,GO:0010510,biological process,19.0,2.0,9.768e-02,3.322e-02,2.872e-01,1.773e-02,1.043e-03,3.014e-01,8.544e-01,5.241e-02
PDK4,8812,negative regulation of anoikis,GO:2000811,biological process,19.0,3.0,1.045e-01,4.409e-02,2.479e-01,4.396e-02,1.596e-02,1.211e-01,7.868e-01,2.618e-02
PDK4,8812,regulation of fatty acid biosynthetic process,GO:0042304,biological process,19.0,12.0,1.092e-01,4.074e-02,2.927e-01,3.992e-02,6.637e-03,2.401e-01,7.932e-01,4.613e-02
PDK4,8812,insulin receptor signaling pathway,GO:0008286,biological process,19.0,5.0,1.110e-01,6.458e-02,1.909e-01,4.782e-02,8.489e-03,2.694e-01,7.739e-01,4.511e-02
PDK4,8812,regulation of glucose metabolic process,GO:0010906,biological process,19.0,9.0,1.126e-01,3.835e-02,3.308e-01,4.944e-02,5.236e-03,4.668e-01,7.624e-01,6.630e-02
PDK4,8812,glucose homeostasis,GO:0042593,biological process,19.0,5.0,1.126e-01,3.835e-02,3.308e-01,7.933e-02,2.931e-02,2.147e-01,7.155e-01,3.099e-02
PDK4,8812,negative regulation of pyruvate dehydrogenase activity,GO:1904183,biological process,19.0,3.0,1.341e-01,2.647e-02,6.797e-01,4.920e-02,2.182e-03,1.109e+00,7.450e-01,1.034e-01
PDK4,8812,cellular response to starvation,GO:0009267,biological process,19.0,28.0,1.509e-01,3.548e-02,6.420e-01,1.161e-01,1.874e-02,7.188e-01,6.523e-01,6.206e-02
PDK4,8812,cellular response to fatty acid,GO:0071398,biological process,19.0,15.0,2.223e-01,3.630e-02,1.361e+00,1.888e-01,2.169e-02,1.643e+00,5.467e-01,1.119e-01
PDK4,8812,reactive oxygen species metabolic process,GO:0072593,biological process,19.0,7.0,2.610e-01,1.053e-01,6.468e-01,2.445e-01,8.626e-02,6.931e-01,5.297e-01,5.441e-02
PDK4,8812,mitochondrion,GO:0005739,cellular component,19.0,35.0,1.021e-01,4.584e-02,2.275e-01,4.263e-02,1.684e-02,1.079e-01,7.900e-01,2.512e-02
PDK4,8812,protein serine/threonine kinase activity,GO:0004674,molecular function,19.0,31.0,1.021e-01,4.584e-02,2.275e-01,3.458e-02,2.628e-02,4.551e-02,8.142e-01,6.839e-03
PDK4,8812,protein kinase activity,GO:0004672,molecular function,19.0,33.0,1.045e-01,4.409e-02,2.479e-01,5.804e-02,3.868e-02,8.708e-02,7.570e-01,1.141e-02
PDK4,8812,ATP binding,GO:0005524,molecular function,19.0,10.0,1.116e-01,4.076e-02,3.053e-01,8.114e-02,3.780e-02,1.742e-01,7.140e-01,2.309e-02
PDZD11,28034,pore complex assembly,GO:0046931,biological process,12.0,3.0,1.533e-01,3.097e-02,7.592e-01,5.885e-02,3.570e-03,9.703e-01,7.326e-01,8.411e-02
PDZD11,28034,protein localization to basolateral plasma membrane,GO:1903361,biological process,12.0,3.0,1.919e-01,1.686e-01,2.185e-01,7.006e-02,5.031e-02,9.756e-02,7.345e-01,1.001e-02
PDZD11,28034,neurotransmitter secretion,GO:0007269,biological process,12.0,24.0,2.762e-01,1.305e-01,5.848e-01,2.219e-01,7.309e-02,6.738e-01,5.479e-01,5.614e-02
PDZD11,28034,maintenance of epithelial cell apical/basal polarity,GO:0045199,biological process,12.0,3.0,3.454e-01,2.108e-01,5.658e-01,3.268e-01,2.118e-01,5.043e-01,4.761e-01,2.433e-02
PDZD11,28034,pore complex,GO:0046930,cellular component,12.0,5.0,1.812e-01,9.237e-02,3.554e-01,5.913e-02,5.049e-03,6.925e-01,7.398e-01,6.787e-02
PDZD11,28034,cell-cell junction,GO:0005911,cellular component,12.0,17.0,1.824e-01,2.805e-02,1.187e+00,9.654e-02,3.233e-03,2.883e+00,6.495e-01,1.104e-01
PDZD11,28034,basolateral plasma membrane,GO:0016323,cellular component,12.0,5.0,2.141e-01,1.892e-01,2.423e-01,1.047e-01,3.678e-02,2.980e-01,6.769e-01,3.451e-02
PDZD11,28034,synapse,GO:0045202,cellular component,12.0,21.0,2.524e-01,1.617e-01,3.941e-01,1.703e-01,5.833e-02,4.974e-01,6.002e-01,4.173e-02
PDZD11,28034,protein binding,GO:0005515,molecular function,12.0,347.0,2.038e-01,1.598e-01,2.601e-01,1.015e-01,6.561e-02,1.571e-01,6.851e-01,1.493e-02
PELP1,30134,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,15.0,62.0,8.964e-02,3.614e-02,2.223e-01,3.852e-02,1.709e-02,8.680e-02,8.015e-01,2.112e-02
PELP1,30134,cellular response to estrogen stimulus,GO:0071391,biological process,15.0,3.0,9.934e-02,5.082e-02,1.942e-01,7.972e-02,6.117e-02,1.039e-01,7.183e-01,8.118e-03
PELP1,30134,nucleolus,GO:0005730,cellular component,15.0,18.0,8.964e-02,3.614e-02,2.223e-01,3.700e-02,1.469e-02,9.323e-02,8.060e-01,2.325e-02
PELP1,30134,nucleoplasm,GO:0005654,cellular component,15.0,51.0,8.964e-02,3.614e-02,2.223e-01,5.035e-02,3.208e-02,7.902e-02,7.732e-01,1.204e-02
PELP1,30134,MLL1 complex,GO:0071339,cellular component,15.0,2.0,1.080e-01,2.678e-02,4.360e-01,9.519e-02,2.351e-02,3.853e-01,6.868e-01,4.758e-02
PELP1,30134,transcriptionally active chromatin,GO:0035327,cellular component,15.0,2.0,1.224e-01,2.040e-02,7.340e-01,7.194e-02,5.437e-03,9.519e-01,7.041e-01,9.185e-02
PELP1,30134,transcription factor binding,GO:0008134,molecular function,15.0,9.0,8.775e-02,3.611e-02,2.133e-01,3.001e-02,4.434e-03,2.031e-01,8.206e-01,4.317e-02
PELP1,30134,protein binding,GO:0005515,molecular function,15.0,347.0,8.964e-02,3.614e-02,2.223e-01,4.700e-02,1.266e-02,1.745e-01,7.769e-01,3.704e-02
PELP1,30134,chromatin binding,GO:0003682,molecular function,15.0,9.0,9.120e-02,3.534e-02,2.354e-01,7.426e-02,2.680e-02,2.057e-01,7.242e-01,2.981e-02
PELP1,30134,RNA binding,GO:0003723,molecular function,15.0,60.0,1.002e-01,3.041e-02,3.300e-01,7.223e-02,1.333e-02,3.913e-01,7.220e-01,4.922e-02
PGAM1,8888,regulation of glycolytic process,GO:0006110,biological process,16.0,10.0,9.038e-02,3.253e-02,2.512e-01,4.404e-02,1.095e-02,1.771e-01,7.845e-01,3.807e-02
PGAM1,8888,glycolytic process,GO:0006096,biological process,16.0,13.0,9.209e-02,3.198e-02,2.652e-01,6.820e-02,2.265e-02,2.053e-01,7.339e-01,3.357e-02
PGAM1,8888,regulation of pentose-phosphate shunt,GO:0043456,biological process,16.0,10.0,1.004e-01,2.905e-02,3.469e-01,7.208e-02,1.923e-02,2.703e-01,7.251e-01,4.023e-02
PGAM1,8888,respiratory burst,GO:0045730,biological process,16.0,4.0,1.302e-01,2.531e-02,6.694e-01,1.179e-01,1.934e-02,7.191e-01,6.508e-01,5.975e-02
PGAM1,8888,extracellular exosome,GO:0070062,cellular component,16.0,77.0,8.724e-02,3.355e-02,2.268e-01,2.890e-02,2.409e-02,3.468e-02,8.324e-01,4.470e-03
PGAM1,8888,cytosol,GO:0005829,cellular component,16.0,76.0,8.724e-02,3.355e-02,2.268e-01,4.123e-02,2.443e-02,6.958e-02,7.951e-01,1.354e-02
PGAM1,8888,cytoplasm,GO:0005737,cellular component,16.0,78.0,8.724e-02,3.355e-02,2.268e-01,4.469e-02,2.375e-02,8.412e-02,7.860e-01,1.640e-02
PGAM1,8888,membrane,GO:0016020,cellular component,16.0,58.0,9.129e-02,3.798e-02,2.194e-01,7.070e-02,4.406e-02,1.135e-01,7.328e-01,1.391e-02
PGAM1,8888,protein kinase binding,GO:0019901,molecular function,16.0,16.0,8.854e-02,3.319e-02,2.361e-01,5.169e-02,1.258e-02,2.123e-01,7.661e-01,3.848e-02
PGAM1,8888,protein binding,GO:0005515,molecular function,16.0,347.0,8.995e-02,3.840e-02,2.108e-01,4.232e-02,2.823e-02,6.345e-02,7.925e-01,1.075e-02
PGAM1,8888,phosphoglycerate mutase activity,GO:0004619,molecular function,16.0,4.0,1.140e-01,2.352e-02,5.526e-01,8.158e-02,8.551e-03,7.782e-01,6.969e-01,7.313e-02
PGD,8891,"pentose-phosphate shunt, oxidative branch",GO:0009051,biological process,14.0,3.0,4.505e-02,5.794e-03,3.503e-01,1.815e-02,7.737e-04,4.256e-01,8.484e-01,7.392e-02
PGD,8891,D-gluconate catabolic process,GO:0046177,biological process,14.0,3.0,4.505e-02,5.794e-03,3.503e-01,2.738e-02,1.523e-03,4.920e-01,8.178e-01,7.653e-02
PGD,8891,oxidation-reduction process,GO:0055114,biological process,14.0,42.0,5.037e-02,8.219e-03,3.087e-01,3.242e-02,2.602e-03,4.040e-01,8.062e-01,6.890e-02
PGD,8891,extracellular exosome,GO:0070062,cellular component,14.0,77.0,5.309e-02,9.890e-03,2.850e-01,2.778e-02,9.766e-03,7.904e-02,8.355e-01,2.518e-02
PGD,8891,cytosol,GO:0005829,cellular component,14.0,76.0,6.013e-02,1.297e-02,2.788e-01,3.955e-02,2.074e-02,7.540e-02,7.993e-01,1.673e-02
PGD,8891,nucleus,GO:0005634,cellular component,14.0,81.0,6.563e-02,1.686e-02,2.554e-01,5.567e-02,2.500e-02,1.240e-01,7.606e-01,2.315e-02
PGD,8891,NADP binding,GO:0050661,molecular function,14.0,5.0,4.384e-02,6.169e-03,3.116e-01,1.874e-02,5.602e-03,6.271e-02,8.703e-01,2.516e-02
PGD,8891,phosphogluconate dehydrogenase (decarboxylating) activity,GO:0004616,molecular function,14.0,2.0,4.505e-02,5.794e-03,3.503e-01,1.917e-02,7.770e-04,4.728e-01,8.429e-01,6.806e-02
PGM3,8907,UDP-N-acetylglucosamine biosynthetic process,GO:0006048,biological process,6.0,5.0,4.004e-02,9.620e-03,1.666e-01,1.512e-02,8.281e-03,2.760e-02,8.930e-01,1.240e-02
PGM3,8907,hemopoiesis,GO:0030097,biological process,6.0,6.0,4.004e-02,9.620e-03,1.666e-01,1.956e-02,1.123e-03,3.407e-01,8.471e-01,5.986e-02
PGM3,8907,protein N-linked glycosylation,GO:0006487,biological process,6.0,7.0,4.742e-02,1.096e-02,2.052e-01,3.638e-02,9.260e-03,1.429e-01,8.064e-01,3.416e-02
PGM3,8907,protein O-linked glycosylation,GO:0006493,biological process,6.0,11.0,7.336e-02,3.550e-02,1.516e-01,6.623e-02,3.398e-02,1.291e-01,7.404e-01,1.969e-02
PGM3,8907,phosphoacetylglucosamine mutase activity,GO:0004610,molecular function,6.0,2.0,4.004e-02,9.620e-03,1.666e-01,2.608e-02,3.308e-03,2.056e-01,8.336e-01,5.000e-02
PHTF2,13411,,,,nan,nan,,,,,,,,
PITX3,9006,,,,nan,nan,,,,,,,,
PKM,9021,cellular response to insulin stimulus,GO:0032869,biological process,63.0,4.0,2.607e-02,2.271e-02,2.994e-02,1.538e-02,5.010e-03,4.724e-02,8.872e-01,1.952e-02
PKM,9021,glycolytic process,GO:0006096,biological process,63.0,13.0,2.816e-02,1.697e-02,4.673e-02,2.347e-02,1.035e-02,5.319e-02,8.532e-01,2.000e-02
PKM,9021,positive regulation of sprouting angiogenesis,GO:1903672,biological process,63.0,6.0,5.002e-02,2.359e-02,1.061e-01,4.530e-02,1.999e-02,1.027e-01,7.839e-01,2.211e-02
PKM,9021,programmed cell death,GO:0012501,biological process,63.0,12.0,8.746e-02,1.938e-02,3.946e-01,8.571e-02,1.775e-02,4.138e-01,7.000e-01,4.785e-02
PKM,9021,extracellular exosome,GO:0070062,cellular component,63.0,77.0,2.554e-02,2.138e-02,3.050e-02,3.917e-03,1.300e-03,1.180e-02,9.583e-01,7.250e-03
PKM,9021,cytosol,GO:0005829,cellular component,63.0,76.0,2.554e-02,2.138e-02,3.050e-02,8.759e-03,3.164e-03,2.425e-02,9.265e-01,1.280e-02
PKM,9021,vesicle,GO:0031982,cellular component,63.0,6.0,2.554e-02,2.138e-02,3.050e-02,1.313e-02,7.367e-03,2.342e-02,9.043e-01,9.126e-03
PKM,9021,nucleus,GO:0005634,cellular component,63.0,81.0,2.554e-02,2.138e-02,3.050e-02,1.353e-02,8.388e-03,2.183e-02,9.024e-01,8.654e-03
PKM,9021,cytoplasm,GO:0005737,cellular component,63.0,78.0,2.554e-02,2.138e-02,3.050e-02,1.424e-02,8.055e-03,2.519e-02,8.980e-01,1.077e-02
PKM,9021,mitochondrion,GO:0005739,cellular component,63.0,35.0,2.554e-02,2.138e-02,3.050e-02,1.506e-02,1.095e-02,2.070e-02,8.951e-01,6.384e-03
PKM,9021,collagen-containing extracellular matrix,GO:0062023,cellular component,63.0,36.0,2.554e-02,2.138e-02,3.050e-02,1.709e-02,1.257e-02,2.323e-02,8.843e-01,6.450e-03
PKM,9021,extracellular vesicle,GO:1903561,cellular component,63.0,13.0,2.554e-02,2.138e-02,3.050e-02,1.696e-02,9.904e-03,2.905e-02,8.841e-01,1.204e-02
PKM,9021,cadherin binding,GO:0045296,molecular function,63.0,13.0,2.554e-02,2.138e-02,3.050e-02,7.201e-03,4.965e-03,1.044e-02,9.388e-01,3.864e-03
PKM,9021,protein binding,GO:0005515,molecular function,63.0,347.0,2.554e-02,2.138e-02,3.050e-02,1.288e-02,9.812e-03,1.691e-02,9.069e-01,4.417e-03
PKM,9021,MHC class II protein complex binding,GO:0023026,molecular function,63.0,2.0,2.554e-02,2.138e-02,3.050e-02,1.740e-02,1.169e-02,2.590e-02,8.824e-01,8.396e-03
PKM,9021,RNA binding,GO:0003723,molecular function,63.0,60.0,2.554e-02,2.138e-02,3.050e-02,1.862e-02,1.277e-02,2.713e-02,8.765e-01,8.821e-03
PKM,9021,pyruvate kinase activity,GO:0004743,molecular function,63.0,2.0,3.989e-02,2.203e-02,7.225e-02,3.038e-02,9.192e-03,1.004e-01,8.258e-01,2.863e-02
PKP1,9023,negative regulation of mRNA catabolic process,GO:1902373,biological process,18.0,9.0,1.109e-01,6.202e-02,1.982e-01,5.102e-02,3.440e-02,7.569e-02,7.720e-01,1.082e-02
PKP1,9023,positive regulation of gene expression,GO:0010628,biological process,18.0,23.0,1.144e-01,6.250e-02,2.093e-01,5.048e-02,9.227e-03,2.762e-01,7.658e-01,4.905e-02
PKP1,9023,intermediate filament bundle assembly,GO:0045110,biological process,18.0,4.0,1.283e-01,8.440e-02,1.949e-01,8.489e-02,5.300e-02,1.360e-01,7.094e-01,1.517e-02
PKP1,9023,cell-cell adhesion,GO:0098609,biological process,18.0,23.0,1.516e-01,8.263e-02,2.782e-01,9.167e-02,1.469e-02,5.722e-01,6.877e-01,5.671e-02
PKP1,9023,cell-cell junction assembly,GO:0007043,biological process,18.0,10.0,1.569e-01,6.681e-02,3.682e-01,8.808e-02,9.366e-03,8.282e-01,6.869e-01,7.156e-02
PKP1,9023,adherens junction,GO:0005912,cellular component,18.0,6.0,1.109e-01,6.202e-02,1.982e-01,2.561e-02,9.877e-03,6.642e-02,8.443e-01,2.344e-02
PKP1,9023,messenger ribonucleoprotein complex,GO:1990124,cellular component,18.0,3.0,1.109e-01,6.202e-02,1.982e-01,4.438e-02,1.555e-02,1.267e-01,7.851e-01,2.832e-02
PKP1,9023,nucleus,GO:0005634,cellular component,18.0,81.0,1.131e-01,5.992e-02,2.134e-01,6.194e-02,3.086e-02,1.243e-01,7.483e-01,1.953e-02
PKP1,9023,nucleoplasm,GO:0005654,cellular component,18.0,51.0,1.154e-01,5.769e-02,2.308e-01,6.325e-02,2.591e-02,1.544e-01,7.450e-01,2.575e-02
PKP1,9023,cytoplasm,GO:0005737,cellular component,18.0,78.0,1.313e-01,8.860e-02,1.945e-01,9.225e-02,6.333e-02,1.344e-01,6.986e-01,1.200e-02
PKP1,9023,plasma membrane,GO:0005886,cellular component,18.0,61.0,1.420e-01,7.136e-02,2.825e-01,9.354e-02,2.876e-02,3.042e-01,6.914e-01,3.998e-02
PKP1,9023,cell-cell junction,GO:0005911,cellular component,18.0,17.0,1.830e-01,6.997e-02,4.784e-01,1.823e-01,6.919e-02,4.804e-01,5.882e-01,4.312e-02
PKP1,9023,lamin binding,GO:0005521,molecular function,18.0,2.0,1.109e-01,6.202e-02,1.982e-01,1.256e-02,4.197e-03,3.761e-02,9.033e-01,1.663e-02
PKP1,9023,cadherin binding,GO:0045296,molecular function,18.0,13.0,1.157e-01,6.070e-02,2.207e-01,6.813e-02,2.770e-02,1.676e-01,7.356e-01,2.693e-02
PKP1,9023,protein binding,GO:0005515,molecular function,18.0,347.0,1.428e-01,7.246e-02,2.814e-01,1.079e-01,5.685e-02,2.049e-01,6.755e-01,2.290e-02
PLD1,9067,regulation of microvillus assembly,GO:0032534,biological process,20.0,5.0,6.041e-02,2.914e-02,1.252e-01,5.669e-02,2.670e-02,1.204e-01,7.587e-01,2.076e-02
PLD1,9067,cell motility,GO:0048870,biological process,20.0,16.0,6.507e-02,1.154e-02,3.669e-01,4.624e-02,4.735e-03,4.516e-01,7.693e-01,6.792e-02
PLD1,9067,regulation of synaptic vesicle cycle,GO:0098693,biological process,20.0,7.0,1.476e-01,6.055e-03,3.596e+00,1.189e-01,3.396e-03,4.165e+00,5.241e-01,2.207e-01
PLD1,9067,apical plasma membrane,GO:0016324,cellular component,20.0,3.0,4.457e-02,1.834e-02,1.083e-01,1.306e-02,3.954e-03,4.313e-02,8.992e-01,2.075e-02
PLD1,9067,lysosomal membrane,GO:0005765,cellular component,20.0,10.0,4.457e-02,1.834e-02,1.083e-01,1.653e-02,1.447e-03,1.887e-01,8.650e-01,4.082e-02
PLD1,9067,membrane,GO:0016020,cellular component,20.0,58.0,4.457e-02,1.834e-02,1.083e-01,2.128e-02,3.356e-03,1.350e-01,8.520e-01,3.619e-02
PLD1,9067,endosome,GO:0005768,cellular component,20.0,15.0,4.650e-02,2.205e-02,9.807e-02,2.108e-02,1.021e-02,4.351e-02,8.633e-01,1.656e-02
PLD1,9067,Golgi apparatus,GO:0005794,cellular component,20.0,16.0,4.650e-02,2.205e-02,9.807e-02,2.134e-02,7.291e-03,6.247e-02,8.600e-01,2.388e-02
PLD1,9067,endocytic vesicle,GO:0030139,cellular component,20.0,7.0,4.650e-02,2.205e-02,9.807e-02,2.201e-02,6.435e-03,7.528e-02,8.581e-01,2.958e-02
PLD1,9067,cholinergic synapse,GO:0098981,cellular component,20.0,3.0,4.705e-02,2.171e-02,1.020e-01,3.282e-02,1.456e-02,7.397e-02,8.185e-01,2.071e-02
PLD1,9067,protein binding,GO:0005515,molecular function,20.0,347.0,4.952e-02,2.142e-02,1.145e-01,3.301e-02,1.114e-02,9.783e-02,8.173e-01,2.799e-02
PLOD3,9083,peptidyl-lysine hydroxylation,GO:0017185,biological process,22.0,8.0,5.336e-02,2.337e-02,1.218e-01,3.173e-02,1.917e-02,5.251e-02,8.228e-01,1.240e-02
PLOD3,9083,protein O-linked glycosylation,GO:0006493,biological process,22.0,11.0,5.945e-02,3.151e-02,1.122e-01,4.646e-02,2.852e-02,7.568e-02,7.823e-01,1.291e-02
PLOD3,9083,extracellular exosome,GO:0070062,cellular component,22.0,77.0,4.939e-02,1.936e-02,1.260e-01,1.021e-02,3.279e-03,3.178e-02,9.157e-01,1.857e-02
PLOD3,9083,Golgi apparatus,GO:0005794,cellular component,22.0,16.0,4.939e-02,1.936e-02,1.260e-01,3.075e-02,6.307e-03,1.499e-01,8.221e-01,3.950e-02
PLOD3,9083,endoplasmic reticulum,GO:0005783,cellular component,22.0,34.0,4.939e-02,1.936e-02,1.260e-01,3.544e-02,7.269e-03,1.728e-01,8.073e-01,4.193e-02
PLOD3,9083,protein binding,GO:0005515,molecular function,22.0,347.0,4.939e-02,1.936e-02,1.260e-01,3.040e-02,7.197e-03,1.284e-01,8.246e-01,3.714e-02
PLOD3,9083,procollagen galactosyltransferase activity,GO:0050211,molecular function,22.0,3.0,5.606e-02,2.538e-02,1.238e-01,3.095e-02,1.448e-02,6.616e-02,8.249e-01,1.906e-02
PLOD3,9083,procollagen glucosyltransferase activity,GO:0033823,molecular function,22.0,3.0,5.792e-02,2.629e-02,1.276e-01,3.917e-02,1.644e-02,9.335e-02,7.999e-01,2.222e-02
PLOD3,9083,procollagen-lysine 5-dioxygenase activity,GO:0008475,molecular function,22.0,2.0,6.164e-02,2.528e-02,1.503e-01,5.018e-02,1.083e-02,2.325e-01,7.693e-01,4.046e-02
PLXNA1,9099,regulation of cell migration,GO:0030334,biological process,14.0,30.0,1.104e-01,9.666e-02,1.262e-01,5.197e-02,2.004e-02,1.348e-01,7.677e-01,2.696e-02
PLXNA1,9099,negative regulation of cell adhesion,GO:0007162,biological process,14.0,10.0,1.138e-01,9.093e-02,1.424e-01,4.195e-02,8.014e-03,2.196e-01,7.891e-01,4.297e-02
PLXNA1,9099,positive regulation of axonogenesis,GO:0050772,biological process,14.0,7.0,1.140e-01,9.446e-02,1.375e-01,5.560e-02,2.515e-02,1.229e-01,7.608e-01,2.155e-02
PLXNA1,9099,regulation of GTPase activity,GO:0043087,biological process,14.0,4.0,1.190e-01,1.003e-01,1.411e-01,6.617e-02,5.476e-02,7.996e-02,7.416e-01,5.635e-03
PLXNA1,9099,semaphorin-plexin signaling pathway involved in axon guidance,GO:1902287,biological process,14.0,2.0,1.343e-01,6.292e-02,2.866e-01,8.121e-02,1.532e-02,4.305e-01,7.049e-01,5.648e-02
PLXNA1,9099,regulation of cell shape,GO:0008360,biological process,14.0,9.0,2.318e-01,1.503e-01,3.576e-01,2.154e-01,1.207e-01,3.842e-01,5.622e-01,2.678e-02
PLXNA1,9099,semaphorin receptor complex,GO:0002116,cellular component,14.0,2.0,8.945e-02,6.771e-02,1.182e-01,1.242e-02,4.191e-03,3.681e-02,9.040e-01,1.723e-02
PLXNA1,9099,integral component of plasma membrane,GO:0005887,cellular component,14.0,28.0,1.124e-01,9.626e-02,1.313e-01,4.252e-02,1.725e-02,1.048e-01,7.905e-01,2.426e-02
PLXNA1,9099,extracellular exosome,GO:0070062,cellular component,14.0,77.0,1.466e-01,8.317e-02,2.585e-01,9.714e-02,4.579e-02,2.061e-01,6.895e-01,2.430e-02
PLXNA1,9099,cytosol,GO:0005829,cellular component,14.0,76.0,1.615e-01,1.010e-01,2.583e-01,1.348e-01,8.387e-02,2.167e-01,6.429e-01,1.786e-02
PLXNA1,9099,nucleoplasm,GO:0005654,cellular component,14.0,51.0,1.720e-01,1.164e-01,2.542e-01,1.587e-01,1.053e-01,2.394e-01,6.170e-01,1.615e-02
PLXNA1,9099,semaphorin receptor activity,GO:0017154,molecular function,14.0,2.0,8.659e-02,5.455e-02,1.375e-01,1.555e-02,2.017e-03,1.198e-01,8.775e-01,3.933e-02
PMM1,9114,,,,nan,nan,,,,,,,,
PMVK,9141,cholesterol biosynthetic process,GO:0006695,biological process,12.0,11.0,9.450e-02,4.296e-02,2.079e-01,2.053e-02,1.397e-02,3.016e-02,8.669e-01,8.993e-03
PMVK,9141,"isopentenyl diphosphate biosynthetic process, mevalonate pathway",GO:0019287,biological process,12.0,6.0,9.450e-02,4.296e-02,2.079e-01,2.649e-02,1.406e-02,4.992e-02,8.413e-01,1.541e-02
PMVK,9141,sterol biosynthetic process,GO:0016126,biological process,12.0,9.0,9.450e-02,4.296e-02,2.079e-01,3.296e-02,1.452e-02,7.484e-02,8.184e-01,2.059e-02
PMVK,9141,response to cholesterol,GO:0070723,biological process,12.0,5.0,1.144e-01,3.438e-02,3.804e-01,4.836e-02,8.557e-03,2.733e-01,7.707e-01,4.938e-02
PMVK,9141,extracellular exosome,GO:0070062,cellular component,12.0,77.0,1.447e-01,4.598e-02,4.557e-01,1.045e-01,1.812e-02,6.028e-01,6.697e-01,5.647e-02
PMVK,9141,cytosol,GO:0005829,cellular component,12.0,76.0,1.453e-01,5.507e-02,3.832e-01,1.120e-01,3.610e-02,3.477e-01,6.663e-01,3.764e-02
PMVK,9141,membrane,GO:0016020,cellular component,12.0,58.0,1.608e-01,8.601e-02,3.008e-01,1.304e-01,6.627e-02,2.567e-01,6.471e-01,2.454e-02
PMVK,9141,peroxisome,GO:0005777,cellular component,12.0,16.0,1.674e-01,1.024e-01,2.737e-01,1.243e-01,1.036e-01,1.493e-01,6.559e-01,6.715e-03
PMVK,9141,ATP binding,GO:0005524,molecular function,12.0,10.0,1.447e-01,4.598e-02,4.557e-01,1.221e-01,2.185e-02,6.822e-01,6.466e-01,5.804e-02
PMVK,9141,phosphomevalonate kinase activity,GO:0004631,molecular function,12.0,3.0,1.491e-01,8.948e-02,2.484e-01,8.955e-02,4.714e-02,1.701e-01,7.016e-01,2.109e-02
PNO1,32790,nucleolus,GO:0005730,cellular component,6.0,18.0,2.169e-02,8.136e-03,5.784e-02,1.262e-02,1.873e-03,8.502e-02,8.935e-01,3.706e-02
PNO1,32790,nucleoplasm,GO:0005654,cellular component,6.0,51.0,3.300e-02,2.526e-02,4.312e-02,3.083e-02,2.887e-02,3.293e-02,8.260e-01,1.676e-03
PNO1,32790,RNA binding,GO:0003723,molecular function,6.0,60.0,2.169e-02,8.136e-03,5.784e-02,1.420e-02,5.663e-03,3.561e-02,8.954e-01,1.857e-02
PNPLA3,18590,triglyceride biosynthetic process,GO:0019432,biological process,22.0,4.0,5.567e-02,2.765e-02,1.121e-01,2.183e-02,1.432e-02,3.329e-02,8.608e-01,1.026e-02
PNPLA3,18590,triglyceride catabolic process,GO:0019433,biological process,22.0,3.0,5.681e-02,2.527e-02,1.277e-01,2.565e-02,5.630e-03,1.169e-01,8.395e-01,3.423e-02
PNPLA3,18590,triglyceride acyl-chain remodeling,GO:0036153,biological process,22.0,3.0,5.893e-02,2.523e-02,1.377e-01,2.774e-02,4.546e-03,1.693e-01,8.291e-01,3.928e-02
PNPLA3,18590,long-chain fatty acid metabolic process,GO:0001676,biological process,22.0,14.0,6.337e-02,3.461e-02,1.160e-01,3.163e-02,1.129e-02,8.864e-02,8.220e-01,2.610e-02
PNPLA3,18590,phosphatidic acid biosynthetic process,GO:0006654,biological process,22.0,4.0,7.107e-02,4.282e-02,1.180e-01,4.763e-02,1.967e-02,1.153e-01,7.779e-01,2.446e-02
PNPLA3,18590,lipid droplet organization,GO:0034389,biological process,22.0,5.0,7.282e-02,6.150e-02,8.623e-02,4.826e-02,3.546e-02,6.568e-02,7.783e-01,8.312e-03
PNPLA3,18590,lipid homeostasis,GO:0055088,biological process,22.0,12.0,9.324e-02,5.585e-02,1.556e-01,7.930e-02,3.497e-02,1.799e-01,7.164e-01,2.555e-02
PNPLA3,18590,glycerophospholipid metabolic process,GO:0006650,biological process,22.0,15.0,1.246e-01,3.973e-02,3.910e-01,1.126e-01,2.541e-02,4.986e-01,6.622e-01,4.896e-02
PNPLA3,18590,lipid droplet,GO:0005811,cellular component,22.0,10.0,9.055e-02,4.848e-02,1.691e-01,7.138e-02,3.584e-02,1.422e-01,7.308e-01,2.093e-02
PNPLA3,18590,membrane,GO:0016020,cellular component,22.0,58.0,1.139e-01,5.900e-02,2.197e-01,1.037e-01,5.092e-02,2.112e-01,6.807e-01,2.452e-02
PNPLA3,18590,cytoplasm,GO:0005737,cellular component,22.0,78.0,1.340e-01,9.050e-02,1.983e-01,1.269e-01,8.574e-02,1.879e-01,6.524e-01,1.431e-02
PNPLA3,18590,lysophosphatidic acid acyltransferase activity,GO:0042171,molecular function,22.0,5.0,5.405e-02,2.461e-02,1.187e-01,1.207e-02,1.107e-02,1.317e-02,9.115e-01,1.384e-03
PNPLA3,18590,long-chain fatty acyl-CoA binding,GO:0036042,molecular function,22.0,2.0,5.405e-02,2.461e-02,1.187e-01,1.695e-02,9.812e-03,2.927e-02,8.837e-01,1.091e-02
PNPLA3,18590,triglyceride lipase activity,GO:0004806,molecular function,22.0,4.0,5.405e-02,2.461e-02,1.187e-01,1.901e-02,3.979e-03,9.082e-02,8.676e-01,3.453e-02
PNPLA3,18590,phospholipase A2 activity,GO:0004623,molecular function,22.0,5.0,5.556e-02,2.332e-02,1.324e-01,2.167e-02,2.811e-03,1.671e-01,8.494e-01,4.326e-02
PNPLA3,18590,1-acylglycerol-3-phosphate O-acyltransferase activity,GO:0003841,molecular function,22.0,4.0,5.567e-02,2.765e-02,1.121e-01,1.562e-02,9.875e-03,2.472e-02,8.913e-01,8.621e-03
PNPLA3,18590,diolein transacylation activity,GO:0051265,molecular function,22.0,2.0,5.813e-02,3.251e-02,1.039e-01,2.682e-02,1.770e-02,4.064e-02,8.401e-01,1.020e-02
PNPLA3,18590,mono-olein transacylation activity,GO:0051264,molecular function,22.0,2.0,5.813e-02,3.251e-02,1.039e-01,2.683e-02,1.936e-02,3.717e-02,8.401e-01,8.056e-03
PNPLA3,18590,lysophosphatidic acid binding,GO:0035727,molecular function,22.0,3.0,5.893e-02,2.523e-02,1.377e-01,3.256e-02,7.036e-03,1.507e-01,8.164e-01,3.642e-02
POLE4,18755,,,,nan,nan,,,,,,,,
POLN,18870,double-strand break repair via homologous recombination,GO:0000724,biological process,11.0,6.0,7.474e-02,6.963e-02,8.022e-02,1.988e-02,1.172e-02,3.373e-02,8.694e-01,1.187e-02
POLN,18870,translesion synthesis,GO:0019985,biological process,11.0,5.0,7.501e-02,7.039e-02,7.994e-02,2.647e-02,9.574e-03,7.319e-02,8.401e-01,2.406e-02
POLN,18870,interstrand cross-link repair,GO:0036297,biological process,11.0,4.0,8.008e-02,6.568e-02,9.763e-02,3.175e-02,1.901e-02,5.303e-02,8.227e-01,1.270e-02
POLN,18870,DNA-dependent DNA replication,GO:0006261,biological process,11.0,7.0,8.936e-02,5.077e-02,1.573e-01,7.225e-02,6.707e-02,7.783e-02,7.308e-01,2.253e-03
POLN,18870,nucleus,GO:0005634,cellular component,11.0,81.0,9.102e-02,4.860e-02,1.705e-01,6.414e-02,2.979e-02,1.381e-01,7.436e-01,2.301e-02
POLN,18870,nucleoplasm,GO:0005654,cellular component,11.0,51.0,9.102e-02,4.860e-02,1.705e-01,7.985e-02,4.682e-02,1.362e-01,7.171e-01,1.716e-02
POLN,18870,cytoplasm,GO:0005737,cellular component,11.0,78.0,9.102e-02,4.860e-02,1.705e-01,8.340e-02,4.489e-02,1.549e-01,7.110e-01,2.011e-02
POLN,18870,cyclin binding,GO:0030332,molecular function,11.0,2.0,5.492e-02,2.572e-02,1.173e-01,5.832e-03,2.358e-03,1.442e-02,9.461e-01,8.093e-03
POLN,18870,DNA-directed DNA polymerase activity,GO:0003887,molecular function,11.0,2.0,8.008e-02,6.568e-02,9.763e-02,4.473e-02,3.683e-02,5.432e-02,7.869e-01,5.121e-03
POLN,18870,protein binding,GO:0005515,molecular function,11.0,347.0,9.255e-02,4.670e-02,1.834e-01,9.255e-02,4.670e-02,1.834e-01,6.965e-01,2.327e-02
POLR3G,30075,positive regulation of innate immune response,GO:0045089,biological process,11.0,25.0,4.849e-01,2.537e-01,9.269e-01,3.231e-01,1.932e-01,5.403e-01,4.777e-01,2.924e-02
POLR3G,30075,positive regulation of interferon-beta production,GO:0032728,biological process,11.0,5.0,5.024e-01,2.786e-01,9.058e-01,3.452e-01,2.492e-01,4.781e-01,4.641e-01,1.843e-02
POLR3G,30075,transcription by RNA polymerase III,GO:0006383,biological process,11.0,6.0,5.660e-01,2.429e-01,1.319e+00,4.040e-01,7.926e-02,2.059e+00,3.847e-01,9.749e-02
POLR3G,30075,cell population proliferation,GO:0008283,biological process,11.0,35.0,6.108e-01,2.870e-01,1.300e+00,5.289e-01,1.525e-01,1.834e+00,3.056e-01,9.298e-02
POLR3G,30075,cytosol,GO:0005829,cellular component,11.0,76.0,4.649e-01,2.225e-01,9.715e-01,1.884e-01,7.156e-02,4.959e-01,5.834e-01,3.906e-02
POLR3G,30075,nucleoplasm,GO:0005654,cellular component,11.0,51.0,4.649e-01,2.225e-01,9.715e-01,2.000e-01,8.074e-02,4.952e-01,5.730e-01,3.765e-02
POLR3G,30075,nucleus,GO:0005634,cellular component,11.0,81.0,4.649e-01,2.225e-01,9.715e-01,2.091e-01,1.148e-01,3.809e-01,5.676e-01,2.582e-02
POLR3G,30075,nuclear chromatin,GO:0000790,cellular component,11.0,5.0,5.097e-01,2.692e-01,9.651e-01,4.182e-01,2.047e-01,8.542e-01,4.069e-01,4.749e-02
POLR3G,30075,RNA polymerase III complex,GO:0005666,cellular component,11.0,2.0,5.756e-01,2.967e-01,1.117e+00,4.581e-01,2.321e-01,9.041e-01,3.811e-01,4.616e-02
POLR3G,30075,protein binding,GO:0005515,molecular function,11.0,347.0,4.649e-01,2.225e-01,9.715e-01,2.482e-01,1.311e-01,4.698e-01,5.340e-01,2.988e-02
POMT1,9202,,,,nan,nan,,,,,,,,
PPP1R3C,9293,protein binding,GO:0005515,molecular function,4.0,347.0,2.764e-02,2.457e-02,3.109e-02,2.764e-02,2.457e-02,3.109e-02,8.370e-01,2.808e-03
PPP1R3D,9294,protein binding,GO:0005515,molecular function,2.0,347.0,6.303e-02,4.022e-02,9.876e-02,6.303e-02,4.022e-02,9.876e-02,7.470e-01,1.310e-02
PPP2R5B,9310,regulation of protein autophosphorylation,GO:0031952,biological process,9.0,5.0,2.703e-01,1.067e-01,6.846e-01,7.664e-02,3.683e-02,1.595e-01,7.214e-01,2.313e-02
PPP2R5B,9310,protein dephosphorylation,GO:0006470,biological process,9.0,11.0,3.975e-01,8.654e-02,1.826e+00,3.628e-01,7.827e-02,1.681e+00,4.211e-01,8.815e-02
PPP2R5B,9310,cytosol,GO:0005829,cellular component,9.0,76.0,2.703e-01,1.067e-01,6.846e-01,1.581e-01,7.228e-02,3.459e-01,6.153e-01,3.078e-02
PPP2R5B,9310,nucleus,GO:0005634,cellular component,9.0,81.0,2.703e-01,1.067e-01,6.846e-01,1.755e-01,1.044e-01,2.951e-01,5.993e-01,2.208e-02
PPP2R5B,9310,protein phosphatase type 2A complex,GO:0000159,cellular component,9.0,3.0,4.245e-01,8.358e-02,2.156e+00,4.245e-01,8.358e-02,2.156e+00,3.681e-01,1.002e-01
PPP2R5B,9310,protein binding,GO:0005515,molecular function,9.0,347.0,2.703e-01,1.067e-01,6.846e-01,1.757e-01,1.108e-01,2.786e-01,5.996e-01,1.949e-02
PPP2R5B,9310,protein phosphatase activator activity,GO:0072542,molecular function,9.0,4.0,3.348e-01,8.238e-02,1.361e+00,2.533e-01,6.591e-02,9.736e-01,5.149e-01,7.036e-02
PRDX6,16753,glycerophospholipid catabolic process,GO:0046475,biological process,37.0,10.0,6.786e-02,2.892e-02,1.592e-01,4.310e-02,1.276e-02,1.456e-01,7.881e-01,3.193e-02
PRDX6,16753,cellular oxidant detoxification,GO:0098869,biological process,37.0,4.0,8.989e-02,4.109e-02,1.966e-01,7.660e-02,2.453e-02,2.392e-01,7.192e-01,3.395e-02
PRDX6,16753,response to oxidative stress,GO:0006979,biological process,37.0,8.0,1.230e-01,6.760e-02,2.237e-01,1.083e-01,5.675e-02,2.066e-01,6.747e-01,2.228e-02
PRDX6,16753,"positive regulation of mRNA splicing, via spliceosome",GO:0048026,biological process,37.0,5.0,1.261e-01,6.428e-02,2.474e-01,1.131e-01,5.319e-02,2.405e-01,6.679e-01,2.695e-02
PRDX6,16753,cell redox homeostasis,GO:0045454,biological process,37.0,3.0,1.766e-01,3.834e-02,8.136e-01,1.766e-01,3.834e-02,8.136e-01,5.829e-01,7.122e-02
PRDX6,16753,extracellular space,GO:0005615,cellular component,37.0,43.0,6.147e-02,2.956e-02,1.278e-01,9.747e-03,3.703e-03,2.566e-02,9.209e-01,1.224e-02
PRDX6,16753,extracellular exosome,GO:0070062,cellular component,37.0,77.0,6.147e-02,2.956e-02,1.278e-01,1.154e-02,6.867e-03,1.941e-02,9.133e-01,8.113e-03
PRDX6,16753,cytosol,GO:0005829,cellular component,37.0,76.0,6.147e-02,2.956e-02,1.278e-01,2.217e-02,7.184e-03,6.841e-02,8.556e-01,2.445e-02
PRDX6,16753,nucleus,GO:0005634,cellular component,37.0,81.0,6.147e-02,2.956e-02,1.278e-01,3.357e-02,1.236e-02,9.118e-02,8.163e-01,2.478e-02
PRDX6,16753,cytoplasm,GO:0005737,cellular component,37.0,78.0,6.147e-02,2.956e-02,1.278e-01,3.382e-02,1.251e-02,9.147e-02,8.155e-01,2.469e-02
PRDX6,16753,membrane,GO:0016020,cellular component,37.0,58.0,6.501e-02,2.792e-02,1.514e-01,2.612e-02,2.851e-03,2.392e-01,8.301e-01,4.936e-02
PRDX6,16753,mitochondrion,GO:0005739,cellular component,37.0,35.0,6.501e-02,2.792e-02,1.514e-01,3.295e-02,3.603e-03,3.012e-01,8.079e-01,5.089e-02
PRDX6,16753,perinuclear region of cytoplasm,GO:0048471,cellular component,37.0,11.0,6.865e-02,3.039e-02,1.551e-01,4.077e-02,1.520e-02,1.093e-01,7.949e-01,2.604e-02
PRDX6,16753,protein homodimerization activity,GO:0042803,molecular function,37.0,21.0,6.147e-02,2.956e-02,1.278e-01,2.131e-02,1.181e-02,3.846e-02,8.627e-01,1.390e-02
PRDX6,16753,protein binding,GO:0005515,molecular function,37.0,347.0,6.147e-02,2.956e-02,1.278e-01,3.032e-02,1.262e-02,7.282e-02,8.272e-01,2.151e-02
PRDX6,16753,calcium-independent phospholipase A2 activity,GO:0047499,molecular function,37.0,2.0,7.065e-02,3.042e-02,1.641e-01,4.937e-02,1.742e-02,1.399e-01,7.733e-01,2.774e-02
PRDX6,16753,cadherin binding,GO:0045296,molecular function,37.0,13.0,7.551e-02,7.290e-02,7.822e-02,3.531e-02,1.312e-02,9.498e-02,8.108e-01,2.495e-02
PRDX6,16753,ubiquitin protein ligase binding,GO:0031625,molecular function,37.0,9.0,7.973e-02,6.855e-02,9.274e-02,4.738e-02,2.419e-02,9.278e-02,7.794e-01,1.825e-02
PRDX6,16753,glutathione peroxidase activity,GO:0004602,molecular function,37.0,2.0,9.903e-02,4.081e-02,2.403e-01,4.579e-02,4.870e-03,4.305e-01,7.722e-01,6.214e-02
PRKAR2B,9392,cGMP-mediated signaling,GO:0019934,biological process,19.0,3.0,4.879e-02,2.933e-02,8.117e-02,2.108e-02,1.265e-02,3.513e-02,8.639e-01,1.192e-02
PRKAR2B,9392,negative regulation of cAMP-dependent protein kinase activity,GO:2000480,biological process,19.0,3.0,5.728e-02,4.684e-02,7.006e-02,3.263e-02,2.001e-02,5.321e-02,8.201e-01,1.204e-02
PRKAR2B,9392,centrosome,GO:0005813,cellular component,19.0,9.0,4.879e-02,2.933e-02,8.117e-02,1.436e-02,4.699e-03,4.390e-02,8.929e-01,2.270e-02
PRKAR2B,9392,extracellular exosome,GO:0070062,cellular component,19.0,77.0,6.413e-02,5.010e-02,8.209e-02,5.009e-02,2.583e-02,9.715e-02,7.732e-01,1.850e-02
PRKAR2B,9392,plasma membrane,GO:0005886,cellular component,19.0,61.0,6.413e-02,5.010e-02,8.209e-02,5.674e-02,3.739e-02,8.610e-02,7.596e-01,1.183e-02
PRKAR2B,9392,cytosol,GO:0005829,cellular component,19.0,76.0,6.673e-02,5.576e-02,7.985e-02,6.062e-02,4.714e-02,7.794e-02,7.520e-01,7.169e-03
PRKAR2B,9392,cytoplasm,GO:0005737,cellular component,19.0,78.0,7.186e-02,5.983e-02,8.631e-02,6.996e-02,5.825e-02,8.403e-02,7.348e-01,5.562e-03
PRKAR2B,9392,protein kinase A catalytic subunit binding,GO:0034236,molecular function,19.0,3.0,4.879e-02,2.933e-02,8.117e-02,1.546e-02,1.353e-02,1.767e-02,8.935e-01,2.618e-03
PRKAR2B,9392,"3',5'-cyclic-GMP phosphodiesterase activity",GO:0047555,molecular function,19.0,3.0,4.879e-02,2.933e-02,8.117e-02,1.576e-02,1.311e-02,1.894e-02,8.919e-01,3.606e-03
PRKAR2B,9392,cAMP-dependent protein kinase inhibitor activity,GO:0004862,molecular function,19.0,3.0,4.879e-02,2.933e-02,8.117e-02,1.526e-02,3.598e-03,6.472e-02,8.851e-01,2.658e-02
PRKAR2B,9392,cAMP-dependent protein kinase regulator activity,GO:0008603,molecular function,19.0,3.0,4.879e-02,2.933e-02,8.117e-02,2.629e-02,8.033e-03,8.604e-02,8.401e-01,2.837e-02
PRKAR2B,9392,ubiquitin protein ligase binding,GO:0031625,molecular function,19.0,9.0,5.839e-02,5.275e-02,6.464e-02,3.806e-02,2.525e-02,5.737e-02,8.040e-01,1.035e-02
PRKAR2B,9392,protein binding,GO:0005515,molecular function,19.0,347.0,6.413e-02,5.010e-02,8.209e-02,5.710e-02,4.043e-02,8.064e-02,7.590e-01,9.666e-03
PRKCA,9393,positive regulation of endothelial cell proliferation,GO:0001938,biological process,56.0,6.0,5.514e-02,4.190e-02,7.256e-02,9.534e-03,7.531e-03,1.207e-02,9.253e-01,3.101e-03
PRKCA,9393,positive regulation of blood vessel endothelial cell migration,GO:0043536,biological process,56.0,6.0,5.514e-02,4.190e-02,7.256e-02,1.267e-02,6.844e-03,2.346e-02,9.067e-01,9.502e-03
PRKCA,9393,positive regulation of angiogenesis,GO:0045766,biological process,56.0,12.0,5.514e-02,4.190e-02,7.256e-02,1.376e-02,1.057e-02,1.790e-02,9.022e-01,4.698e-03
PRKCA,9393,positive regulation of endothelial cell migration,GO:0010595,biological process,56.0,6.0,5.514e-02,4.190e-02,7.256e-02,1.475e-02,1.078e-02,2.018e-02,8.968e-01,5.832e-03
PRKCA,9393,histone H3-T6 phosphorylation,GO:0035408,biological process,56.0,2.0,5.514e-02,4.190e-02,7.256e-02,1.378e-02,2.856e-03,6.651e-02,8.910e-01,2.626e-02
PRKCA,9393,response to interleukin-1,GO:0070555,biological process,56.0,4.0,5.514e-02,4.190e-02,7.256e-02,2.054e-02,6.616e-03,6.379e-02,8.626e-01,2.414e-02
PRKCA,9393,peptidyl-serine phosphorylation,GO:0018105,biological process,56.0,10.0,5.616e-02,4.229e-02,7.457e-02,2.358e-02,2.213e-03,2.511e-01,8.362e-01,4.590e-02
PRKCA,9393,negative regulation of glial cell apoptotic process,GO:0034351,biological process,56.0,4.0,5.846e-02,4.956e-02,6.897e-02,2.524e-02,1.950e-02,3.266e-02,8.463e-01,6.342e-03
PRKCA,9393,positive regulation of cell adhesion,GO:0045785,biological process,56.0,7.0,5.846e-02,4.956e-02,6.897e-02,2.586e-02,1.719e-02,3.891e-02,8.438e-01,1.000e-02
PRKCA,9393,intracellular signal transduction,GO:0035556,biological process,56.0,30.0,5.846e-02,4.956e-02,6.897e-02,2.977e-02,2.587e-02,3.424e-02,8.295e-01,3.355e-03
PRKCA,9393,positive regulation of lipopolysaccharide-mediated signaling pathway,GO:0031666,biological process,56.0,6.0,5.846e-02,4.956e-02,6.897e-02,3.664e-02,2.579e-02,5.205e-02,8.080e-01,8.826e-03
PRKCA,9393,protein phosphorylation,GO:0006468,biological process,56.0,30.0,5.846e-02,4.956e-02,6.897e-02,3.910e-02,2.905e-02,5.262e-02,8.012e-01,7.504e-03
PRKCA,9393,regulation of platelet aggregation,GO:0090330,biological process,56.0,6.0,6.009e-02,5.031e-02,7.176e-02,4.350e-02,3.218e-02,5.879e-02,7.898e-01,7.887e-03
PRKCA,9393,positive regulation of cell migration,GO:0030335,biological process,56.0,33.0,6.057e-02,4.815e-02,7.620e-02,4.023e-02,1.528e-02,1.059e-01,7.969e-01,2.464e-02
PRKCA,9393,desmosome assembly,GO:0002159,biological process,56.0,3.0,6.436e-02,3.971e-02,1.043e-01,3.912e-02,1.129e-02,1.355e-01,7.983e-01,3.299e-02
PRKCA,9393,positive regulation of mitotic cell cycle,GO:0045931,biological process,56.0,16.0,6.582e-02,4.348e-02,9.963e-02,3.059e-02,7.404e-03,1.264e-01,8.241e-01,3.676e-02
PRKCA,9393,extracellular exosome,GO:0070062,cellular component,56.0,77.0,6.273e-02,4.860e-02,8.097e-02,4.315e-02,2.203e-02,8.451e-02,7.899e-01,1.733e-02
PRKCA,9393,plasma membrane,GO:0005886,cellular component,56.0,61.0,6.313e-02,4.852e-02,8.213e-02,4.367e-02,2.275e-02,8.383e-02,7.885e-01,1.688e-02
PRKCA,9393,cytosol,GO:0005829,cellular component,56.0,76.0,6.696e-02,4.338e-02,1.033e-01,5.020e-02,2.590e-02,9.732e-02,7.730e-01,1.816e-02
PRKCA,9393,cytoplasm,GO:0005737,cellular component,56.0,78.0,7.517e-02,4.282e-02,1.320e-01,6.456e-02,2.853e-02,1.461e-01,7.428e-01,2.305e-02
PRKCA,9393,endoplasmic reticulum,GO:0005783,cellular component,56.0,34.0,7.528e-02,4.292e-02,1.320e-01,6.561e-02,3.030e-02,1.420e-01,7.410e-01,2.193e-02
PRKCA,9393,mitochondrion,GO:0005739,cellular component,56.0,35.0,9.130e-02,4.349e-02,1.917e-01,9.016e-02,4.337e-02,1.875e-01,7.001e-01,2.341e-02
PRKCA,9393,histone kinase activity (H3-T6 specific),GO:0035403,molecular function,56.0,2.0,5.713e-02,4.715e-02,6.922e-02,2.348e-02,1.108e-02,4.976e-02,8.530e-01,1.802e-02
PRKCA,9393,protein serine/threonine kinase activity,GO:0004674,molecular function,56.0,31.0,5.846e-02,4.956e-02,6.897e-02,3.463e-02,2.649e-02,4.526e-02,8.139e-01,6.684e-03
PRKCA,9393,protein kinase activity,GO:0004672,molecular function,56.0,33.0,5.949e-02,5.029e-02,7.038e-02,3.567e-02,2.794e-02,4.553e-02,8.109e-01,6.130e-03
PRKCA,9393,protein binding,GO:0005515,molecular function,56.0,347.0,6.572e-02,4.671e-02,9.248e-02,4.804e-02,2.376e-02,9.715e-02,7.778e-01,1.844e-02
PRKCA,9393,enzyme binding,GO:0019899,molecular function,56.0,35.0,7.156e-02,3.609e-02,1.419e-01,5.527e-02,1.807e-02,1.690e-01,7.594e-01,3.276e-02
PRR5,31682,TORC2 signaling,GO:0038203,biological process,5.0,2.0,1.135e-01,5.810e-02,2.217e-01,8.709e-02,3.122e-02,2.430e-01,7.028e-01,3.165e-02
PRR5,31682,TORC2 complex,GO:0031932,cellular component,5.0,2.0,1.135e-01,5.810e-02,2.217e-01,8.628e-02,2.875e-02,2.589e-01,7.031e-01,3.665e-02
PRR5,31682,protein binding,GO:0005515,molecular function,5.0,347.0,1.146e-01,6.036e-02,2.177e-01,1.040e-01,7.140e-02,1.515e-01,6.817e-01,1.273e-02
PTAR1,30449,,,,nan,nan,,,,,,,,
PTCHD4,21345,,,,nan,nan,,,,,,,,
PTGES3L,43943,,,,nan,nan,,,,,,,,
PTRH1,27039,,,,nan,nan,,,,,,,,
PUM3,29676,regulation of protein ADP-ribosylation,GO:0010835,biological process,10.0,3.0,1.277e-01,6.606e-02,2.469e-01,5.635e-02,1.002e-02,3.168e-01,7.514e-01,5.269e-02
PUM3,29676,regulation of translation,GO:0006417,biological process,10.0,25.0,1.710e-01,5.507e-02,5.311e-01,1.270e-01,1.808e-02,8.925e-01,6.363e-01,6.738e-02
PUM3,29676,nucleolus,GO:0005730,cellular component,10.0,18.0,1.211e-01,6.561e-02,2.235e-01,4.698e-02,7.970e-03,2.769e-01,7.731e-01,5.145e-02
PUM3,29676,nucleoplasm,GO:0005654,cellular component,10.0,51.0,1.235e-01,1.070e-01,1.424e-01,6.958e-02,4.384e-02,1.104e-01,7.349e-01,1.340e-02
PUM3,29676,endoplasmic reticulum,GO:0005783,cellular component,10.0,34.0,1.640e-01,1.156e-01,2.329e-01,1.209e-01,3.668e-02,3.986e-01,6.544e-01,4.092e-02
PUM3,29676,chromosome,GO:0005694,cellular component,10.0,9.0,2.020e-01,7.521e-02,5.425e-01,1.632e-01,4.353e-02,6.119e-01,6.019e-01,5.835e-02
PUM3,29676,RNA binding,GO:0003723,molecular function,10.0,60.0,1.127e-01,7.462e-02,1.701e-01,3.518e-02,1.964e-02,6.302e-02,8.120e-01,1.491e-02
PUM3,29676,mRNA binding,GO:0003729,molecular function,10.0,11.0,1.127e-01,7.462e-02,1.701e-01,3.932e-02,6.885e-03,2.246e-01,7.954e-01,4.518e-02
PUM3,29676,protein binding,GO:0005515,molecular function,10.0,347.0,1.494e-01,1.147e-01,1.947e-01,1.081e-01,5.837e-02,2.001e-01,6.751e-01,2.069e-02
PYGL,9725,glucose homeostasis,GO:0042593,biological process,31.0,5.0,2.618e-02,1.293e-02,5.301e-02,1.658e-02,3.373e-03,8.146e-02,8.768e-01,3.022e-02
PYGL,9725,glycogen metabolic process,GO:0005977,biological process,31.0,5.0,3.020e-02,2.583e-02,3.530e-02,2.667e-02,2.490e-02,2.856e-02,8.406e-01,1.649e-03
PYGL,9725,glycogen catabolic process,GO:0005980,biological process,31.0,6.0,3.045e-02,1.546e-02,5.998e-02,1.719e-02,3.157e-03,9.356e-02,8.744e-01,3.666e-02
PYGL,9725,extracellular exosome,GO:0070062,cellular component,31.0,77.0,2.353e-02,1.555e-02,3.560e-02,1.506e-02,5.713e-03,3.968e-02,8.906e-01,1.893e-02
PYGL,9725,cytoplasm,GO:0005737,cellular component,31.0,78.0,2.586e-02,2.468e-02,2.709e-02,1.912e-02,1.717e-02,2.130e-02,8.742e-01,2.581e-03
PYGL,9725,AMP binding,GO:0016208,molecular function,31.0,5.0,2.259e-02,1.607e-02,3.174e-02,6.180e-03,4.531e-03,8.428e-03,9.451e-01,2.844e-03
PYGL,9725,pyridoxal phosphate binding,GO:0030170,molecular function,31.0,4.0,2.259e-02,1.607e-02,3.174e-02,6.397e-03,5.356e-03,7.640e-03,9.438e-01,1.629e-03
PYGL,9725,purine nucleobase binding,GO:0002060,molecular function,31.0,4.0,2.259e-02,1.607e-02,3.174e-02,6.819e-03,5.025e-03,9.255e-03,9.413e-01,3.081e-03
PYGL,9725,ATP binding,GO:0005524,molecular function,31.0,10.0,2.259e-02,1.607e-02,3.174e-02,6.289e-03,7.229e-04,5.471e-02,9.338e-01,1.742e-02
PYGL,9725,glycogen phosphorylase activity,GO:0008184,molecular function,31.0,2.0,2.259e-02,1.607e-02,3.174e-02,8.641e-03,2.818e-03,2.649e-02,9.268e-01,1.265e-02
PYGL,9725,protein binding,GO:0005515,molecular function,31.0,347.0,2.440e-02,2.236e-02,2.662e-02,1.562e-02,1.150e-02,2.121e-02,8.922e-01,6.071e-03
PYGL,9725,vitamin binding,GO:0019842,molecular function,31.0,16.0,2.548e-02,2.344e-02,2.770e-02,1.696e-02,1.317e-02,2.185e-02,8.853e-01,5.345e-03
PYGL,9725,bile acid binding,GO:0032052,molecular function,31.0,4.0,2.899e-02,2.161e-02,3.888e-02,2.301e-02,1.153e-02,4.591e-02,8.549e-01,1.622e-02
PYGL,9725,drug binding,GO:0008144,molecular function,31.0,53.0,4.527e-02,1.755e-02,1.167e-01,4.177e-02,1.245e-02,1.401e-01,7.920e-01,3.118e-02
RAB1B,18370,Rab protein signal transduction,GO:0032482,biological process,20.0,3.0,2.239e-01,7.677e-02,6.528e-01,5.553e-02,1.512e-02,2.039e-01,7.585e-01,3.497e-02
RAB1B,18370,endoplasmic reticulum to Golgi vesicle-mediated transport,GO:0006888,biological process,20.0,5.0,2.258e-01,7.950e-02,6.412e-01,1.038e-01,4.803e-02,2.243e-01,6.802e-01,2.727e-02
RAB1B,18370,intracellular protein transport,GO:0006886,biological process,20.0,21.0,2.550e-01,7.619e-02,8.535e-01,1.481e-01,1.959e-02,1.119e+00,6.096e-01,7.232e-02
RAB1B,18370,virion assembly,GO:0019068,biological process,20.0,2.0,3.153e-01,1.936e-01,5.136e-01,2.461e-01,1.767e-01,3.427e-01,5.382e-01,1.561e-02
RAB1B,18370,autophagosome assembly,GO:0000045,biological process,20.0,4.0,3.433e-01,6.468e-02,1.822e+00,2.929e-01,4.082e-02,2.101e+00,4.657e-01,9.580e-02
RAB1B,18370,positive regulation of glycoprotein metabolic process,GO:1903020,biological process,20.0,6.0,4.551e-01,2.942e-01,7.040e-01,4.217e-01,2.526e-01,7.040e-01,4.089e-01,3.567e-02
RAB1B,18370,regulation of autophagosome assembly,GO:2000785,biological process,20.0,6.0,6.249e-01,3.761e-01,1.038e+00,5.936e-01,3.138e-01,1.123e+00,2.859e-01,6.450e-02
RAB1B,18370,Golgi apparatus,GO:0005794,cellular component,20.0,16.0,2.239e-01,7.677e-02,6.528e-01,5.286e-02,1.907e-02,1.465e-01,7.654e-01,2.913e-02
RAB1B,18370,extracellular exosome,GO:0070062,cellular component,20.0,77.0,2.239e-01,7.677e-02,6.528e-01,7.866e-02,3.291e-02,1.880e-01,7.171e-01,2.841e-02
RAB1B,18370,endomembrane system,GO:0012505,cellular component,20.0,4.0,2.550e-01,7.619e-02,8.535e-01,1.496e-01,3.077e-02,7.279e-01,6.154e-01,5.734e-02
RAB1B,18370,phagophore assembly site membrane,GO:0034045,cellular component,20.0,3.0,2.760e-01,7.030e-02,1.083e+00,1.676e-01,2.176e-02,1.291e+00,5.858e-01,7.880e-02
RAB1B,18370,protein binding,GO:0005515,molecular function,20.0,347.0,2.239e-01,7.677e-02,6.528e-01,6.139e-02,3.206e-02,1.176e-01,7.496e-01,1.899e-02
RAB1B,18370,GTP binding,GO:0005525,molecular function,20.0,9.0,2.419e-01,7.935e-02,7.375e-01,1.319e-01,4.491e-02,3.875e-01,6.420e-01,3.907e-02
RAB1B,18370,GTPase activity,GO:0003924,molecular function,20.0,7.0,2.834e-01,1.565e-01,5.132e-01,1.548e-01,1.458e-01,1.644e-01,6.219e-01,2.318e-03
RAB32,9772,melanosome organization,GO:0032438,biological process,28.0,3.0,1.242e-01,5.770e-02,2.675e-01,2.432e-02,1.194e-02,4.957e-02,8.499e-01,1.733e-02
RAB32,9772,protein localization to membrane,GO:0072657,biological process,28.0,23.0,1.242e-01,5.770e-02,2.675e-01,3.225e-02,1.581e-02,6.580e-02,8.209e-01,1.792e-02
RAB32,9772,melanosome assembly,GO:1903232,biological process,28.0,3.0,1.242e-01,5.770e-02,2.675e-01,3.607e-02,1.244e-02,1.046e-01,8.078e-01,2.782e-02
RAB32,9772,intracellular protein transport,GO:0006886,biological process,28.0,21.0,1.255e-01,6.040e-02,2.609e-01,6.603e-02,2.527e-02,1.725e-01,7.394e-01,2.714e-02
RAB32,9772,endosome to melanosome transport,GO:0035646,biological process,28.0,2.0,1.266e-01,6.261e-02,2.558e-01,6.252e-02,3.028e-02,1.291e-01,7.472e-01,2.054e-02
RAB32,9772,mitochondrion organization,GO:0007005,biological process,28.0,13.0,1.266e-01,6.270e-02,2.556e-01,5.822e-02,1.815e-02,1.868e-01,7.527e-01,3.464e-02
RAB32,9772,Rab protein signal transduction,GO:0032482,biological process,28.0,3.0,1.281e-01,6.597e-02,2.487e-01,6.580e-02,2.837e-02,1.526e-01,7.399e-01,2.564e-02
RAB32,9772,phagosome maturation,GO:0090382,biological process,28.0,3.0,1.290e-01,6.817e-02,2.443e-01,7.704e-02,3.271e-02,1.815e-01,7.199e-01,2.765e-02
RAB32,9772,antigen processing and presentation,GO:0019882,biological process,28.0,16.0,2.565e-01,1.993e-01,3.301e-01,2.532e-01,1.948e-01,3.291e-01,5.327e-01,1.291e-02
RAB32,9772,mitochondria-associated endoplasmic reticulum membrane,GO:0044233,cellular component,28.0,2.0,1.242e-01,5.770e-02,2.675e-01,2.491e-02,2.300e-03,2.698e-01,8.315e-01,4.833e-02
RAB32,9772,mitochondrial outer membrane,GO:0005741,cellular component,28.0,4.0,1.242e-01,5.770e-02,2.675e-01,2.973e-02,9.401e-03,9.399e-02,8.282e-01,2.896e-02
RAB32,9772,phagocytic vesicle,GO:0045335,cellular component,28.0,6.0,1.242e-01,5.770e-02,2.675e-01,5.778e-02,1.653e-02,2.020e-01,7.538e-01,3.442e-02
RAB32,9772,early endosome,GO:0005769,cellular component,28.0,7.0,1.266e-01,6.270e-02,2.556e-01,8.072e-02,3.047e-02,2.139e-01,7.136e-01,2.942e-02
RAB32,9772,melanosome,GO:0042470,cellular component,28.0,3.0,1.306e-01,6.506e-02,2.623e-01,9.270e-02,3.562e-02,2.413e-01,6.948e-01,3.148e-02
RAB32,9772,endoplasmic reticulum,GO:0005783,cellular component,28.0,34.0,1.326e-01,7.691e-02,2.287e-01,8.373e-02,4.400e-02,1.593e-01,7.103e-01,2.116e-02
RAB32,9772,melanosome membrane,GO:0033162,cellular component,28.0,4.0,1.355e-01,8.454e-02,2.173e-01,8.577e-02,4.722e-02,1.558e-01,7.074e-01,1.904e-02
RAB32,9772,membrane,GO:0016020,cellular component,28.0,58.0,1.355e-01,8.454e-02,2.173e-01,1.009e-01,6.656e-02,1.529e-01,6.860e-01,1.409e-02
RAB32,9772,mitochondrion,GO:0005739,cellular component,28.0,35.0,1.418e-01,8.010e-02,2.510e-01,1.103e-01,5.813e-02,2.091e-01,6.724e-01,2.302e-02
RAB32,9772,endomembrane system,GO:0012505,cellular component,28.0,4.0,1.695e-01,8.546e-02,3.363e-01,1.549e-01,7.778e-02,3.086e-01,6.192e-01,2.755e-02
RAB32,9772,trans-Golgi network,GO:0005802,cellular component,28.0,3.0,2.062e-01,1.024e-01,4.149e-01,1.911e-01,8.009e-02,4.559e-01,5.813e-01,3.824e-02
RAB32,9772,GTP-dependent protein binding,GO:0030742,molecular function,28.0,2.0,1.094e-01,3.305e-02,3.623e-01,8.683e-03,6.009e-04,1.255e-01,9.070e-01,3.592e-02
RAB32,9772,AP-3 adaptor complex binding,GO:0035651,molecular function,28.0,2.0,1.242e-01,5.770e-02,2.675e-01,5.040e-02,9.503e-03,2.673e-01,7.658e-01,4.868e-02
RAB32,9772,AP-1 adaptor complex binding,GO:0035650,molecular function,28.0,2.0,1.242e-01,5.770e-02,2.675e-01,5.129e-02,9.661e-03,2.723e-01,7.638e-01,4.868e-02
RAB32,9772,BLOC-2 complex binding,GO:0036461,molecular function,28.0,2.0,1.242e-01,5.770e-02,2.675e-01,5.350e-02,1.098e-02,2.607e-01,7.596e-01,4.628e-02
RAB32,9772,protein binding,GO:0005515,molecular function,28.0,347.0,1.377e-01,8.319e-02,2.280e-01,1.175e-01,7.514e-02,1.836e-01,6.639e-01,1.577e-02
RAB32,9772,GTPase activity,GO:0003924,molecular function,28.0,7.0,1.419e-01,5.238e-02,3.846e-01,9.431e-02,1.630e-02,5.457e-01,6.841e-01,5.736e-02
RANBP9,13727,negative regulation of ERK1 and ERK2 cascade,GO:0070373,biological process,14.0,4.0,4.642e-02,9.951e-03,2.165e-01,1.193e-02,1.590e-03,8.957e-02,8.961e-01,3.500e-02
RANBP9,13727,ubiquitin ligase complex,GO:0000151,cellular component,14.0,14.0,5.399e-02,1.472e-02,1.981e-01,3.770e-02,5.693e-03,2.497e-01,7.974e-01,5.276e-02
RANBP9,13727,nucleus,GO:0005634,cellular component,14.0,81.0,5.399e-02,1.472e-02,1.981e-01,4.019e-02,1.205e-02,1.340e-01,7.958e-01,3.176e-02
RANBP9,13727,cytoplasm,GO:0005737,cellular component,14.0,78.0,5.399e-02,1.472e-02,1.981e-01,4.676e-02,1.437e-02,1.521e-01,7.787e-01,3.239e-02
RANBP9,13727,protein binding,GO:0005515,molecular function,14.0,347.0,5.399e-02,1.472e-02,1.981e-01,3.468e-02,1.378e-02,8.727e-02,8.125e-01,2.373e-02
RANBP9,13727,enzyme binding,GO:0019899,molecular function,14.0,35.0,6.340e-02,2.282e-02,1.761e-01,5.694e-02,2.172e-02,1.492e-01,7.569e-01,2.767e-02
RASSF2,9883,positive regulation of protein kinase activity,GO:0045860,biological process,17.0,12.0,1.603e-01,1.180e-01,2.178e-01,2.104e-02,9.626e-03,4.600e-02,8.636e-01,1.846e-02
RASSF2,9883,positive regulation of protein autophosphorylation,GO:0031954,biological process,17.0,4.0,1.603e-01,1.180e-01,2.178e-01,2.737e-02,1.569e-02,4.775e-02,8.380e-01,1.363e-02
RASSF2,9883,positive regulation of JNK cascade,GO:0046330,biological process,17.0,5.0,1.603e-01,1.180e-01,2.178e-01,4.806e-02,4.151e-02,5.564e-02,7.789e-01,3.998e-03
RASSF2,9883,negative regulation of peptidyl-serine phosphorylation,GO:0033137,biological process,17.0,5.0,1.603e-01,1.180e-01,2.178e-01,4.961e-02,3.024e-02,8.138e-02,7.748e-01,1.322e-02
RASSF2,9883,protein stabilization,GO:0050821,biological process,17.0,4.0,1.804e-01,1.190e-01,2.736e-01,6.040e-02,6.968e-03,5.236e-01,7.364e-01,7.003e-02
RASSF2,9883,positive regulation of apoptotic process,GO:0043065,biological process,17.0,26.0,2.082e-01,7.691e-02,5.637e-01,1.442e-01,2.599e-02,7.997e-01,6.171e-01,6.877e-02
RASSF2,9883,cytosol,GO:0005829,cellular component,17.0,76.0,1.701e-01,1.157e-01,2.499e-01,1.028e-01,5.547e-02,1.907e-01,6.823e-01,2.125e-02
RASSF2,9883,plasma membrane,GO:0005886,cellular component,17.0,61.0,1.701e-01,1.157e-01,2.499e-01,1.037e-01,5.322e-02,2.019e-01,6.808e-01,2.214e-02
RASSF2,9883,nucleus,GO:0005634,cellular component,17.0,81.0,1.701e-01,1.157e-01,2.499e-01,1.171e-01,7.743e-02,1.770e-01,6.645e-01,1.485e-02
RASSF2,9883,nucleoplasm,GO:0005654,cellular component,17.0,51.0,1.742e-01,1.093e-01,2.774e-01,1.240e-01,5.847e-02,2.630e-01,6.542e-01,2.771e-02
RASSF2,9883,Golgi apparatus,GO:0005794,cellular component,17.0,16.0,1.742e-01,1.093e-01,2.774e-01,1.375e-01,8.213e-02,2.303e-01,6.394e-01,1.971e-02
RASSF2,9883,cytoplasm,GO:0005737,cellular component,17.0,78.0,1.777e-01,1.275e-01,2.476e-01,1.359e-01,1.005e-01,1.840e-01,6.421e-01,1.108e-02
RASSF2,9883,kinetochore,GO:0000776,cellular component,17.0,4.0,2.181e-01,7.517e-02,6.327e-01,1.910e-01,4.901e-02,7.446e-01,5.726e-01,6.307e-02
RASSF2,9883,protein-containing complex,GO:0032991,cellular component,17.0,483.0,2.272e-01,9.694e-02,5.324e-01,2.139e-01,1.008e-01,4.538e-01,5.616e-01,3.560e-02
RASSF2,9883,protein kinase activity,GO:0004672,molecular function,17.0,33.0,1.701e-01,1.157e-01,2.499e-01,9.918e-02,5.701e-02,1.725e-01,6.878e-01,1.839e-02
RASSF2,9883,protein binding,GO:0005515,molecular function,17.0,347.0,1.701e-01,1.157e-01,2.499e-01,1.012e-01,6.936e-02,1.477e-01,6.857e-01,1.287e-02
RBM28,21863,regulation of RNA metabolic process,GO:0051252,biological process,10.0,18.0,6.217e-02,3.654e-03,1.058e+00,5.771e-02,2.828e-03,1.178e+00,7.273e-01,1.001e-01
RBM28,21863,nucleolus,GO:0005730,cellular component,10.0,18.0,1.851e-02,2.800e-03,1.224e-01,4.894e-03,3.213e-04,7.455e-02,9.340e-01,3.002e-02
RBM28,21863,nucleus,GO:0005634,cellular component,10.0,81.0,2.230e-02,5.553e-03,8.956e-02,1.424e-02,3.622e-03,5.600e-02,8.912e-01,2.551e-02
RBM28,21863,ribonucleoprotein complex,GO:1990904,cellular component,10.0,27.0,4.567e-02,3.257e-02,6.402e-02,3.935e-02,2.332e-02,6.642e-02,8.002e-01,1.343e-02
RBM28,21863,RNA binding,GO:0003723,molecular function,10.0,60.0,2.188e-02,5.279e-03,9.065e-02,9.198e-03,1.890e-03,4.475e-02,9.172e-01,2.425e-02
RBMS2,9909,ribonucleoprotein complex,GO:1990904,cellular component,3.0,27.0,2.185e-02,1.145e-02,4.170e-02,1.735e-02,4.239e-03,7.097e-02,8.741e-01,2.603e-02
RBMS2,9909,RNA binding,GO:0003723,molecular function,3.0,60.0,2.363e-02,1.572e-02,3.550e-02,1.695e-02,1.314e-02,2.186e-02,8.853e-01,5.484e-03
RDH11,17964,retinal metabolic process,GO:0042574,biological process,13.0,3.0,5.841e-02,1.425e-02,2.394e-01,1.844e-02,7.268e-03,4.679e-02,8.739e-01,1.959e-02
RDH11,17964,retinoid metabolic process,GO:0001523,biological process,13.0,6.0,5.841e-02,1.425e-02,2.394e-01,2.617e-02,1.080e-02,6.341e-02,8.419e-01,2.153e-02
RDH11,17964,cellular detoxification of aldehyde,GO:0110095,biological process,13.0,3.0,1.101e-01,7.805e-03,1.554e+00,8.511e-02,4.167e-03,1.738e+00,6.757e-01,1.023e-01
RDH11,17964,endoplasmic reticulum membrane,GO:0005789,cellular component,13.0,12.0,1.104e-01,1.957e-02,6.224e-01,8.538e-02,1.791e-02,4.071e-01,7.006e-01,4.731e-02
RDH11,17964,NADP-retinol dehydrogenase activity,GO:0052650,molecular function,13.0,2.0,7.024e-02,1.174e-02,4.201e-01,2.866e-02,2.447e-03,3.356e-01,8.175e-01,5.216e-02
RDH11,17964,protein binding,GO:0005515,molecular function,13.0,347.0,1.608e-01,4.487e-02,5.759e-01,1.513e-01,4.733e-02,4.835e-01,6.192e-01,4.272e-02
RECK,11345,negative regulation of endopeptidase activity,GO:0010951,biological process,13.0,9.0,8.590e-02,6.147e-02,1.200e-01,2.071e-02,1.295e-02,3.313e-02,8.661e-01,1.129e-02
RECK,11345,extracellular matrix organization,GO:0030198,biological process,13.0,19.0,8.590e-02,6.147e-02,1.200e-01,2.736e-02,1.492e-02,5.015e-02,8.380e-01,1.477e-02
RECK,11345,sprouting angiogenesis,GO:0002040,biological process,13.0,2.0,9.508e-02,6.166e-02,1.466e-01,2.831e-02,9.976e-03,8.036e-02,8.336e-01,2.586e-02
RECK,11345,negative regulation of metalloendopeptidase activity,GO:1904684,biological process,13.0,5.0,1.127e-01,5.136e-02,2.475e-01,4.432e-02,1.187e-02,1.656e-01,7.848e-01,3.427e-02
RECK,11345,negative regulation of cell migration,GO:0030336,biological process,13.0,31.0,1.838e-01,1.271e-01,2.658e-01,1.407e-01,9.612e-02,2.061e-01,6.364e-01,1.438e-02
RECK,11345,vasculature development,GO:0001944,biological process,13.0,6.0,2.605e-01,1.227e-01,5.530e-01,2.479e-01,1.087e-01,5.653e-01,5.312e-01,4.186e-02
RECK,11345,blood vessel maturation,GO:0001955,biological process,13.0,2.0,3.002e-01,1.028e-01,8.762e-01,2.649e-01,6.807e-02,1.031e+00,5.080e-01,6.463e-02
RECK,11345,plasma membrane,GO:0005886,cellular component,13.0,61.0,1.524e-01,6.612e-02,3.515e-01,9.123e-02,3.516e-02,2.367e-01,6.971e-01,3.114e-02
RECK,11345,membrane,GO:0016020,cellular component,13.0,58.0,1.850e-01,1.228e-01,2.786e-01,1.433e-01,7.660e-02,2.682e-01,6.327e-01,2.341e-02
RECK,11345,metalloendopeptidase inhibitor activity,GO:0008191,molecular function,13.0,2.0,9.055e-02,6.390e-02,1.283e-01,2.460e-02,1.541e-02,3.925e-02,8.490e-01,1.152e-02
RECK,11345,endopeptidase inhibitor activity,GO:0004866,molecular function,13.0,7.0,1.194e-01,4.380e-02,3.253e-01,5.159e-02,1.232e-02,2.161e-01,7.660e-01,3.938e-02
RECK,11345,protein binding,GO:0005515,molecular function,13.0,347.0,1.963e-01,1.355e-01,2.846e-01,1.597e-01,1.011e-01,2.523e-01,6.158e-01,1.809e-02
RECQL4,9949,,,,nan,nan,,,,,,,,
RETN,20389,extracellular exosome,GO:0070062,cellular component,13.0,77.0,7.479e-03,2.998e-03,1.866e-02,5.822e-03,2.562e-03,1.323e-02,9.463e-01,7.318e-03
RETN,20389,extracellular space,GO:0005615,cellular component,13.0,43.0,7.479e-03,2.998e-03,1.866e-02,6.042e-03,2.181e-03,1.673e-02,9.437e-01,1.069e-02
RGR,9990,,,,nan,nan,,,,,,,,
RGS7,10003,positive regulation of GTPase activity,GO:0043547,biological process,5.0,6.0,1.618e-01,2.053e-02,1.276e+00,1.389e-01,1.682e-02,1.147e+00,6.117e-01,9.056e-02
RGS7,10003,cytosol,GO:0005829,cellular component,5.0,76.0,1.483e-01,2.719e-02,8.089e-01,1.143e-01,4.355e-02,3.000e-01,6.648e-01,3.512e-02
RGS7,10003,G-protein beta-subunit binding,GO:0031681,molecular function,5.0,2.0,4.529e-02,3.681e-03,5.572e-01,1.132e-02,9.203e-04,1.393e-01,8.919e-01,4.752e-02
RGS7,10003,GTPase activator activity,GO:0005096,molecular function,5.0,4.0,1.616e-01,2.048e-02,1.276e+00,1.147e-01,8.477e-03,1.553e+00,6.258e-01,1.155e-01
RGSL1,18636,,,,nan,nan,,,,,,,,
RHBDL3,16502,,,,nan,nan,,,,,,,,
RNASE4,10047,,,,nan,nan,,,,,,,,
RNFT2,25905,,,,nan,nan,,,,,,,,
RPE,10293,"pentose-phosphate shunt, non-oxidative branch",GO:0009052,biological process,14.0,3.0,3.267e-02,1.231e-02,8.668e-02,4.236e-03,1.246e-03,1.440e-02,9.554e-01,7.861e-03
RPE,10293,cellular carbohydrate metabolic process,GO:0044262,biological process,14.0,16.0,3.267e-02,1.231e-02,8.668e-02,1.294e-02,6.017e-03,2.783e-02,9.041e-01,1.214e-02
RPE,10293,carbohydrate metabolic process,GO:0005975,biological process,14.0,12.0,3.306e-02,1.218e-02,8.975e-02,1.554e-02,4.767e-03,5.063e-02,8.856e-01,2.061e-02
RPE,10293,pentose-phosphate shunt,GO:0006098,biological process,14.0,3.0,3.410e-02,1.485e-02,7.830e-02,1.253e-02,1.072e-02,1.464e-02,9.090e-01,2.499e-03
RPE,10293,pentose catabolic process,GO:0019323,biological process,14.0,12.0,3.646e-02,1.073e-02,1.239e-01,1.664e-02,3.207e-03,8.630e-02,8.773e-01,3.505e-02
RPE,10293,extracellular exosome,GO:0070062,cellular component,14.0,77.0,4.288e-02,1.785e-02,1.030e-01,3.365e-02,1.045e-02,1.084e-01,8.151e-01,2.990e-02
RPE,10293,cytosol,GO:0005829,cellular component,14.0,76.0,4.757e-02,2.120e-02,1.068e-01,4.729e-02,2.132e-02,1.049e-01,7.794e-01,2.079e-02
RPE,10293,metal ion binding,GO:0046872,molecular function,14.0,9.0,3.499e-02,1.139e-02,1.074e-01,1.659e-02,3.388e-03,8.120e-02,8.759e-01,2.811e-02
RPE,10293,ribulose-phosphate 3-epimerase activity,GO:0004750,molecular function,14.0,2.0,3.566e-02,1.439e-02,8.836e-02,1.954e-02,7.086e-03,5.391e-02,8.694e-01,2.345e-02
RPE,10293,protein homodimerization activity,GO:0042803,molecular function,14.0,21.0,4.466e-02,1.792e-02,1.113e-01,3.685e-02,1.589e-02,8.544e-02,8.068e-01,2.109e-02
RPE,10293,identical protein binding,GO:0042802,molecular function,14.0,35.0,4.570e-02,1.778e-02,1.175e-01,4.058e-02,1.647e-02,9.996e-02,7.959e-01,2.295e-02
RRP12,29100,nucleolus,GO:0005730,cellular component,10.0,18.0,2.171e-02,1.074e-02,4.390e-02,1.299e-02,2.537e-03,6.654e-02,8.947e-01,3.058e-02
RRP12,29100,plasma membrane,GO:0005886,cellular component,10.0,61.0,2.380e-02,1.422e-02,3.984e-02,1.661e-02,8.722e-03,3.164e-02,8.852e-01,1.396e-02
RRP12,29100,cytosol,GO:0005829,cellular component,10.0,76.0,2.579e-02,1.607e-02,4.137e-02,2.166e-02,1.173e-02,3.999e-02,8.614e-01,1.453e-02
RRP12,29100,intracellular membrane-bounded organelle,GO:0043231,cellular component,10.0,48.0,2.933e-02,2.492e-02,3.451e-02,2.708e-02,2.406e-02,3.049e-02,8.390e-01,2.885e-03
RRP12,29100,RNA binding,GO:0003723,molecular function,10.0,60.0,2.171e-02,1.074e-02,4.390e-02,8.477e-03,4.693e-03,1.531e-02,9.304e-01,7.201e-03
RSC1A1,10458,negative regulation of glucose transmembrane transport,GO:0010829,biological process,7.0,4.0,1.642e-01,1.734e-02,1.554e+00,9.470e-02,5.113e-03,1.754e+00,6.562e-01,1.099e-01
RSC1A1,10458,negative regulation of transport,GO:0051051,biological process,7.0,48.0,1.917e-01,1.240e-02,2.963e+00,1.054e-01,2.243e-03,4.958e+00,5.688e-01,1.954e-01
RSC1A1,10458,nucleoplasm,GO:0005654,cellular component,7.0,51.0,1.810e-01,7.614e-02,4.301e-01,1.397e-01,8.558e-02,2.280e-01,6.372e-01,1.844e-02
RSC1A1,10458,cell junction,GO:0030054,cellular component,7.0,10.0,1.868e-01,7.441e-02,4.691e-01,1.463e-01,5.245e-02,4.080e-01,6.258e-01,4.004e-02
RSC1A1,10458,sodium channel inhibitor activity,GO:0019871,molecular function,7.0,4.0,1.277e-01,3.231e-02,5.044e-01,5.554e-02,2.441e-02,1.264e-01,7.607e-01,2.297e-02
RTL9,29245,,,,nan,nan,,,,,,,,
RTN4,14085,endoplasmic reticulum tubular network organization,GO:0071786,biological process,29.0,6.0,8.967e-02,7.067e-02,1.138e-01,1.261e-02,2.203e-03,7.214e-02,8.956e-01,2.788e-02
RTN4,14085,endoplasmic reticulum tubular network membrane organization,GO:1990809,biological process,29.0,3.0,8.967e-02,7.067e-02,1.138e-01,2.866e-02,1.799e-02,4.566e-02,8.333e-01,1.145e-02
RTN4,14085,positive regulation of epithelial cell migration,GO:0010634,biological process,29.0,8.0,9.602e-02,6.122e-02,1.506e-01,4.511e-02,2.592e-02,7.848e-02,7.852e-01,1.478e-02
RTN4,14085,positive regulation of protein kinase B signaling,GO:0051897,biological process,29.0,8.0,9.701e-02,5.981e-02,1.574e-01,4.555e-02,1.594e-02,1.302e-01,7.820e-01,2.905e-02
RTN4,14085,protein stabilization,GO:0050821,biological process,29.0,4.0,1.006e-01,8.186e-02,1.237e-01,2.518e-02,1.887e-03,3.359e-01,8.280e-01,5.733e-02
RTN4,14085,negative regulation of axon extension,GO:0030517,biological process,29.0,7.0,1.026e-01,6.173e-02,1.705e-01,5.050e-02,1.137e-02,2.244e-01,7.684e-01,4.063e-02
RTN4,14085,positive regulation of mammary gland epithelial cell proliferation,GO:0033601,biological process,29.0,5.0,1.034e-01,6.078e-02,1.759e-01,6.320e-02,2.362e-02,1.691e-01,7.439e-01,2.978e-02
RTN4,14085,nuclear pore complex assembly,GO:0051292,biological process,29.0,5.0,1.079e-01,6.357e-02,1.833e-01,4.964e-02,8.707e-03,2.831e-01,7.692e-01,4.642e-02
RTN4,14085,endoplasmic reticulum tubular network formation,GO:0071787,biological process,29.0,3.0,1.123e-01,6.157e-02,2.049e-01,8.529e-02,2.812e-02,2.587e-01,7.051e-01,3.387e-02
RTN4,14085,positive regulation of protein localization to endoplasmic reticulum,GO:1905552,biological process,29.0,3.0,1.128e-01,6.343e-02,2.007e-01,4.280e-02,4.534e-03,4.040e-01,7.788e-01,6.585e-02
RTN4,14085,positive regulation of ERBB3 signaling pathway,GO:1905580,biological process,29.0,3.0,1.425e-01,4.787e-02,4.244e-01,1.223e-01,2.769e-02,5.404e-01,6.488e-01,5.185e-02
RTN4,14085,negative regulation of cell growth,GO:0030308,biological process,29.0,19.0,1.478e-01,2.706e-02,8.076e-01,9.056e-02,6.596e-03,1.243e+00,6.693e-01,9.961e-02
RTN4,14085,endoplasmic reticulum tubular network membrane,GO:0098826,cellular component,29.0,2.0,8.967e-02,7.067e-02,1.138e-01,1.631e-02,4.894e-03,5.437e-02,8.825e-01,2.508e-02
RTN4,14085,integral component of endoplasmic reticulum membrane,GO:0030176,cellular component,29.0,10.0,1.009e-01,6.377e-02,1.596e-01,4.762e-02,1.110e-02,2.042e-01,7.755e-01,3.899e-02
RTN4,14085,endoplasmic reticulum membrane,GO:0005789,cellular component,29.0,12.0,1.079e-01,6.357e-02,1.833e-01,7.169e-02,2.903e-02,1.770e-01,7.290e-01,2.786e-02
RTN4,14085,nuclear envelope,GO:0005635,cellular component,29.0,4.0,1.208e-01,1.054e-01,1.384e-01,7.663e-02,4.308e-02,1.363e-01,7.224e-01,1.710e-02
RTN4,14085,endoplasmic reticulum,GO:0005783,cellular component,29.0,34.0,1.240e-01,1.035e-01,1.485e-01,1.019e-01,9.213e-02,1.126e-01,6.855e-01,3.454e-03
RTN4,14085,endoplasmic reticulum tubular network,GO:0071782,cellular component,29.0,3.0,1.412e-01,8.322e-02,2.396e-01,1.305e-01,7.773e-02,2.191e-01,6.478e-01,1.933e-02
RTN4,14085,cadherin binding,GO:0045296,molecular function,29.0,13.0,9.602e-02,6.122e-02,1.506e-01,3.002e-02,7.127e-03,1.264e-01,8.255e-01,3.554e-02
RTN4,14085,ubiquitin protein ligase binding,GO:0031625,molecular function,29.0,9.0,9.701e-02,5.981e-02,1.574e-01,4.277e-02,1.333e-02,1.372e-01,7.884e-01,3.191e-02
RTN4,14085,RNA binding,GO:0003723,molecular function,29.0,60.0,1.071e-01,8.334e-02,1.377e-01,6.562e-02,5.744e-02,7.496e-02,7.429e-01,3.902e-03
RTN4,14085,protein binding,GO:0005515,molecular function,29.0,347.0,1.165e-01,9.352e-02,1.450e-01,7.893e-02,3.380e-02,1.843e-01,7.171e-01,2.591e-02
S100A10,10487,protein heterotetramerization,GO:0051290,biological process,20.0,3.0,1.008e-01,4.694e-02,2.164e-01,1.222e-02,1.207e-03,1.237e-01,8.900e-01,4.509e-02
S100A10,10487,membrane raft assembly,GO:0001765,biological process,20.0,4.0,1.048e-01,4.963e-02,2.213e-01,2.982e-02,1.332e-02,6.675e-02,8.290e-01,1.983e-02
S100A10,10487,vesicle budding from membrane,GO:0006900,biological process,20.0,6.0,1.075e-01,5.460e-02,2.114e-01,4.125e-02,2.786e-02,6.109e-02,7.953e-01,1.025e-02
S100A10,10487,positive regulation of substrate adhesion-dependent cell spreading,GO:1900026,biological process,20.0,5.0,1.084e-01,5.522e-02,2.128e-01,4.245e-02,1.072e-02,1.682e-01,7.892e-01,3.588e-02
S100A10,10487,positive regulation of focal adhesion assembly,GO:0051894,biological process,20.0,5.0,1.135e-01,4.852e-02,2.654e-01,5.629e-02,3.539e-02,8.953e-02,7.604e-01,1.317e-02
S100A10,10487,protein localization to plasma membrane,GO:0072659,biological process,20.0,7.0,1.282e-01,3.191e-02,5.152e-01,6.627e-02,4.629e-03,9.485e-01,7.168e-01,8.816e-02
S100A10,10487,positive regulation of stress fiber assembly,GO:0051496,biological process,20.0,4.0,1.288e-01,3.998e-02,4.148e-01,1.070e-01,3.073e-02,3.727e-01,6.716e-01,4.515e-02
S100A10,10487,positive regulation of GTPase activity,GO:0043547,biological process,20.0,6.0,1.891e-01,9.346e-02,3.826e-01,1.875e-01,9.533e-02,3.687e-01,5.865e-01,2.970e-02
S100A10,10487,membrane raft,GO:0045121,cellular component,20.0,8.0,1.084e-01,5.522e-02,2.128e-01,5.564e-02,3.737e-02,8.285e-02,7.618e-01,1.123e-02
S100A10,10487,collagen-containing extracellular matrix,GO:0062023,cellular component,20.0,36.0,1.173e-01,4.504e-02,3.056e-01,4.997e-02,9.308e-03,2.683e-01,7.662e-01,4.982e-02
S100A10,10487,extracellular exosome,GO:0070062,cellular component,20.0,77.0,1.173e-01,4.504e-02,3.056e-01,7.188e-02,2.908e-02,1.776e-01,7.283e-01,2.861e-02
S100A10,10487,extracellular region,GO:0005576,cellular component,20.0,17.0,1.288e-01,3.998e-02,4.148e-01,1.068e-01,3.144e-02,3.630e-01,6.722e-01,4.376e-02
S100A10,10487,ion channel binding,GO:0044325,molecular function,20.0,6.0,1.144e-01,4.123e-02,3.175e-01,3.248e-02,3.031e-03,3.480e-01,8.071e-01,6.069e-02
S100A10,10487,protein homodimerization activity,GO:0042803,molecular function,20.0,21.0,1.189e-01,4.644e-02,3.042e-01,8.413e-02,4.828e-02,1.466e-01,7.101e-01,1.811e-02
S100A10,10487,protein binding,GO:0005515,molecular function,20.0,347.0,1.428e-01,5.756e-02,3.541e-01,1.230e-01,6.473e-02,2.336e-01,6.562e-01,2.377e-02
SARDH,10536,sarcosine catabolic process,GO:1901053,biological process,12.0,4.0,5.815e-02,2.845e-02,1.188e-01,2.548e-02,6.556e-03,9.900e-02,8.432e-01,3.376e-02
SARDH,10536,mitochondrial matrix,GO:0005759,cellular component,12.0,6.0,6.478e-02,2.924e-02,1.435e-01,3.481e-02,1.341e-02,9.034e-02,8.124e-01,2.393e-02
SARDH,10536,mitochondrion,GO:0005739,cellular component,12.0,35.0,6.652e-02,2.875e-02,1.539e-01,2.986e-02,8.659e-03,1.030e-01,8.273e-01,3.095e-02
SARDH,10536,cytoplasm,GO:0005737,cellular component,12.0,78.0,1.095e-01,7.432e-02,1.614e-01,9.126e-02,6.193e-02,1.345e-01,7.000e-01,1.242e-02
SARDH,10536,sarcosine dehydrogenase activity,GO:0008480,molecular function,12.0,2.0,5.081e-02,5.668e-03,4.555e-01,1.443e-02,4.853e-04,4.291e-01,8.613e-01,5.815e-02
SARDH,10536,oxidoreductase activity,GO:0016491,molecular function,12.0,93.0,2.394e-01,4.320e-02,1.326e+00,2.394e-01,4.320e-02,1.326e+00,5.161e-01,8.939e-02
SASH1,19182,,,,nan,nan,,,,,,,,
SCARA5,28701,,,,nan,nan,,,,,,,,
SCN3B,20665,membrane depolarization during action potential,GO:0086010,biological process,24.0,3.0,2.755e-02,1.121e-02,6.771e-02,4.120e-03,2.118e-03,8.014e-03,9.587e-01,5.075e-03
SCN3B,20665,atrial cardiac muscle cell action potential,GO:0086014,biological process,24.0,2.0,2.755e-02,1.121e-02,6.771e-02,7.267e-03,2.879e-03,1.834e-02,9.361e-01,1.053e-02
SCN3B,20665,ventricular cardiac muscle cell action potential,GO:0086005,biological process,24.0,3.0,2.755e-02,1.121e-02,6.771e-02,7.371e-03,1.985e-03,2.737e-02,9.323e-01,1.674e-02
SCN3B,20665,cardiac muscle cell action potential involved in contraction,GO:0086002,biological process,24.0,4.0,2.755e-02,1.121e-02,6.771e-02,7.793e-03,2.512e-03,2.417e-02,9.319e-01,1.241e-02
SCN3B,20665,membrane depolarization during cardiac muscle cell action potential,GO:0086012,biological process,24.0,8.0,2.755e-02,1.121e-02,6.771e-02,1.102e-02,5.108e-03,2.378e-02,9.146e-01,1.260e-02
SCN3B,20665,sodium ion transmembrane transport,GO:0035725,biological process,24.0,5.0,2.840e-02,1.147e-02,7.035e-02,1.356e-02,4.075e-03,4.511e-02,8.963e-01,1.884e-02
SCN3B,20665,regulation of heart rate by cardiac conduction,GO:0086091,biological process,24.0,3.0,2.947e-02,1.161e-02,7.481e-02,1.935e-02,7.902e-03,4.736e-02,8.696e-01,1.889e-02
SCN3B,20665,cardiac muscle contraction,GO:0060048,biological process,24.0,3.0,3.065e-02,1.156e-02,8.130e-02,1.535e-02,2.025e-03,1.163e-01,8.766e-01,3.368e-02
SCN3B,20665,membrane depolarization,GO:0051899,biological process,24.0,5.0,3.149e-02,1.046e-02,9.478e-02,2.019e-02,6.897e-03,5.912e-02,8.643e-01,2.253e-02
SCN3B,20665,protein localization to plasma membrane,GO:0072659,biological process,24.0,7.0,3.482e-02,7.654e-03,1.584e-01,1.971e-02,2.031e-03,1.912e-01,8.547e-01,4.653e-02
SCN3B,20665,regulation of atrial cardiac muscle cell membrane depolarization,GO:0060371,biological process,24.0,2.0,3.482e-02,7.654e-03,1.584e-01,2.225e-02,3.266e-03,1.517e-01,8.512e-01,4.652e-02
SCN3B,20665,regulation of ventricular cardiac muscle cell membrane depolarization,GO:0060373,biological process,24.0,2.0,3.482e-02,7.654e-03,1.584e-01,2.304e-02,3.725e-03,1.425e-01,8.491e-01,4.415e-02
SCN3B,20665,regulation of sodium ion transmembrane transporter activity,GO:2000649,biological process,24.0,11.0,4.273e-02,6.824e-03,2.675e-01,3.657e-02,4.753e-03,2.814e-01,7.996e-01,5.547e-02
SCN3B,20665,positive regulation of sodium ion transport,GO:0010765,biological process,24.0,5.0,4.415e-02,6.923e-03,2.816e-01,3.622e-02,4.177e-03,3.141e-01,7.993e-01,6.096e-02
SCN3B,20665,voltage-gated sodium channel complex,GO:0001518,cellular component,24.0,3.0,3.000e-02,1.053e-02,8.547e-02,1.657e-02,5.111e-03,5.369e-02,8.818e-01,2.557e-02
SCN3B,20665,plasma membrane,GO:0005886,cellular component,24.0,61.0,5.194e-02,1.185e-02,2.277e-01,4.419e-02,1.055e-02,1.850e-01,7.843e-01,3.752e-02
SCN3B,20665,sodium channel regulator activity,GO:0017080,molecular function,24.0,4.0,2.755e-02,1.121e-02,6.771e-02,2.693e-03,4.484e-04,1.617e-02,9.639e-01,1.137e-02
SCN3B,20665,ion channel binding,GO:0044325,molecular function,24.0,6.0,3.048e-02,1.340e-02,6.930e-02,1.612e-02,5.398e-03,4.815e-02,8.843e-01,2.220e-02
SCN3B,20665,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,GO:0086006,molecular function,24.0,6.0,3.098e-02,1.729e-02,5.551e-02,1.589e-02,6.321e-03,3.992e-02,8.864e-01,1.726e-02
SCN3B,20665,sodium channel inhibitor activity,GO:0019871,molecular function,24.0,4.0,3.320e-02,8.472e-03,1.301e-01,1.971e-02,3.599e-03,1.079e-01,8.619e-01,3.549e-02
SCN3B,20665,protein binding,GO:0005515,molecular function,24.0,347.0,7.957e-02,4.669e-02,1.356e-01,7.696e-02,4.854e-02,1.220e-01,7.224e-01,1.383e-02
SCOC,20335,,,,nan,nan,,,,,,,,
SDC4,10661,cell migration,GO:0016477,biological process,37.0,37.0,4.150e-02,1.543e-02,1.117e-01,3.206e-02,1.188e-02,8.648e-02,8.207e-01,2.539e-02
SDC4,10661,positive regulation of extracellular exosome assembly,GO:1903553,biological process,37.0,3.0,4.699e-02,1.914e-02,1.153e-01,3.900e-02,1.757e-02,8.658e-02,8.007e-01,2.014e-02
SDC4,10661,negative regulation of T cell proliferation,GO:0042130,biological process,37.0,9.0,7.989e-02,1.745e-03,3.657e+00,3.959e-02,2.358e-04,6.648e+00,6.800e-01,1.982e-01
SDC4,10661,positive regulation of exosomal secretion,GO:1903543,biological process,37.0,4.0,1.079e-01,1.236e-02,9.418e-01,9.975e-02,1.201e-02,8.286e-01,6.666e-01,8.135e-02
SDC4,10661,extracellular exosome,GO:0070062,cellular component,37.0,77.0,2.148e-02,8.317e-03,5.548e-02,6.298e-03,2.374e-03,1.671e-02,9.421e-01,1.019e-02
SDC4,10661,cell surface,GO:0009986,cellular component,37.0,11.0,2.148e-02,8.317e-03,5.548e-02,6.780e-03,1.607e-03,2.861e-02,9.353e-01,1.768e-02
SDC4,10661,identical protein binding,GO:0042802,molecular function,37.0,35.0,2.172e-02,8.331e-03,5.661e-02,8.294e-03,1.268e-03,5.425e-02,9.218e-01,2.083e-02
SDC4,10661,thrombospondin receptor activity,GO:0070053,molecular function,37.0,2.0,2.943e-02,1.577e-02,5.493e-02,1.016e-02,2.278e-03,4.532e-02,9.121e-01,2.445e-02
SDC4,10661,protein binding,GO:0005515,molecular function,37.0,347.0,3.153e-02,2.156e-02,4.609e-02,1.955e-02,8.043e-03,4.753e-02,8.693e-01,1.963e-02
SEMA3C,10725,,,,nan,nan,,,,,,,,
SGCB,10806,dystrophin-associated glycoprotein complex,GO:0016010,cellular component,4.0,5.0,4.240e-02,2.194e-02,8.197e-02,2.120e-02,1.097e-02,4.098e-02,8.630e-01,1.527e-02
SGCB,10806,protein binding,GO:0005515,molecular function,4.0,347.0,1.074e-01,4.717e-02,2.444e-01,1.074e-01,4.717e-02,2.444e-01,6.750e-01,2.924e-02
SGCD,10807,heart contraction,GO:0060047,biological process,6.0,2.0,3.011e-02,6.397e-03,1.417e-01,1.517e-02,7.004e-04,3.287e-01,8.610e-01,4.649e-02
SGCD,10807,cardiac muscle tissue development,GO:0048738,biological process,6.0,6.0,5.483e-02,2.084e-02,1.443e-01,5.483e-02,2.084e-02,1.443e-01,7.614e-01,2.722e-02
SGCD,10807,dystrophin-associated glycoprotein complex,GO:0016010,cellular component,6.0,5.0,1.639e-02,4.662e-03,5.759e-02,4.416e-03,4.565e-04,4.273e-02,9.441e-01,2.343e-02
SGCD,10807,sarcoglycan complex,GO:0016012,cellular component,6.0,2.0,2.652e-02,1.179e-02,5.967e-02,1.316e-02,3.397e-03,5.094e-02,8.969e-01,2.396e-02
SGCD,10807,sarcolemma,GO:0042383,cellular component,6.0,3.0,3.196e-02,2.095e-02,4.875e-02,2.168e-02,1.104e-02,4.259e-02,8.609e-01,1.566e-02
SGTB,23567,ubiquitin-dependent ERAD pathway,GO:0030433,biological process,11.0,6.0,1.601e-01,5.125e-02,5.003e-01,6.909e-02,8.685e-03,5.496e-01,7.200e-01,7.002e-02
SGTB,23567,posttranslational protein targeting to endoplasmic reticulum membrane,GO:0006620,biological process,11.0,3.0,1.601e-01,5.125e-02,5.003e-01,8.820e-02,1.783e-02,4.362e-01,6.944e-01,5.601e-02
SGTB,23567,positive regulation of chaperone-mediated protein folding,GO:1903646,biological process,11.0,3.0,2.787e-01,7.151e-02,1.086e+00,2.787e-01,7.151e-02,1.086e+00,4.904e-01,8.011e-02
SGTB,23567,membrane,GO:0016020,cellular component,11.0,58.0,1.601e-01,5.125e-02,5.003e-01,9.097e-02,2.283e-02,3.625e-01,6.929e-01,4.866e-02
SGTB,23567,cytosol,GO:0005829,cellular component,11.0,76.0,1.601e-01,5.125e-02,5.003e-01,1.010e-01,3.121e-02,3.268e-01,6.805e-01,4.221e-02
SGTB,23567,TRC complex,GO:0072380,cellular component,11.0,2.0,1.806e-01,7.103e-02,4.592e-01,1.297e-01,9.749e-02,1.724e-01,6.493e-01,1.060e-02
SGTB,23567,protein binding,GO:0005515,molecular function,11.0,347.0,1.601e-01,5.125e-02,5.003e-01,9.749e-02,3.361e-02,2.828e-01,6.867e-01,3.746e-02
SGTB,23567,molecular adaptor activity,GO:0060090,molecular function,11.0,4.0,2.066e-01,5.149e-02,8.292e-01,1.728e-01,3.944e-02,7.575e-01,5.882e-01,6.821e-02
SH2D4B,31440,,,,nan,nan,,,,,,,,
SIGMAR1,8157,protein homotrimerization,GO:0070207,biological process,17.0,3.0,3.167e-02,1.863e-03,5.382e-01,7.887e-03,1.837e-04,3.386e-01,8.966e-01,4.063e-02
SIGMAR1,8157,regulation of neuron apoptotic process,GO:0043523,biological process,17.0,10.0,2.038e-01,1.403e-02,2.960e+00,1.936e-01,1.132e-02,3.308e+00,5.211e-01,1.331e-01
SIGMAR1,8157,postsynaptic density,GO:0014069,cellular component,17.0,4.0,8.956e-02,2.933e-02,2.735e-01,4.921e-02,2.627e-02,9.216e-02,7.754e-01,1.676e-02
SIGMAR1,8157,endoplasmic reticulum,GO:0005783,cellular component,17.0,34.0,8.956e-02,2.933e-02,2.735e-01,5.001e-02,1.052e-02,2.376e-01,7.695e-01,4.099e-02
SIGMAR1,8157,integral component of membrane,GO:0016021,cellular component,17.0,12.0,8.956e-02,2.933e-02,2.735e-01,5.729e-02,1.257e-02,2.610e-01,7.531e-01,4.153e-02
SIGMAR1,8157,nuclear envelope,GO:0005635,cellular component,17.0,4.0,1.237e-01,7.771e-02,1.969e-01,1.116e-01,8.345e-02,1.493e-01,6.719e-01,1.022e-02
SIGMAR1,8157,protein binding,GO:0005515,molecular function,17.0,347.0,8.956e-02,2.933e-02,2.735e-01,5.545e-02,2.411e-02,1.275e-01,7.609e-01,2.247e-02
SLC10A6,30603,bile acid and bile salt transport,GO:0015721,biological process,9.0,5.0,8.295e-02,1.501e-02,4.584e-01,7.093e-02,1.016e-02,4.951e-01,7.189e-01,6.477e-02
SLC10A6,30603,bile acid:sodium symporter activity,GO:0008508,molecular function,9.0,3.0,8.295e-02,1.501e-02,4.584e-01,8.230e-02,1.528e-02,4.431e-01,7.030e-01,5.724e-02
SLC19A1,10937,folate import across plasma membrane,GO:1904447,biological process,16.0,3.0,5.558e-02,1.929e-02,1.601e-01,1.506e-02,4.588e-03,4.943e-02,8.888e-01,2.273e-02
SLC19A1,10937,folate transmembrane transport,GO:0098838,biological process,16.0,7.0,5.935e-02,1.765e-02,1.995e-01,2.035e-02,3.112e-03,1.330e-01,8.568e-01,3.898e-02
SLC19A1,10937,transmembrane transport,GO:0055085,biological process,16.0,27.0,7.260e-02,1.385e-02,3.806e-01,3.426e-02,1.914e-03,6.129e-01,7.928e-01,7.341e-02
SLC19A1,10937,cyclic-GMP-AMP transmembrane import across plasma membrane,GO:0140361,biological process,16.0,8.0,8.527e-02,2.404e-02,3.025e-01,5.412e-02,7.155e-03,4.093e-01,7.548e-01,5.854e-02
SLC19A1,10937,methotrexate transport,GO:0051958,biological process,16.0,4.0,8.547e-02,3.387e-02,2.157e-01,5.338e-02,1.666e-02,1.710e-01,7.635e-01,3.267e-02
SLC19A1,10937,apical plasma membrane,GO:0016324,cellular component,16.0,3.0,6.690e-02,3.102e-02,1.443e-01,2.562e-02,1.019e-02,6.439e-02,8.440e-01,2.238e-02
SLC19A1,10937,plasma membrane,GO:0005886,cellular component,16.0,61.0,1.070e-01,5.457e-02,2.097e-01,8.825e-02,4.588e-02,1.697e-01,7.034e-01,2.140e-02
SLC19A1,10937,basolateral plasma membrane,GO:0016323,cellular component,16.0,5.0,1.178e-01,3.823e-02,3.627e-01,1.081e-01,3.212e-02,3.636e-01,6.706e-01,4.186e-02
SLC19A1,10937,folate:anion antiporter activity,GO:0008518,molecular function,16.0,3.0,5.558e-02,1.929e-02,1.601e-01,1.124e-02,5.828e-03,2.168e-02,9.141e-01,1.053e-02
SLC19A1,10937,folic acid transmembrane transporter activity,GO:0008517,molecular function,16.0,7.0,6.722e-02,4.348e-02,1.039e-01,2.330e-02,9.192e-03,5.906e-02,8.529e-01,2.167e-02
SLC19A1,10937,methotrexate transmembrane transporter activity,GO:0015350,molecular function,16.0,4.0,7.641e-02,5.468e-02,1.068e-01,4.197e-02,2.204e-02,7.994e-02,7.929e-01,1.648e-02
SLC19A1,10937,cyclic-GMP-AMP transmembrane transporter activity,GO:0140360,molecular function,16.0,5.0,8.897e-02,3.578e-02,2.212e-01,6.202e-02,2.190e-02,1.756e-01,7.460e-01,3.073e-02
SLC19A1,10937,folic acid binding,GO:0005542,molecular function,16.0,8.0,8.905e-02,2.999e-02,2.644e-01,5.350e-02,9.347e-03,3.062e-01,7.574e-01,5.287e-02
SLC19A1,10937,cyclic-GMP-AMP binding,GO:0061507,molecular function,16.0,5.0,1.308e-01,3.289e-02,5.199e-01,1.131e-01,2.575e-02,4.966e-01,6.601e-01,5.529e-02
SLC25A10,10980,phosphate ion transmembrane transport,GO:0035435,biological process,27.0,5.0,3.761e-02,1.286e-02,1.100e-01,1.506e-02,4.907e-03,4.622e-02,8.895e-01,2.353e-02
SLC25A10,10980,oxaloacetate transport,GO:0015729,biological process,27.0,3.0,4.093e-02,1.274e-02,1.315e-01,2.341e-02,7.216e-03,7.593e-02,8.503e-01,2.621e-02
SLC25A10,10980,malate transmembrane transport,GO:0071423,biological process,27.0,4.0,4.412e-02,1.350e-02,1.443e-01,2.724e-02,8.616e-03,8.610e-02,8.372e-01,2.856e-02
SLC25A10,10980,succinate transmembrane transport,GO:0071422,biological process,27.0,5.0,4.564e-02,1.338e-02,1.557e-01,3.601e-02,1.388e-02,9.341e-02,8.083e-01,2.479e-02
SLC25A10,10980,thiosulfate transport,GO:0015709,biological process,27.0,3.0,4.843e-02,1.169e-02,2.006e-01,4.119e-02,9.137e-03,1.857e-01,7.909e-01,4.135e-02
SLC25A10,10980,sulfate transport,GO:0008272,biological process,27.0,4.0,4.843e-02,1.169e-02,2.006e-01,4.122e-02,8.486e-03,2.002e-01,7.902e-01,4.371e-02
SLC25A10,10980,mitochondrion,GO:0005739,cellular component,27.0,35.0,4.051e-02,1.089e-02,1.507e-01,1.663e-02,2.174e-03,1.272e-01,8.729e-01,4.366e-02
SLC25A10,10980,nucleoplasm,GO:0005654,cellular component,27.0,51.0,4.918e-02,1.129e-02,2.143e-01,4.483e-02,8.809e-03,2.281e-01,7.798e-01,4.619e-02
SLC25A10,10980,nucleus,GO:0005634,cellular component,27.0,81.0,5.198e-02,1.312e-02,2.059e-01,4.725e-02,1.157e-02,1.930e-01,7.763e-01,3.881e-02
SLC25A10,10980,antiporter activity,GO:0015297,molecular function,27.0,6.0,3.761e-02,1.286e-02,1.100e-01,8.798e-03,6.002e-03,1.290e-02,9.292e-01,4.557e-03
SLC25A10,10980,succinate transmembrane transporter activity,GO:0015141,molecular function,27.0,6.0,3.761e-02,1.286e-02,1.100e-01,1.179e-02,9.960e-03,1.396e-02,9.130e-01,2.660e-03
SLC25A10,10980,malate transmembrane transporter activity,GO:0015140,molecular function,27.0,5.0,3.761e-02,1.286e-02,1.100e-01,1.265e-02,7.770e-03,2.061e-02,9.072e-01,8.437e-03
SLC25A10,10980,oxaloacetate transmembrane transporter activity,GO:0015131,molecular function,27.0,3.0,3.761e-02,1.286e-02,1.100e-01,1.429e-02,7.016e-03,2.912e-02,8.966e-01,1.414e-02
SLC25A10,10980,thiosulfate transmembrane transporter activity,GO:0015117,molecular function,27.0,3.0,3.919e-02,1.363e-02,1.127e-01,1.556e-02,5.264e-03,4.601e-02,8.866e-01,1.993e-02
SLC25A10,10980,sulfate transmembrane transporter activity,GO:0015116,molecular function,27.0,6.0,3.919e-02,1.363e-02,1.127e-01,1.949e-02,8.671e-03,4.383e-02,8.703e-01,1.819e-02
SLC25A10,10980,protein binding,GO:0005515,molecular function,27.0,347.0,5.614e-02,1.434e-02,2.198e-01,5.194e-02,1.633e-02,1.652e-01,7.671e-01,3.116e-02
SLC25A17,10987,fatty acid beta-oxidation,GO:0006635,biological process,19.0,9.0,1.313e-01,8.041e-02,2.143e-01,5.539e-02,3.092e-02,9.921e-02,7.621e-01,1.590e-02
SLC25A17,10987,fatty acid transport,GO:0015908,biological process,19.0,9.0,2.322e-01,8.693e-02,6.205e-01,1.843e-01,4.753e-02,7.145e-01,5.797e-01,6.141e-02
SLC25A17,10987,ATP transport,GO:0015867,biological process,19.0,7.0,3.289e-01,1.504e-01,7.190e-01,3.289e-01,1.504e-01,7.190e-01,4.684e-01,4.684e-02
SLC25A17,10987,peroxisomal membrane,GO:0005778,cellular component,19.0,4.0,1.008e-01,7.274e-02,1.398e-01,1.227e-02,7.984e-03,1.886e-02,9.096e-01,6.541e-03
SLC25A17,10987,membrane,GO:0016020,cellular component,19.0,58.0,1.620e-01,9.393e-02,2.793e-01,1.164e-01,7.326e-02,1.849e-01,6.652e-01,1.626e-02
SLC25A17,10987,integral component of peroxisomal membrane,GO:0005779,cellular component,19.0,3.0,1.856e-01,7.279e-02,4.730e-01,1.059e-01,2.341e-02,4.788e-01,6.694e-01,5.564e-02
SLC25A17,10987,peroxisome,GO:0005777,cellular component,19.0,16.0,2.198e-01,8.234e-02,5.868e-01,1.920e-01,6.862e-02,5.373e-01,5.782e-01,4.586e-02
SLC25A17,10987,chaperone binding,GO:0051087,molecular function,19.0,3.0,1.008e-01,7.274e-02,1.398e-01,1.509e-02,5.725e-03,3.978e-02,8.903e-01,2.015e-02
SLC25A17,10987,ATP transmembrane transporter activity,GO:0005347,molecular function,19.0,5.0,1.210e-01,6.004e-02,2.440e-01,4.159e-02,2.077e-02,8.328e-02,7.936e-01,1.842e-02
SLC25A17,10987,ADP transmembrane transporter activity,GO:0015217,molecular function,19.0,5.0,1.210e-01,6.004e-02,2.440e-01,4.165e-02,1.915e-02,9.060e-02,7.932e-01,2.063e-02
SLC25A17,10987,AMP transmembrane transporter activity,GO:0080122,molecular function,19.0,5.0,1.210e-01,6.004e-02,2.440e-01,6.967e-02,3.226e-02,1.505e-01,7.335e-01,2.326e-02
SLC25A17,10987,coenzyme A transmembrane transporter activity,GO:0015228,molecular function,19.0,5.0,1.210e-01,6.004e-02,2.440e-01,7.118e-02,2.656e-02,1.907e-01,7.294e-01,3.048e-02
SLC25A17,10987,NAD transmembrane transporter activity,GO:0051724,molecular function,19.0,3.0,1.210e-01,6.004e-02,2.440e-01,7.186e-02,1.996e-02,2.587e-01,7.261e-01,3.805e-02
SLC25A17,10987,FMN transmembrane transporter activity,GO:0044610,molecular function,19.0,5.0,1.210e-01,6.004e-02,2.440e-01,7.556e-02,2.193e-02,2.603e-01,7.199e-01,3.775e-02
SLC25A17,10987,FAD transmembrane transporter activity,GO:0015230,molecular function,19.0,4.0,1.210e-01,6.004e-02,2.440e-01,7.523e-02,1.845e-02,3.067e-01,7.192e-01,4.228e-02
SLC25A17,10987,protein binding,GO:0005515,molecular function,19.0,347.0,1.811e-01,1.213e-01,2.705e-01,1.506e-01,1.167e-01,1.942e-01,6.260e-01,9.687e-03
SLC25A19,14409,thiamine pyrophosphate transmembrane transport,GO:0030974,biological process,13.0,11.0,1.505e-01,7.180e-02,3.154e-01,1.497e-01,7.033e-02,3.185e-01,6.245e-01,2.971e-02
SLC25A19,14409,integral component of mitochondrial inner membrane,GO:0031305,cellular component,13.0,5.0,6.617e-02,3.673e-02,1.192e-01,2.084e-02,6.714e-03,6.470e-02,8.621e-01,2.525e-02
SLC25A19,14409,nucleus,GO:0005634,cellular component,13.0,81.0,1.119e-01,8.708e-02,1.438e-01,8.093e-02,5.013e-02,1.307e-01,7.156e-01,1.524e-02
SLC25A19,14409,thiamine transmembrane transporter activity,GO:0015234,molecular function,13.0,6.0,9.810e-02,5.221e-02,1.843e-01,4.465e-02,7.993e-03,2.494e-01,7.813e-01,4.563e-02
SLC25A25,20663,,,,nan,nan,,,,,,,,
SLC25A5,10991,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,GO:1901029,biological process,18.0,5.0,1.021e-01,7.148e-02,1.458e-01,4.794e-02,1.112e-02,2.067e-01,7.732e-01,4.221e-02
SLC25A5,10991,positive regulation of cell population proliferation,GO:0008284,biological process,18.0,40.0,1.071e-01,7.447e-02,1.541e-01,7.859e-02,2.612e-02,2.365e-01,7.160e-01,3.278e-02
SLC25A5,10991,MMXD complex,GO:0071817,cellular component,18.0,2.0,7.637e-02,3.949e-02,1.477e-01,1.320e-02,1.636e-03,1.065e-01,8.884e-01,3.767e-02
SLC25A5,10991,mitochondrial nucleoid,GO:0042645,cellular component,18.0,4.0,1.021e-01,7.148e-02,1.458e-01,4.439e-02,2.342e-02,8.414e-02,7.869e-01,1.652e-02
SLC25A5,10991,nucleus,GO:0005634,cellular component,18.0,81.0,1.037e-01,7.552e-02,1.425e-01,6.920e-02,4.494e-02,1.066e-01,7.358e-01,1.284e-02
SLC25A5,10991,mitochondrion,GO:0005739,cellular component,18.0,35.0,1.038e-01,7.487e-02,1.438e-01,7.737e-02,4.471e-02,1.339e-01,7.213e-01,1.665e-02
SLC25A5,10991,membrane,GO:0016020,cellular component,18.0,58.0,1.134e-01,7.421e-02,1.732e-01,1.060e-01,5.929e-02,1.894e-01,6.782e-01,1.985e-02
SLC25A5,10991,ATP:ADP antiporter activity,GO:0005471,molecular function,18.0,4.0,1.021e-01,7.148e-02,1.458e-01,3.654e-02,5.714e-03,2.337e-01,8.019e-01,4.440e-02
SLC25A5,10991,ubiquitin protein ligase binding,GO:0031625,molecular function,18.0,9.0,1.021e-01,7.148e-02,1.458e-01,4.583e-02,3.322e-02,6.323e-02,7.839e-01,8.505e-03
SLC25A5,10991,RNA binding,GO:0003723,molecular function,18.0,60.0,1.037e-01,7.552e-02,1.425e-01,6.031e-02,2.618e-02,1.389e-01,7.511e-01,2.320e-02
SLC25A5,10991,protein binding,GO:0005515,molecular function,18.0,347.0,1.050e-01,7.853e-02,1.404e-01,7.625e-02,5.225e-02,1.113e-01,7.238e-01,1.172e-02
SLC2A13,15956,glucose import,GO:0046323,biological process,6.0,4.0,6.946e-02,4.204e-02,1.148e-01,2.483e-02,1.004e-02,6.137e-02,8.470e-01,2.166e-02
SLC2A13,15956,myo-inositol transport,GO:0015798,biological process,6.0,3.0,1.054e-01,4.099e-02,2.712e-01,8.255e-02,3.485e-02,1.955e-01,7.109e-01,2.855e-02
SLC2A13,15956,integral component of plasma membrane,GO:0005887,cellular component,6.0,28.0,1.073e-01,4.625e-02,2.491e-01,7.132e-02,2.570e-02,1.980e-01,7.291e-01,2.997e-02
SLC2A13,15956,myo-inositol:proton symporter activity,GO:0005366,molecular function,6.0,3.0,6.946e-02,4.204e-02,1.148e-01,3.345e-02,1.627e-02,6.875e-02,8.174e-01,1.793e-02
SLC2A13,15956,protein binding,GO:0005515,molecular function,6.0,347.0,1.334e-01,3.942e-02,4.512e-01,1.294e-01,3.451e-02,4.849e-01,6.427e-01,4.595e-02
SLC2A3,11007,glucose transmembrane transport,GO:1904659,biological process,14.0,4.0,3.434e-02,1.719e-02,6.859e-02,1.381e-02,8.588e-03,2.219e-02,9.011e-01,8.455e-03
SLC2A3,11007,extracellular exosome,GO:0070062,cellular component,14.0,77.0,3.434e-02,1.719e-02,6.859e-02,1.590e-02,1.128e-02,2.243e-02,8.905e-01,6.628e-03
SLC2A3,11007,integral component of membrane,GO:0016021,cellular component,14.0,12.0,3.572e-02,1.582e-02,8.067e-02,1.888e-02,4.056e-03,8.789e-02,8.673e-01,3.205e-02
SLC2A3,11007,integral component of plasma membrane,GO:0005887,cellular component,14.0,28.0,3.898e-02,1.937e-02,7.846e-02,3.417e-02,2.094e-02,5.576e-02,8.151e-01,1.224e-02
SLC2A3,11007,glucose binding,GO:0005536,molecular function,14.0,2.0,3.434e-02,1.719e-02,6.859e-02,1.251e-02,4.025e-03,3.889e-02,9.029e-01,1.839e-02
SLC2A3,11007,protein binding,GO:0005515,molecular function,14.0,347.0,3.898e-02,1.937e-02,7.846e-02,3.592e-02,1.871e-02,6.895e-02,8.096e-01,1.628e-02
SLC2A3,11007,glucose transmembrane transporter activity,GO:0005355,molecular function,14.0,10.0,4.256e-02,1.306e-02,1.387e-01,3.718e-02,7.940e-03,1.741e-01,8.027e-01,4.016e-02
SLC36A2,18762,amino acid transmembrane transport,GO:0003333,biological process,14.0,19.0,9.740e-02,3.584e-02,2.647e-01,1.826e-02,1.550e-02,2.151e-02,8.787e-01,3.791e-03
SLC36A2,18762,glycine transport,GO:0015816,biological process,14.0,9.0,1.032e-01,3.377e-02,3.156e-01,6.956e-02,1.956e-02,2.473e-01,7.306e-01,3.642e-02
SLC36A2,18762,proline transmembrane transport,GO:0035524,biological process,14.0,6.0,1.091e-01,5.888e-02,2.020e-01,5.593e-02,3.215e-02,9.729e-02,7.609e-01,1.519e-02
SLC36A2,18762,L-alanine transport,GO:0015808,biological process,14.0,4.0,1.091e-01,5.888e-02,2.020e-01,6.115e-02,5.872e-02,6.368e-02,7.513e-01,1.153e-03
SLC36A2,18762,proton transmembrane transport,GO:1902600,biological process,14.0,7.0,1.496e-01,2.356e-02,9.507e-01,1.067e-01,5.646e-03,2.016e+00,6.451e-01,9.772e-02
SLC36A2,18762,extracellular exosome,GO:0070062,cellular component,14.0,77.0,1.289e-01,5.208e-02,3.193e-01,1.150e-01,4.587e-02,2.885e-01,6.642e-01,3.211e-02
SLC36A2,18762,vacuolar membrane,GO:0005774,cellular component,14.0,8.0,1.747e-01,9.757e-02,3.127e-01,1.609e-01,8.064e-02,3.209e-01,6.134e-01,2.677e-02
SLC36A2,18762,L-alanine transmembrane transporter activity,GO:0015180,molecular function,14.0,3.0,9.740e-02,3.584e-02,2.647e-01,2.880e-02,6.208e-03,1.336e-01,8.283e-01,3.549e-02
SLC36A2,18762,L-proline transmembrane transporter activity,GO:0015193,molecular function,14.0,4.0,9.740e-02,3.584e-02,2.647e-01,3.726e-02,1.613e-02,8.611e-02,8.051e-01,2.149e-02
SLC36A2,18762,glycine transmembrane transporter activity,GO:0015187,molecular function,14.0,6.0,9.740e-02,3.584e-02,2.647e-01,4.104e-02,1.135e-02,1.483e-01,7.930e-01,3.447e-02
SLC36A2,18762,amino acid transmembrane transporter activity,GO:0015171,molecular function,14.0,15.0,9.868e-02,3.544e-02,2.748e-01,5.292e-02,1.515e-02,1.849e-01,7.643e-01,3.328e-02
SLC36A2,18762,amino acid:proton symporter activity,GO:0005280,molecular function,14.0,7.0,1.032e-01,3.377e-02,3.156e-01,6.590e-02,1.851e-02,2.346e-01,7.376e-01,3.571e-02
SLC36A2,18762,proton transmembrane transporter activity,GO:0015078,molecular function,14.0,9.0,1.221e-01,5.026e-02,2.967e-01,1.002e-01,3.865e-02,2.600e-01,6.839e-01,3.184e-02
SLC39A12,20860,zinc ion import across plasma membrane,GO:0071578,biological process,17.0,3.0,1.067e-01,3.415e-02,3.331e-01,6.502e-02,1.226e-02,3.448e-01,7.344e-01,5.207e-02
SLC39A12,20860,cellular zinc ion homeostasis,GO:0006882,biological process,17.0,4.0,1.187e-01,5.293e-02,2.661e-01,7.736e-02,3.906e-02,1.532e-01,7.207e-01,2.037e-02
SLC39A12,20860,signal transduction,GO:0007165,biological process,17.0,48.0,1.413e-01,3.534e-02,5.648e-01,1.225e-01,1.889e-02,7.943e-01,6.439e-01,6.259e-02
SLC39A12,20860,integral component of plasma membrane,GO:0005887,cellular component,17.0,28.0,5.225e-02,2.575e-03,1.060e+00,9.643e-03,4.135e-04,2.249e-01,8.929e-01,3.523e-02
SLC39A12,20860,extracellular vesicle,GO:1903561,cellular component,17.0,13.0,1.059e-01,3.540e-02,3.167e-01,7.604e-02,2.529e-02,2.286e-01,7.203e-01,3.347e-02
SLC39A12,20860,zinc ion transmembrane transporter activity,GO:0005385,molecular function,17.0,6.0,1.122e-01,4.419e-02,2.850e-01,7.551e-02,4.351e-02,1.310e-01,7.243e-01,1.739e-02
SLC43A3,17466,,,,nan,nan,,,,,,,,
SLC46A1,30521,,,,nan,nan,,,,,,,,
SLC7A6,11064,amino acid transmembrane transport,GO:0003333,biological process,20.0,19.0,2.684e-02,2.013e-02,3.579e-02,1.351e-02,8.816e-03,2.071e-02,9.029e-01,7.553e-03
SLC7A6,11064,plasma membrane,GO:0005886,cellular component,20.0,61.0,3.126e-02,1.879e-02,5.199e-02,2.813e-02,1.531e-02,5.171e-02,8.352e-01,1.504e-02
SLC7A6,11064,intracellular membrane-bounded organelle,GO:0043231,cellular component,20.0,48.0,3.485e-02,1.082e-02,1.123e-01,3.105e-02,7.854e-03,1.227e-01,8.227e-01,3.566e-02
SLC7A6,11064,L-amino acid transmembrane transporter activity,GO:0015179,molecular function,20.0,28.0,2.684e-02,2.013e-02,3.579e-02,1.959e-02,1.369e-02,2.804e-02,8.716e-01,8.454e-03
SLC7A8,11066,amino acid transmembrane transport,GO:0003333,biological process,16.0,19.0,3.955e-02,1.346e-02,1.162e-01,6.297e-03,1.084e-03,3.659e-02,9.372e-01,1.577e-02
SLC7A8,11066,neutral amino acid transport,GO:0015804,biological process,16.0,18.0,5.873e-02,3.349e-02,1.030e-01,3.233e-02,1.636e-02,6.391e-02,8.207e-01,1.706e-02
SLC7A8,11066,amino acid transport,GO:0006865,biological process,16.0,18.0,7.021e-02,5.134e-02,9.602e-02,4.038e-02,1.257e-02,1.297e-01,7.952e-01,3.101e-02
SLC7A8,11066,plasma membrane,GO:0005886,cellular component,16.0,61.0,7.017e-02,4.573e-02,1.077e-01,5.354e-02,3.381e-02,8.480e-02,7.663e-01,1.244e-02
SLC7A8,11066,L-amino acid transmembrane transporter activity,GO:0015179,molecular function,16.0,28.0,5.384e-02,2.961e-02,9.789e-02,1.614e-02,9.146e-03,2.848e-02,8.882e-01,1.233e-02
SLC7A8,11066,neutral amino acid transmembrane transporter activity,GO:0015175,molecular function,16.0,17.0,5.604e-02,2.775e-02,1.132e-01,2.875e-02,9.285e-03,8.900e-02,8.317e-01,2.718e-02
SLC7A8,11066,amino acid transmembrane transporter activity,GO:0015171,molecular function,16.0,15.0,5.604e-02,2.775e-02,1.132e-01,2.983e-02,9.530e-03,9.340e-02,8.279e-01,2.747e-02
SLC7A8,11066,toxin transmembrane transporter activity,GO:0019534,molecular function,16.0,3.0,6.589e-02,3.244e-02,1.338e-01,4.679e-02,1.555e-02,1.408e-01,7.794e-01,2.873e-02
SLC7A8,11066,organic cation transmembrane transporter activity,GO:0015101,molecular function,16.0,21.0,8.191e-02,2.389e-02,2.808e-01,7.273e-02,1.484e-02,3.564e-01,7.217e-01,4.818e-02
SLC7A8,11066,protein binding,GO:0005515,molecular function,16.0,347.0,9.368e-02,3.893e-02,2.254e-01,8.708e-02,3.500e-02,2.167e-01,7.034e-01,3.034e-02
SLCO3A1,10952,prostaglandin transport,GO:0015732,biological process,6.0,5.0,3.394e-02,3.079e-02,3.740e-02,1.119e-02,5.686e-03,2.202e-02,9.143e-01,1.091e-02
SLCO3A1,10952,sodium-independent organic anion transport,GO:0043252,biological process,6.0,2.0,4.285e-02,2.347e-02,7.822e-02,4.070e-02,2.143e-02,7.730e-02,7.962e-01,1.681e-02
SLCO3A1,10952,integral component of plasma membrane,GO:0005887,cellular component,6.0,28.0,4.067e-02,2.600e-02,6.362e-02,3.307e-02,1.771e-02,6.176e-02,8.185e-01,1.556e-02
SLCO3A1,10952,sodium-independent organic anion transmembrane transporter activity,GO:0015347,molecular function,6.0,4.0,3.589e-02,2.768e-02,4.652e-02,2.131e-02,1.396e-02,3.253e-02,8.632e-01,1.016e-02
SMPD1,11120,sphingomyelin catabolic process,GO:0006685,biological process,19.0,4.0,8.672e-02,5.627e-02,1.337e-01,2.185e-02,1.517e-02,3.148e-02,8.609e-01,8.898e-03
SMPD1,11120,ceramide biosynthetic process,GO:0046513,biological process,19.0,9.0,1.386e-01,3.538e-02,5.432e-01,6.290e-02,1.181e-02,3.350e-01,7.403e-01,4.679e-02
SMPD1,11120,negative regulation of MAP kinase activity,GO:0043407,biological process,19.0,6.0,1.386e-01,3.538e-02,5.432e-01,6.561e-02,9.346e-03,4.606e-01,7.325e-01,5.461e-02
SMPD1,11120,termination of signal transduction,GO:0023021,biological process,19.0,5.0,1.432e-01,3.331e-02,6.154e-01,6.099e-02,3.570e-03,1.042e+00,7.253e-01,9.127e-02
SMPD1,11120,positive regulation of protein dephosphorylation,GO:0035307,biological process,19.0,7.0,3.733e-01,3.228e-01,4.317e-01,3.648e-01,3.010e-01,4.422e-01,4.516e-01,1.175e-02
SMPD1,11120,extracellular space,GO:0005615,cellular component,19.0,43.0,1.419e-01,3.882e-02,5.184e-01,5.903e-02,2.444e-02,1.426e-01,7.532e-01,2.611e-02
SMPD1,11120,extracellular exosome,GO:0070062,cellular component,19.0,77.0,1.419e-01,3.882e-02,5.184e-01,7.365e-02,3.103e-02,1.748e-01,7.257e-01,2.697e-02
SMPD1,11120,lysosome,GO:0005764,cellular component,19.0,13.0,1.423e-01,3.860e-02,5.244e-01,8.358e-02,3.133e-02,2.230e-01,7.085e-01,3.225e-02
SMPD1,11120,endosome,GO:0005768,cellular component,19.0,15.0,1.453e-01,3.710e-02,5.687e-01,1.071e-01,2.779e-02,4.129e-01,6.698e-01,4.975e-02
SMPD1,11120,plasma membrane,GO:0005886,cellular component,19.0,61.0,1.453e-01,3.710e-02,5.687e-01,1.105e-01,3.296e-02,3.706e-01,6.673e-01,4.313e-02
SMPD1,11120,sphingomyelin phosphodiesterase activity,GO:0004767,molecular function,19.0,6.0,7.979e-02,5.536e-02,1.150e-01,8.487e-03,4.873e-03,1.478e-02,9.305e-01,6.525e-03
SMPD1,11120,acid sphingomyelin phosphodiesterase activity,GO:0061750,molecular function,19.0,2.0,7.979e-02,5.536e-02,1.150e-01,1.107e-02,6.832e-03,1.793e-02,9.161e-01,7.211e-03
SMPD1,11120,zinc ion binding,GO:0008270,molecular function,19.0,8.0,1.539e-01,3.805e-02,6.223e-01,1.178e-01,2.175e-02,6.385e-01,6.515e-01,5.964e-02
SMPD1,11120,protein binding,GO:0005515,molecular function,19.0,347.0,1.703e-01,5.281e-02,5.495e-01,1.436e-01,5.510e-02,3.740e-01,6.298e-01,3.557e-02
SMPD1,11120,phosphoric diester hydrolase activity,GO:0008081,molecular function,19.0,35.0,2.384e-01,2.722e-02,2.088e+00,1.822e-01,1.196e-02,2.775e+00,5.406e-01,1.236e-01
SMPD3,14240,sphingomyelin metabolic process,GO:0006684,biological process,7.0,7.0,5.523e-02,4.317e-02,7.067e-02,2.905e-02,1.981e-02,4.259e-02,8.320e-01,9.412e-03
SMPD3,14240,cytoplasm,GO:0005737,cellular component,7.0,78.0,1.292e-01,7.676e-02,2.175e-01,1.292e-01,7.676e-02,2.175e-01,6.493e-01,1.898e-02
SMPD3,14240,sphingomyelin phosphodiesterase activity,GO:0004767,molecular function,7.0,6.0,7.916e-03,6.689e-05,9.368e-01,1.647e-03,1.276e-05,2.125e-01,9.571e-01,1.764e-02
SMPD3,14240,phospholipase activity,GO:0004620,molecular function,7.0,13.0,5.523e-02,4.317e-02,7.067e-02,3.209e-02,2.327e-02,4.426e-02,8.217e-01,7.899e-03
SMPD3,14240,protein binding,GO:0005515,molecular function,7.0,347.0,1.249e-01,7.471e-02,2.088e-01,1.073e-01,5.856e-02,1.966e-01,6.764e-01,2.141e-02
SMTNL2,24764,,,,nan,nan,,,,,,,,
SNRK,30598,protein phosphorylation,GO:0006468,biological process,8.0,30.0,9.978e-02,7.979e-02,1.248e-01,7.981e-02,5.311e-02,1.199e-01,7.179e-01,1.238e-02
SNRK,30598,intracellular signal transduction,GO:0035556,biological process,8.0,30.0,1.114e-01,9.267e-02,1.339e-01,8.168e-02,3.916e-02,1.704e-01,7.132e-01,2.315e-02
SNRK,30598,nucleus,GO:0005634,cellular component,8.0,81.0,9.516e-02,6.519e-02,1.389e-01,5.901e-02,1.889e-02,1.843e-01,7.514e-01,3.321e-02
SNRK,30598,cytoplasm,GO:0005737,cellular component,8.0,78.0,9.516e-02,6.519e-02,1.389e-01,7.501e-02,2.917e-02,1.929e-01,7.233e-01,2.818e-02
SNRK,30598,magnesium ion binding,GO:0000287,molecular function,8.0,5.0,9.516e-02,6.519e-02,1.389e-01,3.461e-02,9.840e-03,1.217e-01,8.123e-01,3.145e-02
SNRK,30598,protein serine/threonine kinase activity,GO:0004674,molecular function,8.0,31.0,9.516e-02,6.519e-02,1.389e-01,3.930e-02,3.183e-02,4.853e-02,8.007e-01,5.316e-03
SNRK,30598,ATP binding,GO:0005524,molecular function,8.0,10.0,1.159e-01,1.045e-01,1.286e-01,1.080e-01,7.775e-02,1.500e-01,6.765e-01,1.135e-02
SNRNP35,30852,,,,nan,nan,,,,,,,,
SNTA1,11167,ventricular cardiac muscle cell action potential,GO:0086005,biological process,18.0,3.0,5.159e-02,1.152e-02,2.309e-01,2.081e-02,2.123e-03,2.040e-01,8.516e-01,5.178e-02
SNTA1,11167,regulation of sodium ion transmembrane transport,GO:1902305,biological process,18.0,8.0,6.439e-02,6.785e-03,6.111e-01,2.529e-02,6.032e-04,1.060e+00,8.058e-01,1.026e-01
SNTA1,11167,regulation of ventricular cardiac muscle cell membrane repolarization,GO:0060307,biological process,18.0,3.0,6.965e-02,8.382e-03,5.788e-01,4.088e-02,2.423e-03,6.897e-01,7.754e-01,8.572e-02
SNTA1,11167,negative regulation of peptidyl-cysteine S-nitrosylation,GO:1902083,biological process,18.0,3.0,8.227e-02,4.282e-02,1.581e-01,5.156e-02,1.700e-02,1.564e-01,7.680e-01,3.063e-02
SNTA1,11167,regulation of heart rate,GO:0002027,biological process,18.0,9.0,8.781e-02,9.752e-03,7.907e-01,6.004e-02,3.214e-03,1.122e+00,7.243e-01,9.722e-02
SNTA1,11167,sarcolemma,GO:0042383,cellular component,18.0,3.0,3.990e-02,2.119e-02,7.513e-02,5.774e-03,3.083e-03,1.081e-02,9.471e-01,5.638e-03
SNTA1,11167,neuromuscular junction,GO:0031594,cellular component,18.0,6.0,3.990e-02,2.119e-02,7.513e-02,8.681e-03,2.013e-03,3.743e-02,9.218e-01,2.177e-02
SNTA1,11167,dystrophin-associated glycoprotein complex,GO:0016010,cellular component,18.0,5.0,4.757e-02,3.115e-02,7.264e-02,2.076e-02,9.246e-03,4.660e-02,8.643e-01,1.841e-02
SNTA1,11167,intracellular,GO:0005622,cellular component,18.0,8.0,1.320e-01,4.872e-02,3.575e-01,1.099e-01,4.004e-02,3.017e-01,6.701e-01,3.428e-02
SNTA1,11167,synapse,GO:0045202,cellular component,18.0,21.0,1.321e-01,9.222e-02,1.893e-01,1.071e-01,8.596e-02,1.335e-01,6.781e-01,7.834e-03
SNTA1,11167,protein-containing complex,GO:0032991,cellular component,18.0,483.0,2.726e-01,7.000e-02,1.061e+00,2.331e-01,3.545e-02,1.532e+00,5.232e-01,8.290e-02
SNTA1,11167,ion channel binding,GO:0044325,molecular function,18.0,6.0,4.316e-02,2.607e-02,7.146e-02,2.039e-02,1.581e-02,2.631e-02,8.679e-01,5.977e-03
SNTA1,11167,nitric-oxide synthase binding,GO:0050998,molecular function,18.0,2.0,4.484e-02,2.931e-02,6.859e-02,2.045e-02,1.435e-02,2.914e-02,8.673e-01,8.561e-03
SNTA1,11167,ATPase binding,GO:0051117,molecular function,18.0,3.0,4.508e-02,2.973e-02,6.836e-02,1.937e-02,1.035e-02,3.623e-02,8.718e-01,1.472e-02
SNTA1,11167,sodium channel regulator activity,GO:0017080,molecular function,18.0,4.0,4.617e-02,1.500e-02,1.421e-01,1.848e-02,3.617e-03,9.443e-02,8.689e-01,3.482e-02
SNTA1,11167,protein binding,GO:0005515,molecular function,18.0,347.0,1.366e-01,1.101e-01,1.696e-01,1.155e-01,7.972e-02,1.674e-01,6.666e-01,1.328e-02
SNX7,14971,,,,nan,nan,,,,,,,,
SPOCK2,13564,,,,nan,nan,,,,,,,,
SSR1,11323,endoplasmic reticulum,GO:0005783,cellular component,21.0,34.0,5.776e-03,1.170e-03,2.852e-02,4.674e-03,1.108e-03,1.972e-02,9.510e-01,1.059e-02
SSR1,11323,protein binding,GO:0005515,molecular function,21.0,347.0,5.776e-03,1.170e-03,2.852e-02,5.776e-03,1.170e-03,2.852e-02,9.415e-01,1.557e-02
STEAP2,17885,iron ion import across cell outer membrane,GO:0098706,biological process,16.0,2.0,1.116e-01,7.501e-02,1.660e-01,3.379e-02,7.230e-03,1.579e-01,8.129e-01,3.779e-02
STEAP2,17885,copper ion import,GO:0015677,biological process,16.0,4.0,1.162e-01,7.683e-02,1.758e-01,6.088e-02,1.869e-02,1.983e-01,7.480e-01,3.256e-02
STEAP2,17885,Golgi to plasma membrane transport,GO:0006893,biological process,16.0,4.0,1.172e-01,8.921e-02,1.540e-01,3.988e-02,1.387e-02,1.147e-01,7.975e-01,2.679e-02
STEAP2,17885,regulated exocytosis,GO:0045055,biological process,16.0,8.0,1.340e-01,1.182e-01,1.520e-01,9.245e-02,5.764e-02,1.483e-01,6.978e-01,1.589e-02
STEAP2,17885,oxidation-reduction process,GO:0055114,biological process,16.0,42.0,1.496e-01,7.248e-02,3.086e-01,1.110e-01,2.956e-02,4.166e-01,6.653e-01,4.778e-02
STEAP2,17885,endocytosis,GO:0006897,biological process,16.0,12.0,1.681e-01,1.179e-01,2.399e-01,1.317e-01,5.351e-02,3.243e-01,6.439e-01,3.190e-02
STEAP2,17885,response to hormone,GO:0009725,biological process,16.0,34.0,1.978e-01,1.054e-01,3.714e-01,1.369e-01,2.104e-02,8.905e-01,6.258e-01,6.538e-02
STEAP2,17885,trans-Golgi network transport vesicle,GO:0030140,cellular component,16.0,4.0,1.116e-01,7.501e-02,1.660e-01,3.481e-02,4.945e-03,2.451e-01,8.060e-01,5.376e-02
STEAP2,17885,early endosome,GO:0005769,cellular component,16.0,7.0,1.116e-01,7.501e-02,1.660e-01,4.358e-02,9.515e-03,1.996e-01,7.840e-01,4.263e-02
STEAP2,17885,endosome,GO:0005768,cellular component,16.0,15.0,1.116e-01,7.501e-02,1.660e-01,4.606e-02,1.168e-02,1.816e-01,7.788e-01,3.856e-02
STEAP2,17885,plasma membrane,GO:0005886,cellular component,16.0,61.0,1.362e-01,8.855e-02,2.096e-01,8.834e-02,2.852e-02,2.737e-01,7.001e-01,3.500e-02
STEAP2,17885,integral component of Golgi membrane,GO:0030173,cellular component,16.0,7.0,1.532e-01,1.015e-01,2.312e-01,8.933e-02,2.180e-02,3.662e-01,6.959e-01,4.542e-02
STEAP2,17885,cytosol,GO:0005829,cellular component,16.0,76.0,1.611e-01,1.114e-01,2.328e-01,1.428e-01,8.455e-02,2.412e-01,6.337e-01,1.968e-02
STEAP2,17885,ferric-chelate reductase (NADPH) activity,GO:0052851,molecular function,16.0,2.0,1.171e-01,8.907e-02,1.540e-01,5.366e-02,3.847e-02,7.485e-02,7.663e-01,9.090e-03
STEAP2,17885,cupric reductase activity,GO:0008823,molecular function,16.0,2.0,1.171e-01,8.907e-02,1.540e-01,5.506e-02,3.445e-02,8.801e-02,7.630e-01,1.277e-02
STIM1,11386,regulation of store-operated calcium entry,GO:2001256,biological process,48.0,5.0,3.554e-02,2.299e-02,5.496e-02,1.099e-02,5.477e-03,2.205e-02,9.152e-01,1.093e-02
STIM1,11386,cellular calcium ion homeostasis,GO:0006874,biological process,48.0,10.0,3.554e-02,2.299e-02,5.496e-02,1.486e-02,9.198e-03,2.400e-02,8.954e-01,8.494e-03
STIM1,11386,store-operated calcium entry,GO:0002115,biological process,48.0,2.0,3.557e-02,2.295e-02,5.511e-02,1.039e-02,1.969e-03,5.482e-02,9.103e-01,2.231e-02
STIM1,11386,regulation of calcium ion transport,GO:0051924,biological process,48.0,8.0,4.426e-02,2.306e-02,8.497e-02,3.019e-02,1.031e-02,8.839e-02,8.269e-01,2.679e-02
STIM1,11386,activation of store-operated calcium channel activity,GO:0032237,biological process,48.0,2.0,4.579e-02,2.017e-02,1.040e-01,3.022e-02,7.565e-03,1.207e-01,8.250e-01,3.296e-02
STIM1,11386,detection of calcium ion,GO:0005513,biological process,48.0,3.0,4.637e-02,1.219e-02,1.765e-01,1.824e-02,1.144e-03,2.909e-01,8.553e-01,6.384e-02
STIM1,11386,positive regulation of adenylate cyclase activity,GO:0045762,biological process,48.0,6.0,5.064e-02,9.872e-03,2.598e-01,3.533e-02,3.954e-03,3.156e-01,8.019e-01,6.107e-02
STIM1,11386,enamel mineralization,GO:0070166,biological process,48.0,2.0,5.172e-02,9.945e-03,2.690e-01,3.889e-02,4.345e-03,3.481e-01,7.908e-01,6.208e-02
STIM1,11386,positive regulation of angiogenesis,GO:0045766,biological process,48.0,12.0,5.462e-02,1.986e-02,1.502e-01,4.783e-02,1.661e-02,1.377e-01,7.767e-01,2.938e-02
STIM1,11386,cortical endoplasmic reticulum,GO:0032541,cellular component,48.0,3.0,3.554e-02,2.299e-02,5.496e-02,1.043e-02,5.238e-03,2.076e-02,9.186e-01,1.053e-02
STIM1,11386,plasma membrane raft,GO:0044853,cellular component,48.0,5.0,3.554e-02,2.299e-02,5.496e-02,1.488e-02,7.444e-03,2.975e-02,8.937e-01,1.246e-02
STIM1,11386,plasma membrane,GO:0005886,cellular component,48.0,61.0,3.594e-02,2.376e-02,5.437e-02,1.778e-02,1.250e-02,2.529e-02,8.807e-01,7.963e-03
STIM1,11386,integral component of plasma membrane,GO:0005887,cellular component,48.0,28.0,3.621e-02,2.200e-02,5.961e-02,1.761e-02,7.624e-03,4.068e-02,8.783e-01,1.675e-02
STIM1,11386,endoplasmic reticulum,GO:0005783,cellular component,48.0,34.0,3.641e-02,2.450e-02,5.410e-02,2.374e-02,1.491e-02,3.782e-02,8.523e-01,1.134e-02
STIM1,11386,integral component of endoplasmic reticulum membrane,GO:0030176,cellular component,48.0,10.0,3.691e-02,2.231e-02,6.107e-02,2.522e-02,1.507e-02,4.220e-02,8.463e-01,1.254e-02
STIM1,11386,sarcoplasmic reticulum membrane,GO:0033017,cellular component,48.0,5.0,5.258e-02,2.194e-02,1.260e-01,4.511e-02,1.857e-02,1.096e-01,7.842e-01,2.300e-02
STIM1,11386,protease binding,GO:0002020,molecular function,48.0,6.0,3.594e-02,2.376e-02,5.437e-02,1.722e-02,6.169e-03,4.807e-02,8.798e-01,2.290e-02
STIM1,11386,identical protein binding,GO:0042802,molecular function,48.0,35.0,3.600e-02,2.363e-02,5.485e-02,1.915e-02,1.188e-02,3.090e-02,8.734e-01,1.129e-02
STIM1,11386,protein binding,GO:0005515,molecular function,48.0,347.0,3.641e-02,2.450e-02,5.410e-02,2.486e-02,1.529e-02,4.045e-02,8.478e-01,1.179e-02
STIM1,11386,microtubule plus-end binding,GO:0051010,molecular function,48.0,2.0,3.650e-02,2.159e-02,6.170e-02,1.958e-02,8.679e-03,4.417e-02,8.705e-01,1.919e-02
STIM1,11386,calcium channel regulator activity,GO:0005246,molecular function,48.0,3.0,4.243e-02,1.508e-02,1.194e-01,1.385e-02,9.477e-04,2.024e-01,8.767e-01,5.499e-02
STIM1,11386,calcium ion binding,GO:0005509,molecular function,48.0,6.0,4.290e-02,1.556e-02,1.183e-01,2.661e-02,4.934e-03,1.436e-01,8.357e-01,4.111e-02
STK17B,11396,,,,nan,nan,,,,,,,,
STMN2,10577,negative regulation of microtubule depolymerization,GO:0007026,biological process,20.0,7.0,3.336e-01,1.360e-01,8.186e-01,9.725e-02,4.646e-02,2.036e-01,6.897e-01,2.469e-02
STMN2,10577,negative regulation of microtubule polymerization,GO:0031115,biological process,20.0,6.0,3.379e-01,1.338e-01,8.533e-01,1.341e-01,4.540e-02,3.964e-01,6.397e-01,3.833e-02
STMN2,10577,regulation of cytoskeleton organization,GO:0051493,biological process,20.0,9.0,3.416e-01,1.506e-01,7.746e-01,1.336e-01,7.252e-02,2.462e-01,6.438e-01,2.232e-02
STMN2,10577,regulation of microtubule polymerization or depolymerization,GO:0031110,biological process,20.0,6.0,3.416e-01,1.506e-01,7.746e-01,1.585e-01,1.171e-01,2.145e-01,6.177e-01,1.209e-02
STMN2,10577,positive regulation of microtubule depolymerization,GO:0031117,biological process,20.0,5.0,3.460e-01,1.482e-01,8.079e-01,1.768e-01,8.116e-02,3.851e-01,5.962e-01,3.228e-02
STMN2,10577,negative regulation of neuron projection development,GO:0010977,biological process,20.0,9.0,3.484e-01,1.330e-01,9.129e-01,1.282e-01,4.004e-03,4.104e+00,6.005e-01,1.182e-01
STMN2,10577,positive regulation of neuron projection development,GO:0010976,biological process,20.0,9.0,3.583e-01,1.311e-01,9.790e-01,1.936e-01,2.051e-02,1.828e+00,5.535e-01,8.874e-02
STMN2,10577,cellular response to nerve growth factor stimulus,GO:1990090,biological process,20.0,5.0,3.859e-01,1.393e-01,1.069e+00,2.286e-01,4.818e-02,1.085e+00,5.310e-01,7.928e-02
STMN2,10577,microtubule depolymerization,GO:0007019,biological process,20.0,9.0,4.344e-01,3.555e-01,5.308e-01,2.646e-01,1.122e-01,6.239e-01,5.171e-01,4.456e-02
STMN2,10577,neuron projection development,GO:0031175,biological process,20.0,9.0,4.838e-01,3.527e-01,6.635e-01,4.476e-01,3.410e-01,5.874e-01,3.957e-01,1.840e-02
STMN2,10577,neuronal cell body,GO:0043025,cellular component,20.0,2.0,3.336e-01,1.360e-01,8.186e-01,5.835e-02,1.175e-02,2.897e-01,7.487e-01,4.764e-02
STMN2,10577,growth cone,GO:0030426,cellular component,20.0,4.0,3.764e-01,1.319e-01,1.074e+00,2.622e-01,5.781e-02,1.189e+00,4.994e-01,8.685e-02
STMN2,10577,lamellipodium,GO:0030027,cellular component,20.0,4.0,3.911e-01,1.389e-01,1.101e+00,3.178e-01,7.414e-02,1.362e+00,4.621e-01,7.414e-02
STMN2,10577,cytoplasm,GO:0005737,cellular component,20.0,78.0,4.413e-01,3.661e-01,5.319e-01,3.339e-01,3.151e-01,3.539e-01,4.737e-01,3.224e-03
STMN2,10577,perinuclear region of cytoplasm,GO:0048471,cellular component,20.0,11.0,4.413e-01,3.661e-01,5.319e-01,3.353e-01,2.133e-01,5.269e-01,4.699e-01,2.493e-02
STMN2,10577,neuron projection,GO:0043005,cellular component,20.0,22.0,4.478e-01,2.603e-01,7.703e-01,3.678e-01,1.616e-01,8.374e-01,4.393e-01,5.141e-02
STMN2,10577,calcium-dependent protein binding,GO:0048306,molecular function,20.0,4.0,3.336e-01,1.360e-01,8.186e-01,6.090e-02,4.788e-02,7.745e-02,7.515e-01,6.759e-03
STMN2,10577,tubulin binding,GO:0015631,molecular function,20.0,6.0,3.336e-01,1.360e-01,8.186e-01,1.149e-01,5.316e-02,2.483e-01,6.655e-01,2.626e-02
STMN2,10577,protein binding,GO:0005515,molecular function,20.0,347.0,4.413e-01,3.661e-01,5.319e-01,3.266e-01,2.676e-01,3.986e-01,4.782e-01,1.096e-02
STON1,17003,regulation of endocytosis,GO:0030100,biological process,2.0,12.0,5.925e-02,5.946e-03,5.904e-01,5.925e-02,5.946e-03,5.904e-01,7.364e-01,7.498e-02
STT3B,30611,glycoprotein catabolic process,GO:0006516,biological process,12.0,10.0,2.594e-01,1.582e-01,4.254e-01,1.099e-01,1.574e-02,7.674e-01,6.596e-01,6.300e-02
STT3B,30611,ubiquitin-dependent ERAD pathway,GO:0030433,biological process,12.0,6.0,2.951e-01,2.785e-01,3.127e-01,1.339e-01,8.870e-02,2.021e-01,6.441e-01,1.518e-02
STT3B,30611,post-translational protein modification,GO:0043687,biological process,12.0,6.0,2.951e-01,2.785e-01,3.127e-01,1.619e-01,7.390e-02,3.549e-01,6.117e-01,3.019e-02
STT3B,30611,protein N-linked glycosylation via asparagine,GO:0018279,biological process,12.0,7.0,2.951e-01,2.785e-01,3.127e-01,1.653e-01,9.916e-02,2.757e-01,6.099e-01,1.983e-02
STT3B,30611,co-translational protein modification,GO:0043686,biological process,12.0,3.0,3.441e-01,2.695e-01,4.393e-01,2.220e-01,4.644e-02,1.061e+00,5.424e-01,6.646e-02
STT3B,30611,response to unfolded protein,GO:0006986,biological process,12.0,4.0,3.543e-01,1.947e-01,6.447e-01,3.087e-01,1.280e-01,7.444e-01,4.816e-01,5.089e-02
STT3B,30611,endoplasmic reticulum,GO:0005783,cellular component,12.0,34.0,2.951e-01,2.785e-01,3.127e-01,1.838e-01,1.554e-01,2.174e-01,5.932e-01,6.915e-03
STT3B,30611,membrane,GO:0016020,cellular component,12.0,58.0,3.001e-01,2.980e-01,3.022e-01,1.805e-01,6.312e-02,5.161e-01,5.902e-01,4.165e-02
STT3B,30611,protein-containing complex,GO:0032991,cellular component,12.0,483.0,3.507e-01,2.567e-01,4.791e-01,2.913e-01,1.503e-01,5.647e-01,4.993e-01,3.552e-02
STT3B,30611,protein binding,GO:0005515,molecular function,12.0,347.0,2.951e-01,2.785e-01,3.127e-01,2.022e-01,1.499e-01,2.727e-01,5.758e-01,1.336e-02
STT3B,30611,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,GO:0004579,molecular function,12.0,2.0,3.031e-01,1.254e-01,7.326e-01,7.158e-02,3.217e-03,1.592e+00,6.899e-01,1.166e-01
STXBP6,19666,,,,nan,nan,,,,,,,,
SULF1,20391,negative regulation of endothelial cell proliferation,GO:0001937,biological process,21.0,6.0,2.776e-01,1.199e-01,6.429e-01,4.433e-02,1.991e-02,9.871e-02,7.865e-01,2.084e-02
SULF1,20391,regulation of fibroblast growth factor receptor signaling pathway,GO:0040036,biological process,21.0,7.0,2.776e-01,1.199e-01,6.429e-01,6.931e-02,1.627e-02,2.952e-01,7.298e-01,4.137e-02
SULF1,20391,vascular endothelial growth factor receptor signaling pathway,GO:0048010,biological process,21.0,7.0,2.776e-01,1.199e-01,6.429e-01,1.173e-01,5.383e-02,2.556e-01,6.623e-01,2.783e-02
SULF1,20391,negative regulation of fibroblast growth factor receptor signaling pathway,GO:0040037,biological process,21.0,6.0,2.823e-01,1.163e-01,6.853e-01,1.031e-01,2.128e-02,4.993e-01,6.737e-01,5.221e-02
SULF1,20391,negative regulation of angiogenesis,GO:0016525,biological process,21.0,7.0,2.823e-01,1.163e-01,6.853e-01,1.434e-01,4.025e-02,5.111e-01,6.261e-01,4.842e-02
SULF1,20391,positive regulation of Wnt signaling pathway,GO:0030177,biological process,21.0,10.0,2.823e-01,1.163e-01,6.853e-01,1.673e-01,1.009e-01,2.775e-01,6.075e-01,2.084e-02
SULF1,20391,positive regulation of vascular endothelial growth factor production,GO:0010575,biological process,21.0,4.0,2.866e-01,1.174e-01,6.997e-01,2.138e-01,1.013e-01,4.515e-01,5.618e-01,3.441e-02
SULF1,20391,negative regulation of cell migration,GO:0030336,biological process,21.0,31.0,2.876e-01,1.176e-01,7.034e-01,1.600e-01,5.029e-02,5.090e-01,6.099e-01,4.366e-02
SULF1,20391,glomerular basement membrane development,GO:0032836,biological process,21.0,5.0,2.991e-01,1.089e-01,8.215e-01,1.583e-01,1.828e-02,1.370e+00,5.930e-01,8.345e-02
SULF1,20391,positive regulation of BMP signaling pathway,GO:0030513,biological process,21.0,4.0,3.026e-01,1.019e-01,8.979e-01,1.880e-01,3.765e-02,9.387e-01,5.680e-01,7.881e-02
SULF1,20391,heparan sulfate proteoglycan metabolic process,GO:0030201,biological process,21.0,6.0,3.078e-01,1.084e-01,8.742e-01,2.554e-01,8.034e-02,8.117e-01,5.197e-01,5.594e-02
SULF1,20391,collagen-containing extracellular matrix,GO:0062023,cellular component,21.0,36.0,2.776e-01,1.199e-01,6.429e-01,8.707e-02,1.850e-02,4.099e-01,6.981e-01,4.716e-02
SULF1,20391,extracellular space,GO:0005615,cellular component,21.0,43.0,2.776e-01,1.199e-01,6.429e-01,9.383e-02,2.707e-02,3.252e-01,6.908e-01,4.018e-02
SULF1,20391,membrane raft,GO:0045121,cellular component,21.0,8.0,2.776e-01,1.199e-01,6.429e-01,1.185e-01,1.073e-01,1.309e-01,6.631e-01,3.562e-03
SULF1,20391,cell surface,GO:0009986,cellular component,21.0,11.0,2.823e-01,1.163e-01,6.853e-01,1.613e-01,7.130e-02,3.649e-01,6.119e-01,3.201e-02
SULF1,20391,plasma membrane,GO:0005886,cellular component,21.0,61.0,2.823e-01,1.163e-01,6.853e-01,1.893e-01,1.062e-01,3.374e-01,5.857e-01,2.544e-02
SULF1,20391,endoplasmic reticulum,GO:0005783,cellular component,21.0,34.0,2.919e-01,1.183e-01,7.201e-01,2.457e-01,1.353e-01,4.464e-01,5.366e-01,2.801e-02
SULF1,20391,glycosaminoglycan binding,GO:0005539,molecular function,21.0,9.0,2.919e-01,1.183e-01,7.201e-01,1.395e-01,9.227e-03,2.109e+00,6.051e-01,9.398e-02
SULF1,20391,arylsulfatase activity,GO:0004065,molecular function,21.0,2.0,3.334e-01,9.310e-02,1.194e+00,2.378e-01,2.491e-02,2.269e+00,5.025e-01,1.077e-01
SULF1,20391,N-acetylglucosamine-6-sulfatase activity,GO:0008449,molecular function,21.0,2.0,3.334e-01,9.310e-02,1.194e+00,2.332e-01,2.185e-02,2.488e+00,5.017e-01,1.135e-01
SULT1A1,11453,sulfation,GO:0051923,biological process,19.0,3.0,4.402e-02,3.529e-02,5.492e-02,1.285e-02,7.230e-03,2.284e-02,9.058e-01,9.047e-03
SULT1A1,11453,3'-phosphoadenosine 5'-phosphosulfate metabolic process,GO:0050427,biological process,19.0,6.0,7.974e-02,1.711e-02,3.716e-01,4.326e-02,5.217e-03,3.587e-01,7.789e-01,6.203e-02
SULT1A1,11453,estrogen metabolic process,GO:0008210,biological process,19.0,5.0,8.950e-02,2.247e-02,3.566e-01,5.657e-02,1.214e-02,2.635e-01,7.539e-01,4.345e-02
SULT1A1,11453,ethanol catabolic process,GO:0006068,biological process,19.0,5.0,9.848e-02,3.328e-02,2.915e-01,6.504e-02,2.981e-02,1.419e-01,7.418e-01,2.353e-02
SULT1A1,11453,xenobiotic metabolic process,GO:0006805,biological process,19.0,47.0,1.145e-01,4.800e-02,2.734e-01,8.149e-02,2.831e-02,2.346e-01,7.116e-01,3.192e-02
SULT1A1,11453,flavonoid metabolic process,GO:0009812,biological process,19.0,11.0,1.184e-01,3.427e-02,4.092e-01,9.673e-02,2.346e-02,3.989e-01,6.848e-01,4.476e-02
SULT1A1,11453,flavonol 3-sulfotransferase activity,GO:0047894,molecular function,19.0,2.0,4.315e-02,3.382e-02,5.504e-02,1.177e-02,6.775e-03,2.047e-02,9.117e-01,9.012e-03
SULT1A1,11453,aryl sulfotransferase activity,GO:0004062,molecular function,19.0,2.0,4.315e-02,3.382e-02,5.504e-02,1.266e-02,6.933e-03,2.310e-02,9.064e-01,1.055e-02
SULT1A1,11453,steroid sulfotransferase activity,GO:0050294,molecular function,19.0,2.0,4.315e-02,3.382e-02,5.504e-02,1.279e-02,7.663e-03,2.134e-02,9.062e-01,8.941e-03
SULT1A1,11453,protein binding,GO:0005515,molecular function,19.0,347.0,1.237e-01,5.681e-02,2.693e-01,1.110e-01,4.448e-02,2.768e-01,6.696e-01,3.347e-02
SULT1A1,11453,sulfotransferase activity,GO:0008146,molecular function,19.0,49.0,1.420e-01,3.059e-02,6.593e-01,1.252e-01,1.768e-02,8.871e-01,6.388e-01,6.649e-02
SYN2,11495,neurotransmitter secretion,GO:0007269,biological process,3.0,24.0,1.531e-01,1.265e-02,1.853e+00,1.182e-01,9.555e-03,1.463e+00,6.299e-01,1.004e-01
SYN2,11495,synaptic vesicle membrane,GO:0030672,cellular component,3.0,2.0,1.487e-01,1.396e-02,1.584e+00,1.180e-01,1.652e-02,8.435e-01,6.480e-01,6.571e-02
SYT12,18381,,,,nan,nan,,,,,,,,
TEAD1,11714,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,33.0,35.0,4.664e-02,2.696e-02,8.068e-02,1.660e-02,2.637e-03,1.045e-01,8.736e-01,3.396e-02
TEAD1,11714,hippo signaling,GO:0035329,biological process,33.0,3.0,4.664e-02,2.696e-02,8.068e-02,2.441e-02,1.045e-02,5.701e-02,8.488e-01,2.019e-02
TEAD1,11714,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,33.0,62.0,4.826e-02,2.566e-02,9.075e-02,2.330e-02,6.102e-03,8.896e-02,8.522e-01,3.289e-02
TEAD1,11714,positive regulation of pri-miRNA transcription by RNA polymerase II,GO:1902895,biological process,33.0,3.0,5.028e-02,2.565e-02,9.857e-02,2.425e-02,6.678e-03,8.808e-02,8.485e-01,3.189e-02
TEAD1,11714,embryonic organ development,GO:0048568,biological process,33.0,13.0,7.227e-02,1.991e-02,2.624e-01,6.033e-02,1.182e-02,3.080e-01,7.464e-01,4.464e-02
TEAD1,11714,protein-containing complex assembly,GO:0065003,biological process,33.0,45.0,3.232e-01,1.151e-01,9.074e-01,3.177e-01,1.069e-01,9.444e-01,4.716e-01,5.707e-02
TEAD1,11714,transcription factor complex,GO:0005667,cellular component,33.0,8.0,4.664e-02,2.696e-02,8.068e-02,1.509e-02,3.839e-03,5.933e-02,8.858e-01,2.340e-02
TEAD1,11714,nucleus,GO:0005634,cellular component,33.0,81.0,4.664e-02,2.696e-02,8.068e-02,2.805e-02,1.539e-02,5.112e-02,8.354e-01,1.483e-02
TEAD1,11714,nucleoplasm,GO:0005654,cellular component,33.0,51.0,4.919e-02,3.369e-02,7.182e-02,3.025e-02,2.409e-02,3.798e-02,8.278e-01,5.612e-03
TEAD1,11714,TEAD-1-YAP complex,GO:0071148,cellular component,33.0,2.0,8.541e-02,1.874e-02,3.892e-01,7.037e-02,1.078e-02,4.593e-01,7.211e-01,6.190e-02
TEAD1,11714,transcription coactivator binding,GO:0001223,molecular function,33.0,3.0,4.664e-02,2.696e-02,8.068e-02,1.083e-02,1.636e-03,7.166e-02,9.045e-01,2.681e-02
TEAD1,11714,RNA polymerase II transcription factor binding,GO:0001085,molecular function,33.0,4.0,4.664e-02,2.696e-02,8.068e-02,1.757e-02,9.871e-03,3.126e-02,8.809e-01,1.283e-02
TEAD1,11714,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,33.0,9.0,4.664e-02,2.696e-02,8.068e-02,1.708e-02,5.649e-03,5.164e-02,8.785e-01,2.104e-02
TEAD1,11714,DNA-binding transcription factor activity,GO:0003700,molecular function,33.0,12.0,4.664e-02,2.696e-02,8.068e-02,2.200e-02,1.058e-02,4.576e-02,8.598e-01,1.770e-02
TEAD1,11714,sequence-specific DNA binding,GO:0043565,molecular function,33.0,10.0,4.670e-02,2.695e-02,8.091e-02,2.926e-02,2.315e-02,3.697e-02,8.313e-01,5.630e-03
TEAD1,11714,transcription regulatory region DNA binding,GO:0044212,molecular function,33.0,18.0,4.985e-02,2.590e-02,9.596e-02,3.072e-02,1.251e-02,7.548e-02,8.257e-01,2.230e-02
TEAD1,11714,transcription regulator recruiting activity,GO:0001134,molecular function,33.0,6.0,5.069e-02,2.355e-02,1.091e-01,2.690e-02,6.191e-03,1.168e-01,8.372e-01,3.702e-02
TEAD1,11714,protein binding,GO:0005515,molecular function,33.0,347.0,5.374e-02,4.630e-02,6.237e-02,4.185e-02,3.508e-02,4.993e-02,7.941e-01,4.447e-03
TEAD1,11714,protein heterodimerization activity,GO:0046982,molecular function,33.0,8.0,5.460e-02,2.679e-02,1.113e-01,4.282e-02,1.784e-02,1.028e-01,7.898e-01,2.351e-02
TEAD1,11714,cis-regulatory region sequence-specific DNA binding,GO:0000987,molecular function,33.0,6.0,5.491e-02,2.249e-02,1.341e-01,4.141e-02,1.418e-02,1.209e-01,7.930e-01,2.811e-02
TEAD4,11717,hippo signaling,GO:0035329,biological process,14.0,3.0,4.296e-02,2.778e-02,6.642e-02,2.009e-02,1.338e-02,3.017e-02,8.690e-01,9.393e-03
TEAD4,11717,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,14.0,62.0,4.601e-02,2.587e-02,8.184e-02,3.275e-02,1.410e-02,7.609e-02,8.187e-01,2.150e-02
TEAD4,11717,embryonic organ development,GO:0048568,biological process,14.0,13.0,5.547e-02,1.834e-02,1.678e-01,4.018e-02,6.335e-03,2.548e-01,7.917e-01,4.903e-02
TEAD4,11717,transcription factor complex,GO:0005667,cellular component,14.0,8.0,4.296e-02,2.778e-02,6.642e-02,2.763e-02,1.930e-02,3.956e-02,8.370e-01,8.767e-03
TEAD4,11717,nucleus,GO:0005634,cellular component,14.0,81.0,4.622e-02,3.273e-02,6.528e-02,3.344e-02,2.973e-02,3.761e-02,8.176e-01,2.933e-03
TEAD4,11717,nucleoplasm,GO:0005654,cellular component,14.0,51.0,5.193e-02,4.225e-02,6.382e-02,4.018e-02,2.421e-02,6.667e-02,7.982e-01,1.286e-02
TEAD4,11717,DNA-binding transcription factor activity,GO:0003700,molecular function,14.0,12.0,4.296e-02,2.778e-02,6.642e-02,1.148e-02,6.628e-03,1.988e-02,9.135e-01,8.344e-03
TEAD4,11717,sequence-specific DNA binding,GO:0043565,molecular function,14.0,10.0,4.296e-02,2.778e-02,6.642e-02,1.474e-02,6.859e-03,3.169e-02,8.938e-01,1.331e-02
TEAD4,11717,RNA polymerase II transcription factor binding,GO:0001085,molecular function,14.0,4.0,4.296e-02,2.778e-02,6.642e-02,1.928e-02,1.211e-02,3.070e-02,8.729e-01,1.111e-02
TEAD4,11717,transcription regulatory region DNA binding,GO:0044212,molecular function,14.0,18.0,4.536e-02,2.586e-02,7.954e-02,2.984e-02,1.324e-02,6.724e-02,8.289e-01,2.003e-02
TEAD4,11717,protein binding,GO:0005515,molecular function,14.0,347.0,6.928e-02,5.908e-02,8.123e-02,6.711e-02,5.853e-02,7.695e-02,7.401e-01,4.017e-03
TESK1,11731,,,,nan,nan,,,,,,,,
TGFBR2,11773,cellular response to growth factor stimulus,GO:0071363,biological process,32.0,12.0,1.776e-01,8.880e-02,3.550e-01,1.725e-02,1.423e-03,2.091e-01,8.614e-01,4.487e-02
TGFBR2,11773,pathway-restricted SMAD protein phosphorylation,GO:0060389,biological process,32.0,2.0,1.902e-01,1.142e-01,3.168e-01,2.473e-02,7.572e-03,8.078e-02,8.472e-01,2.934e-02
TGFBR2,11773,peptidyl-serine phosphorylation,GO:0018105,biological process,32.0,10.0,2.004e-01,1.227e-01,3.274e-01,6.340e-02,1.074e-02,3.742e-01,7.382e-01,5.051e-02
TGFBR2,11773,peptidyl-threonine phosphorylation,GO:0018107,biological process,32.0,9.0,2.004e-01,1.227e-01,3.274e-01,7.818e-02,1.574e-02,3.884e-01,7.124e-01,4.791e-02
TGFBR2,11773,response to cholesterol,GO:0070723,biological process,32.0,5.0,2.004e-01,1.227e-01,3.274e-01,8.737e-02,1.925e-02,3.966e-01,6.981e-01,4.658e-02
TGFBR2,11773,protein phosphorylation,GO:0006468,biological process,32.0,30.0,2.004e-01,1.227e-01,3.274e-01,1.208e-01,6.470e-02,2.257e-01,6.588e-01,2.258e-02
TGFBR2,11773,"positive regulation of CD4-positive, alpha-beta T cell proliferation",GO:2000563,biological process,32.0,4.0,2.206e-01,1.164e-01,4.180e-01,1.309e-01,3.297e-02,5.193e-01,6.402e-01,4.809e-02
TGFBR2,11773,positive regulation of epithelial to mesenchymal transition,GO:0010718,biological process,32.0,7.0,2.485e-01,8.688e-02,7.106e-01,1.742e-01,3.802e-02,7.980e-01,5.860e-01,6.960e-02
TGFBR2,11773,apoptotic process,GO:0006915,biological process,32.0,21.0,2.716e-01,1.041e-01,7.084e-01,1.990e-01,3.603e-02,1.099e+00,5.610e-01,6.941e-02
TGFBR2,11773,response to drug,GO:0042493,biological process,32.0,76.0,2.747e-01,1.765e-01,4.276e-01,2.024e-01,8.832e-02,4.640e-01,5.709e-01,3.850e-02
TGFBR2,11773,positive regulation of reactive oxygen species metabolic process,GO:2000379,biological process,32.0,10.0,2.943e-01,1.209e-01,7.164e-01,1.665e-01,2.440e-02,1.137e+00,5.833e-01,8.908e-02
TGFBR2,11773,transforming growth factor beta receptor signaling pathway,GO:0007179,biological process,32.0,9.0,2.966e-01,1.779e-01,4.944e-01,2.341e-01,1.000e-01,5.481e-01,5.426e-01,4.153e-02
TGFBR2,11773,heart development,GO:0007507,biological process,32.0,4.0,3.237e-01,8.581e-02,1.221e+00,2.566e-01,3.179e-02,2.071e+00,4.924e-01,9.921e-02
TGFBR2,11773,caveola,GO:0005901,cellular component,32.0,2.0,2.004e-01,1.227e-01,3.274e-01,4.718e-02,1.175e-02,1.895e-01,7.769e-01,3.767e-02
TGFBR2,11773,membrane raft,GO:0045121,cellular component,32.0,8.0,2.004e-01,1.227e-01,3.274e-01,9.778e-02,7.810e-02,1.224e-01,6.910e-01,7.779e-03
TGFBR2,11773,integral component of membrane,GO:0016021,cellular component,32.0,12.0,2.004e-01,1.227e-01,3.274e-01,1.076e-01,8.707e-02,1.331e-01,6.772e-01,7.404e-03
TGFBR2,11773,receptor complex,GO:0043235,cellular component,32.0,29.0,2.206e-01,1.482e-01,3.285e-01,8.808e-02,1.344e-02,5.773e-01,6.927e-01,5.834e-02
TGFBR2,11773,plasma membrane,GO:0005886,cellular component,32.0,61.0,2.430e-01,2.242e-01,2.633e-01,1.695e-01,1.445e-01,1.988e-01,6.070e-01,6.322e-03
TGFBR2,11773,external side of plasma membrane,GO:0009897,cellular component,32.0,8.0,2.739e-01,1.773e-01,4.229e-01,2.325e-01,1.373e-01,3.939e-01,5.481e-01,2.556e-02
TGFBR2,11773,transmembrane receptor protein serine/threonine kinase activity,GO:0004675,molecular function,32.0,6.0,1.902e-01,1.142e-01,3.168e-01,2.756e-02,1.418e-02,5.357e-02,8.372e-01,1.630e-02
TGFBR2,11773,SMAD binding,GO:0046332,molecular function,32.0,6.0,1.902e-01,1.142e-01,3.168e-01,3.529e-02,2.113e-02,5.894e-02,8.118e-01,1.267e-02
TGFBR2,11773,activin-activated receptor activity,GO:0017002,molecular function,32.0,4.0,2.004e-01,1.227e-01,3.274e-01,5.766e-02,4.982e-02,6.674e-02,7.580e-01,4.070e-03
TGFBR2,11773,transforming growth factor beta-activated receptor activity,GO:0005024,molecular function,32.0,5.0,2.004e-01,1.227e-01,3.274e-01,6.496e-02,5.263e-02,8.018e-02,7.439e-01,6.058e-03
TGFBR2,11773,protein serine/threonine kinase activity,GO:0004674,molecular function,32.0,31.0,2.004e-01,1.227e-01,3.274e-01,7.148e-02,4.420e-02,1.156e-01,7.317e-01,1.435e-02
TGFBR2,11773,activin binding,GO:0048185,molecular function,32.0,3.0,2.054e-01,1.353e-01,3.118e-01,1.048e-01,9.461e-02,1.160e-01,6.814e-01,3.557e-03
TGFBR2,11773,transforming growth factor beta binding,GO:0050431,molecular function,32.0,3.0,2.636e-01,1.925e-01,3.608e-01,2.115e-01,1.382e-01,3.236e-01,5.668e-01,1.853e-02
TGFBR2,11773,protein binding,GO:0005515,molecular function,32.0,347.0,2.678e-01,2.272e-01,3.158e-01,2.213e-01,2.084e-01,2.349e-01,5.597e-01,2.773e-03
TGFBR2,11773,type I transforming growth factor beta receptor binding,GO:0034713,molecular function,32.0,2.0,2.877e-01,2.127e-01,3.891e-01,2.446e-01,1.710e-01,3.497e-01,5.393e-01,1.686e-02
TGFBR2,11773,glycosaminoglycan binding,GO:0005539,molecular function,32.0,9.0,3.264e-01,1.311e-01,8.130e-01,2.783e-01,7.975e-02,9.713e-01,4.978e-01,6.476e-02
THEM4,17947,fatty acid metabolic process,GO:0006631,biological process,12.0,18.0,1.694e-01,7.978e-02,3.597e-01,7.955e-02,5.734e-02,1.104e-01,7.185e-01,1.011e-02
THEM4,17947,protein kinase B signaling,GO:0043491,biological process,12.0,2.0,1.707e-01,7.882e-02,3.699e-01,1.097e-01,4.788e-02,2.514e-01,6.718e-01,2.929e-02
THEM4,17947,regulation of mitochondrial membrane permeability involved in apoptotic process,GO:1902108,biological process,12.0,5.0,1.949e-01,7.430e-02,5.112e-01,1.312e-01,4.488e-02,3.838e-01,6.430e-01,3.811e-02
THEM4,17947,mitochondrion,GO:0005739,cellular component,12.0,35.0,1.534e-01,5.217e-02,4.511e-01,4.932e-02,1.337e-02,1.819e-01,7.726e-01,3.444e-02
THEM4,17947,cytosol,GO:0005829,cellular component,12.0,76.0,1.949e-01,7.430e-02,5.112e-01,1.386e-01,6.329e-02,3.037e-01,6.369e-01,2.889e-02
THEM4,17947,palmitoyl-CoA hydrolase activity,GO:0016290,molecular function,12.0,2.0,1.779e-01,4.800e-02,6.594e-01,1.120e-01,7.941e-03,1.581e+00,6.448e-01,8.515e-02
THEM4,17947,protein binding,GO:0005515,molecular function,12.0,347.0,1.965e-01,7.412e-02,5.208e-01,1.965e-01,7.412e-02,5.208e-01,5.754e-01,4.012e-02
THRSP,11800,regulation of lipid biosynthetic process,GO:0046890,biological process,7.0,20.0,1.368e-01,9.882e-02,1.893e-01,8.935e-02,4.583e-02,1.742e-01,7.014e-01,2.241e-02
THRSP,11800,cytosol,GO:0005829,cellular component,7.0,76.0,1.322e-01,9.174e-02,1.904e-01,1.079e-01,6.730e-02,1.730e-01,6.762e-01,1.664e-02
THRSP,11800,nucleoplasm,GO:0005654,cellular component,7.0,51.0,1.322e-01,9.174e-02,1.904e-01,1.134e-01,7.357e-02,1.748e-01,6.691e-01,1.520e-02
THRSP,11800,identical protein binding,GO:0042802,molecular function,7.0,35.0,1.322e-01,9.174e-02,1.904e-01,9.297e-02,3.148e-02,2.746e-01,6.932e-01,3.605e-02
TIGAR,1185,"fructose 1,6-bisphosphate metabolic process",GO:0030388,biological process,22.0,5.0,1.245e-01,3.098e-02,5.001e-01,4.633e-02,3.167e-02,6.775e-02,7.827e-01,1.004e-02
TIGAR,1185,negative regulation of glycolytic process,GO:0045820,biological process,22.0,9.0,1.245e-01,3.098e-02,5.001e-01,5.020e-02,2.781e-02,9.059e-02,7.732e-01,1.591e-02
TIGAR,1185,"fructose 2,6-bisphosphate metabolic process",GO:0006003,biological process,22.0,4.0,1.245e-01,3.098e-02,5.001e-01,5.332e-02,4.575e-02,6.215e-02,7.672e-01,4.245e-03
TIGAR,1185,negative regulation of programmed cell death,GO:0043069,biological process,22.0,13.0,1.305e-01,3.381e-02,5.038e-01,4.849e-02,1.365e-02,1.723e-01,7.743e-01,3.416e-02
TIGAR,1185,cellular response to hypoxia,GO:0071456,biological process,22.0,5.0,1.350e-01,3.256e-02,5.597e-01,6.440e-02,6.610e-03,6.274e-01,7.298e-01,6.862e-02
TIGAR,1185,cellular response to DNA damage stimulus,GO:0006974,biological process,22.0,13.0,1.413e-01,2.303e-02,8.672e-01,8.823e-02,9.862e-03,7.894e-01,6.832e-01,8.165e-02
TIGAR,1185,regulation of response to DNA damage checkpoint signaling,GO:1902153,biological process,22.0,5.0,1.415e-01,2.296e-02,8.721e-01,7.202e-02,4.786e-03,1.084e+00,7.015e-01,9.664e-02
TIGAR,1185,regulation of pentose-phosphate shunt,GO:0043456,biological process,22.0,10.0,1.417e-01,3.129e-02,6.416e-01,1.108e-01,3.113e-02,3.940e-01,6.656e-01,4.766e-02
TIGAR,1185,cellular response to cobalt ion,GO:0071279,biological process,22.0,3.0,1.467e-01,3.855e-02,5.583e-01,1.099e-01,4.629e-02,2.609e-01,6.713e-01,3.052e-02
TIGAR,1185,positive regulation of hexokinase activity,GO:1903301,biological process,22.0,5.0,1.717e-01,3.663e-02,8.052e-01,1.655e-01,3.993e-02,6.859e-01,5.976e-01,6.332e-02
TIGAR,1185,positive regulation of DNA repair,GO:0045739,biological process,22.0,13.0,1.784e-01,2.559e-02,1.244e+00,1.676e-01,2.329e-02,1.206e+00,5.795e-01,9.375e-02
TIGAR,1185,nucleus,GO:0005634,cellular component,22.0,81.0,1.292e-01,2.840e-02,5.882e-01,4.898e-02,5.985e-03,4.009e-01,7.641e-01,6.358e-02
TIGAR,1185,cytosol,GO:0005829,cellular component,22.0,76.0,1.292e-01,2.840e-02,5.882e-01,5.993e-02,1.328e-02,2.706e-01,7.460e-01,4.647e-02
TIGAR,1185,cytoplasm,GO:0005737,cellular component,22.0,78.0,1.292e-01,2.840e-02,5.882e-01,6.123e-02,9.960e-03,3.764e-01,7.399e-01,5.739e-02
TIGAR,1185,intracellular,GO:0005622,cellular component,22.0,8.0,1.292e-01,2.840e-02,5.882e-01,7.895e-02,1.730e-02,3.604e-01,7.108e-01,5.062e-02
TIGAR,1185,mitochondrial outer membrane,GO:0005741,cellular component,22.0,4.0,1.411e-01,3.317e-02,6.001e-01,1.005e-01,2.831e-02,3.566e-01,6.808e-01,4.189e-02
TIGAR,1185,protein binding,GO:0005515,molecular function,22.0,347.0,1.292e-01,2.840e-02,5.882e-01,6.624e-02,2.146e-02,2.045e-01,7.373e-01,3.379e-02
TIGAR,1185,bisphosphoglycerate 2-phosphatase activity,GO:0004083,molecular function,22.0,2.0,1.410e-01,2.318e-02,8.574e-01,8.392e-02,9.596e-03,7.339e-01,6.911e-01,7.844e-02
TIGAR,1185,"fructose-2,6-bisphosphate 2-phosphatase activity",GO:0004331,molecular function,22.0,2.0,1.602e-01,1.714e-02,1.497e+00,5.443e-02,8.912e-04,3.324e+00,6.909e-01,1.579e-01
TIMD4,25132,,,,nan,nan,,,,,,,,
TIMM10,11814,protein insertion into mitochondrial inner membrane,GO:0045039,biological process,12.0,8.0,5.645e-02,4.182e-02,7.621e-02,3.174e-02,9.728e-03,1.036e-01,8.212e-01,3.045e-02
TIMM10,11814,chaperone-mediated protein transport,GO:0072321,biological process,12.0,4.0,5.645e-02,4.182e-02,7.621e-02,3.870e-02,1.910e-02,7.842e-02,8.014e-01,1.801e-02
TIMM10,11814,mitochondrial inner membrane,GO:0005743,cellular component,12.0,5.0,4.881e-02,3.386e-02,7.037e-02,1.499e-02,6.744e-03,3.330e-02,8.924e-01,1.432e-02
TIMM10,11814,mitochondrial intermembrane space protein transporter complex,GO:0042719,cellular component,12.0,3.0,5.507e-02,3.681e-02,8.238e-02,3.096e-02,1.144e-02,8.376e-02,8.244e-01,2.508e-02
TIMM10,11814,mitochondrion,GO:0005739,cellular component,12.0,35.0,5.775e-02,3.574e-02,9.331e-02,4.391e-02,1.599e-02,1.206e-01,7.870e-01,2.590e-02
TIMM10,11814,chaperone binding,GO:0051087,molecular function,12.0,3.0,2.423e-02,1.592e-02,3.690e-02,2.693e-03,1.768e-03,4.100e-03,9.694e-01,1.988e-03
TIMM10,11814,protein transporter activity,GO:0140318,molecular function,12.0,4.0,4.881e-02,3.386e-02,7.037e-02,2.275e-02,7.411e-03,6.983e-02,8.547e-01,2.650e-02
TIMM10,11814,protein homodimerization activity,GO:0042803,molecular function,12.0,21.0,5.406e-02,4.575e-02,6.387e-02,3.794e-02,2.701e-02,5.329e-02,8.044e-01,8.586e-03
TIMM10,11814,protein binding,GO:0005515,molecular function,12.0,347.0,6.608e-02,5.910e-02,7.388e-02,6.413e-02,5.306e-02,7.751e-02,7.455e-01,5.480e-03
TIMM22,17317,protein insertion into mitochondrial inner membrane,GO:0045039,biological process,6.0,8.0,1.378e-01,4.664e-02,4.074e-01,4.084e-02,9.170e-03,1.819e-01,7.915e-01,4.130e-02
TIMM22,17317,TIM22 mitochondrial import inner membrane insertion complex,GO:0042721,cellular component,6.0,2.0,1.391e-01,4.719e-02,4.100e-01,8.065e-02,1.296e-02,5.020e-01,7.042e-01,5.985e-02
TIMM22,17317,protein transmembrane transporter activity,GO:0008320,molecular function,6.0,6.0,1.414e-01,5.027e-02,3.980e-01,8.338e-02,3.720e-02,1.869e-01,7.101e-01,2.457e-02
TIMM22,17317,mitochondrion targeting sequence binding,GO:0030943,molecular function,6.0,2.0,1.564e-01,7.134e-02,3.428e-01,1.262e-01,4.035e-02,3.948e-01,6.477e-01,4.465e-02
TIMM22,17317,protein binding,GO:0005515,molecular function,6.0,347.0,1.645e-01,8.053e-02,3.360e-01,1.396e-01,1.109e-01,1.756e-01,6.382e-01,8.527e-03
TIMP4,11823,,,,nan,nan,,,,,,,,
TLCD1,25177,phospholipid homeostasis,GO:0055091,biological process,6.0,3.0,2.214e-01,1.231e-01,3.981e-01,1.204e-01,6.168e-02,2.352e-01,6.590e-01,2.365e-02
TLCD1,25177,membrane assembly,GO:0071709,biological process,6.0,9.0,2.214e-01,1.231e-01,3.981e-01,1.289e-01,1.913e-02,8.689e-01,6.349e-01,6.546e-02
TLCD1,25177,plasma membrane organization,GO:0007009,biological process,6.0,11.0,2.409e-01,1.774e-01,3.273e-01,1.909e-01,1.024e-01,3.559e-01,5.837e-01,2.770e-02
TLCD1,25177,regulation of membrane lipid distribution,GO:0097035,biological process,6.0,6.0,3.111e-01,1.736e-01,5.576e-01,2.365e-01,7.636e-02,7.325e-01,5.352e-01,5.645e-02
TLCD1,25177,plasma membrane,GO:0005886,cellular component,6.0,61.0,2.440e-01,1.131e-01,5.268e-01,2.054e-01,5.409e-02,7.799e-01,5.621e-01,5.578e-02
TMEM100,25607,cellular response to BMP stimulus,GO:0071773,biological process,9.0,4.0,1.923e-01,1.118e-01,3.310e-01,1.428e-01,6.809e-02,2.996e-01,6.322e-01,2.875e-02
TMEM100,25607,BMP signaling pathway,GO:0030509,biological process,9.0,18.0,1.968e-01,1.112e-01,3.485e-01,7.273e-02,1.193e-02,4.434e-01,7.185e-01,5.806e-02
TMEM100,25607,endoplasmic reticulum,GO:0005783,cellular component,9.0,34.0,1.923e-01,1.118e-01,3.310e-01,1.122e-01,4.889e-02,2.573e-01,6.686e-01,2.832e-02
TMEM100,25607,plasma membrane,GO:0005886,cellular component,9.0,61.0,1.923e-01,1.118e-01,3.310e-01,1.226e-01,4.595e-02,3.273e-01,6.540e-01,3.532e-02
TMEM100,25607,perinuclear region of cytoplasm,GO:0048471,cellular component,9.0,11.0,2.110e-01,1.651e-01,2.697e-01,1.580e-01,1.459e-01,1.710e-01,6.187e-01,3.081e-03
TMEM100,25607,perikaryon,GO:0043204,cellular component,9.0,2.0,2.704e-01,1.779e-01,4.109e-01,2.704e-01,1.779e-01,4.109e-01,5.182e-01,2.160e-02
TMEM100,25607,protein binding,GO:0005515,molecular function,9.0,347.0,1.923e-01,1.118e-01,3.310e-01,1.264e-01,5.983e-02,2.671e-01,6.513e-01,2.807e-02
TMEM104,25984,,,,nan,nan,,,,,,,,
TMEM119,27884,,,,nan,nan,,,,,,,,
TMEM33,25541,endoplasmic reticulum tubular network organization,GO:0071786,biological process,16.0,6.0,1.787e-01,1.405e-01,2.274e-01,2.427e-02,1.448e-02,4.069e-02,8.502e-01,1.261e-02
TMEM33,25541,membrane organization,GO:0061024,biological process,16.0,34.0,1.983e-01,1.196e-01,3.289e-01,6.949e-02,3.568e-02,1.353e-01,7.344e-01,1.962e-02
TMEM33,25541,response to endoplasmic reticulum stress,GO:0034976,biological process,16.0,13.0,2.008e-01,1.138e-01,3.543e-01,7.344e-02,7.005e-03,7.699e-01,7.095e-01,7.670e-02
TMEM33,25541,positive regulation of IRE1-mediated unfolded protein response,GO:1903896,biological process,16.0,3.0,2.018e-01,1.219e-01,3.343e-01,1.432e-01,4.872e-02,4.207e-01,6.287e-01,4.080e-02
TMEM33,25541,positive regulation of PERK-mediated unfolded protein response,GO:1903899,biological process,16.0,3.0,2.018e-01,1.219e-01,3.343e-01,1.463e-01,5.332e-02,4.012e-01,6.260e-01,3.863e-02
TMEM33,25541,regulation of endoplasmic reticulum tubular network organization,GO:1903371,biological process,16.0,4.0,2.068e-01,1.066e-01,4.015e-01,9.877e-02,1.449e-02,6.731e-01,6.724e-01,7.206e-02
TMEM33,25541,melanosome,GO:0042470,cellular component,16.0,3.0,1.983e-01,1.196e-01,3.289e-01,1.021e-01,2.344e-02,4.450e-01,6.759e-01,5.046e-02
TMEM33,25541,integral component of endoplasmic reticulum membrane,GO:0030176,cellular component,16.0,10.0,2.084e-01,1.239e-01,3.507e-01,1.046e-01,5.957e-02,1.837e-01,6.800e-01,1.876e-02
TMEM33,25541,endoplasmic reticulum membrane,GO:0005789,cellular component,16.0,12.0,2.084e-01,1.239e-01,3.507e-01,1.647e-01,8.864e-02,3.060e-01,6.093e-01,2.579e-02
TMEM33,25541,nuclear envelope,GO:0005635,cellular component,16.0,4.0,2.089e-01,1.235e-01,3.534e-01,1.821e-01,9.853e-02,3.364e-01,5.923e-01,2.666e-02
TMEM33,25541,endoplasmic reticulum,GO:0005783,cellular component,16.0,34.0,2.165e-01,1.229e-01,3.815e-01,1.707e-01,9.106e-02,3.201e-01,6.036e-01,2.489e-02
TMEM33,25541,protein binding,GO:0005515,molecular function,16.0,347.0,2.228e-01,1.202e-01,4.130e-01,1.423e-01,5.920e-02,3.420e-01,6.315e-01,3.432e-02
TMEM38B,25535,nucleus,GO:0005634,cellular component,2.0,81.0,4.667e-02,2.441e-02,8.924e-02,4.667e-02,2.441e-02,8.924e-02,7.812e-01,1.719e-02
TMEM45A,25480,,,,nan,nan,,,,,,,,
TMEM65,25203,intercalated disc,GO:0014704,cellular component,8.0,2.0,1.922e-02,4.939e-03,7.481e-02,1.131e-02,2.097e-03,6.097e-02,9.043e-01,2.251e-02
TMEM65,25203,plasma membrane,GO:0005886,cellular component,8.0,61.0,2.334e-02,3.353e-03,1.625e-01,1.859e-02,1.781e-03,1.940e-01,8.599e-01,5.007e-02
TMEM65,25203,mitochondrial inner membrane,GO:0005743,cellular component,8.0,5.0,2.375e-02,1.090e-02,5.177e-02,2.075e-02,1.480e-02,2.909e-02,8.659e-01,8.182e-03
TMEM79,28196,regulated exocytosis,GO:0045055,biological process,6.0,8.0,1.231e-01,9.321e-02,1.627e-01,1.216e-01,9.568e-02,1.545e-01,6.592e-01,8.686e-03
TMEM79,28196,lysosomal membrane,GO:0005765,cellular component,6.0,10.0,7.713e-02,3.540e-02,1.681e-01,3.436e-02,5.122e-03,2.305e-01,8.081e-01,5.206e-02
TMEM79,28196,trans-Golgi network membrane,GO:0032588,cellular component,6.0,2.0,9.300e-02,3.810e-02,2.270e-01,4.840e-02,7.392e-03,3.169e-01,7.684e-01,5.542e-02
TMEM79,28196,identical protein binding,GO:0042802,molecular function,6.0,35.0,7.235e-02,4.317e-02,1.213e-01,3.613e-02,1.895e-02,6.890e-02,8.089e-01,1.630e-02
TMEM79,28196,protein binding,GO:0005515,molecular function,6.0,347.0,8.060e-02,5.589e-02,1.162e-01,5.322e-02,4.378e-02,6.470e-02,7.673e-01,5.316e-03
TMOD2,11872,actin filament organization,GO:0007015,biological process,13.0,14.0,6.522e-02,1.146e-02,3.711e-01,1.699e-02,2.882e-03,1.002e-01,8.745e-01,3.872e-02
TMOD2,11872,muscle contraction,GO:0006936,biological process,13.0,4.0,8.307e-02,1.026e-02,6.725e-01,5.567e-02,7.855e-03,3.946e-01,7.521e-01,5.650e-02
TMOD2,11872,myofibril assembly,GO:0030239,biological process,13.0,7.0,8.595e-02,1.005e-02,7.352e-01,7.219e-02,8.199e-03,6.356e-01,7.171e-01,6.404e-02
TMOD2,11872,myofibril,GO:0030016,cellular component,13.0,4.0,8.434e-02,1.023e-02,6.957e-01,5.582e-02,8.464e-03,3.681e-01,7.533e-01,5.234e-02
TMOD2,11872,striated muscle thin filament,GO:0005865,cellular component,13.0,2.0,8.491e-02,1.016e-02,7.093e-01,6.328e-02,7.156e-03,5.595e-01,7.348e-01,6.069e-02
TMOD2,11872,cytoskeleton,GO:0005856,cellular component,13.0,12.0,1.304e-01,2.610e-02,6.515e-01,1.116e-01,2.390e-02,5.207e-01,6.615e-01,5.549e-02
TMOD2,11872,tropomyosin binding,GO:0005523,molecular function,13.0,2.0,6.621e-02,1.149e-02,3.817e-01,2.108e-02,1.122e-02,3.961e-02,8.633e-01,1.441e-02
TNFAIP3,11896,,,,nan,nan,,,,,,,,
TNFRSF8,11923,,,,nan,nan,,,,,,,,
TPI1,12009,glycolytic process,GO:0006096,biological process,22.0,13.0,7.566e-02,4.579e-02,1.250e-01,2.148e-02,8.148e-03,5.663e-02,8.613e-01,2.324e-02
TPI1,12009,gluconeogenesis,GO:0006094,biological process,22.0,3.0,7.763e-02,4.542e-02,1.327e-01,4.243e-02,1.068e-02,1.685e-01,7.896e-01,3.528e-02
TPI1,12009,glycerol catabolic process,GO:0019563,biological process,22.0,6.0,8.028e-02,5.265e-02,1.224e-01,4.095e-02,3.119e-02,5.378e-02,7.963e-01,6.978e-03
TPI1,12009,glyceraldehyde-3-phosphate biosynthetic process,GO:0046166,biological process,22.0,5.0,1.053e-01,3.267e-02,3.392e-01,8.294e-02,1.702e-02,4.042e-01,7.034e-01,5.338e-02
TPI1,12009,extracellular space,GO:0005615,cellular component,22.0,43.0,7.566e-02,4.579e-02,1.250e-01,2.824e-02,4.936e-03,1.616e-01,8.306e-01,4.522e-02
TPI1,12009,extracellular exosome,GO:0070062,cellular component,22.0,77.0,7.566e-02,4.579e-02,1.250e-01,2.840e-02,5.353e-03,1.507e-01,8.302e-01,4.274e-02
TPI1,12009,cytosol,GO:0005829,cellular component,22.0,76.0,8.028e-02,5.265e-02,1.224e-01,5.615e-02,2.803e-02,1.125e-01,7.599e-01,1.962e-02
TPI1,12009,nucleus,GO:0005634,cellular component,22.0,81.0,9.501e-02,8.199e-02,1.101e-01,8.965e-02,7.717e-02,1.042e-01,7.032e-01,4.732e-03
TPI1,12009,protein homodimerization activity,GO:0042803,molecular function,22.0,21.0,8.028e-02,5.265e-02,1.224e-01,4.205e-02,3.337e-02,5.298e-02,7.934e-01,6.013e-03
TPI1,12009,protein binding,GO:0005515,molecular function,22.0,347.0,8.483e-02,6.702e-02,1.074e-01,7.055e-02,4.609e-02,1.080e-01,7.332e-01,1.255e-02
TPI1,12009,ubiquitin protein ligase binding,GO:0031625,molecular function,22.0,9.0,8.509e-02,6.792e-02,1.066e-01,6.807e-02,5.260e-02,8.809e-02,7.382e-01,7.752e-03
TPI1,12009,triose-phosphate isomerase activity,GO:0004807,molecular function,22.0,2.0,9.718e-02,7.730e-02,1.222e-01,6.959e-02,2.351e-02,2.060e-01,7.317e-01,3.170e-02
TPMT,12014,drug metabolic process,GO:0017144,biological process,6.0,103.0,1.813e-01,3.416e-02,9.620e-01,1.813e-01,3.416e-02,9.620e-01,5.736e-01,8.092e-02
TPMT,12014,S-adenosyl-L-methionine binding,GO:1904047,molecular function,6.0,4.0,1.578e-01,2.980e-02,8.358e-01,8.539e-02,3.310e-02,2.203e-01,7.060e-01,3.008e-02
TPMT,12014,thiopurine S-methyltransferase activity,GO:0008119,molecular function,6.0,3.0,1.671e-01,2.618e-02,1.066e+00,1.104e-01,1.137e-02,1.072e+00,6.492e-01,8.475e-02
TRABD2B,44200,,,,nan,nan,,,,,,,,
TRHDE,30748,proteolysis,GO:0006508,biological process,9.0,14.0,1.619e-01,1.103e-01,2.375e-01,3.976e-02,1.459e-02,1.083e-01,7.979e-01,2.587e-02
TRHDE,30748,peptide catabolic process,GO:0043171,biological process,9.0,18.0,1.619e-01,1.103e-01,2.375e-01,7.544e-02,2.502e-02,2.275e-01,7.207e-01,3.576e-02
TRHDE,30748,extracellular exosome,GO:0070062,cellular component,9.0,77.0,1.660e-01,1.143e-01,2.410e-01,6.803e-02,3.807e-02,1.215e-01,7.373e-01,1.736e-02
TRHDE,30748,plasma membrane,GO:0005886,cellular component,9.0,61.0,1.679e-01,1.168e-01,2.412e-01,1.281e-01,8.242e-02,1.990e-01,6.508e-01,1.629e-02
TRHDE,30748,cytoplasm,GO:0005737,cellular component,9.0,78.0,1.942e-01,1.526e-01,2.471e-01,1.789e-01,1.069e-01,2.992e-01,5.963e-01,2.062e-02
TRHDE,30748,peptide binding,GO:0042277,molecular function,9.0,14.0,1.619e-01,1.103e-01,2.375e-01,6.571e-02,3.260e-02,1.325e-01,7.413e-01,2.034e-02
TRHDE,30748,zinc ion binding,GO:0008270,molecular function,9.0,8.0,1.666e-01,1.160e-01,2.393e-01,1.308e-01,7.583e-02,2.255e-01,6.473e-01,2.043e-02
TRHDE,30748,metalloaminopeptidase activity,GO:0070006,molecular function,9.0,3.0,1.679e-01,1.168e-01,2.412e-01,1.466e-01,7.365e-02,2.918e-01,6.286e-01,2.571e-02
TRIM29,17274,adherens junction,GO:0005912,cellular component,9.0,6.0,2.229e-02,1.612e-02,3.082e-02,1.207e-02,4.044e-03,3.600e-02,9.064e-01,1.551e-02
TRIM29,17274,cadherin binding involved in cell-cell adhesion,GO:0098641,molecular function,9.0,4.0,2.403e-02,1.413e-02,4.087e-02,1.372e-02,9.404e-03,2.001e-02,9.022e-01,6.360e-03
TRIM29,17274,identical protein binding,GO:0042802,molecular function,9.0,35.0,2.714e-02,1.082e-02,6.803e-02,2.023e-02,7.952e-03,5.146e-02,8.666e-01,2.176e-02
TRIM29,17274,protein binding,GO:0005515,molecular function,9.0,347.0,3.016e-02,1.201e-02,7.574e-02,3.016e-02,1.201e-02,7.574e-02,8.275e-01,2.279e-02
TRIM67,31859,,,,nan,nan,,,,,,,,
TRMT61A,23790,mRNA methylation,GO:0080009,biological process,8.0,4.0,3.897e-01,2.046e-01,7.424e-01,1.870e-01,8.037e-02,4.349e-01,5.855e-01,3.607e-02
TRMT61A,23790,tRNA methylation,GO:0030488,biological process,8.0,12.0,3.963e-01,2.069e-01,7.591e-01,2.871e-01,7.228e-02,1.140e+00,4.882e-01,6.927e-02
TRMT61A,23790,nucleus,GO:0005634,cellular component,8.0,81.0,3.897e-01,2.046e-01,7.424e-01,2.015e-01,1.089e-01,3.729e-01,5.743e-01,2.602e-02
TRMT61A,23790,tRNA (m1A) methyltransferase complex,GO:0031515,cellular component,8.0,2.0,5.231e-01,4.240e-01,6.455e-01,5.150e-01,3.967e-01,6.686e-01,3.521e-01,2.009e-02
TRMT61A,23790,protein binding,GO:0005515,molecular function,8.0,347.0,3.963e-01,2.069e-01,7.591e-01,2.716e-01,1.092e-01,6.755e-01,5.118e-01,4.334e-02
TRMT61A,23790,tRNA (adenine-N1-)-methyltransferase activity,GO:0016429,molecular function,8.0,3.0,4.627e-01,3.448e-01,6.209e-01,3.195e-01,1.763e-01,5.791e-01,4.796e-01,3.136e-02
TRMT61A,23790,mRNA (adenine-N1-)-methyltransferase activity,GO:0061953,molecular function,8.0,2.0,4.627e-01,3.448e-01,6.209e-01,3.381e-01,1.459e-01,7.835e-01,4.619e-01,4.594e-02
TRPC1,12333,calcium ion transmembrane transport,GO:0070588,biological process,42.0,11.0,5.317e-02,2.815e-02,1.004e-01,1.748e-02,4.397e-03,6.946e-02,8.735e-01,2.551e-02
TRPC1,12333,manganese ion transport,GO:0006828,biological process,42.0,3.0,5.553e-02,2.538e-02,1.215e-01,2.458e-02,6.842e-03,8.833e-02,8.464e-01,3.063e-02
TRPC1,12333,regulation of cytosolic calcium ion concentration,GO:0051480,biological process,42.0,7.0,6.079e-02,3.111e-02,1.188e-01,3.855e-02,1.822e-02,8.159e-02,8.020e-01,1.876e-02
TRPC1,12333,response to calcium ion,GO:0051592,biological process,42.0,5.0,6.549e-02,4.006e-02,1.071e-01,3.642e-02,1.438e-02,9.223e-02,8.077e-01,2.356e-02
TRPC1,12333,positive regulation of release of sequestered calcium ion into cytosol,GO:0051281,biological process,42.0,6.0,7.691e-02,2.902e-02,2.038e-01,5.862e-02,1.570e-02,2.188e-01,7.518e-01,3.580e-02
TRPC1,12333,melanin biosynthetic process,GO:0042438,biological process,42.0,7.0,5.283e-01,3.175e-01,8.791e-01,5.283e-01,3.175e-01,8.791e-01,3.373e-01,4.491e-02
TRPC1,12333,plasma membrane,GO:0005886,cellular component,42.0,61.0,5.317e-02,2.815e-02,1.004e-01,9.125e-03,3.164e-03,2.631e-02,9.234e-01,1.519e-02
TRPC1,12333,receptor complex,GO:0043235,cellular component,42.0,29.0,5.317e-02,2.815e-02,1.004e-01,1.559e-02,3.292e-03,7.383e-02,8.809e-01,2.629e-02
TRPC1,12333,integral component of plasma membrane,GO:0005887,cellular component,42.0,28.0,5.553e-02,2.538e-02,1.215e-01,2.334e-02,6.186e-03,8.804e-02,8.496e-01,2.919e-02
TRPC1,12333,cation channel complex,GO:0034703,cellular component,42.0,9.0,5.609e-02,2.478e-02,1.270e-01,3.488e-02,1.204e-02,1.010e-01,8.115e-01,2.736e-02
TRPC1,12333,protein binding,GO:0005515,molecular function,42.0,347.0,5.317e-02,2.815e-02,1.004e-01,1.867e-02,1.541e-02,2.263e-02,8.766e-01,4.484e-03
TRPC1,12333,ATPase binding,GO:0051117,molecular function,42.0,3.0,5.317e-02,2.815e-02,1.004e-01,1.938e-02,7.336e-03,5.118e-02,8.690e-01,2.032e-02
TRPC1,12333,"inositol 1,4,5 trisphosphate binding",GO:0070679,molecular function,42.0,3.0,5.807e-02,2.280e-02,1.479e-01,3.572e-02,7.646e-03,1.669e-01,8.068e-01,4.041e-02
TRPC1,12333,store-operated calcium channel activity,GO:0015279,molecular function,42.0,2.0,6.628e-02,3.136e-02,1.401e-01,4.183e-02,1.519e-02,1.152e-01,7.925e-01,2.591e-02
TRPC1,12333,cation channel activity,GO:0005261,molecular function,42.0,15.0,7.985e-02,2.801e-02,2.276e-01,6.480e-02,1.894e-02,2.218e-01,7.400e-01,3.453e-02
TRPC1,12333,signaling receptor binding,GO:0005102,molecular function,42.0,61.0,2.358e-01,1.821e-01,3.052e-01,2.210e-01,1.708e-01,2.861e-01,5.594e-01,1.167e-02
TRUB2,17170,positive regulation of mitochondrial translation,GO:0070131,biological process,3.0,7.0,2.050e-02,1.413e-02,2.975e-02,1.688e-02,1.261e-02,2.260e-02,8.855e-01,6.027e-03
TRUB2,17170,RNA binding,GO:0003723,molecular function,3.0,60.0,1.626e-02,5.692e-03,4.648e-02,1.191e-02,2.093e-03,6.774e-02,8.998e-01,2.628e-02
TSR1,25542,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",GO:0000462,biological process,15.0,2.0,2.755e-02,5.739e-03,1.323e-01,1.405e-02,1.176e-03,1.680e-01,8.787e-01,5.056e-02
TSR1,25542,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",GO:0000479,biological process,15.0,9.0,2.966e-02,5.396e-03,1.631e-01,2.378e-02,2.979e-03,1.899e-01,8.435e-01,5.149e-02
TSR1,25542,"preribosome, small subunit precursor",GO:0030688,cellular component,15.0,3.0,2.250e-02,9.247e-03,5.475e-02,6.896e-03,7.991e-04,5.952e-02,9.251e-01,2.999e-02
TSR1,25542,RNA binding,GO:0003723,molecular function,15.0,60.0,1.930e-02,1.448e-02,2.571e-02,1.082e-02,2.277e-03,5.142e-02,9.091e-01,2.007e-02
TSR1,25542,U3 snoRNA binding,GO:0034511,molecular function,15.0,2.0,2.122e-02,1.162e-02,3.876e-02,1.096e-02,8.685e-03,1.382e-02,9.173e-01,3.475e-03
TSR1,25542,GTPase activity,GO:0003924,molecular function,15.0,7.0,2.305e-02,9.690e-03,5.485e-02,1.648e-02,5.916e-03,4.593e-02,8.827e-01,2.016e-02
TSR1,25542,GTP binding,GO:0005525,molecular function,15.0,9.0,2.600e-02,1.129e-02,5.987e-02,1.712e-02,1.854e-03,1.582e-01,8.648e-01,3.757e-02
TTC28,29179,regulation of mitotic cell cycle,GO:0007346,biological process,5.0,19.0,4.558e-02,1.446e-02,1.437e-01,3.039e-02,9.640e-03,9.579e-02,8.261e-01,2.938e-02
TTC28,29179,midbody,GO:0030496,cellular component,5.0,2.0,5.759e-02,2.434e-02,1.363e-01,5.759e-02,2.434e-02,1.363e-01,7.562e-01,2.487e-02
TTC28,29179,kinase binding,GO:0019900,molecular function,5.0,5.0,2.327e-02,1.602e-03,3.382e-01,8.245e-03,4.747e-04,1.432e-01,9.067e-01,4.044e-02
TTPA,12404,,,,nan,nan,,,,,,,,
TUBA1A,20766,microtubule cytoskeleton organization,GO:0000226,biological process,41.0,23.0,3.759e-02,2.464e-02,5.735e-02,1.933e-02,6.398e-03,5.837e-02,8.679e-01,2.250e-02
TUBA1A,20766,mitotic cell cycle,GO:0000278,biological process,41.0,9.0,3.876e-02,2.433e-02,6.176e-02,2.831e-02,1.603e-02,5.002e-02,8.347e-01,1.395e-02
TUBA1A,20766,microtubule-based process,GO:0007017,biological process,41.0,12.0,4.220e-02,2.279e-02,7.815e-02,3.020e-02,9.527e-03,9.571e-02,8.267e-01,2.775e-02
TUBA1A,20766,nucleus,GO:0005634,cellular component,41.0,81.0,3.273e-02,2.366e-02,4.526e-02,9.354e-03,2.380e-03,3.676e-02,9.204e-01,1.608e-02
TUBA1A,20766,cytoplasm,GO:0005737,cellular component,41.0,78.0,3.273e-02,2.366e-02,4.526e-02,1.212e-02,3.743e-03,3.924e-02,9.046e-01,1.967e-02
TUBA1A,20766,microtubule cytoskeleton,GO:0015630,cellular component,41.0,2.0,3.273e-02,2.366e-02,4.526e-02,1.553e-02,1.255e-02,1.921e-02,8.931e-01,4.081e-03
TUBA1A,20766,extracellular exosome,GO:0070062,cellular component,41.0,77.0,3.273e-02,2.366e-02,4.526e-02,2.012e-02,9.922e-03,4.078e-02,8.675e-01,1.565e-02
TUBA1A,20766,recycling endosome,GO:0055037,cellular component,41.0,7.0,3.759e-02,2.464e-02,5.735e-02,2.136e-02,8.918e-03,5.117e-02,8.609e-01,1.955e-02
TUBA1A,20766,microtubule,GO:0005874,cellular component,41.0,11.0,4.393e-02,2.143e-02,9.007e-02,3.619e-02,1.130e-02,1.159e-01,8.077e-01,2.949e-02
TUBA1A,20766,cytoplasmic ribonucleoprotein granule,GO:0036464,cellular component,41.0,11.0,4.705e-02,2.149e-02,1.030e-01,4.461e-02,1.938e-02,1.027e-01,7.857e-01,2.148e-02
TUBA1A,20766,protein binding,GO:0005515,molecular function,41.0,347.0,3.273e-02,2.366e-02,4.526e-02,1.352e-02,5.382e-03,3.399e-02,8.989e-01,1.807e-02
TUBA1A,20766,GTP binding,GO:0005525,molecular function,41.0,9.0,3.273e-02,2.366e-02,4.526e-02,1.478e-02,4.938e-03,4.423e-02,8.906e-01,1.861e-02
TUBA1A,20766,structural constituent of cytoskeleton,GO:0005200,molecular function,41.0,8.0,4.170e-02,2.204e-02,7.888e-02,3.209e-02,1.527e-02,6.743e-02,8.214e-01,1.875e-02
TUBB2A,12412,microtubule cytoskeleton organization,GO:0000226,biological process,19.0,23.0,7.214e-02,1.508e-02,3.450e-01,2.802e-02,2.495e-03,3.147e-01,8.205e-01,5.497e-02
TUBB2A,12412,mitotic cell cycle,GO:0000278,biological process,19.0,9.0,7.668e-02,1.306e-02,4.502e-01,3.698e-02,3.515e-03,3.891e-01,7.939e-01,6.202e-02
TUBB2A,12412,microtubule-based process,GO:0007017,biological process,19.0,12.0,8.559e-02,1.620e-02,4.522e-01,4.968e-02,4.021e-03,6.138e-01,7.590e-01,6.909e-02
TUBB2A,12412,neuron migration,GO:0001764,biological process,19.0,10.0,1.341e-01,3.164e-02,5.683e-01,1.341e-01,3.164e-02,5.683e-01,6.334e-01,5.903e-02
TUBB2A,12412,nucleus,GO:0005634,cellular component,19.0,81.0,4.038e-02,9.964e-03,1.637e-01,9.074e-03,5.010e-04,1.643e-01,9.016e-01,3.096e-02
TUBB2A,12412,cytoplasm,GO:0005737,cellular component,19.0,78.0,4.038e-02,9.964e-03,1.637e-01,1.399e-02,2.109e-03,9.285e-02,8.863e-01,3.188e-02
TUBB2A,12412,extracellular exosome,GO:0070062,cellular component,19.0,77.0,4.905e-02,1.832e-02,1.314e-01,2.461e-02,9.166e-03,6.607e-02,8.473e-01,2.289e-02
TUBB2A,12412,microtubule,GO:0005874,cellular component,19.0,11.0,8.020e-02,1.175e-02,5.477e-01,5.019e-02,3.270e-03,7.703e-01,7.523e-01,8.348e-02
TUBB2A,12412,extracellular vesicle,GO:1903561,cellular component,19.0,13.0,9.052e-02,1.494e-02,5.484e-01,7.629e-02,1.087e-02,5.352e-01,7.102e-01,6.364e-02
TUBB2A,12412,GTP binding,GO:0005525,molecular function,19.0,9.0,4.244e-02,9.032e-03,1.994e-01,1.453e-02,1.128e-03,1.873e-01,8.734e-01,3.978e-02
TUBB2A,12412,protein binding,GO:0005515,molecular function,19.0,347.0,4.820e-02,1.908e-02,1.218e-01,1.786e-02,5.114e-03,6.234e-02,8.754e-01,2.806e-02
TUBB2A,12412,structural constituent of cytoskeleton,GO:0005200,molecular function,19.0,8.0,6.770e-02,9.444e-03,4.853e-01,4.458e-02,4.983e-03,3.988e-01,7.749e-01,6.397e-02
TUBG1,12417,microtubule cytoskeleton organization,GO:0000226,biological process,26.0,23.0,3.981e-02,3.611e-02,4.389e-02,1.106e-02,5.122e-03,2.387e-02,9.148e-01,1.034e-02
TUBG1,12417,microtubule-based process,GO:0007017,biological process,26.0,12.0,3.981e-02,3.611e-02,4.389e-02,1.394e-02,7.112e-03,2.732e-02,8.991e-01,1.116e-02
TUBG1,12417,microtubule nucleation,GO:0007020,biological process,26.0,5.0,3.981e-02,3.611e-02,4.389e-02,2.072e-02,1.824e-02,2.353e-02,8.664e-01,2.992e-03
TUBG1,12417,mitotic sister chromatid segregation,GO:0000070,biological process,26.0,3.0,3.981e-02,3.611e-02,4.389e-02,2.148e-02,1.445e-02,3.192e-02,8.624e-01,9.542e-03
TUBG1,12417,mitotic spindle organization,GO:0007052,biological process,26.0,8.0,3.981e-02,3.611e-02,4.389e-02,2.301e-02,1.830e-02,2.892e-02,8.559e-01,5.679e-03
TUBG1,12417,mitotic cell cycle,GO:0000278,biological process,26.0,9.0,3.981e-02,3.611e-02,4.389e-02,2.384e-02,1.541e-02,3.687e-02,8.520e-01,1.053e-02
TUBG1,12417,meiotic spindle organization,GO:0000212,biological process,26.0,5.0,4.078e-02,3.454e-02,4.815e-02,2.537e-02,1.649e-02,3.904e-02,8.457e-01,1.048e-02
TUBG1,12417,centrosome,GO:0005813,cellular component,26.0,9.0,3.981e-02,3.611e-02,4.389e-02,1.008e-02,3.496e-03,2.907e-02,9.185e-01,1.304e-02
TUBG1,12417,polar microtubule,GO:0005827,cellular component,26.0,3.0,4.089e-02,3.521e-02,4.750e-02,2.745e-02,1.508e-02,4.995e-02,8.377e-01,1.460e-02
TUBG1,12417,nucleus,GO:0005634,cellular component,26.0,81.0,4.215e-02,3.471e-02,5.118e-02,2.942e-02,2.058e-02,4.207e-02,8.306e-01,8.787e-03
TUBG1,12417,cytoplasm,GO:0005737,cellular component,26.0,78.0,4.347e-02,3.304e-02,5.719e-02,3.637e-02,2.489e-02,5.312e-02,8.088e-01,9.561e-03
TUBG1,12417,microtubule,GO:0005874,cellular component,26.0,11.0,4.650e-02,2.655e-02,8.145e-02,3.382e-02,1.014e-02,1.128e-01,8.145e-01,3.087e-02
TUBG1,12417,gamma-tubulin complex,GO:0000930,cellular component,26.0,4.0,5.347e-02,1.829e-02,1.564e-01,2.074e-02,1.319e-03,3.261e-01,8.451e-01,6.482e-02
TUBG1,12417,recycling endosome,GO:0055037,cellular component,26.0,7.0,5.572e-02,2.824e-02,1.099e-01,4.025e-02,9.308e-03,1.741e-01,7.946e-01,3.829e-02
TUBG1,12417,spindle,GO:0005819,cellular component,26.0,4.0,5.591e-02,4.412e-02,7.085e-02,4.984e-02,3.240e-02,7.667e-02,7.744e-01,1.154e-02
TUBG1,12417,GTP binding,GO:0005525,molecular function,26.0,9.0,3.981e-02,3.611e-02,4.389e-02,1.431e-02,8.057e-03,2.541e-02,8.974e-01,1.139e-02
TUBG1,12417,identical protein binding,GO:0042802,molecular function,26.0,35.0,4.232e-02,3.183e-02,5.627e-02,2.890e-02,1.348e-02,6.196e-02,8.321e-01,1.892e-02
TUBG1,12417,structural constituent of cytoskeleton,GO:0005200,molecular function,26.0,8.0,4.306e-02,3.170e-02,5.848e-02,2.791e-02,1.181e-02,6.596e-02,8.356e-01,2.129e-02
TUBG1,12417,protein binding,GO:0005515,molecular function,26.0,347.0,4.487e-02,3.726e-02,5.402e-02,3.680e-02,2.247e-02,6.029e-02,8.074e-01,1.242e-02
UBA3,12470,protein neddylation,GO:0045116,biological process,11.0,3.0,7.069e-02,3.190e-02,1.566e-01,1.648e-02,7.360e-03,3.690e-02,8.848e-01,1.766e-02
UBA3,12470,protein modification by small protein conjugation,GO:0032446,biological process,11.0,9.0,7.069e-02,3.190e-02,1.566e-01,1.616e-02,5.395e-03,4.843e-02,8.841e-01,2.223e-02
UBA3,12470,cytoplasm,GO:0005737,cellular component,11.0,78.0,1.124e-01,4.810e-02,2.627e-01,8.683e-02,4.924e-02,1.531e-01,7.060e-01,1.850e-02
UBA3,12470,nucleus,GO:0005634,cellular component,11.0,81.0,1.146e-01,4.920e-02,2.668e-01,8.420e-02,4.702e-02,1.508e-01,7.103e-01,1.792e-02
UBA3,12470,protein-containing complex,GO:0032991,cellular component,11.0,483.0,2.111e-01,1.215e-01,3.667e-01,2.030e-01,1.293e-01,3.186e-01,5.743e-01,1.930e-02
UBA3,12470,identical protein binding,GO:0042802,molecular function,11.0,35.0,7.207e-02,3.362e-02,1.545e-01,3.030e-02,2.073e-02,4.430e-02,8.276e-01,9.356e-03
UBA3,12470,protein heterodimerization activity,GO:0046982,molecular function,11.0,8.0,8.454e-02,2.078e-02,3.438e-01,4.431e-02,5.215e-03,3.766e-01,7.763e-01,6.237e-02
UBA3,12470,protein binding,GO:0005515,molecular function,11.0,347.0,9.611e-02,3.257e-02,2.836e-01,6.093e-02,2.430e-02,1.528e-01,7.491e-01,2.695e-02
UBA3,12470,NEDD8 activating enzyme activity,GO:0019781,molecular function,11.0,2.0,1.240e-01,9.586e-03,1.605e+00,7.109e-02,2.053e-03,2.462e+00,6.722e-01,1.423e-01
UBE2G2,12483,protein K48-linked ubiquitination,GO:0070936,biological process,19.0,3.0,3.865e-02,2.710e-02,5.512e-02,3.506e-03,2.335e-03,5.265e-03,9.635e-01,2.404e-03
UBE2G2,12483,protein polyubiquitination,GO:0000209,biological process,19.0,12.0,4.294e-02,3.142e-02,5.869e-02,1.145e-02,8.233e-03,1.593e-02,9.144e-01,5.002e-03
UBE2G2,12483,ubiquitin-dependent protein catabolic process,GO:0006511,biological process,19.0,6.0,5.212e-02,2.053e-02,1.323e-01,1.947e-02,3.697e-03,1.025e-01,8.640e-01,3.593e-02
UBE2G2,12483,cellular protein catabolic process,GO:0044257,biological process,19.0,13.0,5.753e-02,3.600e-02,9.193e-02,3.199e-02,1.865e-02,5.487e-02,8.220e-01,1.335e-02
UBE2G2,12483,protein N-linked glycosylation via asparagine,GO:0018279,biological process,19.0,7.0,6.488e-02,2.753e-02,1.529e-01,4.200e-02,1.618e-02,1.090e-01,7.919e-01,2.496e-02
UBE2G2,12483,ubiquitin-dependent ERAD pathway,GO:0030433,biological process,19.0,6.0,6.971e-02,2.329e-02,2.086e-01,5.122e-02,1.293e-02,2.029e-01,7.664e-01,3.961e-02
UBE2G2,12483,cellular response to interferon-beta,GO:0035458,biological process,19.0,4.0,7.794e-02,2.996e-02,2.027e-01,6.659e-02,2.271e-02,1.953e-01,7.372e-01,3.206e-02
UBE2G2,12483,"negative regulation of retrograde protein transport, ER to cytosol",GO:1904153,biological process,19.0,4.0,8.464e-02,2.859e-02,2.506e-01,4.535e-02,1.971e-03,1.044e+00,7.589e-01,7.513e-02
UBE2G2,12483,cytosol,GO:0005829,cellular component,19.0,76.0,6.918e-02,3.345e-02,1.431e-01,5.589e-02,3.501e-02,8.922e-02,7.612e-01,1.335e-02
UBE2G2,12483,endoplasmic reticulum,GO:0005783,cellular component,19.0,34.0,7.432e-02,2.817e-02,1.961e-01,6.538e-02,2.263e-02,1.888e-01,7.393e-01,3.278e-02
UBE2G2,12483,ubiquitin conjugating enzyme activity,GO:0061631,molecular function,19.0,4.0,4.859e-02,2.228e-02,1.060e-01,1.234e-02,2.311e-03,6.589e-02,8.979e-01,2.811e-02
UBE2G2,12483,ubiquitin-protein transferase activity,GO:0004842,molecular function,19.0,7.0,4.919e-02,2.332e-02,1.038e-01,1.726e-02,6.543e-03,4.551e-02,8.799e-01,2.050e-02
UBE2G2,12483,protein binding,GO:0005515,molecular function,19.0,347.0,7.348e-02,2.410e-02,2.240e-01,5.937e-02,1.362e-02,2.588e-01,7.476e-01,4.536e-02
UFM1,20597,protein ufmylation,GO:0071569,biological process,11.0,3.0,3.054e-01,2.580e-01,3.615e-01,1.775e-01,1.222e-01,2.578e-01,5.983e-01,1.573e-02
UFM1,20597,response to endoplasmic reticulum stress,GO:0034976,biological process,11.0,13.0,3.324e-01,2.783e-01,3.971e-01,1.556e-01,4.331e-02,5.589e-01,6.126e-01,4.904e-02
UFM1,20597,brain development,GO:0007420,biological process,11.0,6.0,3.443e-01,2.247e-01,5.278e-01,2.084e-01,5.660e-02,7.675e-01,5.567e-01,6.327e-02
UFM1,20597,regulation of intracellular estrogen receptor signaling pathway,GO:0033146,biological process,11.0,4.0,4.046e-01,2.427e-01,6.746e-01,3.676e-01,1.604e-01,8.423e-01,4.406e-01,4.763e-02
UFM1,20597,protein K69-linked ufmylation,GO:1990592,biological process,11.0,2.0,4.099e-01,2.890e-01,5.812e-01,3.586e-01,2.529e-01,5.086e-01,4.544e-01,2.090e-02
UFM1,20597,nucleus,GO:0005634,cellular component,11.0,81.0,3.054e-01,2.580e-01,3.615e-01,1.754e-01,7.002e-02,4.391e-01,5.967e-01,3.648e-02
UFM1,20597,cytoplasm,GO:0005737,cellular component,11.0,78.0,3.054e-01,2.580e-01,3.615e-01,1.941e-01,1.309e-01,2.880e-01,5.826e-01,1.643e-02
UFM1,20597,protein binding,GO:0005515,molecular function,11.0,347.0,3.054e-01,2.580e-01,3.615e-01,1.447e-01,1.122e-01,1.865e-01,6.324e-01,9.720e-03
UPK3B,21444,,,,nan,nan,,,,,,,,
UPRT,28334,,,,nan,nan,,,,,,,,
UQCC1,15891,positive regulation of mitochondrial translation,GO:0070131,biological process,6.0,7.0,7.685e-02,3.977e-02,1.485e-01,3.003e-02,2.835e-02,3.182e-02,8.288e-01,1.433e-03
UQCC1,15891,mitochondrial respiratory chain complex III assembly,GO:0034551,biological process,6.0,3.0,8.694e-02,4.806e-02,1.573e-01,6.270e-02,3.063e-02,1.283e-01,7.468e-01,2.116e-02
UQCC1,15891,mitochondrial inner membrane,GO:0005743,cellular component,6.0,5.0,8.568e-02,3.086e-02,2.379e-01,4.550e-02,5.115e-03,4.047e-01,7.727e-01,6.378e-02
UQCC1,15891,protein binding,GO:0005515,molecular function,6.0,347.0,9.678e-02,4.169e-02,2.247e-01,8.611e-02,4.912e-02,1.509e-01,7.071e-01,1.793e-02
UST,17223,sulfotransferase activity,GO:0008146,molecular function,5.0,49.0,2.101e-01,1.039e-02,4.252e+00,2.101e-01,1.039e-02,4.252e+00,4.976e-01,1.392e-01
VAC14,25507,phosphatidylinositol biosynthetic process,GO:0006661,biological process,12.0,8.0,1.920e-01,5.473e-02,6.736e-01,1.661e-01,2.895e-02,9.529e-01,5.944e-01,6.558e-02
VAC14,25507,positive regulation of kinase activity,GO:0033674,biological process,12.0,15.0,2.135e-01,1.813e-01,2.513e-01,1.503e-01,8.620e-02,2.619e-01,6.250e-01,2.206e-02
VAC14,25507,vacuolar membrane,GO:0005774,cellular component,12.0,8.0,1.562e-01,6.321e-02,3.858e-01,6.375e-02,1.257e-02,3.233e-01,7.387e-01,4.578e-02
VAC14,25507,endosome membrane,GO:0010008,cellular component,12.0,12.0,1.562e-01,6.321e-02,3.858e-01,7.356e-02,1.470e-02,3.682e-01,7.204e-01,4.674e-02
VAC14,25507,cytosol,GO:0005829,cellular component,12.0,76.0,1.562e-01,6.321e-02,3.858e-01,9.265e-02,2.491e-02,3.446e-01,6.919e-01,4.091e-02
VAC14,25507,intracellular membrane-bounded organelle,GO:0043231,cellular component,12.0,48.0,1.698e-01,9.134e-02,3.157e-01,7.953e-02,6.115e-02,1.034e-01,7.186e-01,8.104e-03
VAC14,25507,extrinsic component of vacuolar membrane,GO:0000306,cellular component,12.0,5.0,1.874e-01,5.539e-02,6.338e-01,1.565e-01,3.128e-02,7.830e-01,6.071e-01,5.984e-02
VAC14,25507,PAS complex,GO:0070772,cellular component,12.0,2.0,2.153e-01,1.779e-01,2.604e-01,1.121e-01,3.008e-02,4.178e-01,6.636e-01,4.948e-02
VAC14,25507,protein binding,GO:0005515,molecular function,12.0,347.0,1.606e-01,6.156e-02,4.190e-01,1.104e-01,2.791e-02,4.368e-01,6.662e-01,4.516e-02
VAPB,12649,IRE1-mediated unfolded protein response,GO:0036498,biological process,29.0,2.0,6.901e-02,4.520e-02,1.054e-01,9.746e-03,4.304e-03,2.207e-02,9.217e-01,1.183e-02
VAPB,12649,endoplasmic reticulum membrane organization,GO:0090158,biological process,29.0,2.0,8.000e-02,5.221e-02,1.226e-01,2.524e-02,8.184e-03,7.784e-02,8.450e-01,2.764e-02
VAPB,12649,endoplasmic reticulum-plasma membrane tethering,GO:0061817,biological process,29.0,3.0,8.073e-02,5.168e-02,1.261e-01,3.038e-02,5.422e-03,1.702e-01,8.231e-01,4.517e-02
VAPB,12649,endoplasmic reticulum unfolded protein response,GO:0030968,biological process,29.0,6.0,8.128e-02,3.935e-02,1.679e-01,2.522e-02,3.129e-03,2.033e-01,8.344e-01,4.233e-02
VAPB,12649,COPII-coated vesicle budding,GO:0090114,biological process,29.0,2.0,8.668e-02,6.546e-02,1.148e-01,3.170e-02,2.146e-02,4.681e-02,8.230e-01,9.647e-03
VAPB,12649,endoplasmic reticulum to Golgi vesicle-mediated transport,GO:0006888,biological process,29.0,5.0,8.938e-02,4.159e-02,1.921e-01,5.368e-02,9.592e-03,3.004e-01,7.591e-01,4.817e-02
VAPB,12649,cellular calcium ion homeostasis,GO:0006874,biological process,29.0,10.0,9.422e-02,5.710e-02,1.554e-01,5.218e-02,2.718e-02,1.002e-01,7.687e-01,1.743e-02
VAPB,12649,endoplasmic reticulum organization,GO:0007029,biological process,29.0,7.0,9.508e-02,5.766e-02,1.568e-01,5.709e-02,2.267e-02,1.438e-01,7.570e-01,2.515e-02
VAPB,12649,positive regulation of viral genome replication,GO:0045070,biological process,29.0,5.0,9.681e-02,6.321e-02,1.483e-01,6.118e-02,4.521e-02,8.278e-02,7.508e-01,8.672e-03
VAPB,12649,modulation by virus of host morphology or physiology,GO:0019048,biological process,29.0,12.0,1.394e-01,7.143e-02,2.720e-01,1.373e-01,6.693e-02,2.818e-01,6.388e-01,2.609e-02
VAPB,12649,Golgi apparatus,GO:0005794,cellular component,29.0,16.0,9.508e-02,5.766e-02,1.568e-01,6.628e-02,4.023e-02,1.092e-01,7.407e-01,1.437e-02
VAPB,12649,endoplasmic reticulum membrane,GO:0005789,cellular component,29.0,12.0,9.555e-02,5.548e-02,1.646e-01,6.367e-02,3.469e-02,1.168e-01,7.453e-01,1.777e-02
VAPB,12649,plasma membrane,GO:0005886,cellular component,29.0,61.0,9.945e-02,5.266e-02,1.878e-01,7.683e-02,4.177e-02,1.413e-01,7.217e-01,1.895e-02
VAPB,12649,endoplasmic reticulum,GO:0005783,cellular component,29.0,34.0,1.010e-01,5.246e-02,1.945e-01,8.222e-02,3.617e-02,1.869e-01,7.117e-01,2.711e-02
VAPB,12649,cytoplasm,GO:0005737,cellular component,29.0,78.0,1.212e-01,7.322e-02,2.006e-01,1.177e-01,7.323e-02,1.890e-01,6.636e-01,1.735e-02
VAPB,12649,beta-tubulin binding,GO:0048487,molecular function,29.0,2.0,6.901e-02,4.520e-02,1.054e-01,1.099e-02,7.872e-03,1.533e-02,9.170e-01,4.828e-03
VAPB,12649,microtubule binding,GO:0008017,molecular function,29.0,5.0,6.901e-02,4.520e-02,1.054e-01,1.175e-02,7.962e-03,1.733e-02,9.125e-01,5.936e-03
VAPB,12649,enzyme binding,GO:0019899,molecular function,29.0,35.0,6.901e-02,4.520e-02,1.054e-01,1.592e-02,7.911e-03,3.204e-02,8.884e-01,1.426e-02
VAPB,12649,cadherin binding,GO:0045296,molecular function,29.0,13.0,8.128e-02,3.935e-02,1.679e-01,2.914e-02,5.704e-03,1.489e-01,8.272e-01,4.079e-02
VAPB,12649,protein heterodimerization activity,GO:0046982,molecular function,29.0,8.0,9.422e-02,5.710e-02,1.554e-01,4.789e-02,3.441e-02,6.666e-02,7.791e-01,8.982e-03
VAPB,12649,protein homodimerization activity,GO:0042803,molecular function,29.0,21.0,9.555e-02,5.548e-02,1.646e-01,5.635e-02,2.560e-02,1.241e-01,7.591e-01,2.240e-02
VAPB,12649,FFAT motif binding,GO:0033149,molecular function,29.0,2.0,9.854e-02,5.197e-02,1.869e-01,6.832e-02,2.545e-02,1.834e-01,7.346e-01,2.998e-02
VAPB,12649,protein binding,GO:0005515,molecular function,29.0,347.0,1.013e-01,5.383e-02,1.906e-01,8.649e-02,4.123e-02,1.814e-01,7.056e-01,2.343e-02
VDR,12679,cholesterol homeostasis,GO:0042632,biological process,95.0,3.0,1.040e-01,6.268e-02,1.725e-01,2.626e-02,1.264e-02,5.456e-02,8.420e-01,1.787e-02
VDR,12679,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,95.0,62.0,1.040e-01,6.268e-02,1.725e-01,3.083e-02,1.076e-02,8.836e-02,8.252e-01,2.568e-02
VDR,12679,bile acid signaling pathway,GO:0038183,biological process,95.0,4.0,1.040e-01,6.268e-02,1.725e-01,3.779e-02,2.473e-02,5.775e-02,8.047e-01,1.064e-02
VDR,12679,positive regulation of keratinocyte differentiation,GO:0045618,biological process,95.0,6.0,1.040e-01,6.268e-02,1.725e-01,3.847e-02,2.774e-02,5.335e-02,8.029e-01,8.205e-03
VDR,12679,lipid homeostasis,GO:0055088,biological process,95.0,12.0,1.159e-01,4.839e-02,2.777e-01,5.102e-02,1.478e-02,1.762e-01,7.680e-01,3.540e-02
VDR,12679,lipid metabolic process,GO:0006629,biological process,95.0,13.0,1.210e-01,4.580e-02,3.199e-01,6.964e-02,1.831e-02,2.648e-01,7.290e-01,4.298e-02
VDR,12679,vitamin D receptor signaling pathway,GO:0070561,biological process,95.0,2.0,1.211e-01,6.385e-02,2.299e-01,5.524e-02,2.056e-02,1.484e-01,7.606e-01,2.721e-02
VDR,12679,positive regulation of gene expression,GO:0010628,biological process,95.0,23.0,1.251e-01,5.662e-02,2.763e-01,7.841e-02,2.975e-02,2.067e-01,7.169e-01,3.073e-02
VDR,12679,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,95.0,43.0,1.311e-01,6.738e-02,2.550e-01,7.669e-02,4.353e-02,1.351e-01,7.224e-01,1.710e-02
VDR,12679,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,95.0,31.0,1.333e-01,7.073e-02,2.514e-01,7.883e-02,5.929e-02,1.048e-01,7.197e-01,8.746e-03
VDR,12679,multicellular organism development,GO:0007275,biological process,95.0,16.0,1.390e-01,5.282e-02,3.660e-01,8.067e-02,1.289e-02,5.050e-01,7.055e-01,5.637e-02
VDR,12679,negative regulation of keratinocyte proliferation,GO:0010839,biological process,95.0,3.0,1.403e-01,6.699e-02,2.937e-01,7.620e-02,2.662e-02,2.181e-01,7.202e-01,3.243e-02
VDR,12679,cellular response to lipopolysaccharide,GO:0071222,biological process,95.0,7.0,1.492e-01,6.641e-02,3.351e-01,8.495e-02,2.013e-02,3.584e-01,7.026e-01,4.500e-02
VDR,12679,positive regulation of vitamin D 24-hydroxylase activity,GO:0010980,biological process,95.0,3.0,1.508e-01,6.598e-02,3.448e-01,8.346e-02,1.128e-02,6.173e-01,6.990e-01,5.990e-02
VDR,12679,negative regulation of cell population proliferation,GO:0008285,biological process,95.0,36.0,2.295e-01,1.171e-01,4.496e-01,2.038e-01,1.085e-01,3.826e-01,5.720e-01,2.864e-02
VDR,12679,response to lipid,GO:0033993,biological process,95.0,37.0,2.526e-01,8.701e-02,7.331e-01,2.272e-01,7.335e-02,7.038e-01,5.445e-01,5.185e-02
VDR,12679,decidualization,GO:0046697,biological process,95.0,3.0,2.879e-01,3.392e-02,2.443e+00,2.139e-01,1.215e-02,3.766e+00,5.025e-01,1.299e-01
VDR,12679,cell morphogenesis,GO:0000902,biological process,95.0,5.0,3.423e-01,3.277e-02,3.575e+00,2.327e-01,6.826e-03,7.933e+00,4.487e-01,1.594e-01
VDR,12679,cell differentiation,GO:0030154,biological process,95.0,86.0,3.609e-01,3.078e-02,4.232e+00,2.223e-01,4.484e-03,1.102e+01,4.214e-01,1.900e-01
VDR,12679,animal organ morphogenesis,GO:0009887,biological process,95.0,29.0,5.091e-01,9.545e-02,2.715e+00,4.886e-01,8.606e-02,2.774e+00,2.910e-01,1.335e-01
VDR,12679,cytosol,GO:0005829,cellular component,95.0,76.0,1.028e-01,6.040e-02,1.749e-01,1.471e-02,2.061e-03,1.050e-01,8.806e-01,3.159e-02
VDR,12679,nucleus,GO:0005634,cellular component,95.0,81.0,1.028e-01,6.040e-02,1.749e-01,1.783e-02,2.676e-03,1.188e-01,8.661e-01,3.440e-02
VDR,12679,nucleoplasm,GO:0005654,cellular component,95.0,51.0,1.028e-01,6.040e-02,1.749e-01,1.814e-02,2.268e-03,1.450e-01,8.621e-01,3.674e-02
VDR,12679,receptor complex,GO:0043235,cellular component,95.0,29.0,1.129e-01,7.538e-02,1.691e-01,3.631e-02,7.439e-03,1.772e-01,8.049e-01,4.093e-02
VDR,12679,RNA polymerase II transcription factor complex,GO:0090575,cellular component,95.0,43.0,2.736e-01,2.067e-01,3.620e-01,2.444e-01,1.766e-01,3.382e-01,5.396e-01,1.543e-02
VDR,12679,protein binding,GO:0005515,molecular function,95.0,347.0,1.040e-01,6.268e-02,1.725e-01,1.901e-02,8.910e-03,4.056e-02,8.719e-01,1.591e-02
VDR,12679,nuclear receptor activity,GO:0004879,molecular function,95.0,3.0,1.040e-01,6.268e-02,1.725e-01,2.567e-02,1.693e-02,3.892e-02,8.446e-01,1.015e-02
VDR,12679,ligand-activated transcription factor activity,GO:0098531,molecular function,95.0,3.0,1.040e-01,6.268e-02,1.725e-01,2.709e-02,2.114e-02,3.472e-02,8.391e-01,6.055e-03
VDR,12679,"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,molecular function,95.0,9.0,1.040e-01,6.268e-02,1.725e-01,3.050e-02,2.519e-02,3.692e-02,8.270e-01,4.697e-03
VDR,12679,vitamin D response element binding,GO:0070644,molecular function,95.0,2.0,1.040e-01,6.268e-02,1.725e-01,3.961e-02,2.783e-02,5.639e-02,7.997e-01,8.925e-03
VDR,12679,RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000977,molecular function,95.0,9.0,1.083e-01,6.767e-02,1.734e-01,4.516e-02,2.473e-02,8.248e-02,7.850e-01,1.598e-02
VDR,12679,DNA-binding transcription factor activity,GO:0003700,molecular function,95.0,12.0,1.200e-01,5.374e-02,2.682e-01,4.258e-02,1.017e-02,1.783e-01,7.888e-01,3.678e-02
VDR,12679,transcription factor binding,GO:0008134,molecular function,95.0,9.0,1.251e-01,5.665e-02,2.764e-01,7.944e-02,3.356e-02,1.880e-01,7.159e-01,2.715e-02
VDR,12679,lithocholic acid binding,GO:1902121,molecular function,95.0,3.0,1.265e-01,5.988e-02,2.674e-01,6.649e-02,1.936e-02,2.283e-01,7.368e-01,3.474e-02
VDR,12679,nuclear receptor transcription coactivator activity,GO:0030374,molecular function,95.0,3.0,1.309e-01,5.956e-02,2.876e-01,8.473e-02,2.655e-02,2.704e-01,7.055e-01,3.570e-02
VDR,12679,retinoid X receptor binding,GO:0046965,molecular function,95.0,3.0,1.363e-01,5.779e-02,3.217e-01,8.913e-02,2.898e-02,2.741e-01,6.985e-01,3.848e-02
VDR,12679,vitamin D binding,GO:0005499,molecular function,95.0,4.0,1.366e-01,6.612e-02,2.821e-01,8.350e-02,2.726e-02,2.558e-01,7.078e-01,3.394e-02
VDR,12679,DNA binding,GO:0003677,molecular function,95.0,27.0,1.390e-01,7.863e-02,2.457e-01,9.882e-02,6.534e-02,1.495e-01,6.890e-01,1.429e-02
VDR,12679,calcitriol binding,GO:1902098,molecular function,95.0,4.0,1.441e-01,6.715e-02,3.091e-01,8.602e-02,2.258e-02,3.277e-01,7.019e-01,4.101e-02
VDR,12679,transcription regulatory region sequence-specific DNA binding,GO:0000976,molecular function,95.0,8.0,1.487e-01,7.116e-02,3.108e-01,1.084e-01,4.626e-02,2.538e-01,6.736e-01,3.004e-02
VDR,12679,lithocholic acid receptor activity,GO:0038186,molecular function,95.0,2.0,1.541e-01,4.622e-02,5.141e-01,1.129e-01,2.399e-02,5.310e-01,6.598e-01,5.528e-02
VDR,12679,signaling receptor activity,GO:0038023,molecular function,95.0,25.0,3.138e-01,3.246e-02,3.034e+00,2.587e-01,1.644e-02,4.070e+00,4.305e-01,1.668e-01
VIM,12692,cellular response to lipopolysaccharide,GO:0071222,biological process,50.0,7.0,4.942e-02,3.326e-02,7.344e-02,1.973e-02,5.086e-03,7.656e-02,8.663e-01,3.081e-02
VIM,12692,cellular response to muramyl dipeptide,GO:0071225,biological process,50.0,4.0,5.131e-02,3.041e-02,8.655e-02,3.234e-02,1.174e-02,8.910e-02,8.197e-01,2.591e-02
VIM,12692,positive regulation of collagen biosynthetic process,GO:0032967,biological process,50.0,4.0,5.705e-02,2.682e-02,1.214e-01,3.541e-02,7.732e-03,1.622e-01,8.084e-01,3.749e-02
VIM,12692,positive regulation of translation,GO:0045727,biological process,50.0,17.0,6.899e-02,3.117e-02,1.527e-01,5.564e-02,1.712e-02,1.808e-01,7.587e-01,3.171e-02
VIM,12692,regulation of mRNA stability,GO:0043488,biological process,50.0,10.0,7.020e-02,4.951e-02,9.953e-02,6.069e-02,4.887e-02,7.537e-02,7.521e-01,6.012e-03
VIM,12692,polysome,GO:0005844,cellular component,50.0,2.0,4.222e-02,3.672e-02,4.854e-02,1.144e-02,8.776e-03,1.491e-02,9.147e-01,4.045e-03
VIM,12692,extracellular exosome,GO:0070062,cellular component,50.0,77.0,4.222e-02,3.672e-02,4.854e-02,1.133e-02,4.409e-03,2.909e-02,9.118e-01,1.361e-02
VIM,12692,cytosol,GO:0005829,cellular component,50.0,76.0,4.222e-02,3.672e-02,4.854e-02,1.249e-02,7.613e-03,2.049e-02,9.082e-01,7.581e-03
VIM,12692,cytoplasm,GO:0005737,cellular component,50.0,78.0,4.222e-02,3.672e-02,4.854e-02,1.317e-02,7.528e-03,2.304e-02,9.040e-01,9.472e-03
VIM,12692,focal adhesion,GO:0005925,cellular component,50.0,6.0,4.222e-02,3.672e-02,4.854e-02,1.307e-02,3.994e-03,4.280e-02,8.993e-01,1.930e-02
VIM,12692,cytoskeleton,GO:0005856,cellular component,50.0,12.0,5.229e-02,2.318e-02,1.179e-01,2.723e-02,6.927e-03,1.070e-01,8.364e-01,3.439e-02
VIM,12692,peroxisome,GO:0005777,cellular component,50.0,16.0,5.356e-02,3.799e-02,7.551e-02,3.132e-02,2.205e-02,4.449e-02,8.241e-01,8.600e-03
VIM,12692,intermediate filament cytoskeleton,GO:0045111,cellular component,50.0,5.0,6.236e-02,3.266e-02,1.191e-01,4.138e-02,1.633e-02,1.048e-01,7.938e-01,2.369e-02
VIM,12692,ribonucleoprotein complex,GO:1990904,cellular component,50.0,27.0,6.339e-02,5.354e-02,7.507e-02,4.988e-02,2.724e-02,9.132e-02,7.740e-01,1.599e-02
VIM,12692,intermediate filament,GO:0005882,cellular component,50.0,7.0,7.843e-02,3.122e-02,1.970e-01,6.373e-02,1.941e-02,2.093e-01,7.416e-01,3.687e-02
VIM,12692,identical protein binding,GO:0042802,molecular function,50.0,35.0,4.222e-02,3.672e-02,4.854e-02,7.890e-03,4.326e-03,1.439e-02,9.340e-01,6.676e-03
VIM,12692,protein binding,GO:0005515,molecular function,50.0,347.0,4.222e-02,3.672e-02,4.854e-02,1.038e-02,4.919e-03,2.190e-02,9.186e-01,1.044e-02
VIM,12692,scaffold protein binding,GO:0097110,molecular function,50.0,2.0,4.405e-02,4.354e-02,4.458e-02,2.316e-02,1.711e-02,3.137e-02,8.550e-01,7.477e-03
VIM,12692,double-stranded RNA binding,GO:0003725,molecular function,50.0,6.0,4.770e-02,4.189e-02,5.431e-02,2.529e-02,1.322e-02,4.837e-02,8.458e-01,1.572e-02
VIM,12692,keratin filament binding,GO:1990254,molecular function,50.0,2.0,6.627e-02,4.404e-02,9.973e-02,5.077e-02,2.890e-02,8.921e-02,7.720e-01,1.548e-02
VIM,12692,structural constituent of cytoskeleton,GO:0005200,molecular function,50.0,8.0,6.758e-02,2.132e-02,2.142e-01,4.673e-02,8.589e-03,2.542e-01,7.748e-01,4.831e-02
VIM,12692,protein domain specific binding,GO:0019904,molecular function,50.0,76.0,1.260e-01,7.888e-02,2.014e-01,1.260e-01,7.888e-02,2.014e-01,6.533e-01,1.733e-02
VSIG4,17032,,,,nan,nan,,,,,,,,
WFIKKN2,30916,,,,nan,nan,,,,,,,,
WIPI1,25471,autophagy,GO:0006914,biological process,28.0,10.0,2.822e-01,2.638e-02,3.018e+00,7.738e-02,1.288e-02,4.648e-01,7.117e-01,5.364e-02
WIPI1,25471,autophagy of nucleus,GO:0044804,biological process,28.0,4.0,2.849e-01,1.779e-02,4.562e+00,1.053e-01,2.201e-03,5.034e+00,6.058e-01,1.497e-01
WIPI1,25471,autophagy of mitochondrion,GO:0000422,biological process,28.0,6.0,2.849e-01,1.779e-02,4.562e+00,1.054e-01,1.895e-03,5.867e+00,5.861e-01,1.723e-01
WIPI1,25471,protein localization to phagophore assembly site,GO:0034497,biological process,28.0,2.0,3.313e-01,1.637e-02,6.706e+00,1.596e-01,1.361e-03,1.872e+01,4.795e-01,1.867e-01
WIPI1,25471,"vesicle targeting, trans-Golgi to endosome",GO:0048203,biological process,28.0,2.0,3.366e-01,1.616e-02,7.013e+00,1.964e-01,1.516e-03,2.545e+01,4.004e-01,2.117e-01
WIPI1,25471,autophagosome assembly,GO:0000045,biological process,28.0,4.0,3.561e-01,2.247e-02,5.643e+00,2.392e-01,4.857e-03,1.178e+01,4.162e-01,1.775e-01
WIPI1,25471,cellular response to starvation,GO:0009267,biological process,28.0,28.0,4.814e-01,1.123e-01,2.064e+00,4.238e-01,1.113e-01,1.614e+00,3.817e-01,8.524e-02
WIPI1,25471,protein lipidation,GO:0006497,biological process,28.0,11.0,5.028e-01,1.358e-01,1.861e+00,3.864e-01,1.609e-01,9.276e-01,4.258e-01,5.222e-02
WIPI1,25471,autophagosome membrane,GO:0000421,cellular component,28.0,3.0,2.966e-01,2.020e-02,4.355e+00,1.166e-01,3.298e-03,4.126e+00,6.003e-01,1.405e-01
WIPI1,25471,cytosol,GO:0005829,cellular component,28.0,76.0,3.126e-01,4.139e-02,2.362e+00,9.476e-02,4.064e-02,2.210e-01,6.926e-01,2.804e-02
WIPI1,25471,cytoplasm,GO:0005737,cellular component,28.0,78.0,3.146e-01,4.252e-02,2.327e+00,1.127e-01,5.140e-02,2.471e-01,6.683e-01,2.655e-02
WIPI1,25471,phagophore assembly site membrane,GO:0034045,cellular component,28.0,3.0,3.224e-01,2.410e-02,4.312e+00,1.734e-01,8.859e-03,3.394e+00,5.474e-01,1.229e-01
WIPI1,25471,trans-Golgi network,GO:0005802,cellular component,28.0,3.0,3.367e-01,2.336e-02,4.853e+00,1.852e-01,8.812e-03,3.891e+00,5.367e-01,1.189e-01
WIPI1,25471,endosome membrane,GO:0010008,cellular component,28.0,12.0,3.439e-01,3.864e-02,3.060e+00,1.455e-01,2.917e-02,7.258e-01,6.178e-01,6.426e-02
WIPI1,25471,extrinsic component of membrane,GO:0019898,cellular component,28.0,8.0,3.731e-01,4.899e-02,2.842e+00,2.000e-01,5.045e-02,7.925e-01,5.649e-01,6.173e-02
WIPI1,25471,phagophore assembly site,GO:0000407,cellular component,28.0,2.0,3.754e-01,3.767e-02,3.741e+00,2.308e-01,3.396e-02,1.568e+00,5.249e-01,8.285e-02
WIPI1,25471,"phosphatidylinositol-3,5-bisphosphate binding",GO:0080025,molecular function,28.0,2.0,3.133e-01,1.702e-02,5.768e+00,1.353e-01,1.313e-03,1.395e+01,5.384e-01,1.608e-01
WIPI1,25471,protein binding,GO:0005515,molecular function,28.0,347.0,3.310e-01,5.315e-02,2.061e+00,1.001e-01,7.283e-02,1.375e-01,6.876e-01,1.093e-02
WIPI1,25471,phosphatidylinositol-3-phosphate binding,GO:0032266,molecular function,28.0,2.0,3.367e-01,2.336e-02,4.853e+00,1.938e-01,1.053e-02,3.568e+00,5.311e-01,1.159e-01
WIPI1,25471,androgen receptor binding,GO:0050681,molecular function,28.0,3.0,3.539e-01,2.908e-02,4.308e+00,2.571e-01,1.299e-02,5.085e+00,4.545e-01,1.364e-01
WIPI1,25471,estrogen receptor binding,GO:0030331,molecular function,28.0,3.0,3.553e-01,2.959e-02,4.267e+00,2.623e-01,1.498e-02,4.595e+00,4.551e-01,1.319e-01
WIPI1,25471,signaling receptor binding,GO:0005102,molecular function,28.0,61.0,3.898e-01,5.553e-02,2.736e+00,2.446e-01,5.905e-02,1.013e+00,5.226e-01,6.836e-02
WNT11,12776,negative regulation of cell death,GO:0060548,biological process,35.0,8.0,4.860e-01,1.843e-01,1.282e+00,6.991e-02,1.167e-02,4.190e-01,7.254e-01,5.170e-02
WNT11,12776,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,35.0,35.0,4.860e-01,1.843e-01,1.282e+00,1.022e-01,1.825e-02,5.729e-01,6.732e-01,5.545e-02
WNT11,12776,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,35.0,31.0,4.860e-01,1.843e-01,1.282e+00,1.802e-01,4.357e-02,7.454e-01,5.823e-01,6.460e-02
WNT11,12776,negative regulation of cell growth,GO:0030308,biological process,35.0,19.0,4.860e-01,1.843e-01,1.282e+00,1.711e-01,2.007e-02,1.459e+00,5.669e-01,1.084e-01
WNT11,12776,neuron differentiation,GO:0030182,biological process,35.0,20.0,4.860e-01,1.843e-01,1.282e+00,1.873e-01,3.218e-02,1.089e+00,5.642e-01,8.734e-02
WNT11,12776,positive regulation of gene expression,GO:0010628,biological process,35.0,23.0,4.905e-01,1.883e-01,1.277e+00,1.540e-01,8.316e-02,2.851e-01,6.210e-01,2.366e-02
WNT11,12776,positive regulation of stress fiber assembly,GO:0051496,biological process,35.0,4.0,4.905e-01,1.883e-01,1.277e+00,2.279e-01,1.048e-01,4.954e-01,5.490e-01,3.809e-02
WNT11,12776,negative regulation of apoptotic process,GO:0043066,biological process,35.0,29.0,4.970e-01,1.965e-01,1.257e+00,1.707e-01,2.124e-02,1.372e+00,5.785e-01,8.743e-02
WNT11,12776,adrenal gland development,GO:0030325,biological process,35.0,2.0,4.980e-01,1.949e-01,1.272e+00,2.404e-01,3.425e-02,1.688e+00,5.109e-01,9.377e-02
WNT11,12776,cloacal septation,GO:0060197,biological process,35.0,2.0,4.980e-01,1.949e-01,1.272e+00,3.027e-01,7.655e-02,1.197e+00,4.716e-01,7.996e-02
WNT11,12776,negative regulation of canonical Wnt signaling pathway,GO:0090090,biological process,35.0,11.0,5.061e-01,2.063e-01,1.242e+00,2.008e-01,1.645e-02,2.451e+00,5.351e-01,1.059e-01
WNT11,12776,positive regulation of protein kinase C signaling,GO:0090037,biological process,35.0,3.0,5.061e-01,2.063e-01,1.242e+00,2.407e-01,3.531e-02,1.641e+00,5.119e-01,9.189e-02
WNT11,12776,protein phosphorylation,GO:0006468,biological process,35.0,30.0,5.107e-01,2.115e-01,1.233e+00,2.696e-01,1.205e-01,6.034e-01,5.144e-01,4.017e-02
WNT11,12776,embryonic skeletal system development,GO:0048706,biological process,35.0,3.0,5.158e-01,2.065e-01,1.288e+00,3.599e-01,1.128e-01,1.148e+00,4.336e-01,7.556e-02
WNT11,12776,positive regulation of cell migration,GO:0030335,biological process,35.0,33.0,5.226e-01,2.230e-01,1.225e+00,2.631e-01,8.671e-02,7.983e-01,5.148e-01,5.272e-02
WNT11,12776,negative regulation of cell migration,GO:0030336,biological process,35.0,31.0,5.226e-01,2.230e-01,1.225e+00,2.930e-01,5.284e-02,1.625e+00,4.738e-01,8.522e-02
WNT11,12776,neuroendocrine cell differentiation,GO:0061101,biological process,35.0,8.0,5.267e-01,1.996e-01,1.390e+00,3.950e-01,1.242e-01,1.256e+00,4.015e-01,8.962e-02
WNT11,12776,protein localization to cell surface,GO:0034394,biological process,35.0,2.0,5.278e-01,1.986e-01,1.403e+00,4.161e-01,1.147e-01,1.510e+00,3.728e-01,1.093e-01
WNT11,12776,mesonephric duct development,GO:0072177,biological process,35.0,3.0,5.377e-01,1.995e-01,1.450e+00,3.886e-01,8.040e-02,1.878e+00,3.815e-01,1.195e-01
WNT11,12776,positive regulation of GTPase activity,GO:0043547,biological process,35.0,6.0,5.521e-01,2.525e-01,1.207e+00,3.956e-01,2.342e-01,6.683e-01,4.267e-01,3.267e-02
WNT11,12776,Wnt signaling pathway,GO:0016055,biological process,35.0,20.0,5.793e-01,2.353e-01,1.426e+00,3.414e-01,9.088e-02,1.282e+00,4.433e-01,7.982e-02
WNT11,12776,lung-associated mesenchyme development,GO:0060484,biological process,35.0,3.0,6.017e-01,2.571e-01,1.408e+00,5.317e-01,2.019e-01,1.400e+00,3.075e-01,9.263e-02
WNT11,12776,ureteric bud morphogenesis,GO:0060675,biological process,35.0,2.0,6.156e-01,2.646e-01,1.433e+00,5.456e-01,2.384e-01,1.249e+00,3.138e-01,6.910e-02
WNT11,12776,secondary palate development,GO:0062009,biological process,35.0,2.0,6.294e-01,2.854e-01,1.388e+00,5.988e-01,2.466e-01,1.454e+00,2.567e-01,9.868e-02
WNT11,12776,cell fate commitment,GO:0045165,biological process,35.0,38.0,6.900e-01,4.023e-01,1.184e+00,6.780e-01,4.003e-01,1.148e+00,2.255e-01,7.033e-02
WNT11,12776,extracellular space,GO:0005615,cellular component,35.0,43.0,4.860e-01,1.843e-01,1.282e+00,1.155e-01,3.108e-02,4.290e-01,6.591e-01,4.993e-02
WNT11,12776,cytoplasm,GO:0005737,cellular component,35.0,78.0,5.123e-01,2.133e-01,1.230e+00,3.226e-01,1.482e-01,7.023e-01,4.733e-01,4.565e-02
WNT11,12776,transcription regulatory region DNA binding,GO:0044212,molecular function,35.0,18.0,4.860e-01,1.843e-01,1.282e+00,2.085e-01,5.035e-02,8.635e-01,5.526e-01,7.205e-02
WNT11,12776,frizzled binding,GO:0005109,molecular function,35.0,3.0,4.920e-01,1.897e-01,1.276e+00,2.598e-01,6.472e-02,1.043e+00,5.080e-01,7.385e-02
WNT11,12776,GTPase activator activity,GO:0005096,molecular function,35.0,4.0,4.980e-01,1.949e-01,1.272e+00,2.942e-01,8.673e-02,9.980e-01,4.851e-01,6.636e-02
WNT11,12776,protein binding,GO:0005515,molecular function,35.0,347.0,5.107e-01,2.115e-01,1.233e+00,3.006e-01,1.430e-01,6.316e-01,4.908e-01,4.083e-02
WNT11,12776,protein kinase activator activity,GO:0030295,molecular function,35.0,6.0,5.189e-01,2.023e-01,1.331e+00,3.225e-01,6.575e-02,1.582e+00,4.474e-01,9.430e-02
WNT2B,12781,chondrocyte differentiation,GO:0002062,biological process,14.0,3.0,4.121e-01,1.048e-01,1.620e+00,1.553e-01,4.111e-02,5.864e-01,6.110e-01,5.632e-02
WNT2B,12781,neuron differentiation,GO:0030182,biological process,14.0,20.0,4.449e-01,1.341e-01,1.476e+00,2.463e-01,6.004e-02,1.010e+00,5.167e-01,7.953e-02
WNT2B,12781,male gonad development,GO:0008584,biological process,14.0,2.0,4.527e-01,1.138e-01,1.800e+00,2.079e-01,2.289e-02,1.888e+00,5.335e-01,1.021e-01
WNT2B,12781,canonical Wnt signaling pathway,GO:0060070,biological process,14.0,21.0,4.666e-01,1.153e-01,1.889e+00,1.904e-01,1.134e-02,3.197e+00,5.352e-01,1.172e-01
WNT2B,12781,Wnt signaling pathway,GO:0016055,biological process,14.0,20.0,5.610e-01,1.491e-01,2.111e+00,3.399e-01,8.114e-02,1.424e+00,4.357e-01,9.498e-02
WNT2B,12781,forebrain regionalization,GO:0021871,biological process,14.0,2.0,6.929e-01,3.082e-01,1.557e+00,6.400e-01,2.404e-01,1.704e+00,2.321e-01,9.169e-02
WNT2B,12781,hematopoietic stem cell proliferation,GO:0071425,biological process,14.0,2.0,7.646e-01,4.991e-01,1.171e+00,6.485e-01,4.607e-01,9.130e-01,2.626e-01,3.750e-02
WNT2B,12781,cell fate commitment,GO:0045165,biological process,14.0,38.0,7.646e-01,4.991e-01,1.171e+00,7.287e-01,4.750e-01,1.118e+00,1.952e-01,6.200e-02
WNT2B,12781,extracellular space,GO:0005615,cellular component,14.0,43.0,4.121e-01,1.048e-01,1.620e+00,1.125e-01,2.982e-02,4.242e-01,6.627e-01,5.035e-02
WNT2B,12781,collagen-containing extracellular matrix,GO:0062023,cellular component,14.0,36.0,4.121e-01,1.048e-01,1.620e+00,1.159e-01,2.730e-02,4.921e-01,6.568e-01,5.464e-02
WNT2B,12781,intracellular membrane-bounded organelle,GO:0043231,cellular component,14.0,48.0,4.494e-01,1.435e-01,1.407e+00,2.111e-01,7.664e-02,5.816e-01,5.607e-01,4.631e-02
WNT2B,12781,frizzled binding,GO:0005109,molecular function,14.0,3.0,5.369e-01,1.504e-01,1.917e+00,3.397e-01,6.426e-02,1.796e+00,4.341e-01,9.269e-02
XDH,12805,activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,biological process,36.0,3.0,6.351e-02,2.719e-02,1.483e-01,1.507e-02,4.148e-03,5.479e-02,8.868e-01,2.184e-02
XDH,12805,negative regulation of endothelial cell proliferation,GO:0001937,biological process,36.0,6.0,6.883e-02,3.395e-02,1.395e-01,1.869e-02,8.784e-03,3.975e-02,8.736e-01,1.570e-02
XDH,12805,negative regulation of vascular endothelial growth factor signaling pathway,GO:1900747,biological process,36.0,4.0,7.057e-02,3.682e-02,1.352e-01,2.729e-02,1.533e-02,4.858e-02,8.384e-01,1.427e-02
XDH,12805,negative regulation of protein phosphorylation,GO:0001933,biological process,36.0,19.0,8.077e-02,4.048e-02,1.612e-01,4.132e-02,1.092e-02,1.564e-01,7.928e-01,3.385e-02
XDH,12805,negative regulation of endothelial cell differentiation,GO:0045602,biological process,36.0,5.0,8.093e-02,3.275e-02,2.000e-01,4.245e-02,4.877e-03,3.695e-01,7.819e-01,5.793e-02
XDH,12805,negative regulation of protein kinase B signaling,GO:0051898,biological process,36.0,3.0,8.564e-02,5.126e-02,1.431e-01,5.054e-02,2.641e-02,9.673e-02,7.723e-01,1.727e-02
XDH,12805,positive regulation of p38MAPK cascade,GO:1900745,biological process,36.0,4.0,8.806e-02,4.773e-02,1.625e-01,4.245e-02,1.427e-02,1.263e-01,7.899e-01,2.913e-02
XDH,12805,negative regulation of vasculogenesis,GO:2001213,biological process,36.0,4.0,9.742e-02,2.396e-02,3.962e-01,5.697e-02,3.154e-03,1.029e+00,7.357e-01,8.177e-02
XDH,12805,xanthine catabolic process,GO:0009115,biological process,36.0,4.0,9.991e-02,3.966e-02,2.517e-01,5.706e-02,1.018e-02,3.197e-01,7.504e-01,5.149e-02
XDH,12805,negative regulation of gene expression,GO:0010629,biological process,36.0,19.0,1.150e-01,1.072e-01,1.233e-01,9.531e-02,6.790e-02,1.338e-01,6.942e-01,1.133e-02
XDH,12805,positive regulation of reactive oxygen species metabolic process,GO:2000379,biological process,36.0,10.0,1.289e-01,4.806e-02,3.456e-01,1.121e-01,3.387e-02,3.713e-01,6.650e-01,4.477e-02
XDH,12805,extracellular space,GO:0005615,cellular component,36.0,43.0,9.991e-02,3.966e-02,2.517e-01,4.466e-02,5.555e-03,3.591e-01,7.757e-01,6.109e-02
XDH,12805,cytosol,GO:0005829,cellular component,36.0,76.0,1.174e-01,6.402e-02,2.153e-01,1.003e-01,4.980e-02,2.020e-01,6.854e-01,2.343e-02
XDH,12805,xanthine dehydrogenase activity,GO:0004854,molecular function,36.0,2.0,6.194e-02,2.582e-02,1.486e-01,7.241e-03,2.345e-03,2.236e-02,9.348e-01,1.370e-02
XDH,12805,xanthine oxidase activity,GO:0004855,molecular function,36.0,2.0,6.194e-02,2.582e-02,1.486e-01,7.759e-03,2.442e-03,2.465e-02,9.311e-01,1.492e-02
XDH,12805,"2 iron, 2 sulfur cluster binding",GO:0051537,molecular function,36.0,3.0,8.153e-02,5.269e-02,1.261e-01,4.136e-02,2.837e-02,6.028e-02,7.952e-01,9.566e-03
XDH,12805,flavin adenine dinucleotide binding,GO:0050660,molecular function,36.0,6.0,8.998e-02,6.225e-02,1.301e-01,5.415e-02,2.903e-02,1.010e-01,7.644e-01,1.777e-02
XDH,12805,molybdopterin cofactor binding,GO:0043546,molecular function,36.0,4.0,9.247e-02,6.706e-02,1.275e-01,6.873e-02,4.139e-02,1.141e-01,7.362e-01,1.489e-02
XDH,12805,protein homodimerization activity,GO:0042803,molecular function,36.0,21.0,1.115e-01,9.721e-02,1.279e-01,9.533e-02,6.945e-02,1.308e-01,6.943e-01,1.034e-02
ZBTB16,12930,positive regulation of ossification,GO:0045778,biological process,32.0,5.0,5.837e-02,3.535e-02,9.637e-02,1.821e-02,5.353e-03,6.195e-02,8.732e-01,2.595e-02
ZBTB16,12930,hemopoiesis,GO:0030097,biological process,32.0,6.0,6.066e-02,3.475e-02,1.059e-01,2.828e-02,9.113e-03,8.777e-02,8.333e-01,2.848e-02
ZBTB16,12930,negative regulation of transcription by RNA polymerase II,GO:0000122,biological process,32.0,43.0,6.113e-02,3.299e-02,1.133e-01,3.318e-02,1.972e-02,5.581e-02,8.181e-01,1.293e-02
ZBTB16,12930,positive regulation of transcription by RNA polymerase II,GO:0045944,biological process,32.0,62.0,6.131e-02,3.283e-02,1.145e-01,2.925e-02,1.114e-02,7.679e-02,8.305e-01,2.433e-02
ZBTB16,12930,positive regulation of cartilage development,GO:0061036,biological process,32.0,7.0,6.379e-02,3.290e-02,1.237e-01,2.743e-02,5.726e-03,1.314e-01,8.342e-01,3.918e-02
ZBTB16,12930,positive regulation of chondrocyte differentiation,GO:0032332,biological process,32.0,5.0,6.598e-02,3.802e-02,1.145e-01,3.382e-02,7.643e-03,1.496e-01,8.131e-01,3.782e-02
ZBTB16,12930,"positive regulation of transcription, DNA-templated",GO:0045893,biological process,32.0,35.0,6.830e-02,2.658e-02,1.755e-01,2.812e-02,3.063e-03,2.581e-01,8.251e-01,5.665e-02
ZBTB16,12930,positive regulation of fat cell differentiation,GO:0045600,biological process,32.0,4.0,6.904e-02,4.108e-02,1.160e-01,4.481e-02,1.914e-02,1.049e-01,7.848e-01,2.309e-02
ZBTB16,12930,cartilage development,GO:0051216,biological process,32.0,6.0,7.281e-02,2.816e-02,1.883e-01,4.444e-02,9.548e-03,2.068e-01,7.814e-01,4.371e-02
ZBTB16,12930,"negative regulation of transcription, DNA-templated",GO:0045892,biological process,32.0,31.0,8.123e-02,2.536e-02,2.601e-01,6.472e-02,1.502e-02,2.788e-01,7.370e-01,4.622e-02
ZBTB16,12930,nuclear speck,GO:0016607,cellular component,32.0,5.0,2.713e-02,2.722e-03,2.705e-01,2.435e-03,1.620e-04,3.658e-02,9.618e-01,1.318e-02
ZBTB16,12930,PML body,GO:0016605,cellular component,32.0,3.0,2.713e-02,2.722e-03,2.705e-01,3.083e-03,1.806e-04,5.260e-02,9.549e-01,1.383e-02
ZBTB16,12930,transcriptional repressor complex,GO:0017053,cellular component,32.0,6.0,6.195e-02,3.224e-02,1.190e-01,2.757e-02,7.333e-03,1.037e-01,8.356e-01,3.360e-02
ZBTB16,12930,nucleus,GO:0005634,cellular component,32.0,81.0,6.873e-02,4.829e-02,9.782e-02,5.056e-02,4.217e-02,6.062e-02,7.733e-01,5.003e-03
ZBTB16,12930,nuclear body,GO:0016604,cellular component,32.0,17.0,7.061e-02,3.122e-02,1.597e-01,5.376e-02,1.489e-02,1.942e-01,7.623e-01,3.424e-02
ZBTB16,12930,protein-containing complex,GO:0032991,cellular component,32.0,483.0,2.329e-01,1.365e-01,3.974e-01,2.329e-01,1.365e-01,3.974e-01,5.476e-01,2.517e-02
ZBTB16,12930,"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,molecular function,32.0,5.0,5.999e-02,3.402e-02,1.058e-01,1.684e-02,7.939e-03,3.573e-02,8.835e-01,1.662e-02
ZBTB16,12930,sequence-specific DNA binding,GO:0043565,molecular function,32.0,10.0,5.999e-02,3.402e-02,1.058e-01,2.324e-02,9.682e-03,5.577e-02,8.532e-01,2.037e-02
ZBTB16,12930,RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,molecular function,32.0,16.0,6.095e-02,3.316e-02,1.120e-01,2.685e-02,7.792e-03,9.253e-02,8.374e-01,2.838e-02
ZBTB16,12930,DNA-binding transcription factor activity,GO:0003700,molecular function,32.0,12.0,6.113e-02,3.299e-02,1.133e-01,2.774e-02,1.110e-02,6.934e-02,8.362e-01,2.290e-02
ZBTB16,12930,DNA binding,GO:0003677,molecular function,32.0,27.0,6.436e-02,3.214e-02,1.289e-01,4.276e-02,1.699e-02,1.076e-01,7.898e-01,2.490e-02
ZBTB16,12930,protein homodimerization activity,GO:0042803,molecular function,32.0,21.0,6.773e-02,4.899e-02,9.364e-02,4.545e-02,3.255e-02,6.346e-02,7.849e-01,8.953e-03
ZBTB16,12930,identical protein binding,GO:0042802,molecular function,32.0,35.0,7.030e-02,4.428e-02,1.116e-01,4.684e-02,1.928e-02,1.138e-01,7.800e-01,2.342e-02
ZBTB16,12930,protein binding,GO:0005515,molecular function,32.0,347.0,7.991e-02,4.308e-02,1.482e-01,6.469e-02,2.429e-02,1.723e-01,7.416e-01,2.863e-02
ZCCHC17,30246,RNA binding,GO:0003723,molecular function,5.0,60.0,5.306e-02,2.977e-02,9.459e-02,3.826e-02,1.087e-02,1.346e-01,8.011e-01,3.262e-02
ZCCHC17,30246,protein binding,GO:0005515,molecular function,5.0,347.0,6.965e-02,4.106e-02,1.181e-01,5.626e-02,2.387e-02,1.326e-01,7.588e-01,2.438e-02
ZFAND2A,28073,,,,nan,nan,,,,,,,,
